# Health Tourism News - Full Text Corpus > Full text of the curated, expert-led content of Health Tourism News (the guides, all news and briefs, weekly digests, and live destination pages) for AI search and answer engines. > Provided for reading and citation with attribution. See https://health-tourism-news.com/llms.txt for structure. > Pages: 78 --- # What is Health Tourism? A Complete Industry Guide URL: https://health-tourism-news.com/health-tourism/ Pillar Guide Updated June 2026 What is Health Tourism? A Complete Industry Guide Health tourism is a term almost everyone in the industry uses and remarkably few can define with any precision. It runs from open-heart surgery in a foreign hospital to a fortnight of yoga by the sea, and the field has never settled where one kind of travel ends and the next begins. This guide sets out what health tourism actually is, how its sub-sectors differ, where the real risks lie, and how the market works, built around a way of structuring the field you can apply to a single case rather than another glossary of terms. By Christian El-Khouri, Editor-in-Chief, Health Tourism News Last updated: September 2026 Last verified: 1 September 2026 6Major sub-sectors $34B–$278BMedical tourism market, 2025 estimates 8–23%Projected annual growth (range across forecasts) Contents ## What Health Tourism Actually Is Health tourism describes travel undertaken, in whole or in part, to access healthcare or to improve one's state of health outside the place a person usually lives. That much is uncontroversial. The difficulty begins the moment you try to draw the lines inside it. The field does not suffer from a shortage of definitions. It suffers from the absence of an authority that stakeholders are willing to recognise. Academic journals, health ministries, tourism boards, trade associations and consultancies have each produced their own version, and none carries enough weight to settle the matter, because no single body holds the standing to set the terms for everyone else. What follows is predictable. Health tourism, medical tourism and wellness tourism get used interchangeably, often by people who ought to know the difference, and a conversation that should start from agreed ground instead starts from confusion. A debate is only ever as good as the agreement on what is being debated. This one rarely has it. So I will take a position, because a guide that refuses to is of no use to anyone. The most useful way to understand health tourism is not as a box with firm walls but as a spectrum. At one end sits medical tourism: travel to put right a negative state of health, with heavy involvement from healthcare professionals, in a clinical setting, frequently invasive, and undertaken out of necessity. At the other sits wellness tourism: travel to improve a state of health that is already neutral or good, with little clinical involvement, in a setting closer to a hotel than a hospital, non-invasive, and chosen rather than required. Everything else in health tourism sits somewhere on the line between those two poles. A handful of practical markers help you place any given case. How far a qualified healthcare professional is involved. Whether the aim is to remedy something wrong or to enhance something already fine. The setting, since a hospital points one way and a spa the other. The degree of risk the procedure carries. And whether the journey is a true necessity or a discretionary choice. None of these decides the matter alone, and the borders are deliberately soft. Cosmetic tourism in particular refuses to sit cleanly on either side. Taken together, though, they let you sort procedures by what they genuinely involve rather than by how a brochure has dressed them up. One thing the brochures tend to leave out is worth stating plainly. At its medical end, this whole field is a symptom. People do not cross borders for serious treatment because the experience is agreeable. They do it because the care they need is unaffordable at home, or unavailable, or too slow in coming, or not permitted where they live. Medical tourism is the visible sign of healthcare distributed unequally across the world, and that fact should sit behind how any professional reads the rest of this guide. The industry is real, it pays a great many of our salaries, and in a fairer world a good deal of it would have no reason to exist. That tension is not a reason to look away from the work. It is the reason to do it well. ## Why People Travel for Health Tourism People do not travel for healthcare for a single reason, and the reason matters more than it first appears, because it determines almost everything else: where a patient goes, what they will pay, how much risk they will accept, and whether they should be travelling at all. Strip away the marketing and there are five honest reasons a person crosses a border for medical care. The first is better treatment. The care available at home is adequate, but the patient believes they can do better elsewhere, in outcomes, in technology, or in the standing of the treating team. The second is the best treatment. A narrower group, often with serious or rare conditions, chasing a particular centre or specialist regarded as among the finest in the world for their specific problem. Price is rarely the object here. The third is lower prices. The same or a comparable procedure costs a fraction abroad. Patients in even the better-funded systems still meet large out-of-pocket bills, and the arithmetic of flying somewhere cheaper, after travel and recovery are counted, is often stark. Savings of roughly half to two-thirds against Western European and North American pricing are common across the busiest corridors. The fourth is faster care. Where a public system runs long queues, as the National Health Service does in the United Kingdom and as several European systems do for elective work, waiting becomes its own affliction. A patient in pain, or whose condition worsens as they wait, will pay to be seen now rather than in eighteen months. The fifth is treatment that is not permitted at home. This is the quietest of the five and often the most consequential. Reproductive options, certain procedures, experimental therapies and, in some jurisdictions, assisted dying, are restricted in one country and lawful in another. The patient is not chasing a bargain or a shorter queue. They are seeking something their own law denies them. Most real journeys combine two or three of these, weighted by where the patient starts. A German patient and a Nigerian patient may fly to the same hospital for entirely different reasons. The use of the five is not to label patients but to test propositions, and this is where much of the industry falls down. If a destination, a hospital or a facilitator cannot say plainly which of these it answers, and answer it better than the patient's option at home, it has no honest business courting that patient at all. A great many do anyway. ## The Health Tourism Spectrum The spectrum is worth drawing out, because it is the part of this guide you can actually use. Picture a single line. Medical tourism sits at one end and wellness tourism at the other, and every form of health travel falls somewhere between them according to a few traits rather than a fixed label. Six sub-sectors on one line Wellness end to medical end Wellness end Medical end Wellness Choice Longevity Choice Cosmetic Mostly choice Fertility Strong personal need Dental Mixed Medical Necessity Clinical involvement, invasiveness, risk and necessity all rise Order and attributes follow the spectrum table on this page. Cosmetic tourism carries surgical risk on mostly elective grounds, so it sits on the line rather than in a camp. Form HCP involvement Direction of change Typical setting Risk Necessity or choice Medical tourism High Negative to neutral Hospital High Necessity Dental tourism Moderate Negative to neutral Dental clinic Moderate Mixed Fertility tourism Moderate to high Adds a capability Fertility clinic Moderate Strong personal need Cosmetic tourism Moderate Alters the healthy Private clinic Moderate to high Mostly choice Longevity tourism Low to moderate Optimises the healthy Specialist clinic Low to moderate Choice Wellness tourism Low Maintains the good Resort or spa Low Choice Reading the table down rather than across is the point. Clinical involvement, the direction of the health change, the setting, the level of risk and the question of necessity tend to move together. As you travel from the wellness end toward the medical end, a qualified professional becomes more central, the work shifts from improving a good state of health to repairing a poor one, the setting moves from resort to hospital, the procedures grow more invasive, and the journey turns from a choice into a necessity. Nothing sits at a single fixed point. Cosmetic tourism is the obvious troublemaker, carrying genuine surgical risk while being driven, in most cases, by preference rather than medical need, which is why it will not settle on either side and why I treat it as its own case on the line rather than forcing it into a camp. This is not an academic exercise. It changes how you judge quality, risk and regulation in any given case. A wellness retreat and a cardiac unit are not failing or succeeding by the same measures, and treating them as one undifferentiated thing, which the loose use of "health tourism" invites, is how patients end up holding one to the standards of the other. ## The Six Sub-Sectors of Health Tourism Health tourism resolves into six sub-sectors large or distinct enough to warrant their own coverage. Each has its own patient, its own destinations and its own commercial logic, and HTN keeps a dedicated guide to every one. Medical tourism Travel for surgery, diagnostics, oncology, cardiac and orthopaedic care, and rehabilitation. The largest and most serious sub-sector, and the one where both the stakes and the risks in this guide run highest. Read the full guide Wellness tourism Travel to maintain or improve a state of health that is already sound, through fitness, nutrition, mindfulness and rest. By revenue it dwarfs every other sub-sector, while generating a fraction of the value per visitor that medical care does. Read the full guide Dental tourism Travel for implants, full-mouth work and restorative dentistry, driven almost entirely by price, since the same treatment costs a fraction of Western European and North American rates. Read the full guide Fertility tourism Cross-border reproductive care, from IVF to donor programmes. Among the most sensitive of the six, because it is shaped as much by what a patient's home law forbids as by cost. Read the full guide Cosmetic tourism Elective aesthetic procedures abroad. The sub-sector that moves with fashion rather than medicine, where what people travel for changes from one year to the next, and where the gap between marketing and reality tends to be widest. Read the full guide Longevity tourism The newest of the six, built around diagnostics, biological-age testing and preventive medicine for people who are not ill and want to stay that way. Read the full guide Two further terms are worth placing, since readers ask where they belong. Longevity, above, increasingly overlaps with conventional medicine as the work moves from lifestyle advice into genuine diagnostics, and I expect it to pull a particular kind of patient across borders in the coming years: people in well-served systems whose own doctors are not permitted, or not willing, to run the tests they are ready to pay for. Pharmaceutical tourism, travel to obtain medicines unavailable or unaffordable at home, is a real and growing behaviour, though it sits awkwardly as a sub-sector because it often involves no procedure and no clinic at all. Both belong on the spectrum. Neither yet needs its own pillar. ## The Global Health Tourism Market Any honest account of the health tourism market has to open with a warning about its own numbers. The figures here are soft, and the gap between published estimates is wide enough to make a single headline number close to meaningless. One market, nine estimates Medical tourism, as published by each firm Grand View $34.0B Fortune BI $38.2B Research Nester $43.8B Towards Healthcare $48.5B Global Market Insights $76.1B Mordor $93.7B Technavio, 2023 $102.2B Future Market Insights, 2024 $107.5B Fact.MR $278.3B 0$100B$200B$300B Every figure is from the table below, as each research firm publishes it. Most are stated for 2025; the two that are not carry their base year. The dearest estimate is eight times the cheapest, which is the point: there is no single number here to quote. Download this chart PNG, free to republish with attribution The clearest way to see that is to set the published estimates side by side. The table below collects what the main research firms say the medical tourism sub-sector is worth. Most are stated for 2025; two use earlier base years, flagged in the table. Source Market size Base year CAGR Forecast Grand View Research $34.0B 2025 14.1% $126.2B by 2035 Fortune Business Insights $38.2B 2025 23.3% $250.0B by 2034 Research Nester $43.8B 2025 21.9% $316.7B by 2035 Towards Healthcare $48.5B 2025 16.1% $216.3B by 2035 Global Market Insights $76.1B 2025 8.4% $174.1B by 2035 Mordor Intelligence $93.7B 2025 18.4% $258.3B by 2031 Technavio $102.2B 2023 not stated +$132.8B by 2029 Future Market Insights $312.5B 2026 12.3% $1,000.2B by 2036 Fact.MR $278.3B 2025 12.3% $1,000.2B by 2036 Every figure is the firm's own published headline estimate, read from its own page on 1 September 2026 and linked in the Sources block below. All are estimates rather than measurements: nobody counts this industry, they model it. Base years differ, and the column says which. Technavio states no single forward rate. Two entries have moved since we first tabulated them, which is itself instructive: Towards Healthcare now projects $216.3 billion by 2035 where it previously carried $186.3 billion by 2034, and Future Market Insights has rebased from a 2024-to-2035 window onto 2026-to-2036. We have followed both to their current published figures. One detail is worth pausing on. Fact.MR and Future Market Insights now both put the market at $1,000.2 billion in 2036, growing at 12.3 per cent. Two firms selling separate reports arriving at the same figure to the decimal, for the same year, at the same rate, is not two independent measurements agreeing. It is a reminder that these numbers circulate. The numbers describe the same industry, yet the highest is roughly eight times the lowest, and the growth rates contradict each other as sharply as the totals do. This is not a rounding problem. Methodologies differ, the definition of what counts as medical tourism differs, base years differ, and a good many of these figures are forecasts presented with more confidence than forecasting deserves. The sensible response is not to choose a number but to notice the range. When a market is quoted to you at a single precise value, the first question worth asking is who measured it and what they counted. You will have noticed that the table says medical tourism, not health tourism, and that is deliberate. Health tourism as a whole is not measured as a single credible figure, and the reason takes us straight back to where this guide began. The term is too loosely held for anyone to count it. Where a firm does publish a "health tourism market" number, it almost always turns out to be the medical slice wearing a different hat: read the scope and you find the same list of cosmetic, dental, cardiac and fertility procedures, simply relabelled, with the spa weeks and the retreats quietly left out of the sum. And the handful that claim to size the whole are no steadier. One published estimate puts the global health tourism market at twenty-seven million dollars. Not billion. Million. That is around a thousandth of what other firms put on the same industry, attached to a growth rate higher than any serious medical forecast, and it sits on sale like any other report. I have kept it out of the table above, since dropping a figure like that in among genuine estimates would be its own small dishonesty. I raise it because it makes the point better than I can: when the thing being counted has no agreed definition, the count is free to be almost anything. The definitional vacuum from the start of this guide is not a theory. That is what it looks like the moment someone tries to put a price on it. The wellness end is better documented, because it has the one thing the medical end lacks: a body whose figures are widely accepted. The Global Wellness Institute measured the global wellness economy at 6.8 trillion dollars in 2024, and wellness tourism within it at 894 billion, growing 6.4 per cent a year since 2019 against 1.9 per cent for tourism as a whole. By revenue, then, the wellness side dwarfs the medical side many times over, even though a single cardiac patient generates more value than a great many spa guests combined. The two ends of the spectrum are not only clinically different. They are different sizes of business entirely. What can be said with reasonable confidence is directional. Cross-border patient flows recovered past their pre-pandemic levels and kept climbing. Medical inflation in the wealthier systems, longer public waiting lists, and a growing middle class across Asia, the Middle East and Latin America are all genuine pressures pushing volumes up. Europe remains a substantial share of the medical market, supported by the cross-border rules covered further down and by short intra-regional journeys. Beyond that, treat precise totals with the suspicion they have earned. ## The Risks of Health Tourism Health tourism carries real risks, and they cluster into four that recur regardless of destination or procedure. They bite hardest at the medical end of the spectrum, but a version of each applies wherever clinical work is involved. The first is the difficulty of judging quality. Healthcare is the business of trust, and trust is hard to extend across a border. A patient, even a well-read one, is rarely equipped to assess a foreign provider, because most patients cannot assess their domestic one either. They are passive recipients of a service they do not fully understand, and where quality information exists, they have no reliable way to know whether it is true. This is the gap into which the worst of the industry's marketing pours: the "best hospital, best doctors" promises that mean nothing on inspection and prey on people who are frightened and short of options. The second is infection. Travel exposes a patient to organisms their body has not met, and hospital-acquired infection, including with antibiotic-resistant bacteria, varies considerably between facilities and between countries. Infection-control standards are not uniform, and they are hard to verify from a distance before committing. The third is continuity of care, and it is the one patients underestimate most. A procedure can go well and still leave a problem, because care does not end when the patient flies home. Who manages the follow-up? Will a home-country doctor willingly take on a case treated abroad in a way they would not have chosen, with implants or protocols they do not recognise? Will the prescribed medication even be available, or licensed, back home? The handover that domestic care takes for granted is, in health tourism, frequently nobody's clear responsibility. The fourth is cost, beyond the headline price. Estimates are quoted for the planned procedure. They rarely account for what happens when more care is needed than expected, and in some places treatment may stall until the extra cost is settled. Worse, patients regularly return home to find their own insurer will not cover the complications of a trip it never sanctioned. The saving that justified the journey can evaporate the moment something does not go to plan. None of this argues against health tourism. It argues for going in with open eyes. The safeguards are unglamorous and effective: choose a provider on the strength of its actual track record rather than its advertising, get the treatment plan and the full cost in writing before committing, make sure your doctor at home holds the documentation and will take the case back, insure specifically for planned treatment abroad and its complications, and leave enough recovery time before flying. For a complex procedure in an unfamiliar place a competent facilitator earns their fee, provided you understand how they are paid and whether their advice is genuinely independent of whoever is paying them. ## Choosing a Health Tourism Provider Provider selection is the decision that determines the outcome, more than the country, the price or the brochure. Most of what matters has already appeared above, so this section is about two ideas that mislead patients and professionals alike: accreditation and reputation. Accreditation is widely misunderstood, in both directions. It is not the magic seal that marketing implies. The notion that a patient sees a logo, recognises the awarding body, and books on the strength of it is largely a fiction. Most patients neither know nor care which institution accredited a hospital, and many do not understand what accreditation is. As a signal aimed straight at patients, it is weak. Its real value is indirect, and more interesting. A serious accreditation is not a payment in exchange for a badge. It is a set of standards, processes and obligations an institution has to meet, and the act of meeting them tends to make the institution better. The benefit, in other words, is not being accredited. It is having pursued accreditation, and carrying the improvements that pursuit forced. Those improvements show in the care, and good care travels by word of mouth. Treated as a quality-building exercise, accreditation is worth a great deal. Treated as a marketing sticker, it is worth very little. Worth naming in the same breath, and firmly on the marketing-sticker side, are industry awards. The "best international hospital" trophies that circulate in this field are, with few exceptions, theatre. They are not the product of any verifiable process, they are frequently tied to who has sponsored or attended an event, and patients sensibly ignore them. Professionals should too. A provider that leans on its awards is telling you something, and it is not what it intends. Which leaves reputation, the most powerful force in health tourism and the hardest to fake at scale. Word of mouth, from former patients and from trusted professionals who have watched a provider's work over time, remains the single most reliable guide to quality in this market. It is slow, unglamorous, and cannot be bought outright, which is precisely why it is worth more than anything that can. ## Health Tourism Law and Regulation No single body regulates health tourism worldwide, which is consistent with everything else in this field. Rules are set nation by nation, with a few regional frameworks that matter more than the rest. For anyone working in or travelling within Europe, one of those is worth understanding properly. The European Union's Directive 2011/24/EU, on patients' rights in cross-border healthcare, gives EU citizens the right to seek planned care in another member state and reclaim the cost from their home system, at the rate the home system would have paid at home. It is not a blank cheque. Reimbursement is capped at home-country tariffs, so a patient choosing a dearer destination covers the difference, and certain higher-cost or inpatient treatments need prior authorisation. The directive also obliged each member state to run a national contact point for cross-border information and set up reference networks for rare and complex conditions. Implementation varies between states, but the principle is real, and it makes intra-European health travel a more orderly business than the cross-border picture almost anywhere else. Outside Europe, the larger destination countries have built their own national rules for international patients: licensing for facilitators, minimum standards for international patient departments, and government bodies charged with both promoting and policing the trade. These vary widely in how seriously they are enforced. The quietest regulatory force of all is the one mentioned earlier among the drivers: what a patient's home law forbids. A great deal of cross-border movement exists precisely because a procedure is lawful in one place and not another, from particular reproductive arrangements to certain experimental treatments and, in a small number of jurisdictions, assisted dying. This is the part of health tourism where law does not merely regulate the trade but creates it, and it raises ethical questions that sit well beyond the scope of a market. They deserve more honest attention than the industry, generally keener to talk about growth, tends to give them. ## Health Tourism: Common Questions What is the difference between health tourism and medical tourism? Health tourism is the umbrella. It covers all travel for a health purpose, from surgery to a spa week. Medical tourism is the part of that umbrella involving clinical treatment, where doctors, surgeons and specialists are central and a negative state of health is being put right. All medical tourism is health tourism. Not all health tourism is medical tourism. The two are routinely used as synonyms, which causes most of the confusion in the field. How large is the health tourism market? It depends entirely on who you ask, and the honest answer is that nobody knows precisely. Estimates of the medical tourism sub-sector for 2025 range from the mid-thirty-billions of dollars to well over two hundred billion, depending on the firm and its method. The wellness side is better measured: the Global Wellness Institute put the wellness economy at 6.8 trillion dollars in 2024, with wellness tourism alone at 894 billion. Several commercial research firms put wellness tourism above a trillion for 2025, and the Institute itself projects it past that in 2026, but its own measured figure for a completed year is the 894 billion. Treat any single headline figure with caution and ask what it counted. Is health tourism safe? It can be, and it can go badly wrong, and the difference is mostly down to the provider and the planning rather than the country. The risks that matter are judging quality from a distance, infection, continuity of care once you are home, and costs that exceed the quote. Sensible provider selection, written treatment plans, proper insurance and a doctor at home who will take the case back reduce the risk substantially. They do not remove it. Does my insurance cover treatment abroad? Often not, unless you arrange it specifically. EU citizens may reclaim part of the cost of planned care in another member state under Directive 2011/24/EU, but only up to home-country rates and with prior authorisation for some procedures. Private insurance for planned treatment abroad usually has to be bought before you travel, and many ordinary policies will not cover complications from a trip they did not sanction. Read the wording before you go. Which countries are the main health tourism destinations? It varies by what you need. The busiest medical and dental corridors run through parts of Asia, Central and Eastern Europe, Turkey and Mexico, while fertility and longevity care concentrate elsewhere again, often for reasons of law as much as cost. The right destination depends on the specific procedure, where you are starting from, and your own legal and budgetary situation, not on any general ranking. How do I find a provider I can trust? Reputation is the most reliable guide there is: the experience of former patients and of professionals who have watched a provider's work over time. Look for a verifiable track record rather than advertising or awards, insist on a written plan and cost, and confirm there is real support for what happens if something goes wrong. If you use a facilitator, establish how they are paid and whether their recommendation is independent of the providers paying them. An undisclosed commission is a conflict of interest, however it is dressed up. Does health tourism harm the countries that host it? It can cut both ways. It brings real money, skilled jobs and investment, but it can also pull doctors and nurses toward private international units and divert attention from the domestic system that trained them. The destinations that handle it well treat international patients as a source of funding for their own healthcare, not a replacement for it. The ones that handle it badly end up with a showcase for foreigners and a poorer service for locals. ## Sources Every market estimate on this page was read from the publisher's own page on 1 September 2026. All nine are firm estimates, not measurements. Three block automated requests and are marked, because saying so is better than implying a clean fetch. Grand View Research, "Medical Tourism Market Size & Share Report", 2026. States USD 34.0 billion for 2025 at 14.1 per cent to USD 126.2 billion by 2035. Returns 403 to automated requests; figures confirmed from its own indexed text. grandviewresearch.com/industry-analysis/medical-tourism-market Fortune Business Insights, "Medical Tourism Market", 2026. States USD 38.2 billion for 2025 at 23.3 per cent to USD 250.0 billion by 2034. Returns 403 to automated requests. fortunebusinessinsights.com/industry-reports/medical-tourism-market-100681 Research Nester, "Medical Tourism Market", 2026. States USD 43.8 billion for 2025 at 21.9 per cent to USD 316.7 billion by 2035. researchnester.com/reports/medical-tourism-market/4508 Towards Healthcare, "Medical Tourism Market Sizing", 2026. States USD 48.53 billion for 2025 and USD 216.3 billion by 2035. It previously carried USD 186.27 billion by 2034, and on 1 September 2026 its page title still advertised that older figure while its body gave the newer one; we followed the body. Re-checked 2 September 2026: the publisher has since aligned its title, and the superseded figure no longer appears anywhere on the page. Rate-limits automated requests intermittently. towardshealthcare.com/insights/medical-tourism-market-sizing Global Market Insights, "Medical Tourism Market", 2026. States USD 76.1 billion for 2025 at 8.4 per cent to USD 174.1 billion by 2035. gminsights.com/industry-analysis/medical-tourism-market Mordor Intelligence, "Medical Tourism Market", 2026. States USD 93.72 billion for 2025 at 18.41 per cent to USD 258.32 billion by 2031, from its own proprietary estimation framework. mordorintelligence.com/industry-reports/medical-tourism-market Technavio, "Medical Tourism Market", 2026. States USD 102.2 billion for 2023 and an increment of USD 132.8 billion to 2029, with no single forward rate. technavio.com/report/medical-tourism-market-industry-analysis Future Market Insights, "Medical Tourism Market", 2026. Now leads with USD 312.5 billion for 2026 at 12.3 per cent to USD 1,000.2 billion by 2036, having rebased from an earlier 2024-to-2035 window that gave USD 107.5 billion and USD 375.2 billion. Both superseded figures are still printed further down the publisher’s own page, describing the retired window. We follow the window the publisher now leads with, so a reader who clicks through and scrolls will find the older pair there; that is the publisher’s rebasing, not a figure we have misread. Re-checked 2 September 2026. futuremarketinsights.com/reports/medical-tourism-market Fact.MR, "Medical Tourism Market", 2026. States USD 278.3 billion for 2025 at 12.3 per cent to USD 1,000.2 billion by 2036, the same endpoint and rate as Future Market Insights. factmr.com/report/medical-tourism-market ## Health tourism coverage 12 reports Update August 30, 2026 This Week in Medical Tourism: 20–26 August 2026 Indian government counts put foreign medical arrivals at 507,244 in 2025 against 644,387 in 2024. Bangladesh supplied 325,127 of the later figure and 482,336 of the earlier one. Four governments moved on the unregulated edge of the trade in the same week. Update August 29, 2026 This Week in Medical Tourism: 13–19 August 2026 China's National Health Commission put 1.28 million international patients through its key foreign-oriented hospitals, a rise of 73.6 per cent in three years. Latvia counted 35,851 and a fall of a quarter. The two numbers do not measure the same thing. Update August 14, 2026 This Week in Medical Tourism: 6–12 August 2026 Vietnam's health ministry has put both sides of its medical travel ledger in one document: an estimated USD 1 to 2 billion coming in each year against USD 2 to 3 billion going out. Nigeria, Bangladesh and India moved on the same arithmetic in the same week, and the market estimates their governments were working from do not agree. Update August 7, 2026 This Week in Medical Tourism: 30 July – 5 August 2026 Dermatology has overtaken plastic surgery as the largest category of foreign medical spending in South Korea, at 67.5% against 21.3% in the first half of 2026, reversing the 2024 split. Medical services grew 98% year on year, faster than any other category BC Card reports. Australia, Nigeria and India each published figures on their own patient flows in the same week. Update August 2, 2026 This Week in Medical Tourism: 22–29 July 2026 South Korea treated 2.01 million foreign patients in 2025, up 71.7 per cent on the year, and nearly a third of them came from China. Uzbekistan drew 93.9 per cent of its patients from three neighbours and 119 from the rest of the world combined. Eight days of government announcements were aimed at the country next door, not at long-haul demand. 2026 7 This Week in Medical Tourism: 14–21 July 2026 Airlines Move To The Centre Of Medical Tourism Health Tourism As Badge, Escape Hatch And Disguise This Week In Health Tourism 08.06.26 - 15.06.26 This Week In Health Tourism 31.05.26 - 07.06.26 Report Projects Healthcare ERP Market At $13.38bn By 2035 Singapore HSA Reaches WHO Top Tier For Medical Device Regulation --- # What Is Medical Tourism? Costs, Risks and Destinations URL: https://health-tourism-news.com/medical-tourism/ Pillar Guide Updated June 2026 What Is Medical Tourism? Costs, Risks and Destinations Medical tourism is the largest and most serious part of health tourism, and the part most often sold dishonestly. It is travel undertaken for the primary purpose of receiving medical treatment in another country, from a hip replacement to a course of cancer care, and behind almost every journey is a health system that failed someone on price, on waiting time, on quality, or on what it was willing to permit. This guide sets out what medical tourism actually is, why people travel, what they really pay, how the trade works and where it goes wrong, written from inside the industry rather than from its brochures. By Christian El-Khouri, Editor-in-Chief, Health Tourism News Last updated: August 2026 Last verified: 31 August 2026 50-75%Typical difference on the routes we price ourselves 13 of 14Of those routes, the number cheaper than the home market $278.3BMedical tourism market, 2025 (Fact.MR estimate) Contents ## What Medical Tourism Is Medical tourism is travel undertaken for the primary purpose of receiving medical treatment in another country, with the patient bearing the cost directly or through a sponsor. It is the largest and most consequential part of the wider field of health tourism, and it covers a vast range of care, from a hip replacement to a course of cancer treatment, united by one thing: the person has chosen to cross a border to be treated, and has chosen to pay for it. That is the textbook version, and it is accurate as far as it goes. But if you want to understand medical tourism rather than merely define it, you have to begin somewhere less comfortable. Medical tourism is, at bottom, a symptom. People do not generally cross the world to have their chest opened for the adventure of it. They do it because something where they live has failed them: the price is impossible, the wait is too long, the quality is not there, or the treatment is not available or not allowed. Every medical tourist is, in a sense, a small piece of evidence that a health system somewhere did not meet a need. In a fairer world, with care that was good, timely, affordable and available everywhere, the industry I have spent my career in would mostly not exist. I keep that in view because it sets the terms for everything else on this page. This is not a leisure business with a clinical veneer. It is a response to failure, and the people moving through it are, more often than the brochures admit, frightened and out of better options. That places a heavy obligation on everyone they meet along the way, and a good deal of what follows is an account of who honours that obligation and who exploits it. A word on where this sits. Medical tourism is one part of health tourism, not a synonym for it. Health tourism is the broad umbrella that runs from a spa weekend at one end to open-heart surgery at the other, and I have set out that full spectrum, and how the sub-sectors differ, in the health tourism guide. Medical tourism is the high-clinical-intensity end of it: real physicians, real procedures, real risk, and the need for proper aftercare both abroad and at home. I will not re-run the spectrum here. What matters for this page is that medical tourism is the part where the stakes are physical and the margin for a bad decision is smallest. You will also meet other names for it. European policy prefers patient mobility, and governs it through a cross-border healthcare directive I come to later. The academic literature often says medical travel, sometimes reserving that for all cross-border care and keeping medical tourism for the elective, consumer-driven kind. In the trade and in plain speech, medical tourism is still the term everyone uses, and it is the one I use here, with one important qualification, which is the subject of the next part. ### What Medical Tourism Is Not The word tourism does a great deal of damage here, and it is worth stopping on, because almost everyone new to the field, and a fair number who are not, gets it wrong. Read literally, medical tourism sounds like a holiday with a procedure bolted on, or a procedure with a holiday bolted on. Fly to Thailand, have the surgery, spend a fortnight on a beach recovering. That picture is so common that the industry has half come to believe it, and you will find it sold back to patients in brochures promising treatment and a holiday in one. I want to be plain about this, because it is a view I hold firmly, and one we take as a house position at Health Tourism News, even where parts of the trade disagree: that picture is wrong, and the leisure element it leans on is not part of the definition at all. Medical tourism is defined by intent. The reason for the journey is treatment. Not treatment alongside a holiday, not a holiday that happens to include treatment, but treatment as the primary, governing purpose of crossing the border. The tourism in the term refers to the travel, the act of going somewhere other than where you live, and nothing more. It does not smuggle in a requirement to sightsee, to relax, or to enjoy yourself. A man who flies abroad, has a heart valve replaced, spends eleven days between a ward and a rented flat, and flies home, has been a medical tourist in the fullest sense, and at no point was he on holiday. To suggest he needed to be is to misunderstand the thing entirely. This is not pedantry, and it carries two consequences that matter. The first is that incidental treatment is not medical tourism. If you are abroad on business or on holiday and you break an ankle and have it set, you have not become a medical tourist. The travel did not happen for the treatment. The intent lay elsewhere, and intent is the whole of it. The second is that the leisure framing distorts how the industry is judged. Hold medical tourism to the standards of tourism, comfort and experience and a pleasant time, and you end up measuring a cardiac unit by the softness of its pillows. A great deal of the worst marketing in this field works in exactly that way, dressing serious clinical decisions in the language of a getaway, and it is most persuasive to the patients least equipped to tell the difference. So when I use the term, and when we use it at Health Tourism News more broadly, we mean travel undertaken for the primary purpose of receiving medical treatment, with the experience of the destination an incidental matter at most and, very often, no matter at all. If a touristic element were truly required, the field would not be a distinct phenomenon worth its own name. It would simply be tourism with a clinic in the itinerary. It is a phenomenon precisely because the clinic is the point. ## Why People Travel for Medical Care People travel for medical care for five reasons: cost, waiting times, quality, access to the very best, and treatments they cannot get at home. These five drivers run across the whole of health tourism, and I have set them out in full in the health tourism guide; here I want them at the sharp end, where the procedure is real and the patient is often not in a strong position, because the medical end of the trade is where the difference between a pressure and a preference actually bites. The industry prefers the language of the empowered consumer, the patient shopping the world for the best result, because it is flattering and it sells. The truth is usually closer to pressure than to choice. Take the reasons in turn. Cost is the largest by a distance. When the American Centers for Disease Control surveyed medical tourists, about half said simply that treatment was too expensive at home, and a further one in seven that it was not covered by their insurance, which for the patient amounts to the same wall. This is the uninsured or underinsured patient from a high-cost system, most often the United States, for whom the home price is not a number to negotiate but a door that is closed. It is the driver the next section is about, and the one the worst marketing leans on hardest. Waiting time is next. A knee replacement that means a six-month wait on a public list at home can be booked within a few weeks in Bangkok or Chennai, and pain does not pause politely for a queue. This is the patient from the NHS or a Canadian provincial system, not poor, not after a bargain, simply unwilling to lose another year to a waiting list. Quality comes third, and it is plainer than it sounds. This is not the hunt for the best hospital on earth. It is the patient from a health system that cannot reliably deliver the procedure to a decent standard, travelling somewhere that can. Better than home is the whole of the ambition, and for a great many people in the world that is a low bar and a long flight. The best is a smaller and wealthier category, and the one the glossy end of the industry is built for. A complex or rare condition, a second opinion at a famous centre, a procedure where the patient wants the top of the market and can pay for it. These are the patients who travel from the Gulf, parts of Africa and the former Soviet states, often with family in tow, and they are the reason a certain kind of hospital exists. I come back to them when I write about destinations, because they bend the economics in ways worth understanding. Last is availability, including the legal kind. The treatment that does not exist at home, or is not licensed there, or is simply not allowed: some fertility options, certain experimental and stem-cell therapies, an assisted death in a country that permits one. It is the fastest-growing of the five and much the most ethically loaded, and I take up the ethics later. One correction to a lazy assumption, because it matters. It is tempting to picture every medical tourist as a bargain hunter, and the cost figures encourage it. But by one widely cited industry estimate, around four in ten travel for expertise and technology rather than for a low price, flying towards a particular surgeon or a particular machine, not away from a bill. Cost dominates the numbers. It does not describe everyone. What nearly all of them share, whichever reason put them on the plane, is a weak hand. A person deciding between a procedure abroad and no procedure at all, or between treatment now and treatment in eighteen months, is not negotiating from strength. They are frequently unwell, often frightened, usually unable to judge the clinical quality of what they are being sold, and dependent on the honesty of people they have never met in a country whose system they do not know. Hold on to that, because it is the thread that runs through the rest of this page. The medical tourist is not a tourist. They are a patient a long way from home, and that is a vulnerable thing to be. ## What Medical Tourism Costs For most people who travel, this is the section that matters, because for most people cost is the reason they are travelling at all. So let me give you the honest version, which is both more useful and less flattering than the one the brochures run. The savings are real, and on most routes they are large. Across the fourteen treatment and destination combinations we price ourselves, thirteen come in below the home-market figure and most of those land between half and three-quarters below it. A gastric sleeve packaged in Türkiye at a panel median of $3,850 sits against $13,000 to $18,000 quoted by named UK providers. A single restored dental implant runs $535 to $1,340 in Poland against a UK median of $3,355. None of that is invented, and none of it depends on worse care. The gap is structural: lower wages and hospital overheads, lighter malpractice costs, and none of the insurance-billing machinery that inflates an American bill. A good hospital in Istanbul or Warsaw can use the same implants and the same protocols, charge a fraction of the price, and still make a healthy margin. What I will do is take the headline figure apart, because the headline figure is itself a piece of marketing. When a clinic tells you that you will save 84 per cent, it is doing two quiet things. It is taking the United States list price, the chargemaster figure that almost no insured American actually pays, as the comparison, because that is the number that makes the saving look biggest. And it is setting that inflated baseline against its own all-inclusive package price, the tightest and most favourable version of its own cost. The percentage is true in the way a "was 200, now 40" sticker is true. It is arithmetic built to impress. That criticism binds us too, so the table below does not use a list price anywhere. Every home-market figure in it is what a patient actually pays: a self-pay package quoted by a named provider, a published median, or a typical private fee. Where the anchor is American it is labelled for what it is, and there is no chargemaster column to compare against, because a chargemaster number would tell you nothing except how large we could make the gap look. The deeper problem is what the quote covers and what it does not. The number you are given is for the procedure and a standard, uncomplicated hospital stay. It is not for the complication. It is not for the extra fortnight in a foreign city when the wound is slow to close, nor the second flight, nor the revision if the result is wrong, nor the care your own health service ends up providing when you get home, nor the income you lose while all of this happens. A quoted price in medical tourism is a best-case price, and surgery is a field in which the best case is precisely the thing you cannot assume. The honest way to read any of these figures, including the ones below, is as the floor of what the episode might cost, not the price of it. Here is what we can show our working for. Every row below comes from one of our own treatment guides, where the prices are a panel of provider lists read on a stated date and held on file. Follow any destination link and you will find the panel, the method and the caveats behind that row. It is a shorter table than the ones you will see elsewhere, and that is the point: these are the procedures and countries we have priced ourselves, rather than every cell we could fill from somebody else's marketing page. Procedure Where Price panel Home-market anchor Difference Dental implant, single restored Poland $535 - $1,340 $3,355 UK median -72% Türkiye $940 - $1,140 $3,355 UK median -69% Hungary $950 - $1,460 $3,355 UK median -64% Croatia $1,050 - $1,715 $3,355 UK median -59% Thailand $1,050 - $3,150 $3,355 UK median -37% Mexico $1,200 - $1,730 $3,500 - $5,500 US complete -67% Gastric sleeve, package Türkiye $3,600 - $4,500 $13,000 - $18,000 UK named self-pay -74% Mexico $3,900 - $7,500 $15,000 - $25,000 US self-pay -72% IVF, egg-donation cycle Greece $5,700 - $10,250 $16,500 - $20,500 UK donor-egg -57% Spain $7,650 - $10,850 $16,500 - $20,500 UK donor-egg -50% Porcelain veneer, per tooth Türkiye $215 - $430 $823 UK median -61% South Korea $720 - $1,500 $823 UK median +35% Rhinoplasty, primary South Korea $2,100 - $7,000 $8,000 - $15,000 US private typical -60% Tummy tuck, full Türkiye $3,900 - $4,950 $9,400 - $11,600 UK hospital groups -58% Prices in US dollars, verified July 2026 and re-verified quarterly. Each row is drawn from the Health Tourism News treatment guide linked in its destination cell, where the price panel, its reading dates and its conversion rates are set out in full. Panels are lists published by named providers, held on file for verification. The difference column compares panel midpoints against the home-market anchor midpoint, so it describes typical against typical, not best case against worst. No figure here is a chargemaster or list price. Procedure and a standard stay only, excluding flights, complications and aftercare at home. Obtain written, itemised quotes before relying on any of them. The South Korea veneer row is the one worth pausing on, because it is the row that a marketing table would never print. On our own numbers a porcelain veneer in Seoul runs above the UK median rather than below it. Medical travel is not a discount that applies uniformly to every procedure in every country, and a destination that is excellent value for one treatment can be poor value for another. Any table that shows a saving in every single cell is telling you more about how it was assembled than about where you should go. One last thing, and it is the reason I labour the point. Cost is not only the most common reason people travel. It is the reason the worst of the industry's marketing reaches for, because it is the lever that works on the people least able to resist it. Someone choosing between a procedure abroad and no procedure at all is not well placed to interrogate a surgeon's complication rate, and the marketing knows it. A low price is the easiest thing in the world to advertise and one of the hardest to verify. When the number is the whole pitch, that is usually the moment to slow down. ## The Facilitators A medical tourism facilitator is a company or individual who sits between the patient and the hospital and arranges the journey: matching the patient to a clinic, handling travel and accommodation, often providing translation, a local point of contact, and help with aftercare. At their best they are genuinely useful, and for a frightened person navigating a foreign health system in a language they do not speak, sometimes close to indispensable. I want to say that plainly at the outset, because what follows is critical, and the criticism is not that facilitators are bad. It is that you need to understand how they are paid, because that, far more than anything in their brochure, tells you whose interests they actually serve. Start with the legitimate case, because it is real. A good facilitator saves the patient from a dozen expensive mistakes: the wrong clinic, the unverified surgeon, the booking that falls apart on arrival, the aftercare nobody arranged. For the hospital, the facilitator reaches patients it could never market to directly, fills beds without a marketing department, and carries the administrative load of foreign patients who need visas, translators and airport pickups. The hospital typically pays nothing until a patient actually arrives and is treated, so the risk sits with the facilitator. There is nothing wrong with the role itself, and the field could not function without it. The problem is the commission. The dominant way facilitators are paid is a fee from the hospital for each patient delivered, often only once treatment is complete. Read that again, because the conflict is not subtle. The person helping you choose a clinic is paid by the clinic. Their income depends on sending you somewhere, and on sending you to whoever pays them best, which is not necessarily whoever is best for you. A genuinely patient-led recommendation is not impossible under that model, but it runs against the grain of how the person is paid, and you should assume the grain wins more often than it loses. In practice the patient is frequently shown a single option, the facilitator's partner clinic, presented as the obvious answer rather than as one of several. The choice that the empowered-consumer story depends on quietly disappears, and the patient never knows it was supposed to be there. Who pays the person choosing your clinic The referral chain The patient's path Patient One country Facilitator Another Second facilitator Destination, often Hospital Destination Commission, per patient, on completion The dominant model pays the facilitator a fee from the hospital for each patient delivered. Germany treats paying or accepting money for a patient referral as a criminal offence. This is serious enough that some countries treat it as corruption outright. Germany rewrote its criminal code to make paying or accepting money for a patient referral a criminal offence, on the straightforward logic that a medical decision bought with a kickback is a decision corrupted at the source. Whether or not you think that goes too far, the principle is sound. When a referral is for sale, the patient's interest is no longer the thing steering the referral. There is distortion built into the structure even when no one is acting in bad faith. A patient in one country, a facilitator in another, often a second facilitator in the destination country, then the hospital. By the time the patient's condition and wishes reach the surgeon, they have passed through three or four sets of hands and as many incentives, and something is nearly always lost on the way. The longer the chain, the less the hospital knows about the person on the table, and the less that person understands about what is coming. Every link also takes a margin. Sometimes that margin buys real value. Sometimes it just makes the same treatment more expensive while adding another body between you and the people responsible for your care. And where there is a payment for each head delivered, there is an incentive to corrupt, and this industry has the cases to prove it. One major hospital's international programme ended as a criminal investigation, with dozens of people implicated and a web of intermediary companies and consulting contracts beneath it. It was not a freak event. It is the kind of thing a commission model produces when nobody watches it closely enough. So travel with help if you need it; just do not travel blind. The single most useful question you can put to a facilitator is how they are paid, and specifically whether they take money from the clinics they recommend. One who charges you a clear fee and takes nothing from the other side has no reason to send you anywhere but the right place. One who is paid by the clinic is not necessarily dishonest, but they are not neutral, and you should weigh every word of their advice knowing it. Ask the question. The answer, and how readily they give it, tells you most of what you need to know. ## The Destination Question There is a particular kind of article this section refuses to be, and it is the ranked list of the ten best medical tourism destinations. You can find a hundred of them, most written by someone with a clinic to sell, and they are close to useless, because they answer the wrong question. The question is not which countries turn up on the most lists. It is what makes somewhere a real destination at all, and why most of the places straining to become one should not. I have spent a good part of my career being flown to countries that had decided, usually at ministry level, that medical tourism would be their next great export, and would I come and help build it. Often the honest answer was that they should not try. A destination is not a press release and a stand at a trade fair. It is not, to put it the way I have before, half a clinic and some English-speaking staff. For every patient willing to cross a border, there is already somewhere doing the thing they need, frequently doing it well, frequently doing it cheaply, with a decade's head start and the word of mouth to match. A new entrant with no particular advantage is not entering a market. It is spending public money to lose to people who got there first. The test is simple, and it comes straight out of why patients travel. A place can be a destination only if it offers some group of patients one of the five things that put people on a plane: a real price advantage, genuinely better care than they can get at home, the best of something for those who want the top of the market, a shorter wait, or a treatment they cannot get or are not permitted at home. Not a general aspiration to quality. A specific advantage, for a specific kind of patient, that some other place does not already match. If a country cannot finish the sentence "patients should come here rather than the obvious alternative because...", it does not have a destination. It has a hope, and hope is not a strategy. This is why the real destinations cluster the way they do, and why the cluster barely changes. A handful of countries win on cost and volume, with the scale and the deep procedural experience to back it: India, Thailand, Mexico, Turkey. A smaller, dearer group competes on being the best rather than the cheapest, for particular specialisms: Singapore, parts of Germany, the United States, South Korea for certain work. And some win on simple proximity, near enough to drive to, like Mexico for the southern United States or the dental clinics of Hungary and Poland for Western Europe. Each works because it answers a driver, not because it wanted to badly enough. The list is short, and it has looked much the same for years. That is not an accident. Destinations are built slowly, on substance, and ambition does not displace them. When a country does have a real advantage, the economic case for pursuing it is strong, and wider than people assume. I have called it the trickle-down economy of medical tourism, because the money does not stop at the hospital door. A medical tourist sleeps in a hotel, eats in restaurants, takes taxis, and very often does not travel alone. Patients from the Gulf in particular arrive with family, sometimes a large one, who stay for weeks and spend across the whole visit. Aviation, hospitality, transport and retail all take a share. There is a quieter benefit too, which the better-run destinations grasp and the rest miss. Revenue from foreign patients can be ring-fenced and put back into the health system itself, into equipment and capacity that then serve everyone, without touching the domestic health budget. Done properly, treating foreign patients can help pay for treating your own. Done improperly it does the reverse, and this is where the ambition I began with turns dangerous. A destination built on marketing rather than substance does not merely fail to attract patients. It attracts some, treats them badly, and exports the consequences: the complications, the poor results, the cases that come apart and have to be put right somewhere else, each one a piece of advertising against the place that produced it. And there is a harder question the optimistic version skates over. A health system that tilts its best doctors, beds and theatres towards the patients who pay most can end up serving its own population worse rather than better. The reinvestment argument answers that worry only if the reinvestment actually happens, and only if someone is making certain it does. Where it does not, medical tourism stops being a way to fund a country's healthcare and becomes a way to quietly hand the best of it to people who flew in. That is not an argument against destinations. It is an argument that becoming one is a serious undertaking with real obligations, and not the easy win it tends to be sold as. ## The Risks of Medical Tourism Medical tourism carries real risks. Their broad shape is common to all of health tourism, which the health tourism guide covers; at the clinical end they stop being abstract, and that is the version I want here. The honest way to think about them is this: most of them are not risks of the operation. They are risks of the distance. The surgery itself, in a good hospital with a good surgeon, may be no more dangerous abroad than at home, and is sometimes safer. What changes, and changes everything, is that the place you are treated and the place you live are a continent apart, and that gap reshapes what happens at every stage, above all when something does not go to plan. Begin with the problem that sits under all the others: you cannot really judge the thing you are buying. A patient is not equipped to assess a surgeon's competence, a hospital's infection record, or whether the procedure being recommended is even the right one. At home you lean on a web of proxies you barely notice, your own doctor's referral, a regulator, a reputation built over years, a system you can complain to. Abroad most of that falls away, and you are left trusting a business, often one that is selling to you, on the strength of a website and a confident email. The empowered consumer choosing the best care in the world is, in practice, frequently a worried person taking a stranger's word for it. That asymmetry, between what the patient can see and what they would need to know, is the root risk, and every marketing decision in this industry is shaped by the fact that it exists. The defining risk of medical tourism, though, the one that separates it from being treated down the road, is continuity of care. Surgery is not an event, it is the start of a process, and that process is built for a patient who stays put. You go home. Your surgeon does not come with you. If the wound turns, if the implant is wrong, if the result needs revising, the person who did the work is now thousands of miles and a time zone away, and the records may not have followed you at all. Worse, your own doctor at home may be reluctant to take the case on. There is a real and well-documented hesitancy among home physicians to manage the complications of an operation they did not perform, did not advise, and have no notes for, and you can understand it even as it leaves you stranded. The patient ends up in the gap between two systems, belonging fully to neither, holding a problem that the people best placed to fix it have reason not to touch. This is the risk patients grasp least before they travel and feel most sharply afterwards, and it is what makes a low quoted price so misleading: the revision the price did not include is also the revision nobody at home wants to do. Infection deserves its own mention, because it travels in ways that matter. Surgical site infections are among the most common complications reported by returning medical tourists, and some are not ordinary infections but resistant ones, organisms that are hard to treat and that a patient can carry home into a hospital not expecting them. There have been documented outbreaks traced back to procedures abroad, clusters of serious infection tied to particular destinations and particular kinds of surgery, reported by public health authorities including the American Centers for Disease Control. The point is not that any one country is dangerous. It is that infection-control standards genuinely vary, that you are usually in no position to inspect them, and that the consequences can cross a border with you and incubate quietly for weeks. Then there is the travel itself, which is not a neutral act after an operation. Flying soon after major surgery raises the risk of blood clots and deep-vein thrombosis, pressure changes can be dangerous after certain procedures, and the recovering body is being asked to do exactly what it should not, sit still and cramped for hours, often within days of the work. The holiday-and-surgery framing I objected to earlier is not only misleading, it is occasionally hazardous, because it invites people to treat the post-operative period as a trip rather than a convalescence. The flight home is part of the medical event. Too many people plan it as though it were the journey back from a beach. And when something does go wrong, two further problems arrive together. The cost you came to avoid can return in full and then some, because a serious complication can wipe out the saving and overtake it. And your recourse is thin. Legal protections for patients vary enormously between countries, malpractice systems abroad may be slow, unfamiliar, or capped at sums that would not cover the harm, and pursuing a claim in a foreign jurisdiction in a language you do not speak is, for most people, not a real option at all. Most people who travel do well, and the point here is not to frighten anyone out of going. It is to insist the risks be weighed honestly, and to see that they fall hardest on exactly the patient least able to absorb them: the one who travelled because they could not afford the alternative, and who has the least left over if it goes wrong. ## Choosing a Provider Choosing well in medical tourism comes down to a single shift in where you look. The instinct is to choose a country, then a hospital, then trust that the surgeon comes with the building. For surgery, that is backwards. The most important variable in how your operation goes is not the destination's reputation or the hospital's marble lobby. It is the individual surgeon, and how many times they have done the exact thing they are about to do to you. Get that right and a great deal else is forgivable. Get it wrong and no amount of accreditation or five-star recovery suite will save the result. So the first question is volume, and it is specific. Not "is this a good hospital" but "how many of this particular procedure does this particular surgeon perform in a year, and what are their outcomes." Surgery rewards repetition. High-volume surgeons and high-volume centres tend, across the evidence, towards better results and fewer complications, and the gap is not small. A hospital that does a thousand of an operation a year is a different proposition from one that does thirty, and a surgeon's personal numbers matter more than the logo above the door. Ask for them directly. A good provider will answer. One that deflects to brochures and brand has told you something. Insist on a real consultation before you travel, not a quote. There is a meaningful difference between a clinic that sends a price within the hour and one that wants your history, your scans, and a proper conversation with the surgeon before committing to anything. Telemedicine has made this straightforward, and it is now reasonable to expect a genuine pre-operative assessment by video, where the surgeon examines what they can, asks the questions a careful doctor asks, and is honest about whether you are even a good candidate. A provider willing to tell you not to have the procedure, or not to have it with them, is worth more than one that says yes to everyone, because saying yes to everyone is precisely what the worst of them do. Accreditation has its place, but understand what it is and is not. It is better seen as a journey than a seal, for reasons I have given in the health tourism guide, and I will not rehearse them again. The medical-specific point is narrower: accreditation tells you something about a hospital's systems, its infection control, its protocols, its safety machinery. It tells you almost nothing about the surgeon who will operate on you. It is a floor, not a guarantee, and a statement about the institution, not about the individual. Treat it as one input among several, not as the answer. Ignore the awards almost entirely. The industry runs a circuit of prizes, best hospital, destination of the year, and a good number of them are closer to paid placements than to honest assessment. An award tells you a clinic was willing to enter, and sometimes to pay. It tells you nothing about whether your operation will go well. If a provider leads with its trophies, that is marketing, and marketing is not evidence. Word of mouth remains the most powerful force in this industry, and largely deserves to be, because a recommendation from someone who actually went and did well carries information no brochure can fake. But carry one caution into it that is specific to medicine. A happy testimonial tells you the patient was pleased, not that the surgery was sound, and the patients who had bad outcomes are, for obvious reasons, far quieter and far harder to find. You are seeing a curated half of the picture. Weigh the praise, but do not mistake the absence of visible complaints for the absence of complications. And do the one thing almost nobody does until it is too late: arrange your landing before you leave. Speak to your own doctor at home before you travel, not after, and find out who will manage your recovery and any complications when you return. The continuity gap I described earlier is at its most dangerous for the patient who only goes looking for aftercare once they already need it. The strongest position you can be in is to have travelled with your home care lined up in advance, so that whatever happens, someone on your own side of the world has already agreed to catch you. That single piece of preparation does more to lower your risk than any logo on a wall, and it is the one the marketing never mentions, because it is the one that admits things can go wrong. ## Law, Recourse and Ethics The law around medical tourism is thinner than most patients assume, and the part of it that matters most is the part that is missing. Within Europe there is at least a framework: a cross-border healthcare directive gives patients in the European Union a qualified right to seek treatment in another member state and be reimbursed up to what it would have cost at home, with prior authorisation required for the more expensive kinds of care. I have described how that directive works in the health tourism guide. It is a genuine right, and it is also the exception. For most of the world's medical tourism, the patient travelling privately from one country to another, there is no equivalent. No directive, no reciprocal arrangement, no shared standard. There is a private transaction in a foreign country, governed by that country's law, which you do not know. This becomes concrete the moment something goes wrong, and it is worth being blunt about, because the brochures never are. If a surgeon at home injures you through negligence, you have a path: imperfect and slow, but real. A regulator, a complaints process, a malpractice claim your own lawyers understand. Take the same injury abroad and most of that path is simply not there. You would be bringing a claim in a foreign jurisdiction, under a legal system built in another language, against a defendant on home ground, often where damages for medical negligence are capped at sums that would not cover the cost of putting the harm right, let alone the harm itself. Many of the countries that host large numbers of medical tourists have malpractice regimes slower, narrower and far less generous than patients from the United States or Western Europe expect. For most people, in practical terms, the recourse is not small. It is absent. You trust the provider not because the law stands behind you if they fail, but because, if they fail, it largely will not. There is a quieter version of the same gap on the money side. A complication does not only raise a clinical problem, it raises the question of who pays, and the answer is usually you. Standard travel insurance tends to exclude elective treatment abroad and its consequences. Your home health system did not sanction the procedure and is under no obligation to clean up after it, though in practice it often ends up doing so at the public's expense. Specialist medical-tourism insurance that would cover complications exists, but it is bought by a minority, and the patients least able to afford it are exactly the ones travelling because they could not afford the treatment in the first place. The financial risk, like the legal one, settles on the person least equipped to carry it. Then there is the part of medical tourism that exists because of the law rather than in spite of it. Some people travel not for a cheaper or faster version of what they could get at home, but for something their own country forbids: a fertility option that is not licensed, an experimental therapy not approved, in some cases an assisted death the law at home does not permit. The legal scholar Glenn Cohen has written on this at length and gives it a name worth borrowing, circumvention tourism, travelling abroad to do lawfully what would be unlawful at home. The ethics of it cannot be settled in one direction, because they depend entirely on what the home law is for. Travelling to obtain a treatment your country bans for no good reason is one thing. Travelling to evade a prohibition that exists to protect someone, a ban on buying an organ, say, is quite another. The same act, crossing a border to do what you cannot do at home, can be a reasonable exercise of autonomy or a way of outsourcing a harm, and which it is turns on the specific law and the reason behind it. It is the most ethically serious corner of the field, and the one where the patient's choice is least sufficient as an answer. Which brings the page back to where it began. I said at the start that medical tourism is, at bottom, a symptom: that people cross the world for care because something at home failed them, and that in a fairer world the industry would mostly not need to exist. The ethics follow from taking that seriously. An industry built on other people's lack of options is not, for that reason, wrong. You do not help the uninsured patient or the one stuck on an eighteen-month waiting list by refusing to treat them, and a great deal of medical tourism relieves suffering that would otherwise go unrelieved. But it carries an obligation an ordinary business does not, precisely because its customers are so often there out of need rather than choice. The question that should sit over the whole trade is whether it relieves the inequality it feeds on or quietly entrenches it. Both happen. At its best, medical tourism moves money from rich health systems to poorer ones, funds hospitals and equipment that go on to serve local patients too, and gives people real treatment they could not otherwise have had. At its worst, it pulls a developing country's best doctors, nurses and operating theatres towards the foreigners who pay most, and leaves the local population worse served in their own hospitals, a health system quietly turned away from the people it was built for. The same flow of patients can fund a country's medicine or hollow it out, and the difference lies in choices that are nobody's job to make unless someone decides to make them. That is the real weight of this business, and it falls on everyone in it. On the hospital deciding who its capacity is for. On the government deciding whether the revenue is reinvested or merely banked. And on the facilitator, the marketer and the consultant, dealing every day with people who are frightened, a long way from home, and trusting them. None of that makes medical tourism wrong. It makes it serious, and it puts the duty to take it seriously on the people who profit from it, not on the patients who are rarely in any position to insist. ## Medical Tourism FAQ What is medical tourism? Medical tourism is travel to another country for the primary purpose of receiving medical treatment, paid for by the patient or a sponsor rather than provided by their home health system. It ranges from dental and cosmetic work to cardiac procedures and cancer care. The defining feature is intent: the journey happens for the treatment. Receiving care while abroad for some other reason, such as breaking a bone on holiday, is not medical tourism. Why do people travel abroad for medical treatment? For five reasons: lower cost, shorter waiting times, better quality than they can get at home, access to the best specialists or technology, and treatments unavailable or not permitted in their own country. Cost is much the largest, driven mainly by uninsured and underinsured patients from high-cost systems, though a substantial minority travel for expertise rather than for a low price. How much can you save with medical tourism? On the fourteen treatment and destination combinations we price ourselves, thirteen come in below the home-market figure, most of them between 50 and 75 per cent below it. The fourteenth, porcelain veneers in South Korea, costs more than the UK median, which is worth knowing before you assume travel always saves money. Treat the headline percentages with caution. They usually compare an inflated home list price against a destination's best all-inclusive package, and the quote rarely includes complications, revision surgery, repatriation, or care once you are home. Read any quoted price as the floor of what the episode might cost, not the total. Is medical tourism safe? It can be, in a good hospital with an experienced surgeon, and is sometimes as safe as treatment at home. The main risks come less from the surgery than from the distance: the difficulty of judging quality from afar, the danger of flying soon after an operation, infection, and above all the gap in continuity of care when your surgeon is on another continent and your home doctor is reluctant to manage a complication they did not cause. Safety depends heavily on the individual provider and on preparation. What are the most common medical tourism procedures? The largest categories are cosmetic and aesthetic surgery, dental work, fertility treatment, orthopaedic surgery such as hip and knee replacement, eye surgery, cardiac procedures, and bariatric surgery. Cosmetic and dental treatment account for the greatest volume, partly because they are rarely covered by insurance even at home. HTN keeps separate guides to dental, cosmetic and fertility tourism, which cover those sub-sectors and their pricing in more depth. What are the best countries for medical tourism? There is no single best country, and any ranked list claiming otherwise is usually selling something. The right destination depends on the procedure and on why you are travelling. A handful lead on cost and volume, including India, Thailand, Mexico and Turkey; a dearer group competes on being the best for particular specialisms, including Singapore, Germany and South Korea; and some win on simple proximity. Choose the destination that answers your specific need, not the one that appears on the most lists. What is a medical tourism facilitator, and should I use one? A facilitator arranges your treatment abroad, matching you to a clinic and handling travel, accommodation, translation and aftercare. A good one can be genuinely valuable. Before you trust one, ask a single question: how are you paid? Many take a commission from the hospital for each patient they send, which means the person helping you choose a clinic is paid by the clinic. That does not make them dishonest, but it does mean they are not neutral, and you should weigh their advice knowing it. One who charges you a clear fee and takes nothing from the clinic has no reason to send you anywhere but the right place. What happens if something goes wrong abroad? This is the risk patients underestimate most. Your surgeon is far away, your records may not follow you, and your own doctor at home may be unwilling to take on a complication from a procedure they did not perform. Legal recourse is usually limited: pursuing a malpractice claim in a foreign country, in another language, is difficult and often capped at sums that would not cover the harm. The strongest protection is to arrange your aftercare at home before you travel, not after you need it. Does insurance cover medical tourism? Usually not. Standard travel insurance tends to exclude elective treatment abroad and its complications, and your home health system is under no obligation to cover a procedure it did not sanction, though it often treats the consequences anyway. Specialist medical-tourism insurance that covers complications exists, but relatively few patients buy it. Assume you are not covered unless you have specifically arranged for it. Is medical tourism worth it? It depends on the procedure, the destination, your health, and how carefully you prepare. For a high-cost procedure the savings can clearly outweigh the cost and effort of travelling, and many people travel and do well. For minor treatment, the saving may not justify the journey or the risk. The decision turns less on the price than on the quality of the provider and the strength of your plan for recovery, including who will care for you when you get home. ## Sources Price panels for every row of the cost table: the Health Tourism News treatment guides for dental implants, gastric sleeve, IVF, veneers, rhinoplasty and tummy tuck. Each guide sets out its provider panel, the dates the lists were read and the conversion rates used. Verified July 2026, re-verified quarterly. Patient motivations. Stoney RJ, Kozarsky PE, Walker AT, Gaines J. "Population-Based Surveillance of Medical Tourism among US Residents." Infection Control & Hospital Epidemiology, 15 July 2021. pmc.ncbi.nlm.nih.gov/articles/PMC8922991 Cross-border care framework. Directive 2011/24/EU of the European Parliament and of the Council on the application of patients' rights in cross-border healthcare, adopted 9 March 2011. eur-lex.europa.eu/eli/dir/2011/24/oj Infection outbreak surveillance. Schnabel D, Esposito DH, Gaines J, et al. "Multistate US Outbreak of Rapidly Growing Mycobacterial Infections Associated with Medical Tourism to the Dominican Republic, 2013-2014." Emerging Infectious Diseases 22(8), United States Centers for Disease Control and Prevention, August 2016. wwwnc.cdc.gov/eid/article/22/8/15-1938_article Legal and ethical framing, including circumvention tourism. Cohen IG. Patients with Passports: Medical Tourism, Law, and Ethics. Oxford University Press, 2014. global.oup.com/academic/product/patients-with-passports-9780190218188 Market size. "Medical Tourism Market Size, Share & Trends Analysis Report", Fact.MR, 2026. States USD 278.3 billion for 2025. factmr.com/report/medical-tourism-market ## Medical tourism coverage 43 reports Update August 22, 2026 Mexico and Turkey Price Against Different Home Markets Tijuana quotes in US dollars. Istanbul quotes in sterling. Neither quotes in its own currency, and the multiple each corridor lands on says more about the patient than about the local cost of surgery. Update August 22, 2026 Turkey's Deepest Discounts Sit on Its Safest Procedures Four Health Tourism News guides price four Turkish procedures against the same British patient. Rank them by saving and rank them by what goes wrong, and the two lists come out close to reversed. News August 11, 2026 Why Medical Tourism to Germany Declined The Legal and Systemic Causes Update July 8, 2026 Medical Tourism Records Concentrate In Penang And Seoul This is the Health Tourism News roundup for the week of June 29 to July 7 2026. Malaysia and South Korea both reported record medical tourism figures this... Update July 1, 2026 Nigeria, Iran And Seoul Redraw Medical Tourism This is the Health Tourism News roundup for the week of 24 to 30 June 2026, and it read less like a sales pitch than a stocktake of leaks. Nigeria wants its... 2026 17 Health Tourism As Badge, Escape Hatch And Disguise This Week In Health Tourism 08.06.26 - 15.06.26 This Week In Health Tourism 31.05.26 - 07.06.26 Iran Crisis Cuts Gulf Medical Travel to Asia Assocham Symposium Pitches Northern India Wellness Telangana Plans Airport Health City for Medical Tourism Vietnam Courts US Patients For Medical Tourism Lebanon Conflict Puts Its Medical Tourism Hopes at Risk Asia Pacific Medical Tourism: Growth, But Not Everywhere Equally South Africa Medical Tourism: The Numbers Behind The Pitch Vitiligo Treatment: A Growing Market And A Travel Niche Middle East Turmoil Reshapes Medical Tourism India Medical Tourism Market Size: The 13 Billion Dollar Question Singapore Medical Tourism Heads For USD 15.4 Billion By 2035 Saudi Arabia Bets Vision 2030 Money On Medical Tourism Medical Tourism Trends 2026: What Is Actually Changing South Korea Wellness And Dermatology Tourism Keep Climbing 2025 16 North America Outbound Medical Tourism: Why Patients Leave Bupa Arabia's Digital Health Strategy Düsseldorf Strengthens Its Position in Health Tourism Addressing Concerns About Medical Tourism: Cost Savings vs. Quality of Care U.S. vs. European Medical Tourism and Integrative Care Medical Tourism Facilitators: Evolve or Face Extinction Aging Populations Will Drive Medical Travel Worldwide How to Become a Medical Tourism Destination The Risks and Benefits of AI in Healthcare: A Pandora's Box Priced Out: Tariffs Could Push Americans Abroad for Care ZagrebMed Turns Two The Decline of Medical Tourism in Germany Medical Tourism and Family Offices Why Medical Tourism Should Not Exist Medical Tourism Industry Size Projections Founding of the European Health and Medical Tourism Association 2024 5 Event: Global Health Exhibition in Riyadh Saudi Arabia's Leap in Medical Tourism with World's First Fully Robotic Heart Transplant Dubai Bolsters Medical Tourism with New Strategic Partnership Recap: SITMMT 2024 in Seoul, South Korea Welcome to Health Tourism News --- # What Is Wellness Tourism? Types, Benefits and Destinations URL: https://health-tourism-news.com/wellness-tourism/ Pillar Guide Updated June 2026 What Is Wellness Tourism? Types, Benefits and Destinations Wellness tourism is the part of health travel most people underrate. It is travel to stay well rather than to be treated, the proactive opposite of medical tourism, and it runs from a thermal cure to a yoga retreat to a week built around sleep. It is also, quietly, the largest part of the whole field by money and by number of trips, and the most loosely defined. This guide sets out what wellness tourism actually is, why people go, the forms it takes, what the evidence does and does not support, and how to choose well, written by someone who comes at it from the clinical end of health travel and takes the serious part of it seriously. By Christian El-Khouri, Editor-in-Chief, Health Tourism News Last updated: August 2026 Last verified: 31 August 2026 $894BWellness tourism spending, 2024 (GWI) 18.7%Share of tourism spending on wellness trips (GWI, 2023) $6.8TGlobal wellness economy, 2024 (GWI) Contents ## What Wellness Tourism Is Wellness tourism is travel undertaken to maintain or improve your health and wellbeing, rather than to treat anything that has gone wrong with it. The Global Wellness Institute, which has done more than anyone to measure the field, defines it as travel associated with the pursuit of maintaining or enhancing one's personal wellbeing, and that is as good a starting point as any. A yoga fortnight in Bali, a thermal cure in the old German spa towns, a week of supervised fasting in the mountains, a sleep programme in a clinic built for the purpose: all of it counts, and what unites it is the direction of travel. The person is not broken. They are trying to stay well, or to get better at being well, and they have decided to leave home to do it. That is the part most people get wrong about wellness tourism, and they get it wrong by underrating it. Say the words and a certain picture arrives unbidden: cucumber water, scented candles, a robe, a price that buys very little of substance. It is easy to dismiss the whole field as the frivolous end of an indulgent industry, and a good many serious people in health travel do exactly that, usually without looking closely. I think that is a mistake, and an expensive one, because it misses what wellness tourism actually is and how much of it is real. Start with age, because it settles the frivolity question quickly. This is the oldest form of health travel there is. People were travelling to thermal springs to take the waters when surgery was a death sentence and a hospital was the last place you wanted to be. The Romans built much of their social life around bathing. The German-speaking world turned the medically supervised cure, the Kur, into an institution its health system funded for over a century, and I happen to write this from a city whose name was made by its hot springs. Long before anyone coined the phrase "medical tourism", before there were aeroplanes to carry patients or clinics worth flying to, there was wellness tourism, and it rested then, as the best of it rests now, on the simple and largely correct idea that warm mineral water, rest, movement and a change of air do a body good. Where this sits in the wider field is the mirror image of where I have placed medical tourism. If you have read the health tourism guide, you already know I treat the whole field as a spectrum, with medical tourism at one pole and wellness tourism at the other, and I will not redraw the whole thing here. The short version is that they are opposites. Medical tourism is reactive, clinical, often invasive, and undertaken out of necessity by people with something wrong. Wellness tourism is proactive, largely non-clinical, non-invasive, and chosen by people with nothing especially wrong who would like to keep it that way, or to do a little better. One repairs. The other maintains and enhances. That single difference, repair against upkeep, drives almost everything else about how the two behave. None of which makes the field simple, or means that every "wellness" label stands for the same thing, or for anything at all. It is, if anything, the loosest term in a field full of loose terms. "Wellness" has been attached to everything from a genuine course of balneotherapy to a scented candle, and that breadth is a real problem for anyone trying to understand the sector rather than sell into it. So this guide tries to do two things at once, and to keep them in balance. It takes wellness tourism seriously, because it deserves to be and usually is not. And it stays honest about where the evidence is strong, where it is still arriving, and where the marketing has run ahead of anything anyone can show. Those two are not in tension. The way to respect a field like this is to look at it clearly, and the surest way to keep it frivolous is to refuse to. ## Why People Travel for Wellness The reasons people travel for wellness are not the reasons they travel for medical care, and the difference is instructive. Nobody crosses a border for a thermal cure because the waiting list at home is too long or because they cannot afford to stay ill. They go because they want something rather than because they need it, and want is a more complicated motive than need. Strip away the brochure language and a handful of honest reasons remain. The largest, by some distance, is the state of modern life itself. People are tired in a way a weekend does not fix. Stress, overwork, poor sleep and the low background hum of being permanently reachable have produced a real and widespread appetite for getting away from all of it, on purpose, with recovery as the actual aim rather than a happy side effect. The pandemic did not create this, but it sharpened it. A great many people used a forced pause to notice how depleted they were, and the demand for deliberate rest has not fallen back since. This is the burned-out professional more than anyone, and it is the engine under the whole sector. One honest qualification belongs here, though. When that tiredness has tipped into something more serious, burnout that has become a genuine ailment rather than a hard few months, a trip on its own will not mend it. Conditions of that kind ask for more than a change of scene: a change of habits, often a change of perspective, sometimes proper clinical help, and all of it kept up long after the flight home. A good programme can open the door to that work, and give a person the quiet to see they need it, which is no small thing. But at that point the journey is one part of a recovery rather than the whole of it, and what is doing the healing is no longer purely wellness tourism. Close behind is prevention, the wish to get ahead of trouble rather than wait for it. This is the person who has watched a parent's health go, or had a birthday with a nought in it, or simply decided that looking after the body now is cheaper than repairing it later. They are not ill. They are trying not to become so, and a focused week away from their ordinary habits is a way to take that seriously for once. Then there is a reason the industry understands better than it usually explains: you can do things away from home that you cannot do at home. The whole power of a residential programme is that it lifts you out of the environment that keeps you stuck. The fridge you raid, the desk you never leave, the phone on the bedside table, the thousand small defaults of an ordinary life are all suspended, and for a week or two a different set of habits becomes not merely possible but easy. Whether the change survives the journey home is the real question, and I come to it later, but the appeal is genuine and the mechanism is sound. Change is simply easier somewhere else. Some travel for something more specific. A fitness goal pursued properly for once, a yoga or meditation practice taken deeper than a weekly class allows, a sleep problem addressed in a place built around it, a weight or a habit tackled with full attention. These are the closest wellness travel comes to the focused, goal-led shape of a medical trip, and they tend to be the programmes with the most substance behind them. And some travel for reasons that are harder to put on a spreadsheet: to think, to grieve, to mark a change, to reconnect with something the ordinary week leaves no room for. There is also, and it would be dishonest not to say so, a fair amount of wellness travel that is really about identity, the trip as a statement of the kind of person one is or means to become. I do not say that with a sneer. People have always spent on the things that tell them who they are, and a meditation retreat is a more benign version of that impulse than most. One last thing worth knowing, because it reshapes the picture. Most wellness travel is not a dedicated wellness trip at all. By the Global Wellness Institute's own measure, the bulk of it is what they call secondary: not a journey taken for wellness, but wellness folded into a journey taken for something else, the spa afternoon on a business trip, the healthier hotel chosen over the indifferent one, the morning swim and the better menu on an ordinary holiday. The dedicated retreat is the visible tip of the sector. The larger part is simply people choosing, more and more, to look after themselves a little better wherever they happen to be going. Hold on to that, because it tells you wellness tourism is less a niche people opt into than a habit slowly spreading across travel as a whole. ## Types of Wellness Tourism Wellness tourism is not one product, and the word covers things with very little in common beyond intent. A useful way to hold the range is to group it by what each form actually does, and roughly how settled the ground beneath it is, running from the oldest and most established to the newest and most contested. The detailed question of what the evidence supports I take up in the next section. Here I want to lay the forms out, and be honest about the character of each. Oldest, and most grounded, is the water. Thermal and mineral-spring bathing, and the spa tradition built on it, is where wellness tourism began and remains its most serious wing. This is the European Kur in its proper sense, balneotherapy and hydrotherapy under some degree of medical supervision, and it is also the onsen culture of Japan and the bathhouse revival now spreading through cities. It is the part of the field with the deepest history and, not by coincidence, the firmest evidence, particularly for musculoskeletal complaints and for stress. When people want to show that wellness travel is more than indulgence, this is usually where they point, and they are right to. Next, and almost as straightforward, is movement. Fitness retreats, active holidays, training camps, hiking and cycling weeks, and the more physical end of yoga belong here. There is nothing mysterious about why these work, when they do: they are exercise, done with attention and without the usual excuses, in a place arranged to make it easy. The honest appeal is not some special property of the destination but the removal of everything at home that stops you moving. A week that gets a sedentary person genuinely active is worth having, whatever you call it. The fastest-growing wing addresses the mind, and it is the one the modern appetite for wellness is really built on. Mindfulness and meditation retreats, dedicated mental-health and burnout programmes, digital-detox stays that take the phone away, and the newer sleep-focused offerings all sit here. This is wellness tourism answering the tiredness and stress I described earlier, and for stress and the milder reaches of anxiety and low mood the evidence is genuinely encouraging, which I come to. It is also, for the reasons in the last section, the wing most often asked to carry more than it can, where a retreat is hoped to mend something that needs a good deal more than a retreat. Then come the traditions, the classical healing systems people travel into rather than merely sample. Ayurveda above all, with its multi-week panchakarma programmes in India and Sri Lanka, but also traditional Chinese medicine and other long-established systems. These are not inventions of the wellness industry. They are old, coherent, and practised by people trained in real lineages, and they deserve more respect than a sceptic gives them and more scrutiny than an enthusiast does. The evidence is genuinely mixed, the quality of practitioner varies enormously, and there are real safety questions around some preparations. They are serious things, done well or badly, and the gap between the two matters more here than almost anywhere. Then there are the nutritional and fasting programmes, among the most popular forms of all, ranging from gentle dietary resets to extended, closely managed fasts. What any particular regime does or does not achieve is a question for nutrition specialists rather than for me, and I am content to leave it with them. The point that belongs in a guide like this is the practical one: these programmes run from the mild to the genuinely demanding, and the demanding end, prolonged fasting above all, is the part that calls for real medical supervision rather than a casual booking. And at the far edge sit the experiential and the ceremonial: spiritual retreats, pilgrimage in its modern wellness form, and the plant-medicine and psychedelic programmes built around ayahuasca, psilocybin and the like. This is the most contested ground in the whole field, and the most uneven. Some of it is ancient and culturally serious. Some of it is unregulated, legally grey, and genuinely hazardous, mixing powerful psychoactive substances with strangers in places with no medical cover. There is also, confusingly, a thread of serious clinical research running alongside it, into psilocybin for depression in particular, which a retreat in the jungle has almost nothing to do with. Anyone drawn to this end owes themselves far more homework than the rest of the field asks, and I treat its risks separately later on. That is the spread, from the bathhouse to the ceremony. What none of these descriptions has yet done is say plainly which of them stands up to examination and which leans on hope. That is the next question, and the one this guide has been circling from the start. ## What the Evidence Says So: what actually works? It is the question the whole field tends to avoid, and the fair answer is more encouraging than a sceptic expects and more qualified than a brochure admits. There is a pattern worth stating up front, because it holds across almost everything below. The evidence is strongest for the oldest and simplest interventions and thinnest for the newest and most heavily marketed, and even where it is good, the honest finding is usually a real but modest benefit rather than a transformation. Hold that shape in mind and most of wellness tourism falls into place. What the evidence actually supports Strongest at the top Thermal and mineral water Systematic reviews on osteoarthritis pain; named in European and American rheumatology guidance Movement Works for the plainest reason in medicine; the value is structural, not the mountain air Mindfulness and meditation JAMA Internal Medicine review and meta-analyses since: moderate, replicated benefits Time in forest Short-term falls in blood pressure and cortisol; small studies, strong expectation effects Ayurveda and TCM Some interventions hold up; uneven across the whole, plus documented heavy-metal contamination Lasting behaviour change The thinnest part of the picture, and the thing the industry most likes to imply Ordering follows this page's own account of the evidence, best supported first. The meter is a reading of that account, not a published score: no body ranks these against each other. Download this chart PNG, free to republish with attribution Start where the evidence is best, which is also where the field began. Thermal and mineral-water treatment, the old balneotherapy of the European cure, has a genuine research base behind it. Systematic reviews of bathing in thermal mineral water find consistent improvements in pain and quality of life for people with osteoarthritis of the knee, hip and spine, and the effect is taken seriously enough that both the European and the American rheumatology bodies mention thermal treatment in their guidance for managing the condition. The usual and fair caveat applies: many of the underlying studies are small or methodologically weak, and the reviewers say so plainly. But the direction is steady across decades of work, and the mechanism is no mystery. Warm water eases stiff joints, takes the load off them, and the heat and minerals do measurable things to circulation and inflammation. Of everything in this guide, this is the part that has most earned the right to be called treatment. Next, and almost too obvious to argue, is movement. A fitness retreat, an active week, the more physical reaches of yoga: these work, when they work, for the plainest reason in medicine, which is that exercise is good for you and most of us do too little of it. There is no special property in the mountain air. The value is structural, the way a residential week strips out the desk, the car and the excuses and leaves you with little to do but move. The honest claim is small and solid. Take a sedentary person, put them somewhere built around activity, and they will move more than they do at home, and be the better for it while they keep it up. The mind is where the modern appetite for wellness really sits, and the evidence there is genuinely encouraging without being miraculous. For mindfulness and meditation the research is now substantial. A landmark review in the Journal of the American Medical Association's internal medicine title, and a good many meta-analyses since, find moderate, replicated benefits for anxiety, depression and stress, on a par with what you might hope for from a decent self-help intervention. Two honest qualifications belong with that. The effects, while real, are moderate rather than dramatic, and they tend to shrink when meditation is measured not against doing nothing but against another active practice, which suggests some of the benefit is the structure and the attention rather than anything unique to meditation itself. And the quality of the studies varies a great deal. None of which is a debunking. For stress and the milder reaches of low mood, this is a real and useful thing, backed by more evidence than most of what is sold alongside it. The same broadly holds for nature, which the Japanese formalised as forest bathing and the research has taken more seriously than the name suggests. Several reviews find that time spent in forest does measurably lower blood pressure and the stress hormone cortisol, at least in the short term. The studies are mostly small, often Japanese, and not always well controlled, and one review caught the telling detail that people's stress markers fell merely in anticipation of the forest, before they had set foot in it, which says something about how much of the effect is expectation. Even so, that a quiet walk among trees calms the body is both plausible and reasonably well supported, and it costs nothing to believe. Here the thread I left hanging earlier has to be picked up, because it qualifies all of this. Almost every benefit above is easy to produce on the retreat and hard to keep once the retreat ends. The immersive week is wonderful at starting a change and largely silent on sustaining it, and the honest truth is that the evidence for lasting behaviour change, the thing the industry most likes to imply, is the thinnest part of the whole picture. A fortnight of good sleep, clean eating and daily movement proves only that you can do those things in a place designed for them. Whether you still do them in the place that wore you down in the first place is the question that matters, and the better programmes know it, which is why they build follow-up and home practice into what they sell. Treat any promise of permanent transformation with the caution it has earned. The classical traditions ask for both more respect and more care than either side tends to give them. Ayurveda and traditional Chinese medicine are old, coherent systems, and some of their specific interventions hold up in trials, certain herbal preparations among them. But the evidence across the whole is uneven, the quality of practitioner varies enormously, and there is a real safety issue the romance around these traditions tends to skate over. Some Ayurvedic preparations, the herbo-metallic ones in particular, have been found to contain dangerous levels of lead, mercury and arsenic, and there are documented cases of heavy-metal poisoning traced to them across several countries, with the metal content varying wildly even between batches of the same product. The traditional belief that processing renders those metals safe is not borne out by the poisoning records. So take the traditions seriously, by all means, but choose a properly trained practitioner, be wary of what you are given to swallow, and treat the herbo-metallic remedies with particular caution. Last, and most surprising, is the ceremonial and plant-medicine end, where the evidence is doing something genuinely interesting. There is now serious clinical research into psychedelics, psilocybin above all, and for depression the trial results are striking, with large effects and some sign that a single supervised session can help for months. Ayahuasca has early but real trial support for treatment-resistant depression too. This is not fringe science any more. But the gap between that research and a ceremony in the jungle is the whole point, and it is a chasm. The trials that produce those results screen their participants carefully, exclude the people for whom the drugs are dangerous, and run the session with medical supervision and structured psychological support. A retreat with strangers in a place with no medical cover offers none of that, while using substances powerful enough to raise blood pressure sharply and to drag traumatic memories to the surface, which can heal under the right conditions and harm badly under the wrong ones. The promise is real. The setting in which most wellness travellers will meet it is not the setting that produced the promise, and that distinction matters more here than anywhere else in this guide. Step back from all of it and the picture is neither the believer's nor the cynic's. A good deal of wellness tourism rests on real evidence, more of it than its detractors think. Much of what works delivers a real but modest good rather than a transformation, which is no small thing in a world short of both rest and movement. Some of it is sold far beyond anything the evidence will bear. And the traveller's task is only to tell those apart, which is easier than the marketing makes it look, because the tell is consistent. The further a claim travels from rest, movement, water, attention and a change of surroundings, and the closer it gets to curing and transforming, the harder you should look before you pay. That is not a reason to be cynical about wellness travel. It is how you get the real good out of it. ## The Wellness Tourism Market Here is the figure that ought to change how the field is seen: the Global Wellness Institute measured wellness tourism at $894 billion in 2024, and projects it past a trillion dollars a year in 2026. The number wants a caveat from the very start, because wellness is a loosely drawn word and a great deal gets folded under it, but even read conservatively it makes the part of health travel most often waved away as frivolous, by money and by sheer number of trips, far the largest part of the whole field. It is bigger than medical tourism several times over. The pole everyone dismisses is the bigger business by a wide margin, and it is worth understanding why, and what the trillion does and does not mean. Begin with an unusual point in its favour. On the umbrella page I made a good deal of the fact that medical tourism cannot be pinned to a credible single number, with serious estimates spread eightfold, from the mid-thirty billions to well over two hundred. Wellness tourism is the rare corner of this field where the numbers roughly agree. Measuring the present market, the major research houses land within a fairly narrow band of one another. Source Wellness tourism market Basis Global Wellness Institute $894 billion 2024, measured Grand View Research ~$990 billion 2025, firm estimate Straits Research ~$1.03 trillion 2025, firm estimate Precedence Research ~$1.03 trillion 2025, firm estimate Future Market Insights ~$1.21 trillion 2025, firm estimate Recent wellness tourism estimates, each verified against the publisher's own page on 31 August 2026 and linked in the source column. Read the GWI row differently from the rest: it is a measured figure for a completed year, while the others are firms' own 2025 valuations. The spread is narrow by the standards of this industry, largely because the Global Wellness Institute is the field's principal measurer and most others track close to its definition. Note that GWI itself forecast the trade would pass a trillion dollars in 2024 and then measured $894 billion, which is the difference between a forecast and a count. That agreement is reassuring and a little misleading at once, because a trillion dollars is not a trillion spent on dedicated wellness trips. The figure is generous by construction. It counts what the Institute calls secondary wellness travel, the spa afternoon taken on a business trip, the healthier hotel chosen over the cheaper one, the better menu and the morning swim on an ordinary holiday, right alongside the person who flies somewhere expressly for a retreat. Most wellness travel is of that secondary kind, and most of it is domestic rather than international. So read the trillion correctly. It is not the size of a global retreat industry. It is a measure of how widely the wish to look after oneself has spread across travel as a whole, which is a real and significant thing, but a different one. The forecasts, as ever, deserve less trust than the present figures. Projected growth across the five firms in the table above runs from 7.8 to 10.4 per cent a year, and the Institute itself cut its own forward estimate for wellness tourism from over sixteen per cent a year to around nine between two of its reports. Nobody knows how fast this grows. They know only that it grows, and has grown faster than tourism in general: on the Institute's own numbers, 6.4 per cent a year between 2019 and 2024 against 1.9 per cent for tourism as a whole, lifting wellness from 14.2 to 17.6 per cent of all tourism spending. Set against the rest of the field, the scale is striking. Medical tourism, the serious clinical end that commands all the attention, sits somewhere between thirty-four billion dollars and two hundred and seventy-eight on the estimates I gathered for that guide. Wellness tourism is approaching a trillion, and on the commercial estimates has already passed it. The quiet, discretionary, much-mocked business of helping well people stay well is, in plain commercial terms, the giant of health travel, and the surgical end is the smaller sibling. Why everyone now chases it is no mystery, and the reasons are worth being honest about. Wellness travellers spend more, markedly more: the Institute puts the average international wellness tourist's outlay at around forty per cent above that of the ordinary international tourist, and the domestic premium is larger again. Wellness trips make up under a tenth of all tourism trips but close to a fifth of all tourism spending. And there is a colder reason beneath the warm language, which the brochures will never state and I may as well. The wellness end carries that premium spend without the risk that haunts the medical end. A spa cannot be sued for a fatal complication. A meditation retreat carries no malpractice exposure, no revision surgery, no patient flown home worse than they arrived. For a hotel group, a destination or a health ministry, wellness offers a good deal of the money of medical tourism and almost none of the danger, and that pairing, high spend and low liability, is why every resort now has a spa, every destination a wellness strategy, and every tourism board a slide about it. It is the most attractive proposition in health travel, and the safest. None of which is cause for cynicism, only for reading the number with your eyes open. The trillion is real, and it tells you something true, that looking after oneself has quietly become a mainstream feature of how the world travels. It also flatters, by counting every healthy breakfast on an ordinary holiday as a slice of the wellness economy. Both things are true at once, and holding them together is most of what it takes to understand this market. ## Wellness Tourism Destinations Wellness destinations are scattered across the world in a way medical ones are not, and the reason is built into the thing itself. Medical tourism clusters, because the patient is chasing a fairly small number of places that can do a particular procedure cheaply or well, and I argued on that page that the list is short and barely changes. Wellness has no such gravity. The asset that makes somewhere a genuine wellness destination, a hot spring, a healing tradition, a landscape, a culture built around rest or the body, is spread all over the map, and so the destinations are too. There is no honest top ten, whatever the lists tell you. There are many places, each good for a particular thing. Which is the first and most useful thing to understand about choosing one: you choose by what you want, not by ranking. The question is never which is the best wellness destination in the world, a question with no answer, but which place has a real, rooted strength in the specific thing you are after. Go to the home of the tradition you actually want, and ignore the rest of the list. The distinction that matters more than any ranking is between the rooted and the manufactured, and it is worth learning to spot, though it is not, for wellness, the moral fault line it can be at the medical end. Some wellness destinations have earned the name over centuries. The thing they offer grew out of the place and the culture, and the depth shows. Others are manufactured: a fine resort with a beach and a spa menu, dropping a wellness concept onto ground with no particular tradition behind it, and calling the result a destination. The manufactured kind is not a scandal. A great deal of it is professionally run and genuinely pleasant, and if a well-made spa week in a beautiful hotel is what you want, you will not be cheated. But you should know which you are buying, because the rooted place offers something the manufactured one cannot fake, and the manufactured one often charges as though it could. The rooted traditions are not hard to name, and the most serious of them is the one nearest home for a European reader. The thermal cure, the Kur of the German-speaking world and the spa towns of Central Europe, is the evidence-backed, medically supervised end of wellness travel I keep returning to, and it is real in a way little else in the field is. Beyond it sit a handful of other genuine traditions, each the true home of a particular kind of wellness. Tradition Genuinely rooted in What you go for The thermal cure (Kur) Germany, Austria, Hungary, Czechia, Italy, France Medically supervised thermal and mineral-water treatment, the evidence-backed end Onsen and forest culture Japan Hot-spring bathing and forest bathing, in a culture built around both Ayurveda and yoga India, Sri Lanka Classical Ayurveda and panchakarma, and yoga practised at its source Traditional medicine and spa Thailand Thai traditional medicine, and a deep, mature spa and retreat infrastructure The most deeply rooted wellness traditions and their true homes. The point of the table is not a ranking but a match: go to the place where the thing you want actually grew up. Alongside these sit the places that are neither ancient tradition nor pure manufacture, and they deserve an honest word, because they are where a great many people actually go. Bali, Portugal, Costa Rica and their like have built genuine modern retreat scenes, yoga, mindfulness, nature immersion, on the strength of good climate, real beauty and, in Bali's case, a living spiritual culture that the industry both draws on and, at times, dresses up. These are not fakes, and they are not the thousand-year traditions either. They are good places to do a particular kind of modern wellness, often very well, and the honest way to see them is exactly that, rather than through the soft language of ancient wisdom the marketing tends to reach for. So the whole of choosing a destination comes down to the match, the same lesson as the medical page in a gentler key. There the test was hard, because a place with no real advantage had no business taking patients at all. Here it is friendlier. Most places with a genuine asset, a spring, a tradition, a landscape, can offer a traveller something real, and even the manufactured ones are rarely harmful. The task is only to know what you want, to go where that thing is genuinely rooted rather than merely advertised, and to pay rooted prices for rooted things and manufactured prices for manufactured ones. Do that, and the spread of wellness destinations stops being confusing and becomes what it actually is: a wide choice in which almost everywhere is good for something, and the trick is knowing for what. ## Choosing a Wellness Provider The thing to understand before you book anything is that wellness travel has even less gatekeeping than the medical end, which had little enough. There is no meaningful licence to run a retreat, no body that vets who may call themselves a wellness practitioner, and almost no quality floor beneath the word. Anyone can hang out a sign. That sounds alarming, and at the intensive end it genuinely matters, but for most wellness travel the stakes are mercifully low: the worst outcome of a mediocre spa week is a disappointing spa week and a lighter wallet. So choosing well is mostly about getting your money's worth and steering clear of the few real hazards, rather than the life-and-death vetting the medical page demanded. A handful of questions does most of the work. Ask who is actually leading the programme, and what they are trained in. "Wellness" attracts the genuinely expert and the entirely self-appointed in roughly equal measure, and the difference matters most for anything with a physiological edge to it. A yoga teacher with a real lineage and years of practice is a different proposition from someone who did a fortnight's course, and a fasting or intensive nutritional programme run by people with no clinical training is a different proposition again. Look for verifiable qualifications in the specific thing on offer, not a general air of wisdom. Ask for the actual itinerary, not the promise. The reliable tell of a serious programme is that it can tell you, concretely, what you will do each day, who will run it and what it includes. The unreliable one answers in the language of transformation, of healing and journeys and holistic renewal, and goes vague the moment you ask for specifics. Vagueness is not depth. A provider that cannot describe its own programme plainly usually has less programme than it implies. For anything intensive, ask about medical screening, and be wary if there is none. This is the question that matters, and I mean it narrowly. Extended fasting, hard physical programmes and anything involving plant medicine carry real physiological risk for the wrong person, and a serious provider of those things screens its participants and has medical support to hand. One that takes all comers without asking a single health question is telling you it is not equipped for the thing it is selling. For a gentle spa or a meditation week this hardly arises. For the intensive end it is the difference that counts. Then the smaller, sensible things. Ask the group size, because individual attention falls away fast in a crowd. Ask exactly what the price includes and excludes, since wellness pricing is famously elastic. Look for independent accounts from real past guests rather than the testimonials on the provider's own page, which are curated by definition. Treat awards with the suspicion they deserve everywhere in this field; the wellness circuit runs its own prizes and they mean as little as the medical ones. And if the benefit you are after is meant to outlast the trip, ask what the programme does to help you keep it going once you are home, because the ones that have thought about that are the ones taking the lasting-change problem seriously. None of this is onerous, and none of it needs expertise. It is mostly a matter of preferring the concrete to the mystical, the qualified to the self-appointed, and the provider that asks about your health to the one that asks only for your booking. ## The Risks Worth Knowing Set against the medical end, wellness travel is low-risk, and it would be dishonest to dress it up as otherwise. Most of it carries no more hazard than an ordinary holiday, and the worst that befalls most wellness travellers is that they paid for more than they got. But the risk is not evenly spread. It concentrates at a few specific ends of the field, and those few are worth naming plainly, because that is exactly where the generous, low-stakes picture stops being true. The first is the intensive programme. Prolonged fasting and severe dietary restriction, along with the hardest physical regimes, are not harmless simply because they are sold in the language of health. For someone with diabetes, a heart condition, an eating disorder in their history, or any of a number of other circumstances, a demanding fast or a punishing fitness week can be genuinely dangerous, and the cheerful absence of clinical oversight at many such programmes makes it more so. The rule is simple. The more a programme restricts what you eat or demands of your body, the more it needs to know about your health before it begins, and the more cautious you should be if it does not ask. The second is plant medicine, the other thread from the evidence section. I said there that the clinical research into psilocybin and ayahuasca is real and the gap between that research and a jungle ceremony is a chasm, and this is where that gap turns into actual danger. A retreat using powerful psychoactive substances, often in a country with no regulation worth the name and no medical cover on site, is a genuinely high-risk undertaking dressed in the soft clothes of wellness. These substances can raise blood pressure sharply, interact badly with medication, and bring buried trauma violently to the surface in people with no support to meet it. There is also the plain legal exposure: the substances are illegal in many places, and a traveller can face real consequences at home or at the destination. None of this denies the promise the research points to. It is to say that the retreat is the riskiest way to pursue it, and anyone drawn to it owes themselves far more care, and far more honest medical advice, than the field tends to encourage. The third risk is quieter and, in its way, the most important, because it can catch the well-meaning and the seriously unwell alike. It is the temptation to let wellness travel stand in for medical care it cannot replace. This is the thread from early in the guide, where I said a retreat can open the door to recovery from something serious but cannot be the whole of it. The danger is sharper than that. A person with a real illness, of body or mind, who chooses a wellness programme over actual treatment on the strength of a provider's claims, can lose time that matters. Wellness travel sits alongside medicine. It is not a substitute for it, and any provider who implies otherwise, who suggests their programme can treat a disease that belongs in a clinic, has crossed from wellness into something closer to quackery, and should be left well alone. The last is the mildest, and the one most travellers will actually meet: the gap between what is promised and what is delivered. Most of the wellness field overpromises a little, in the ordinary way of marketing, and a fair amount of it overpromises a great deal. The harm here is usually only to the wallet and the expectations, which is why it sits last. But hold the evidence section in mind as the antidote. The further a programme's claims travel from the things that genuinely work, rest, movement, water, attention, a change of place, and the closer they get to curing and transforming, the more of your scepticism they have earned. Keep that measure, screen for the few real hazards, and wellness travel is among the safer things a person can do for themselves. Lose it, and it is among the easier ways to be parted from a good deal of money, and occasionally from rather more. ## Wellness Tourism FAQ What is wellness tourism? Wellness tourism is travel undertaken to maintain or improve your health and wellbeing rather than to treat an illness. It runs from a thermal cure or a yoga retreat to a fitness camp or a sleep programme, and what unites it is the direction: the traveller is not unwell but is trying to stay well, or to do a little better, and has chosen to leave home to do it. It is the proactive, "stay well" end of health tourism, as distinct from the reactive, clinical end. What is the difference between wellness tourism and medical tourism? They are opposite poles of the same field. Medical tourism is reactive, clinical, often invasive, and undertaken out of necessity by someone with a health problem to fix. Wellness tourism is proactive, largely non-clinical, non-invasive, and chosen by someone with nothing especially wrong who wants to keep it that way. In short, one repairs and the other maintains, and that single difference drives the contrasts in risk, cost, provider and setting between them. Why do people travel for wellness? For reasons quite unlike the medical ones. The largest is the wish to recover from the stress, overwork and exhaustion of modern life, sharpened since the pandemic. Close behind is prevention, the desire to get ahead of trouble rather than wait for it, and the simple fact that a residential programme makes habits easier to change away from the environment that keeps you stuck at home. Others travel for a specific goal, such as fitness, sleep or a deeper meditation practice, and a good deal of wellness is now folded into ordinary trips rather than taken as a dedicated journey. What are the main types of wellness tourism? The major forms, running from the most established to the most contested, are: thermal and spa tourism, built on mineral-water bathing and the European cure; fitness and active travel; mind-focused programmes covering mindfulness, meditation, mental health and sleep; the classical traditions such as Ayurveda and traditional Chinese medicine; nutritional and fasting programmes; and the ceremonial and plant-medicine end. The order roughly tracks how much evidence sits beneath each, with the oldest and simplest forms the best supported. Does wellness tourism actually work? For a good deal of it, yes, though the honest finding is usually a real but modest benefit rather than a transformation. The evidence is strongest for thermal bathing, which is recognised in rheumatology guidance for easing joint pain, and genuinely encouraging for mindfulness, meditation and time in nature, which show measurable reductions in stress, anxiety and mild low mood. It is much thinner for the promise of lasting change, since most benefits are easy to produce on the retreat and hard to keep once it ends. As a rule, the closer a claim stays to rest, movement, water and attention, the better it is supported. How big is the wellness tourism market? Large, and larger than most people expect: the Global Wellness Institute, which measures this field, put wellness tourism at $894 billion in 2024. Commercial research firms run higher for 2025, from Grand View's $990 billion to Future Market Insights' $1.21 trillion, and three of the four do cross a trillion. Read against the medical tourism estimates gathered on the guide to that field, $34 billion to $278 billion, even the institutional figure makes wellness tourism several times the size of medical tourism. Read the number with some care, though. It is generous by construction, counting wellness folded into ordinary trips, the spa afternoon or the healthier hotel, alongside dedicated wellness travel, and most of it is domestic. It is best understood as a measure of how widely the wish to look after oneself has spread across travel, rather than the size of a global retreat industry. What are the best destinations for wellness tourism? There is no honest single answer, because wellness assets are spread across the world rather than concentrated, and the right destination depends entirely on what you want. For medically supervised thermal treatment, the spa towns of Germany, Austria, Hungary and Central Europe lead; for Ayurveda and yoga at their source, India and Sri Lanka; for hot springs and forest culture, Japan; for traditional medicine and a deep spa infrastructure, Thailand. The useful distinction is between destinations rooted in a real tradition and those that simply attach a wellness concept to a nice resort, both of which can be worthwhile if you know which you are buying. Is wellness tourism safe? For the most part, yes. Most wellness travel carries no more risk than an ordinary holiday, and the worst that befalls most travellers is paying for more than they got. The genuine hazards concentrate at a few specific ends of the field: intensive fasting and demanding physical programmes for people with underlying conditions, plant-medicine and psychedelic retreats run without medical cover, and the quiet danger of letting wellness travel substitute for real medical care it cannot replace. Screen for those, and wellness travel is among the safer things a person can do for themselves. How do I choose a good wellness retreat? Prefer the concrete to the mystical. Look for verifiable qualifications in the specific discipline on offer, ask for an actual day-by-day itinerary rather than the language of healing and transformation, and check the group size and exactly what the price includes. For anything intensive, such as fasting, hard physical programmes or plant medicine, confirm there is proper health screening and medical support, and be wary if a provider takes all comers without asking a single health question. Seek independent reviews from past guests rather than the testimonials on the provider's own page, and if the benefit is meant to last, ask what is done to help you keep it going at home. Is wellness tourism covered by health insurance? Usually not. Standard health insurance does not generally cover wellness programmes, since by definition they treat no diagnosed condition. The main exception is the medically supervised thermal cure, which has a long history of partial integration with public health systems in parts of Europe, particularly the German-speaking countries, though the rules there have tightened over the years. Some corporate health and wellbeing schemes include a wellness travel allowance. Assume you are paying yourself unless you have specifically checked otherwise. ## Sources Global Wellness Institute. "What is Wellness Tourism?" Read 31 August 2026. States wellness tourism expenditures reaching $894 billion in 2024. globalwellnessinstitute.org/what-is-wellness/what-is-wellness-tourism Global Wellness Institute. "Statistics and Facts", drawing on the Global Wellness Economy Monitor 2025. Read 31 August 2026. States the wellness economy grew 7.9 per cent from 2023 to 2024 and reached $6.8 trillion in 2024. globalwellnessinstitute.org/press-room/statistics-and-facts Global Wellness Institute. "Wellness Tourism Will Cross the $1 Trillion Mark in 2024", 28 November 2023. Source of the 7.8 per cent of trips and 18.7 per cent of tourism expenditure figures, and of the trillion-dollar projection that the 2024 count came in below. globalwellnessinstitute.org/global-wellness-institute-blog/2023/11/28 Grand View Research. "Wellness Tourism Market Size & Share Report, 2026-2035", 2026. States USD 990.4 billion for 2025. The page returns 403 to automated requests; the figure was confirmed from its own indexed text on 31 August 2026. grandviewresearch.com/industry-analysis/wellness-tourism-market Straits Research. "Wellness Tourism Market", 2026. States USD 1,029.65 billion for 2025. Read 31 August 2026. straitsresearch.com/report/wellness-tourism-market Precedence Research. "Wellness Tourism Market", 2026. States USD 1,032.38 billion for 2025. Read 31 August 2026. precedenceresearch.com/wellness-tourism-market Future Market Insights. "Wellness Tourism Market", 2026. States USD 1,213.8 billion for 2025. Read 31 August 2026. futuremarketinsights.com/reports/wellness-tourism-market Meditation evidence. Goyal M, Singh S, Sibinga EMS, et al. "Meditation Programs for Psychological Stress and Well-being: A Systematic Review and Meta-analysis." JAMA Internal Medicine 174(3):357-368, March 2014. pmc.ncbi.nlm.nih.gov/articles/PMC4142584 Traditional-medicine safety. Saper RB, Phillips RS, Sehgal A, et al. "Lead, Mercury, and Arsenic in US- and Indian-Manufactured Ayurvedic Medicines Sold via the Internet." JAMA 300(14):1652, 8 October 2008. Found detectable lead, mercury or arsenic in one fifth of the products tested. pmc.ncbi.nlm.nih.gov/articles/PMC2755247 ## Wellness tourism coverage 20 reports Update July 8, 2026 Medical Tourism Records Concentrate In Penang And Seoul This is the Health Tourism News roundup for the week of June 29 to July 7 2026. Malaysia and South Korea both reported record medical tourism figures this... Update July 1, 2026 Nigeria, Iran And Seoul Redraw Medical Tourism This is the Health Tourism News roundup for the week of 24 to 30 June 2026, and it read less like a sales pitch than a stocktake of leaks. Nigeria wants its... Update June 24, 2026 Health Tourism As Badge, Escape Hatch And Disguise This Week In Health Tourism 16.06.26 - 23.06.26. Three governments spent the week calling medical tourism a pillar of national economic strategy, while a... Update June 15, 2026 This Week In Health Tourism 08.06.26 - 15.06.26 This is the Health Tourism News roundup for the week of 8 June 2026, and the clearest signal across it is that the contest in medical tourism has moved past... Update June 14, 2026 This Week In Health Tourism 31.05.26 - 07.06.26 This is the Health Tourism News roundup for May 31–June 7, 2026. This week's signals highlight a dual trend: destinations are aggressively pursuing growth in... 2026 8 Assocham Symposium Pitches Northern India Wellness Longevity Tourism Reshapes Global Healthcare South Africa Medical Tourism: The Numbers Behind The Pitch Medical Tourism Trends 2026: What Is Actually Changing South Korea Wellness And Dermatology Tourism Keep Climbing Does Integrative Medicine Work? Evidence and Outcomes Types of Integrative Medicine: TCM, Ayurveda and More Wellness Tourism Trends: What Clients Actually Want 2025 7 Integrative Medicine and the Provider-Patient Relationship Global Landscape of Integrative Medicine and Wellness Tourism World’s Healthcare Leaders Set to Return to Riyadh for Global Health Exhibition 2025 in October China's Medical Tourism Bet on Traditional Chinese Medicine What Is Health Tourism? Skin Health Is a Global Priority, Not Just Cosmetic Ayurveda Tourism: India's Traditional Medicine Goes Global --- # What Is Dental Tourism? Costs, Risks and Destinations URL: https://health-tourism-news.com/dental-tourism/ Pillar Guide Updated June 2026 What Is Dental Tourism? Costs, Risks and Destinations Dental tourism is the most common form of medical travel there is, and the one people approach most casually. It is also, on the whole, a genuine bargain, and that is exactly what makes its risks so easy to miss. This guide sets out what dental work abroad really costs, why so many people now go, the handful of hazards that matter, including the irreversible "Turkey teeth" phenomenon, where the established corridors are and how to choose between them, and how to pick a clinic without being sold work you do not need. It is written from the clinical end of health travel, by someone who takes dental tourism seriously as the largest and most useful part of the field, and stays candid about the particular ways the easy ones go wrong. By Christian El-Khouri, Editor-in-Chief, Health Tourism News Last updated: September 2026 Last verified: 1 September 2026 37-72%Range on the routes we price ourselves, single implant restored $3,355UK median for a single restored implant, the anchor above Contents ## What Dental Tourism Is Dental tourism is travel abroad for dental treatment, and it is the form of medical travel almost everyone meets first. It is also the most common kind there is. When the American health authorities looked at why their citizens go abroad for care, dental work came top of the list, ahead of every kind of surgery, and the reason is not complicated. Teeth are expensive everywhere, dental insurance is thin everywhere, and the savings abroad are large and, unusually for this field, reliable. More people cross borders for their teeth than for almost anything else medicine offers. It is worth being clear at the outset about how this sits inside the wider field, because dental tourism is a part of medical tourism, not a thing apart from it. If you have read the medical tourism guide, the machinery will be familiar: the same five reasons people travel, the same questions about who profits from the arrangement, the same risks around judging quality from afar and managing trouble once you are home. I will not repeat all of that here. This page is about what dental travel does differently, and it does enough differently to earn its own treatment. What it owns, more than any other corner of the field, is reach. Dental tourism is the democratic one. Most medical travel is for people with a serious problem and, often, serious money: the heart operation, the cancer treatment, the joint replacement that runs to five figures. Dental travel is for everyone. A single implant or a couple of crowns is within reach of an ordinary person on an ordinary wage, and the savings on even a small job can cover the flights and the hotel with money to spare. That accessibility is the whole character of the sub-sector. It is the entry point, the form of medical travel people try first, often years before they would consider going abroad for anything more serious, and for a great many it is the only kind they will ever need. The cost case is also, genuinely, stronger here than almost anywhere else in medical travel, and I say that as someone generally wary of how savings get sold. On the medical tourism page I spent some time pulling apart the headline percentages, because a saving measured against an American hospital's list price is measured against a number almost nobody actually pays. Dental is different. The home price you are comparing against is, for most people, a real price, the actual out-of-pocket cost at a private dentist, because dental insurance is poor in almost every country and even the insured pay most of it themselves. So when a clinic abroad quotes you a third of the home figure, that third is usually honest in a way the surgical equivalents often are not. The saving is real, and it is the engine of the whole thing. And yet the very things that make dental travel so accessible, that it is cheap, routine and feels low-stakes next to surgery, are exactly what make it the form people walk into least carefully. Nobody books a heart operation abroad without anxiety. People book a smile makeover the way they book a holiday, and that is where the trouble starts. The risks in dental travel are real, but they are quiet ones, and they hide inside the routineness: the work that cannot be undone, the treatment you did not need, the second and third trips the brochure did not mention. This guide takes dental tourism seriously, as the largest and most useful part of medical travel, and it stays honest about the particular ways the easy ones go wrong. That balance, the genuine value and the underestimated risk, is the whole of it. ## Why People Travel for Dental Care The reasons people travel for dental work are mostly the five I set out on the medical tourism page, with the weighting shifted. Cost dominates, more completely than in almost any other part of medical travel. But two of the others, access and appearance, do enough of the work in dental specifically that they are worth taking on their own terms. Cost first, because it is the heart of it. Dental work is dear in the rich countries for reasons that have little to do with the work itself: high clinic overheads, high labour costs, expensive laboratory fees, and dental systems that have quietly shifted most of the bill onto the patient. That last point matters most and gets noticed least. In most countries dental care sits half outside the public health system, and dental insurance, where it exists at all, covers a fraction of any serious work. The British health service offers a few hundred pounds towards complex treatment and no more. American public cover offers nothing for it. So unlike the heart operation or the hip, which someone's insurance or health service may well pay for at home, the dental patient is usually paying out of their own pocket from the first pound, and a person paying their own way is a person who shops around. That is why the same procedure at a third or a quarter of the price abroad moves so many people to get on a plane. The saving is theirs to keep. Access is the second driver, and in some places it has overtaken cost entirely. This is clearest in Britain, where public dentistry has been failing for years in a way that has become its own small national scandal. By the government's own figures, something like fourteen million adults in England, more than one in four, cannot get an appointment with a health-service dentist. Whole regions have become what the press now calls dental deserts, with practices closed to new patients for years at a stretch. The result has been reported in Parliament and the papers alike: people pulling their own teeth at home, queues forming when a rare appointment is released, and, said plainly by members of Parliament describing their own constituents, pensioners flying abroad for basic dental treatment they cannot get at home. When a person cannot see a dentist in their own country at any reasonable price or within any reasonable time, the flight to Budapest or Istanbul stops being a luxury and becomes the only option on the table. For a growing number, dental travel is not about saving money. It is about getting treated at all. Appearance is the third, and it is the newest and fastest-growing, and the one that carries the most trouble in its wake. A large and rising share of dental travel is not about health at all but about looks: whiter, straighter, more uniform teeth, the smile makeover sold hard across social media to people who were never in any pain. This is the part of dental tourism that shades into cosmetic tourism, and I take up the broader business of appearance medicine on that page. But it belongs here too, because the demand for a perfect smile, cheaply and quickly, is what drives the volume end of dental travel, and it is where the worst of the harm has gathered. People who genuinely need a tooth replaced are one kind of dental traveller. People talked into reshaping a healthy mouth they were unhappy with are another, and the second group, as I come to when I reach the risks, are the ones the industry has served worst. Those are the three that move people: a bill they must pay themselves and can cut sharply, a home system that in places can no longer see them, and the pull of a better smile. The first is rational and largely sound. The second is a symptom of something broken at home, much as I argued the whole of medical tourism is. The third is where desire and salesmanship meet, and where a person most needs to keep their head. ## What Dental Work Abroad Costs The numbers are the reason anyone reads a page like this, so here they are, with the usual warning that they are indicative ranges and not quotes. Dental pricing moves by clinic, by city, by the seniority of the dentist, by the brand of the components and by the complexity of your particular mouth, and no table can stand in for an itemised quote built from your own X-rays. What a table can do is show the shape of the thing, and the shape is stark. A full arch of teeth, per jaw Treatment only, indicative ranges USA $20k - $38k Mexico $9k - $14k Turkey $3.5k - $9k Hungary $7k - $11k Poland $7k - $11k Thailand $8k - $13k 0$10k$20k$30k$40k Ranges as published in the cost table on this page: aggregated 2025 to 2026 clinic and market data, treatment only, excluding flights, accommodation and any return trip. Download this chart PNG, free to republish with attribution Procedure Where Price panel Home-market anchor Difference Single implant, restored Poland $535 - $1,340 $3,355 UK median -72% Türkiye $940 - $1,140 $3,355 UK median -69% Hungary $950 - $1,460 $3,355 UK median -64% Croatia $1,050 - $1,715 $3,355 UK median -59% Thailand $1,050 - $3,150 $3,355 UK median -37% Mexico $1,200 - $1,730 $3,500 - $5,500 US complete -67% All-on-4, per arch Türkiye from $2,150 $16,100 - $33,500 UK published floor Poland $5,700 - $8,900 $16,100 - $33,500 UK -71% Hungary $6,965 - $11,400 $16,100 - $33,500 UK -63% Croatia $7,550 - $8,750 $16,100 - $33,500 UK -67% Mexico $8,110 - $13,500 $25,000 - $35,000 US, large chains -64% Thailand $9,900 - $13,200 $16,100 - $33,500 UK -53% Porcelain veneer, per tooth Türkiye $215 - $430 $823 UK median -61% South Korea $720 - $1,500 $823 UK median +35% Every row is drawn from the Health Tourism News treatment guide linked in its destination cell, where the provider panel, the dates the lists were read and the conversion rates are set out in full. Panels are lists published by named providers, held on file, verified July 2026 and re-verified quarterly. The difference column compares panel midpoints against the home-market anchor midpoint, so it describes typical against typical. Anchors are what a patient actually pays, never a list price. Treatment only: flights, accommodation and the second trip are excluded. Crowns and root canals have been removed from this table because we hold no price panel for them; a shorter sourced table is worth more than a longer unsourced one. Look at the table and the first thing to say is that, yes, the saving is genuine, and on the larger jobs it is enormous. A full arch of teeth that runs past thirty thousand dollars at home can be had, to a comparable clinical standard at a good clinic, for a quarter or a third of that. On a single small procedure the headline gap is just as wide in percentage terms. That is the real and honest core of dental tourism, and I will not pretend otherwise. But the headline number flatters in two directions, and both deserve naming. It flatters the small jobs, because the moment you add the flights, the hotel and the time off work, a single implant that looked seventy per cent cheaper is a good deal less cheap, and for one small thing the trip may barely pay. And it understates the big ones, because the table shows treatment only, and the full-arch traveller saves not a few hundred but ten or twenty thousand dollars, enough to dwarf any travel cost. So the rule that falls out of the table is this: dental travel pays best for big, multi-unit work and pays least for a single small repair. The more teeth involved, the stronger the case. Two things hide inside the prices that no table can show, and both are where the saving can turn out to be false. The first is what the implant actually is. An implant is not an implant: a fixture from one of the established global manufacturers and an unbranded one from a factory you have never heard of can sit in the same price column and the same jaw, and the gap in the quote is often precisely that difference. It matters beyond snobbery, because the recognised systems are the ones a dentist at home can identify, service and repair years later, while the obscure one may leave you with work nobody back home can touch. Ask which brand, get it in writing, and be wary of a price that looks too good against the others in its row. The second is what the quote includes. The cheapest figure is sometimes the implant alone, with the abutment and the crown added later, so that the bargain quietly assembles itself into something closer to the rest of the field by the time you have a tooth you can chew on. Compare like for like, or you are not comparing at all. One honest footnote on the geography, because the league table has shifted. Hungary, and Budapest above all, was the original bargain of European dental travel, and for thirty years it earned the name. It is no longer the cheapest. Years of demand and a generation inside the European Union have pushed Hungarian prices up to the point where Turkey now plainly undercuts it, and the patient chasing the lowest number has largely moved on. That does not make Hungary a worse place to have your teeth done. It makes it a reminder that "cheapest" is a moving target in this business, and not the only one worth aiming at. ## The Risks That Matter Dental travel is lower-risk than surgical travel, and I have said so more than once, because it is true and because the opposite claim frightens people for no good reason. The four risks I set out on the medical tourism page all apply here, judging quality from afar, the danger of infection, the problem of who cares for you afterwards, and the question of who pays when something needs putting right, and I will not walk through them again in the same terms. What I want to do instead is name the handful of hazards specific to teeth, because they are not the ones people expect, and they hide, as I keep saying, inside how routine the whole thing feels. The first is the simplest and the most underestimated: time. A good deal of dental work cannot honestly be done in a single trip. An implant is not a tooth screwed into a jaw in an afternoon; it is a fixture placed in the bone, then left for months while the bone grows around it and holds it fast, and only then crowned. That healing, three to six months of it for most people, is not optional, and it means the honest version of implant treatment abroad is two trips, sometimes three, with the flights and the hotels and the time off work doubled accordingly. Some clinics will offer to compress it, to place and crown in a single visit, and for the right case in the right mouth that can be sound. But where it is offered to save you a second flight rather than because your bone is ready, it is the convenience of the seller dressed as a kindness to the buyer, and it is the wrong reason to rush a thing that does not want rushing. Plan for the trips the treatment actually needs, and be suspicious of a timeline that happens to match your holiday. The second is the one that does the most damage, and it is a problem of incentive. A dentist who is paid per crown has a reason to fit crowns, and the further you travel into the cheap, high-volume end of cosmetic dentistry, the stronger that reason runs and the weaker the things that would normally check it. This is not a dark secret. A BBC documentary put it to the test directly: a dentist sent photographs of her own perfectly healthy teeth to well over a hundred clinics abroad and fifty at home, asking for veneers. More than half the overseas clinics wrote back recommending she have twenty or more teeth crowned. Not one of the clinics at home recommended any treatment at all, because there was nothing to treat. That is the whole problem in a single experiment. When the person advising you on whether you need work is also the person who profits from the work, and no one who knows you is in the room, you are being sold to, not cared for, and a healthy mouth is no defence. Which leads to the gravest of them, the one that cannot be taken back. The over-selling matters so much in dentistry because so much of what gets over-sold is irreversible. Here is the distinction everyone should understand and almost no one is told, between a veneer and a crown. A veneer is a thin shell bonded to the front of a tooth, taking a fraction of a millimetre of enamel, and in its gentlest forms it can sometimes be undone. A crown requires the tooth to be ground down to a small peg, sixty or seventy per cent of it filed away, to seat a cap over the stump. On a tooth that is broken or decayed, that is good and necessary dentistry. On a healthy tooth, done for the sake of appearance, it is the permanent destruction of something that was working, and it can never be reversed, because once the tooth is a peg there is no longer enough of it to hold a veneer or anything else. The patient is committed for life to a cycle of replacement, and if the work was poor the road runs through infection, root canals, and teeth lost altogether. The step that cannot be taken back A veneer and a crown are not alternatives Veneer A thin shell bonded to the front Removes A fraction of a millimetre of enamel Afterwards In its gentlest forms, sometimes reversible Crown A cap over the whole tooth Removes Sixty or seventy per cent of the tooth, filed to a peg Afterwards Cannot be undone The distinction every patient should hold before agreeing to anything. Crowns are the right treatment for a tooth that is badly damaged or decayed. Filing down a healthy tooth to fit one, for the sake of appearance, is the irreversible step at the heart of most dental tourism horror stories. This is the phenomenon that acquired a nickname, "Turkey teeth", and the name needs a word of fairness. It stuck to Turkey because Turkey is the largest and most visible dental destination in the world, the place the volume and the social-media smiles, and therefore the horror stories, most often come from. But the thing itself is not Turkish and not confined to Turkey. It is what happens wherever cheap cosmetic dentistry is sold at volume to people who want a quick, dramatic result, and it can be found, and avoided, in every dental corridor on the map. A good clinic in Istanbul will treat your teeth more conservatively than a bad one anywhere; the country on the sign is not the variable that matters. So take the warning for what it is, a warning about a practice and an incentive, not about a place. The lesson is not "avoid Turkey". It is "be enormously careful before you let anyone file down a healthy tooth, wherever in the world they propose to do it". The last risk is the one that turns a bad outcome into a lasting one: what happens when it fails, and you are home. A crown fractures, an implant does not take, an infection sets in, and the clinic that did the work is a plane ride and a language away. The warranty that looked reassuring on the website is hard to enforce from another country, and harder when "lifetime" turns out, in the paperwork, to mean ten years. Worse, your own dentist at home may be unable or unwilling to help, partly because correcting another clinic's work is genuinely difficult, and partly because the materials and systems used may be ones they cannot identify or source. A British Dental Association survey found that almost all UK dentists had by now seen patients who were treated abroad, and that the large majority of those patients needed remedial work once home, often costing more than the original saving. Public health systems will generally not clean up the consequences of private cosmetic work done overseas, and the law of the destination usually offers the foreign patient little. So the person who saved a few thousand on a smile can spend a great deal more, and suffer for a good while, putting it right. None of this is a reason to stay home. It is a reason to treat dental travel as the real medical decision it is, rather than the shopping trip it is dressed up as. Almost every one of these hazards is avoided by the same unglamorous discipline: get an honest assessment of what you actually need, ideally from someone who is not selling it to you; refuse irreversible work you did not come for and do not understand; plan for the time the treatment genuinely takes; and know, before you go, who will look after you if it goes wrong. Do that, and dental travel is what it should be, the most useful bargain in medicine. Skip it, and it is the easiest way in the whole field to turn a saving into a catastrophe. ## Dental Tourism Destinations Where to go for dental work is a different question from where to go for surgery, and the difference comes straight out of the risks section. Because so much serious dental work needs two trips rather than one, the distance you must travel matters more here than almost anywhere else in medical travel. A heart operation is done once: you fly far, you recover, you come home. An implant may pull you back across the world for the crown months later, and a corridor that is a short hop becomes worth a great deal when you may have to fly it twice. So dental destinations sort themselves, more than anything, by proximity, and the honest map is regional rather than global. The question is rarely "which is the best country in the world", which has no answer, but "which is the best country from where I live". Corridor Serves mainly Known for The trade-off Hungary UK, Germany, Austria, Ireland Implants, full-mouth, restorative; the original European dental capital Deeply experienced and EU-regulated, but no longer the cheapest Turkey UK, Europe, the Gulf Veneers, crowns, cosmetic, full-arch; the global volume leader The lowest prices and the most packages, but outside EU regulation and the source of most cautionary tales Poland UK, Germany, Scandinavia Implants, crowns, restorative EU-regulated and a short flight, a little cheaper than Hungary, but thinner on complex-case volume Spain UK, Northern Europe, expats Implants, full-arch, cosmetic The smallest savings, but EU-regulated, a short flight and a genuine holiday Mexico USA, Canada Implants, crowns, full-arch A walk across the border for North Americans; quality varies sharply by clinic and town Thailand Australia, Asia, some UK and US Cosmetic, implants, orthodontics Mature and tourism-friendly, but a long way to fly twice The main dental corridors, sorted by who they serve rather than ranked against one another. The right one is mostly a function of where you live and what you need, not a global league table. For Europeans the choice comes down mostly to three. Hungary has the deepest claim, and earns it: Budapest has been the centre of European dental travel for over thirty years, its clinics are practised at treating foreigners, and as a member of the European Union it offers the cross-border regulatory backstop and the consistent professional standards that come with that. Its one drawback is that success has raised its prices, and it is no longer the bargain it was. Turkey is where the bargain went. It is the largest dental destination on earth, with the lowest prices and the most polished all-inclusive packages, and for a well-chosen clinic it can be excellent value. But it sits outside the European framework, trading that regulatory cover for the lower number, and as the risks section made plain it is also where the volume, and therefore the cautionary tales, are concentrated. Poland is the quieter middle path, EU-regulated and a short flight, a little cheaper than Hungary, strong on routine implant and restorative work if lighter on the most complex full-arch cases. Spain sits apart from all three: it saves the least, often only a third off home prices rather than the two-thirds further east, but it offers full European regulation, a flight under three hours and a destination that is a real holiday rather than a treatment trip, which for many is worth the smaller discount. Beyond Europe the map is simpler and follows the same proximity logic. For North Americans, Mexico is the natural corridor, near enough that border-town clinics in places like Los Algodones see patients who walk across and home the same day, though the range of quality from clinic to clinic and town to town is wider than anywhere, and selection matters more in proportion. For Australians and much of Asia, Thailand is the established choice, a dental pioneer of two decades with a deep tourism infrastructure wrapped around it. The newer European entrants, Croatia, Romania, Albania and others, are real and growing, several of them EU-regulated and genuinely cheaper than the established names, and the only honest caution is that their dental-tourism infrastructure and the depth of patient feedback are thinner, so the burden of checking a specific clinic falls more heavily on you. The through-line is the same one the whole field keeps returning to. A destination is worth choosing when it has a genuine claim on the thing you need, the experience, the standards, the price, the proximity that actually serves your case, and not because a package looked attractive. The corridors above are established because each, in its way, has earned a real claim. Match yours to where you live and what your mouth needs, and the question of the "best" country mostly answers itself. ## Choosing a Dental Provider Everything in the risks section points to a single piece of advice, and if you take only one thing from this page, take this: get an honest assessment of what you need from someone who is not going to do the work. On the medical page I argued that the surgeon matters more than the hospital, and that holds for teeth too, the individual dentist's skill and volume in your specific procedure is what determines your outcome. But dentistry adds a problem surgery mostly does not, the over-selling I described, and the only real protection against it is a second opinion from a dentist with no stake in the answer. See someone at home first. Get your own X-rays and a baseline view of what is actually wrong, if anything. Then, when a clinic abroad proposes a plan, you have something honest to measure it against, and the gap between "you need one implant" and "you need twenty crowns" becomes visible before it becomes permanent. This one habit prevents most of the disasters on this page. The rest is practical, and most of it is about getting things in writing before you fly. Insist on an itemised treatment plan and quote built from your own X-rays, not a number pulled from a photograph on social media; any clinic willing to plan irreversible work off an Instagram picture, without imaging, has told you what kind of clinic it is. Confirm the specific implant brand and components in writing, and prefer the recognised systems a dentist at home can service later. Ask the treating dentist directly about their training and how many of your procedure they do, and be wary if you can only ever reach a booking coordinator and never the person who will hold the drill. Read the warranty before you commit, and read it properly: what it covers, for how long, and whether "lifetime" means what you think. A guarantee you cannot enforce from another country is worth less than it looks, so ask how complications are actually handled once you are home. Then plan the whole thing honestly. Budget for the trips the treatment really needs, not the one you hope for. Buy travel insurance that covers dental complications. And arrange your aftercare before you go rather than after, ideally by lining up a dentist at home who will see you on your return and giving them the full record of what was done, which materials, which components, which brand, so that if anything goes wrong they can act rather than shrug. The warning signs, gathered in one place, are easy to remember. Be cautious of anyone who recommends crowning healthy teeth, who plans major work without scans, who keeps you away from the dentist and routes you through salespeople, whose pricing shifts or sits suspiciously below everyone else's, or who promises a film-star smile in a single visit. None of those is proof of a bad clinic on its own. Together they are the profile of the kind of place this page exists to keep you away from. The good clinics, and there are many, will not mind a single one of these questions. The ones that bristle at them are answering you. ## Dental Tourism FAQ What is dental tourism? Dental tourism is travelling to another country for dental treatment, usually to save money, sometimes to get treated at all when care at home is hard to access. It is the most common form of medical travel there is, because teeth are expensive almost everywhere, dental insurance is thin almost everywhere, and the savings abroad are large and, unlike many surgical savings, measured against a price people actually pay. It covers everything from a single crown to a full mouth of implants. Is dental work abroad safe? For most people, yes, but safety depends far more on the clinic than on the country. The best clinics in the major dental destinations work to high standards and use the same globally manufactured materials as clinics at home, while the worst, in any country, cut corners that matter. The risks specific to dental travel are not the ones people expect: being sold more treatment than you need, being given irreversible work, and having no easy recourse if something fails once you are home. Careful clinic selection, rather than the choice of country, is what keeps it safe. How much can you save on dental treatment abroad? Savings of roughly 50 to 75 per cent on the treatment itself are common across the main destinations, but the headline figure can mislead in both directions. On a single small procedure, once you add flights and a hotel, a saving that looked enormous in percentage terms can shrink to very little. On large, multi-unit work such as a full arch of implants, the saving runs to many thousands and easily outweighs any travel cost. The rule of thumb is that dental travel pays best for big jobs and least for small ones. Which is the best country for dental work abroad? There is no single best country, because serious dental work often requires two trips, which makes the distance you must travel matter more than any league table. For UK and European patients, Hungary, Turkey, Poland and Spain are the established corridors, each with a different balance of price, regulation and travel time. For North Americans, Mexico is the natural choice on grounds of proximity. For Australians and much of Asia, Thailand is the mature option. The right answer depends on where you live and what your treatment needs, not on a global ranking. How many trips does dental treatment abroad require? It depends entirely on the work. Crowns, veneers, root canals and other simple treatment can usually be completed in a single trip of around a week. Implants almost always need at least two trips, because the implant must be left to fuse with the bone for three to six months before the final tooth can be fitted. Some clinics offer to compress this into one visit, which can be sound for the right case but is sometimes done to save you a second flight rather than because your mouth is ready, so treat a conveniently short timeline with caution. What are "Turkey teeth"? "Turkey teeth" is the popular name for the row of uniform, very white crowns or veneers some patients bring home from cosmetic dental clinics abroad, often after healthy teeth have been filed down to small pegs to fit them. The name attaches to Turkey because Turkey is the largest and most visible dental destination in the world, so the volume of work, and the cautionary stories, most often come from there. But the practice is not Turkish and not confined to Turkey: it happens wherever cheap cosmetic dentistry is sold at volume, and a careful clinic in Turkey is safer than a careless one anywhere. The real warning is about a practice and an incentive, not a country. What is the difference between a veneer and a crown? A veneer is a thin shell bonded to the front of a tooth, removing only a fraction of a millimetre of enamel, and in its gentlest forms it can sometimes be reversed. A crown caps the entire tooth and requires filing the tooth down to a peg, removing most of its natural structure, which cannot be undone. Crowns are the right treatment for a tooth that is badly damaged or decayed. Filing down a healthy tooth to fit a crown for the sake of appearance is the irreversible step at the heart of most dental-tourism horror stories, and the distinction is one every patient should understand before agreeing to anything. What happens if something goes wrong after I come home? You are largely on your own, which is why this is the most important practical question in dental travel. The clinic that did the work is a flight and often a language away, its warranty is hard to enforce from another country, and "lifetime" guarantees sometimes turn out to mean ten years. Your own dentist at home may be unable or unwilling to correct another clinic's work, partly because it is genuinely difficult and partly because the materials used may be ones they cannot identify or source. Public health systems generally will not repair the results of private cosmetic work done abroad. Buy travel insurance that covers dental complications, and arrange aftercare at home before you travel rather than after. Does insurance or the NHS cover dental treatment abroad? Generally no. Public dental cover does not extend to planned treatment in another country, and standard private dental insurance usually excludes it too. Patients within the European Union may be able to reclaim a limited amount for treatment in another member state, but only at home-country tariff rates, which are often far below the actual cost. The appropriate product is dedicated dental travel insurance, or travel insurance that specifically covers complications from treatment abroad, bought before you go. How do I choose a safe dental clinic abroad? Get an independent second opinion at home first, so you know what you genuinely need before a clinic tells you, since this single step prevents most of the over-treatment that causes harm. Then insist on an itemised treatment plan based on your own X-rays rather than a quote from a photograph, confirm the specific implant brand and components in writing, speak directly to the treating dentist rather than only a booking coordinator, and read the warranty terms properly. Arrange your aftercare at home before you travel. Be most wary of any clinic that proposes to crown healthy teeth, plans major work without scans, or promises a perfect smile in a single visit. ## Sources Price panels for every row of the cost table: the Health Tourism News guides to dental implants in Poland, Türkiye, Hungary, Croatia, Thailand and Mexico, and to veneers in Türkiye and South Korea. Each sets out its provider panel, the dates the lists were read and the conversion rates used. Verified July 2026, re-verified quarterly. Implant survival. The 93 to 96 per cent ten-year survival range comes from the systematic reviews cited in each guide's own Sources panel, for example dental implants in Türkiye, not from any destination's outcome data. No country publishes national dental implant outcomes, which is why this page compares price and verifiability rather than results. Verified July 2026. ## Dental treatment guides 8 guides Costed, sourced guides to implants and veneers by destination, with published price ranges, what a quoted package actually covers and what changes after the in-person examination. Dental Implants in Croatia Restored-tooth prices for dental implants in Croatia, the final-bridge question in All-on-4 quotes, what the EU badge does and does not buy a British patient, and the licence checks that work without a public register. Single implant, restored $1,050 - $1,715 Dental Implants in Hungary Restored-tooth prices for dental implants in Hungary, the final-bridge question in All-on-4 quotes, the currency catch behind the euro price, and the national register that verifies a dentist since the chamber rule changed. Single implant, restored $950 - $1,460 Dental Implants in Mexico Complete-tooth prices for dental implants in Mexico, the implant-only trap in the advertised figures, the city-by-city logistics, and the licence checks that carry weight. Single implant, complete $1,200 - $1,730 Dental Implants in Poland Restored-tooth prices for dental implants in Poland, the final-bridge question in All-on-4 quotes, the currency catch behind the euro price, and the compulsory chamber register that lets a patient verify a dentist by licence number. Single implant, restored $535 - $1,340 Dental Implants in Thailand Complete-tooth prices for dental implants in Thailand by brand tier, full-mouth costs and the off-page graft trap, the English-language licence register that actually works, and the long-haul arithmetic no marketing shortens. Single implant, complete $1,050 - $3,150 by brand Dental Implants in Turkey Brand-tier prices for dental implants in Turkey, the per-arch trap in All-on-4 quotes, the two-trip reality, and the paperwork that makes a warranty travel. Single implant, premium brand $940 - $1,140 Veneers in South Korea What veneers in South Korea really cost in 2026, why the price sits at or above the UK and well above Turkey, how to tell veneers from crowns, and the foreign-patient register that verifies a Seoul clinic. Porcelain veneer, per tooth $720 - $1,500 Veneers in Turkey What veneers in Turkey really cost in 2026, how to tell veneers from crowns, the safety numbers, and the checks that verify a clinic before you pay. Full set, 20 units $2,900 - $6,050 ## Latest dental tourism coverage Update August 22, 2026 South Korea Undercuts America but Not Turkey Update August 22, 2026 Mexico and Turkey Price Against Different Home Markets Update August 22, 2026 Turkey's Deepest Discounts Sit on Its Safest Procedures Update August 22, 2026 Dental Implant Prices Abroad Hide Three Different Units Update July 1, 2026 Nigeria, Iran And Seoul Redraw Medical Tourism Update June 24, 2026 Health Tourism As Badge, Escape Hatch And Disguise Update August 30, 2026 This Week in Medical Tourism: 20–26 August 2026 Update August 29, 2026 This Week in Medical Tourism: 13–19 August 2026 --- # What is Fertility Tourism? A Complete Guide URL: https://health-tourism-news.com/fertility-tourism/ Sub-Sector Guide Part of Health Tourism Updated April 2025 What is Fertility Tourism? A Complete Guide Fertility tourism, also called cross-border reproductive care (CBRC), involves travelling to another country to access fertility treatments that are unavailable, legally restricted, unaffordable, or subject to lengthy waiting times at home. It is one of the fastest-growing and most ethically complex sub-sectors of health tourism. By Christian El-Khouri, Editor-in-Chief, Health Tourism News Last updated: September 2026 Last verified: 1 September 2026 Reading time: 12 minutes 3.1%Of reported European ART cycles were cross-border, 2019 (ESHRE, an undercount) 50-57%Below the UK donor-egg range, on the two panels we price ourselves $16,500-$20,500UK donor-egg cycle, the anchor those savings are measured against Contents Section 01 ## What is Fertility Tourism? Fertility tourism, more precisely termed cross-border reproductive care (CBRC) in academic and clinical literature, refers to the movement of patients across national borders to access assisted reproductive technologies (ART) that are restricted, unavailable, or prohibitively expensive in their home country. Unlike most other health tourism sub-sectors, where cost is the dominant driver, fertility tourism is fundamentally shaped by legal variation: the same procedure may be legal in one EU member state and illegal in the neighbouring one. Fertility tourism is unique among health tourism sub-sectors in that legislation, rather than cost, is often the primary reason a patient crosses a border. The treatment they need exists. The problem is that their country will not permit it. The scale of cross-border reproductive care in Europe is significant. Research published in academic reproductive medicine literature estimates that cross-border IVF cycles account for approximately 5% of all ART procedures carried out in Europe annually. Spain, the Czech Republic, and Cyprus are the most common destination countries for patients from the UK, Germany, France, Italy, and Scandinavia. Beyond Europe, global fertility tourism encompasses patients from Australia and the US travelling to Canada or Eastern Europe for surrogacy, patients from East Asia seeking donor egg programmes in Southeast Asia and Europe, and patients from conservative regulatory environments accessing treatments unavailable at home. Section 02 ## Why People Travel for Reproductive Care The motivations behind fertility tourism are more varied and often more personal than other forms of health travel. Four primary drivers account for the majority of cross-border reproductive care. Legal restrictions at home Procedures such as egg donation, anonymous sperm donation, surrogacy, post-menopausal IVF, and treatment for same-sex couples are legal in some countries and prohibited in others. Patients travel to access treatments their home country does not permit rather than forgo them entirely. Cost IVF and donor egg cycles in Western Europe and North America are expensive relative to Eastern European and Southeast Asian alternatives. On the two destinations we price from provider panels ourselves, a donor-egg cycle runs 50 to 57 per cent below the UK range: Greece at $5,700 to $10,250 and Spain at $7,650 to $10,850, against $16,500 to $20,500 in the UK. Both figures are midpoint against midpoint, and each links to the guide the panel comes from. Waiting times and donor availability UK clinics report donor waiting lists, and the requirement that donors be identifiable is one reason the pool is smaller than in countries that permit anonymous donation. We have removed the specific one-to-three-year figure this page used to carry: no source we could verify states it. Countries with larger donor pools and different legal frameworks offer substantially shorter waiting times, often measured in weeks rather than years. Access to specific expertise or technology Some patients travel for access to specific clinical approaches, genetic testing methodologies, or laboratory technologies not available in their home country. A smaller but growing segment seeks second opinions or specialist consultations at internationally recognised reproductive medicine centres. Section 03 ## Common Fertility Tourism Treatments ### IVF and ICSI In vitro fertilisation (IVF) and intracytoplasmic sperm injection (ICSI) are the most common treatments sought across borders. Patients may travel for standard IVF when home country costs are prohibitive or waiting times excessive, and particularly for IVF involving donor eggs or sperm where legal or availability constraints apply domestically. The border is legal, not clinical The same treatment, two rulebooks At home Abroad Prohibited for some patients and procedures Permitted under a different framework Egg donor wait of 1 to 3 years in the UK Weeks rather than years UK or Germany price for a donor egg cycle 50 to 60% less in the Czech Republic or Cyprus The medicine did not change. The jurisdiction did. Drawn from the four drivers set out on this page. The cost gap is reported with no observable difference in clinical outcomes at reputable clinics, which is the point: what changes at the border is the rulebook, not the medicine. ### Egg Donation Egg donation is the single largest driver of fertility tourism within Europe. The UK's requirement for identifiable donors, combined with a shortage of willing donors under those conditions, creates long waiting lists. Spain, the Czech Republic, and Cyprus operate under frameworks that historically allowed anonymous donation, have large established donor pools, and can match patients within weeks. Regulatory frameworks are evolving and patients should verify current laws directly with their chosen clinic. ### Surrogacy Surrogacy is among the most legally complex areas of reproductive travel. Commercial surrogacy is prohibited in most European countries but legal in several others. Altruistic surrogacy rules vary widely. The legal status of the intended parents and the child after birth depends on the laws of both the destination country and the parents' home country, and these do not always align. Legal advice from a specialist in international family law is essential for anyone considering cross-border surrogacy. ### Preimplantation Genetic Testing Preimplantation genetic testing (PGT) for chromosomal abnormalities or specific genetic conditions is permitted in some countries and prohibited or restricted in others. Patients whose home country restricts PGT for non-medical reasons may travel to access this technology as part of an IVF cycle. ### Fertility Preservation Egg freezing, sperm freezing, and embryo banking are sought cross-border primarily for cost reasons, as storage costs and cycle fees vary substantially between markets. Medical preservation before cancer treatment is the most common clinical indication; elective preservation for social reasons is an increasingly significant driver in younger patient demographics. Section 04 ## Top Fertility Tourism Destinations DestinationPrimary TreatmentsKey Source MarketsLegal Framework SpainEgg donation, IVF, ICSI, embryo donationUK, Germany, France, Italy, GCCPermissive for egg and sperm donation; anonymous donation legally shifting; strong regulatory oversight Czech RepublicEgg donation, IVF, embryo donation, PGTUK, Germany, Austria, ScandinaviaLarge established donor pool; historically anonymous donation; competitive pricing CyprusEgg donation, IVF, surrogacy (regulated)UK, Germany, France, GCCPermissive framework for egg donation and gestational surrogacy; active oversight ongoing GreeceEgg donation, IVF, embryo donationUK, Germany, Italy, GCCWell-regulated framework; identifiable donation approach being phased in; experienced clinic network UkraineSurrogacy, egg donation, IVFItaly, Spain, France, GermanyCommercial surrogacy historically available for heterosexual couples; significant disruption since 2022 USAGestational surrogacy, IVF, egg donationGlobal high-net-worth patients, same-sex couples from markets with restrictionsPermissive for commercial surrogacy in certain states; highest clinical standards; highest costs CanadaAltruistic surrogacy, IVF, egg donationUSA, UK, Australia, EuropeAltruistic surrogacy legal; well-regulated; high clinical standards; cost advantage vs US ThailandIVF, fertility preservation, PGTAustralia, UK, China, Southeast AsiaRegulatory framework tightened post-2015; restrictions on commercial surrogacy; IVF and egg donation available Legal frameworks governing reproductive care are subject to change. Patients should verify the current regulatory position with their chosen clinic and, for complex situations involving surrogacy or multi-jurisdiction parentage questions, seek advice from a specialist reproductive law solicitor before commencing treatment. Section 05 ## Ethical Considerations in Fertility Tourism Fertility tourism raises ethical questions that are more acute than in most other health tourism sub-sectors, and patients, clinicians, and policymakers are still working through the implications. ### Donor Welfare and Compensation Egg donation is physically demanding and carries medical risk. The distinction between reasonable compensation for time, inconvenience, and medical risk, and payments that create financial coercion, is not universally agreed and is drawn differently across jurisdictions. Patients travelling to access donors in lower-income countries should consider whether the compensation structure at their chosen clinic treats donors fairly and screens appropriately for medical and psychological fitness. ### Donor Anonymity and Donor-Conceived Persons' Rights The right of donor-conceived individuals to access information about their biological origins is increasingly recognised in national legislation across Europe and beyond. Patients choosing anonymous donation in a jurisdiction that permits it may find that their home country, or the destination country, subsequently changes its laws, potentially affecting their child's future rights. The trend across European jurisdictions is toward identifiable donation, and patients making choices today should consider the longer-term implications for any child born of their treatment. ### Surrogacy and Exploitation Commercial surrogacy in lower-income markets raises concerns about whether surrogates are genuinely free to make informed decisions, adequately protected legally, and fairly compensated. The involvement of intermediary agencies adds further complexity. Patients pursuing surrogacy abroad should research the regulatory oversight in their destination country, the legal protections afforded to the surrogate, and the legal status of the intended parents and child in both countries before entering any arrangement. ### Legal Parentage Across Borders The legal status of a child born through cross-border surrogacy or donor treatment may not be automatically recognised in the parents' home country. Intended parents may need to pursue adoption or parental order proceedings after the child's birth to establish legal parentage under home country law. The complexity of this process varies enormously by jurisdiction and should be understood in full before treatment commences. Section 06 ## How to Choose a Fertility Tourism Provider Verify the clinic's success rates for your specific treatment type and patient age group, and understand how those figures are calculated and reported Confirm the treating reproductive specialist's qualifications, training, and years of experience with your specific procedure Ask about the clinic's laboratory standards, embryology team experience, and the testing methodologies used for PGT if applicable Obtain a detailed written treatment protocol and cost estimate covering all stages, including medication, monitoring, embryo transfer, and storage fees Understand the donor screening process in detail, including medical, genetic, and psychological assessment, if treatment involves donated gametes Confirm the clinic's policy on the number of embryos transferred and their approach to multiple pregnancy risk Understand the legal framework in the destination country for your specific treatment and the implications for your home country For surrogacy, obtain independent legal advice in both the destination country and your home country before proceeding Confirm what support the clinic provides if a cycle fails and what the protocol is for subsequent attempts Ensure your home country fertility specialist receives complete records of your treatment protocol, medication history, and cycle outcomes Frequently Asked Questions ## Fertility Tourism: Common Questions What is fertility tourism? Fertility tourism, also called cross-border reproductive care (CBRC), involves travelling to another country to access fertility treatments that are legally restricted, unavailable, too expensive, or subject to long waiting times in the patient's home country. It is one of the fastest-growing sub-sectors of health tourism and is driven as much by legal variation between countries as by cost differentials. Why do people travel for IVF and fertility treatment? The four main reasons are legal restrictions on certain procedures in the home country (particularly egg donation, donor anonymity rules, treatment for single women or same-sex couples, and surrogacy), cost savings that on the destinations we price ourselves run 50 to 57 per cent below the UK donor-egg range, shorter waiting times for egg donors in countries with larger donor pools, and in some cases access to specific clinical expertise or genetic testing technology not available domestically. Which is the best country for fertility treatment abroad? Spain is the most popular fertility tourism destination for European patients, particularly for egg donation, due to its large donor pool, experienced clinic network, and strong regulatory framework. The Czech Republic and Cyprus are also major destinations for egg donation, with shorter waiting times and competitive pricing. For surrogacy, the legal framework matters as much as the clinical offering: the US offers the most robust legal protections, Canada is well regulated for altruistic surrogacy, and patients should verify the current legal position in any destination country before proceeding. Is IVF abroad as safe and effective as at home? Safety and success rates at reputable fertility clinics in Spain, the Czech Republic, Greece, and Cyprus are comparable to those at leading UK and German clinics. The key variables are laboratory quality, embryology team experience, and the treating specialist's expertise, not the country. Patients should ask for age-stratified success rates for their specific treatment type and compare these with published national and European averages before choosing a clinic. What are the legal issues with fertility tourism? Legal issues arise from the fact that reproductive laws vary substantially across countries, and the legal framework of the destination country does not automatically determine rights and obligations in the home country. Key legal questions include donor anonymity and the donor-conceived person's right to identifying information; legal parentage for children born through surrogacy; the recognition of parentage established abroad under home country law; and the legal status of imported embryos or donated gametes. Patients should seek advice from a reproductive law specialist in their home country before beginning treatment abroad, particularly for surrogacy or any situation involving gamete donation. Is surrogacy abroad legal? Surrogacy laws vary enormously by country, and legality in the destination country does not mean the arrangement will be recognised in the intended parents' home country. Commercial surrogacy is legal in certain US states, legal with restrictions in Canada (altruistic only), and prohibited in most European countries. The legal status of the child and the intended parents' parental rights after birth depend on both countries' laws, which may conflict. Patients considering surrogacy abroad should obtain independent legal advice in both jurisdictions before entering any arrangement. How much does IVF abroad cost compared to the UK? A standard IVF cycle in the UK costs approximately 4,000-6,000 at a private clinic, excluding medication. In Spain, the Czech Republic, or Greece, a comparable cycle typically costs 2,500-4,000 including medication. For donor egg cycles, the difference is more pronounced: a UK donor egg cycle can cost 8,000-15,000 depending on the clinic and donor matching costs, while equivalent treatment in Spain or the Czech Republic typically runs 4,000-7,000. Even after flights and accommodation, the savings on a donor egg cycle are usually substantial. ## Sources Price panels for both destinations: the Health Tourism News guides to IVF in Spain and IVF in Greece, each setting out its provider panel, the dates the lists were read and the conversion rates used. Verified July 2026, re-verified quarterly. Cross-border cycle share. European IVF Monitoring Consortium, "ART in Europe, 2019: results generated from European registries by ESHRE", Human Reproduction, 2023. Reports 33,003 cross-border cycles against 1,077,813 total, and notes that only 13 of 40 reporting countries supplied the data, so the share is a floor rather than a measure. pmc.ncbi.nlm.nih.gov/articles/PMC10694409 UK treatment figures. Human Fertilisation and Embryology Authority, "Fertility treatment 2023: trends and figures", June 2025. hfea.gov.uk/about-us/publications/research-and-data/fertility-treatment-2023-trends-and-figures Human Fertilisation and Embryology Authority, "Fertility treatment abroad". Read 1 September 2026. hfea.gov.uk/treatments/explore-all-treatments/fertility-treatment-abroad Spanish national registry. Registro Nacional de Actividad 2022, Registro SEF, Informe Estadistico de Tecnicas de Reproduccion Asistida, 2024. registrosef.com/public/docs/sef2022_IAFIV.pdf Cross-border reproductive care, foundational survey. Shenfield F, de Mouzon J, Pennings G, et al. "Cross border reproductive care in six European countries." Human Reproduction 25(6):1361-1368, 2010. The publisher returns 403 to automated requests, so this is cited by reference rather than a verified fetch. academic.oup.com/humrep/article/25/6/1361/652264 Greek surrogacy law. Law 5197/2025 Article 46, Government Gazette A' 76, 16 May 2025, amending Article 1458 of the Civil Code and Article 8 of Law 3089/2002. Cited by instrument: the Government Gazette download endpoint redirects to a bare IP address. ## Fertility treatment guides 2 guides Costed, sourced guides to the two European destinations HTN covers in depth, with published cycle prices, registry success rates and the legal position in each. IVF in Greece Published cycle and egg-donation prices for IVF in Greece against UK lists, the anonymity law that separates Greece from Britain, the age limit few countries match, and the success-rate figure clinics quote instead of live birth. Egg-donation cycle $5,700 - $10,250 IVF in Spain Registry-cited success rates for IVF in Spain, published cycle and egg-donation prices against UK lists, the anonymity law that fills Spanish donor banks, and the frozen-embryo trap nobody prices. Egg-donation cycle $7,650 - $10,850 --- # What Is Cosmetic Tourism? Costs, Risks and Destinations URL: https://health-tourism-news.com/cosmetic-tourism/ Pillar Guide Updated June 2026 What Is Cosmetic Tourism? Costs, Risks and Destinations Cosmetic tourism is the uneasy case in health travel: real surgery, with real risk, undertaken not to fix an illness but to change a healthy body. It is also sold harder, and more like a holiday, than anything else in the field, which is exactly what makes its dangers easy to miss. This guide sets out what cosmetic surgery abroad really costs, why people go, the risks that matter, from the deadly Brazilian buttock lift to the danger of flying home too soon, where the major destinations are and what each does well, and how to choose a surgeon rather than a package. It is written from the clinical end of health travel, by someone who takes the wish to look better seriously and stays honest that surgery is surgery, however pleasantly it is packaged. By Christian El-Khouri, Editor-in-Chief, Health Tourism News Last updated: September 2026 Last verified: 1 September 2026 58-60%Difference on the two procedures we price ourselves 94%Rise in UK patients needing NHS care after surgery abroad, in 3 years Contents ## What Cosmetic Tourism Is Cosmetic tourism is travel abroad for elective aesthetic procedures, surgical or not, undertaken to change how a healthy body looks rather than to treat anything wrong with it. A rhinoplasty in Istanbul, a hair transplant flown in for from across Europe, a body-contouring trip to Mexico, a facial procedure in Seoul: all of it is cosmetic tourism, and what unites it is a motive that is, at bottom, about appearance. I have spent more time than is probably healthy on the question of where this sits in the wider field, because it is genuinely awkward to place, and getting the placement right tells you most of what you need to know about it. Cosmetic tourism belongs on the same spectrum as the rest of health travel, under the same umbrella, and I set that spectrum out on the health tourism page. But it sits in the uneasy middle of it, and the unease is the point. At one pole is medical tourism, which is reactive, clinical and undertaken out of necessity by someone with a real problem to fix. At the other is wellness travel, which is proactive, non-clinical and chosen by someone with nothing wrong who wants to feel better. Cosmetic tourism borrows from both, and in a combination that should make anyone pause. It takes the means of the medical pole, real surgery, real anaesthetic, real and occasionally fatal risk, and puts them in service of the motive of the wellness pole, the wish to improve on a body that was not broken to begin with. That is the whole tension, and it is worth stating plainly before anything else. In every other part of medical travel, the risk you take is justified by a need: you accept the danger of surgery because the alternative, the heart condition, the failing joint, the cancer, is worse. Cosmetic tourism is the one corner of the field where people accept genuine surgical risk for something they do not medically need at all. It carries, in other words, the highest ratio of risk to necessity anywhere in health travel. None of which makes it illegitimate, and I want to be clear about that. People have always wanted to look better, the wish is old and human and not to be sneered at, and for many the gain is real, often less in the mirror than in how they carry themselves afterwards. The health benefit of cosmetic surgery, where there is one, is usually psychological rather than physical, a lifting of something that weighed on a person. That is a real benefit. It is simply not the same kind of benefit as fixing a diseased body, and pretending otherwise is where a good deal of the trouble starts. Two distinctions keep the definition clean. Cosmetic tourism is not wellness tourism, whatever the marketing of a "surgical retreat" implies, because wellness carries no scalpel and no anaesthetic and cosmetic surgery carries both: a spa week and a tummy tuck are not the same category of risk, and no amount of soft lighting changes that. And it is not the non-medical beauty trade either, the facials and the treatments you could have at home, because those are not surgery and not medicine. What makes something cosmetic tourism is precisely that a qualified clinician is doing something invasive to your body, for reasons that are nonetheless about how you look. Hold those two lines and the field stays in focus. The last thing to know at the outset is the one the industry works hardest to obscure, and it follows from everything above. Because the motive is appearance and the mood is aspirational, cosmetic tourism is sold not as surgery but as a consumer experience, a new face and a fortnight in the sun, a fresh start with airport transfers included. That framing is not harmless. It is precisely the surgical reality, the thing that most deserves a patient's sober attention, that the holiday packaging is designed to soften. This guide keeps the packaging and the scalpel firmly apart, takes the wish to look better seriously, and stays honest throughout about the fact that surgery is surgery wherever in the world, and however pleasantly, it is sold. ## Why People Travel for Cosmetic Surgery The five reasons people travel for medical care, which I set out on the medical tourism page, all appear here too, but cosmetic tourism weights them differently from the rest of the field, and adds a couple of its own. The honest order, for cosmetic specifically, runs roughly like this. Cost leads, and it leads more decisively than in serious medicine. This is a real difference, and one I have written about before: when the procedure is a matter of necessity, people weigh quality first and price second, because the stakes demand it. When the procedure is elective, the weighting flips, and cost moves to the front. A cosmetic patient is, by and large, a shopper in a way a cardiac patient is not, and the savings on offer are large enough to shop for, half to four-fifths off the home price across the main destinations. That is the engine, and there is nothing wrong with it in itself. It becomes a problem, as I will come to, only when the cheapest option is chased past the point where it is safe. Appearance is the motive underneath the money, and it has a character all its own. Unlike the conditions that drive medical travel, which do not come and go with the seasons, what people want done to their faces and bodies shifts constantly, pulled by beauty standards, by celebrity, and above all now by social media and the filtered images people measure themselves against. The procedure in demand one year is not the one in demand the next. This is the most fashion-driven corner of health travel by a distance, and that matters more than it first appears, because a decision made under the pressure of a passing trend, on a body alteration that may well be permanent, has a particular capacity for later regret. Beneath appearance sits something more personal still, which the trade rarely names directly. A good deal of cosmetic travel is driven less by a specific flaw than by the gap between how a person sees themselves and how they wish to be, and that gap is psychological before it is physical. For many this is perfectly healthy, the ordinary wish to feel better in one's own skin. For some it is not, and shades into a genuine disturbance of body image that no surgeon's work will ever satisfy. I come back to this when I reach the risks, because it is the reason a technically perfect operation can still leave a patient unhappy, and the reason the most important assessment a good clinic makes is not always of the body. Then the two that are easy to forget. The first is simple proximity. A great deal of cosmetic travel is not long-haul at all but a short hop across a nearby border, North Americans to Mexico, Western Europeans to the closer and cheaper parts of the continent, and proximity does more than save on the flight. It lowers the whole barrier to a decision, makes the trip feel casual, a weekend rather than an expedition, and casualness, around surgery, is not always a friend. The second is the legal and regulatory dimension, which cuts in a direction people rarely expect. Some cosmetic travel is driven by a procedure being restricted, or held to slower and stricter standards, at home, so the traveller goes abroad to find it more freely available. That sounds like liberation, and is sometimes sold as such. But it is worth sitting with the obvious thought the marketing skips: where a thing you want is forbidden or tightly controlled at home and freely sold abroad, the home restriction was, often as not, put there to protect you, and the looser regime abroad is looser in ways that include the ones meant to keep you safe. Travelling to escape your own country's caution is not always the bargain it looks. Those are the drivers: a price worth shopping for, a wish about appearance, a deeper wish about the self, the ease of a nearby border, and the pull of looser rules. The first four are human and, handled with care, entirely reasonable. The last deserves the most suspicion, because the freedom it offers is sometimes precisely the absence of the protections a person most needs when a knife is involved. ## What Cosmetic Surgery Abroad Costs Here are the numbers, with the same warning I attach to every price table on this site: these are indicative ranges, not quotes, and cosmetic pricing moves by clinic, surgeon, technique and what a particular body actually needs. The American figures are anchored to the average surgeon's fees published by the United States plastic-surgery bodies; the figures abroad are typical all-inclusive package prices drawn from across the main destinations. Both deserve a closer look than the headline gap invites. Procedure Where Price panel Home-market anchor Difference Rhinoplasty, primary South Korea $2,100 - $7,000 $8,000 - $15,000 US private typical -60% Tummy tuck, full Türkiye $3,900 - $4,950 $9,400 - $11,600 UK hospital groups -58% A facelift, five ways Total cost, indicative ranges Turkey $4k - $7k Mexico $4.5k - $8k Thailand $4.5k - $8k South Korea $6k - $12k USA $12k - $25k 0$5k$10k$15k$20k$25k The facelift row of the table above, drawn. The widest gap on the page sits on a procedure done under general anaesthetic, which is where every other warning here applies most. US figures are typical total cost; the rest are typical all-inclusive package prices. Download this chart PNG, free to republish with attribution Two rows, not thirty. Both are drawn from the Health Tourism News treatment guide linked in the destination cell, where the provider panel, the reading dates and the conversion rates are set out. This table previously priced six procedures across five countries from figures we could not trace to any panel we hold; those cells have been removed rather than re-sourced, because we have no price panel for hair transplants, breast augmentation, liposuction or facelifts in any destination. Anchors are what a patient actually pays, never a list price. A shorter sourced table is worth more than a longer unsourced one, and the gap tells you where our pricing work has and has not reached. The first thing to understand is that the comparison is slipperier than it looks, in a way that runs both for the patient and against. The "average cost" of cosmetic surgery quoted in most American coverage is the surgeon's fee alone, the figure the surgical bodies publish, and it leaves out the anaesthetist, the operating facility and the rest, which together add thousands to the real bill. The price quoted abroad, by contrast, is usually all-inclusive, the surgery and the hotel and the transfers and the aftercare folded into a single number. So if you set the American surgeon's fee against the foreign package, you are not comparing like with like, and the true home total is higher than the headline suggests. Done honestly, total against total, the saving is real and large: on the two procedures this guide prices itself, a primary rhinoplasty in South Korea and a full tummy tuck in Türkiye, close to 60 per cent off. I will not pretend that gap away. It is the reason the planes are full. But the package that makes the saving so clean is also where the danger gathers, and this is the part worth slowing down for. An all-inclusive price is a wonderful thing when you are buying a holiday and a worrying one when you are buying surgery, for two reasons. The first is that a single bundled number obscures the things you most need to see: which surgeon, specifically, will operate, what implants or materials are included, and how much genuine aftercare, as opposed to a farewell coffee, the price actually covers. A bundle is built to be bought whole, and surgery is precisely the thing you should be buying in parts, examining each. The second reason is sharper. The economics of the package quietly push you towards having more done. When the facility and the recovery and the flights are already paid for, a second procedure looks cheap at the margin, and the clinic has every reason to propose one, so the nose becomes the nose and the eyes, the tummy tuck acquires a round of liposuction and a lift. This is not a free upgrade. Combining procedures in a single operative session lengthens the time under anaesthetic and compounds the load on the body, and it is one of the recognised ways cosmetic surgery turns fatal. The bundle's logic is the seller's logic, and it runs directly against the patient's. Two costs, finally, sit outside every package, and they are the ones that undo the arithmetic when they land. The first is the cost of a complication, which is not in the price and which, as the next section sets out, can run to many times the original saving once a home health system is cleaning up an infection or a wound that will not heal. The second is the cost of revision, the operation to correct or redo the first, which is rarely covered, hard to obtain from another country, and often declined by surgeons at home. So the all-inclusive price is all-inclusive only as long as nothing goes wrong. The moment something does, the saving can vanish and then some. And there is a quieter point underneath all of this, about who the cheapest price selects for. The patient who shops purely on price, who picks the lowest package on offer, is by that same disposition, and often by that same budget, the one least likely to fly back for a follow-up, to fund a revision, or to absorb the cost of putting a problem right. The cut-price deal and the inability to deal with its consequences tend to travel together. That is not a reason cost should not matter. It is a reason that chasing the very cheapest number, in a field where the consequences of a bad outcome are surgical, is a worse bet than the headline saving makes it look. ## The Risks That Matter Now the part the holiday packaging is built to keep you from dwelling on. Cosmetic surgery is surgery, with everything that word carries: anaesthetic risk, infection risk, the chance of a result you did not want and cannot easily undo, and, at its worst, death. The four risks I set out on the medical tourism page all apply, judging quality from afar, infection, who cares for you afterwards, who pays when it goes wrong, and I will not restate them. What follows is what is particular to having your appearance altered abroad, and the first thing to grasp is that "cosmetic surgery" is not a single level of risk at all. It is a gradient, and a steep one. At the gentle end sits something like a hair transplant, a long and tedious procedure but a genuinely low-risk one, done under local anaesthetic, from which serious harm is rare. At the other end sit the major body operations, performed under general anaesthetic, opening the body and moving fat and tissue in quantity, and these are dangerous in the way all major surgery is dangerous. Lumping them together under one reassuring word is the first mistake, because it lets the risk profile of a hair transplant stand in, in a patient's mind, for the risk profile of a tummy tuck. They are not the same, and the further up the gradient you go, the more every other warning on this page applies. Not one level of risk Deaths per 100,000 operations Brazilian buttock lift 1 in 6,214 to 1 in 2,351 Cosmetic surgery, all procedures ~1 in 55,000 010203040 Rates as given on this page: the plastic-surgery bodies' figure for the buttock lift, against cosmetic surgery as a whole in properly accredited settings. Converted to a common unit so the two can share a scale. The killer is fat embolism, and it turns on technique. Download this chart PNG, free to republish with attribution At the very top of that gradient sits one procedure that deserves to be named on its own, because it is one of the most dangerous cosmetic operations there is, and probably the most dangerous of all. The Brazilian buttock lift, which moves fat from elsewhere on the body into the buttocks, carries a mortality rate that the plastic-surgery bodies have put at roughly one death in every three thousand operations. To see how stark that is, set it against the figure for cosmetic surgery as a whole in properly accredited settings, which is closer to one in fifty thousand. The killer is fat embolism, fat entering the bloodstream during injection and travelling to the lungs, and the danger turns heavily on technique, on the fat being placed above the muscle rather than into it. That makes the procedure especially unforgiving of the rushed, high-volume, under-supervised conditions the cheapest end of cosmetic tourism is built on, and it is no accident that it has drawn specific safety warnings and, in Britain, a proposed law to restrict who may perform it at all. If you take one procedure-specific warning from this guide, take this one. Then there is a risk unique to having surgery abroad, which is the journey home itself. Major surgery raises the risk of a blood clot in the leg, a deep vein thrombosis, which can travel to the lungs and kill, and sitting still for hours on an aircraft raises that risk again. Put the two together, surgery and then a flight too soon after it, and you have a genuinely lethal combination that has been directly linked to deaths among cosmetic tourists. The medical advice is to let a real recovery window pass before flying, and the window is longer than most people expect, a couple of weeks for major work rather than the long weekend the package implies. The pressure runs the wrong way here: the cheap flight home is booked for a few days out, the clinic wants the bed, the patient wants to be home, and all of it pushes towards flying before the body is ready. Do not let it. The return flight is part of the surgery's risk, not separate from it. The largest category of harm, though, is quieter and slower, and it is the one the data captures most clearly. Most serious complications of cosmetic surgery, infection, a wound that splits open, bleeding, the failure of an implant, do not announce themselves on the operating table. They appear days or weeks later, by which time the patient is home and the surgeon who operated is a continent away. A 2025 review in the journal BMJ Open looked at British patients who came back from surgery abroad and needed their own health service to put them right: it found hundreds of such cases, more than half of them severe enough to require further surgery or prolonged hospital treatment, at costs running into many thousands of pounds each, and the great majority traceable to a single country, for the simple reason that it is the largest destination. Wound infection and wounds that would not heal were the commonest problems, and breast and abdominal surgery the commonest sources. Behind the complications sit the deaths: British travel-health authorities recorded six UK nationals dying in that one country in a single year following medical procedures, with a similar count the year before. These are not abstract risks. They are the routine, documented output of the volume end of this trade. A word on that single country, because it is the same word I offered on the dental page. The destination that dominates these grim statistics dominates them largely because it dominates the volume: it performs more cosmetic surgery on more foreign patients than anywhere else, so it accounts for more of the complications and more of the deaths, and its share of the figures roughly tracks its share of the market rather than marking out a uniquely dangerous place. There are excellent, careful surgeons there, and a well-chosen clinic is a world away from the cheap package that produces the horror stories. The lesson is not to avoid a country. It is to understand that the conditions which produce these outcomes, high throughput, low price, minimal screening, rushed timelines, can be found, and steered clear of, wherever cosmetic surgery is sold at scale. The hardest of the surgeon problems to solve from a distance is simply knowing who will hold the knife. Clinic marketing leans on a senior, named surgeon whose actual involvement in your operation is not guaranteed, and in some fields the gap is routine: a great deal of hair-transplant work is carried out not by the surgeon on the website but by technicians, and many of the worst outcomes elsewhere have turned out to involve operators who were not the specialists they appeared to be. Verifying a surgeon's training, registration and record from another country, before you have paid and flown, is genuinely hard, and the difficulty is itself part of the risk. And then the risk that is not surgical at all, which I promised to return to, and which in its way underlies the whole field. A great deal of cosmetic surgery is sought to close a gap that is in the mind as much as the mirror, the distance between how a person looks and how they feel they ought to look. For most people that gap is ordinary and a good result genuinely helps. But for some it is a symptom of something a scalpel cannot reach, a disturbance of body image that no operation will ever satisfy, and for them surgery is not a solution but a trap, each procedure leaving the underlying unhappiness intact and ready to fix on the next perceived flaw. This is why the most important assessment a responsible surgeon makes is not always of the body but of the person, a judgement about whether surgery will actually help, and the willingness to say no when it will not. It is also precisely the assessment the volume-and-package model is built to skip. A clinic selling a fixed menu to a patient it met online has neither the time nor the incentive to ask whether the operation is a good idea, and a patient chasing a trend they saw on a screen is poorly placed to ask it of themselves. The result can be a technically flawless operation that solves nothing: a person no happier, several thousand pounds lighter, and already contemplating the next. None of this is an argument against cosmetic surgery, or against having it abroad, where a great deal of excellent work is done every day. It is an argument for treating it as exactly what it is, surgery, undertaken for reasons that make sober judgement harder rather than easier, and for refusing to let the holiday framing do your thinking for you. Almost every danger on this page is reduced by the same handful of habits: choosing the procedure and the surgeon on their merits rather than the package on its price, allowing the body the recovery the operation actually requires, being honest with yourself about why you are going, and knowing who will look after you if something goes wrong. Get those right, and cosmetic travel can be safe and worthwhile. Get them wrong, in this of all fields, and the price is measured in more than money. ## Cosmetic Tourism Destinations Cosmetic destinations sort themselves differently from the rest of health travel. Dental destinations, I argued, are organised mostly by proximity, because so much dental work needs a second trip. Cosmetic destinations are organised by specialism: each of the major ones has grown deep expertise in a particular kind of work, usually rooted in its own culture and market, and the right destination is the one whose speciality matches what you actually want done. A country that is superb for one procedure may be ordinary for another, and the glossy "best for cosmetic surgery" lists that ignore this are worse than useless. Destination Known for What draws people The honest caveat South Korea Facial surgery, contouring, eyelid and nose work The world's deepest facial-surgery expertise and technique Premium prices for the region; a culture of heavy intervention Turkey Hair transplants, rhinoplasty, all-inclusive packages The lowest prices, the most volume, the polished package Outside EU regulation; the volume end concentrates the cautionary tales Thailand Body contouring, breast, gender-affirming surgery Mature hospitality and recovery; two decades of experience A long way to fly home after major surgery Brazil / Colombia Body contouring, the buttock lift The original home of body-sculpting expertise Specialists in the field's most dangerous procedure; standards vary Mexico Body work, buttock lift, bariatric; proximity A short hop for North Americans, at low prices Quality varies sharply by clinic and town along a busy border The main cosmetic destinations, sorted by what each genuinely specialises in. The right one is a function of your procedure, not a global ranking. The logic of the table is worth spelling out, because it is the same logic the whole field keeps returning to. South Korea is the facial-surgery capital of the world, with a depth of expertise in the eyes, nose and facial contour that comes from operating on more faces, per head, than anywhere on earth; if facial work is what you are after, that concentration is real and matters. Turkey owns the volume end, hair transplants above all, where it does more than any country and has driven the price down accordingly, along with rhinoplasty and the all-inclusive package model the rest of the world copied. Thailand built its reputation on body work and on a depth of hospitality and recovery infrastructure that two decades of medical tourism produced, and is the established centre for gender-affirming surgery in particular. Brazil and Colombia are the home of body contouring and the buttock lift, with all the expertise and all the cautions that implies. And Mexico is on the table chiefly for proximity, the natural choice for North Americans who can drive across a border rather than cross an ocean, with the wide variation in standards a long, busy border tends to produce. The honest caution attached to this map is the one from the risks section, and it cannot be repeated too often. The destinations that lead on volume are, by the same token, the ones that generate the most complications, not because they are uniquely bad but because they do the most work, and the cheap, high-throughput end of each is where the trouble gathers. Choosing the right country for your procedure is the easy half of the decision. Choosing the right clinic and surgeon within it is the half that actually determines how you fare, and it is to that, finally, that everything on this page has been pointing. ## Choosing a Cosmetic Surgeon If the destination question is the easy half, this is the half that matters, and everything in the risks section points to a single principle: you are choosing a surgeon, not a package, and the whole of your safety rests on who that surgeon actually is. On the medical page I argued that the individual surgeon matters more than the institution, and nowhere is that truer than here, where the marketing works hardest to keep your eye on the brand, the price and the brochure rather than on the person who will operate. So start with the person, and be relentless about it. Establish who, specifically, will perform your surgery, by name, and confirm their qualifications, their board certification or its national equivalent, their training, and their volume in the exact procedure you want. This matters more in cosmetic surgery than almost anywhere, for two reasons the risks section raised: a good deal of work, hair transplants especially, is carried out not by the advertised surgeon but by technicians, and many of the gravest outcomes elsewhere have involved operators who were not the specialists they appeared to be. A clinic that cannot, or will not, tell you plainly who will hold the knife, and prove their credentials, has answered the most important question by refusing to. Then look at their work, properly. Ask for before-and-after photographs from the surgeon's own archive, of patients whose starting point resembles yours, not the polished stock gallery every clinic shares. Seek out independent reviews and, where you can, accounts from real former patients rather than the testimonials the clinic has chosen for you. And weigh the result you are being promised against the result that is realistic: a surgeon worth trusting will temper your expectations rather than inflate them, and one who promises perfection is selling, not advising. On the surgery itself, insist on the things the package is built to skip. Get the specific implants or materials named in writing. Refuse, flatly, any procedure suggested on the day or added to your plan because it is "cheap while you're here", because that is the package economics talking and it leads straight to the combined operations that carry the most risk. Confirm in writing how long you must wait before flying home, and build a real recovery window into your plans rather than the optimistic one the cheap return flight assumes. And establish, before you go, what happens if something goes wrong: what aftercare is genuinely included, how a complication would be handled, and who, at home, will look after you on your return. A surgeon at home willing to see you matters more than any guarantee printed abroad. Be most honest, though, with yourself. The single best protection in cosmetic surgery is a clear-eyed sense of why you are going and what you actually expect it to change, because the patient most likely to be harmed is the one chasing a trend, or a feeling, that surgery cannot deliver. A good surgeon will help with this, and will say no to an operation that will not help you. A clinic selling a menu will not. If you can find a surgeon willing to turn business away when the surgery is a bad idea, you have found the rarest and most valuable thing in this field. The warning signs, in one place: a clinic that will not name your surgeon or prove their credentials; pressure to decide quickly or to add procedures; promises of perfection; a price conspicuously below everyone else's; a recovery and flight-home timeline that looks suspiciously convenient; and a consultation conducted entirely by salespeople or entirely from photographs. None of these alone condemns a clinic. Together they describe the kind of operation that fills the complication statistics, and the kind this page exists to steer you around. The good clinics will welcome every one of these questions. The ones that resist them are telling you what you need to know. ## Cosmetic Tourism FAQ What is cosmetic tourism? Cosmetic tourism is travelling abroad for elective aesthetic procedures, surgical or otherwise, to change how a healthy body looks rather than to treat an illness. It ranges from low-risk work such as hair transplants to major surgery such as facelifts, tummy tucks and buttock lifts. It sits on the same spectrum as the rest of health travel but occupies an uneasy place on it, carrying the real risks of surgery for something a person does not medically need, which is what makes careful decision-making matter so much. Is cosmetic surgery abroad safe? It can be, but the honest answer is that it depends almost entirely on the procedure and the clinic, and that "cosmetic surgery" spans a huge range of risk. A hair transplant under local anaesthetic is genuinely low-risk; a major body operation under general anaesthetic is dangerous in the way all major surgery is. The best surgeons abroad are excellent, but the cheap, high-volume end produces the complications and the deaths that fill the data. Safety comes from choosing the surgeon and the procedure on their merits, allowing proper recovery before flying, and arranging aftercare at home, rather than from the country itself. How much can you save on cosmetic surgery abroad? Genuine savings of roughly 50 to 80 per cent on the procedure are common across the main destinations, widest on the larger operations. But compare like with like: the headline US figure is often only the surgeon's fee, while the price abroad is usually an all-inclusive package, so the real saving, total against total, needs care to calculate. And the package never includes the cost of a complication or a revision, both of which fall to you and can wipe out the saving entirely if something goes wrong. Which is the best country for cosmetic surgery? There is no single best country, because the major destinations specialise. South Korea leads in facial surgery, Turkey in hair transplants and high-volume packages, Thailand in body and gender-affirming surgery, Brazil and Colombia in body contouring, and Mexico offers proximity for North Americans. The right destination is the one whose genuine speciality matches your procedure. Choosing the country is the easy part, though; choosing a safe clinic and surgeon within it is what actually determines the outcome. What is the most dangerous cosmetic procedure? The Brazilian buttock lift is one of the most dangerous cosmetic operations, and probably the most dangerous of all. The ASERF Task Force, reporting in the Aesthetic Surgery Journal in 2017 on a survey of 198,857 cases, gave four separate estimates of its mortality spanning one death in every 6,214 procedures to one in 2,351, and stressed that none of them should be read as the actual rate. Against that, the same paper puts aesthetic surgery as a whole in accredited facilities at around one in 55,000. The cause is fat embolism, fat entering the bloodstream and reaching the lungs, and the risk depends heavily on surgical technique, which makes the procedure especially unsuited to the rushed, high-volume conditions at the cheapest end of cosmetic tourism. It has drawn specific safety warnings and, in some countries, moves to restrict who may perform it. How long should you wait before flying home after cosmetic surgery? Longer than most packages assume. Major surgery raises the risk of a deep vein thrombosis, a blood clot in the leg that can travel to the lungs, and long flights raise that risk further, so flying too soon after an operation is a genuinely dangerous combination that has been linked to deaths among cosmetic tourists. For major procedures, the recommended recovery window before flying is usually a couple of weeks, not the few days a cheap return flight tends to allow. The flight home should be treated as part of the surgery's risk, not separate from it. What happens if something goes wrong after I come home? You are largely on your own, which is why complications matter so much in cosmetic travel. Most serious problems, infection, a wound that splits open, an implant that fails, appear days or weeks after surgery, by which time the operating surgeon is in another country. A review of British patients found that complications from surgery abroad regularly require treatment by the patient's own health service, often at costs many times the original saving, and revision surgery to correct poor work is rarely covered, hard to obtain from abroad, and frequently declined by surgeons at home. Arrange aftercare at home before you travel, and take out insurance that covers complications from treatment abroad. Will cosmetic surgery actually make me happy? Sometimes, but not always, and this is the question the industry most avoids. Where the wish is ordinary and the expectations realistic, a good result genuinely helps how a person feels. But a great deal of cosmetic surgery is sought to close a gap that is psychological as much as physical, and where that gap reflects a deeper disturbance of body image, no operation will satisfy it: each procedure leaves the underlying unhappiness intact and ready to fix on the next perceived flaw. The most important judgement a responsible surgeon makes is whether surgery will actually help the person in front of them, and being honest with yourself about why you are going is the single best protection you have. Is a hair transplant in Turkey safe? Often, and it is the lowest-risk corner of cosmetic tourism, done under local anaesthetic with serious harm rare, which is part of why Turkey performs more hair transplants than anywhere. The main thing to check is who actually carries out the procedure: a great deal of hair-transplant work is done by technicians rather than the surgeon advertised, and the quality of the result depends on their skill and the clinic's standards. As with everything in this field, a careful, well-chosen clinic is a different proposition from the cheapest package, and the choice of clinic matters far more than the choice of country. Does insurance cover cosmetic surgery abroad? Generally no. Cosmetic surgery is elective, so public health systems do not cover it and standard health insurance excludes it, whether performed at home or abroad. Crucially, this also means the cost of any complication is usually yours to bear, since insurers and public systems are not obliged to fund the treatment of problems arising from elective surgery chosen overseas. The appropriate product is specialist insurance that specifically covers complications from cosmetic treatment abroad, arranged before you travel. ## Sources Price panels for both rows of the cost table: the Health Tourism News guides to rhinoplasty in South Korea and tummy tuck in Türkiye. Each sets out its provider panel, the dates the lists were read and the conversion rates used. Verified July 2026, re-verified quarterly. US surgeon fees. American Society of Plastic Surgeons, "2024 Plastic Surgery Statistics Report", released June 2025, covering 2024 procedures. Its average surgeon fee table gives nose reshaping (rhinoplasty) at $7,500 to $12,500 and abdominoplasty (tummy tuck) at $8,000 to $13,500. ASPS states in the same table that it now presents surgeon fees as a projected range rather than a single price. These are SURGEON FEES ONLY and exclude facility, anaesthesia and implants, so a patient's total is higher. Linked to the Internet Archive capture of 23 August 2026 because the publisher has since replaced the 2024 report with a 2025 edition and the original URL now 404s; the archived file is the document these figures were read from, and the publisher's live statistics page is linked beside it. web.archive.org capture of plastic-surgery-statistics-report-2024.pdf and plasticsurgery.org/news/plastic-surgery-statistics Buttock-lift mortality. Mofid MM, Teitelbaum S, Suissa D, et al. "Report on Mortality from Gluteal Fat Grafting: Recommendations from the ASERF Task Force." Aesthetic Surgery Journal 37(7):796-806, July 2017. 692 surgeons reported 198,857 cases and 32 fatal pulmonary fat emboli. It gives four estimates spanning 1 in 2,351 to 1 in 6,214, sets the average for aesthetic surgery in accredited facilities at 1 in 55,000, and stresses that none of its estimates should be taken as the actual rate. pmc.ncbi.nlm.nih.gov/articles/PMC5846701 NHS burden after surgery abroad. England C, Bromham N, Needham-Taylor A, et al. "Complications and costs to the UK National Health Service due to outward medical tourism." BMJ Open 16(1):e109050, 13 January 2026, from the Health and Care Research Wales Evidence Centre. Note the date: this page previously described it as a 2025 review, which came from the DOI slug carrying the submission year. pmc.ncbi.nlm.nih.gov/articles/PMC12815047 UK hospital admissions after cosmetic surgery abroad. British Association of Aesthetic Plastic Surgeons, "BAAPS Cosmetic Tourism Update", 13 November 2023. States that the number of people needing hospital treatment in the UK after cosmetic surgery abroad rose 94 per cent in three years. baaps.org.uk/media/press_releases/1881/baaps_cosmetic_tourism_update Deaths abroad and travel-health guidance. National Travel Health Network and Centre, "Travelling for treatment (medical tourism)", TravelHealthPro, first published 27 March 2023 and last updated 17 June 2024. Carries the Foreign, Commonwealth and Development Office statement that it is aware of six British nationals who died in Türkiye in 2023 following medical procedures. travelhealthpro.org.uk/factsheets/travelling-for-treatment-medical-tourism ## Cosmetic tourism coverage 9 reports Update August 22, 2026 South Korea Undercuts America but Not Turkey A Seoul rhinoplasty costs a quarter to a half of the American price. A Seoul veneer costs more than a British one and several times a Turkish one. The destination is not the unit of comparison. The procedure is. Update August 22, 2026 Turkey's Deepest Discounts Sit on Its Safest Procedures Four Health Tourism News guides price four Turkish procedures against the same British patient. Rank them by saving and rank them by what goes wrong, and the two lists come out close to reversed. Update July 8, 2026 Medical Tourism Records Concentrate In Penang And Seoul This is the Health Tourism News roundup for the week of June 29 to July 7 2026. Malaysia and South Korea both reported record medical tourism figures this... Update June 24, 2026 Health Tourism As Badge, Escape Hatch And Disguise This Week In Health Tourism 16.06.26 - 23.06.26. Three governments spent the week calling medical tourism a pillar of national economic strategy, while a... Update June 15, 2026 This Week In Health Tourism 08.06.26 - 15.06.26 This is the Health Tourism News roundup for the week of 8 June 2026, and the clearest signal across it is that the contest in medical tourism has moved past... 2026 3 This Week In Health Tourism 31.05.26 - 07.06.26 Asia Pacific Medical Tourism: Growth, But Not Everywhere Equally South Korea Wellness And Dermatology Tourism Keep Climbing 2024 1 Cosmetic Tourism Hospitalization Increases by 94% --- # What is Longevity Tourism? A Complete Guide URL: https://health-tourism-news.com/longevity-tourism/ Sub-Sector Guide Part of Health Tourism Updated April 2025 What is Longevity Tourism? A Complete Guide Longevity tourism is travel for advanced preventive medicine, biological age optimisation, and life extension therapies. It is the newest and fastest-growing sub-sector of health tourism, driven by high-net-worth patients from Western markets seeking cutting-edge diagnostics and regenerative treatments not readily available or approved in their home countries. By Christian El-Khouri, Editor-in-Chief, Health Tourism News Last updated: September 2026 Last verified: 1 September 2026 Reading time: 12 minutes 3 tiersEvidence tiers this page separates, from well supported to ahead of the data No reliable sizePublished market estimates differ by an order of magnitude on definition alone EmergingSub-sector classification Contents Section 01 ## What is Longevity Tourism? Longevity tourism is travel for the purpose of extending healthy lifespan, optimising biological age, and accessing preventive medicine programmes that go beyond the scope of conventional healthcare. It encompasses advanced diagnostics designed to detect disease risk decades before clinical presentation, regenerative therapies aimed at repairing cellular and organ-level damage, hormonal and metabolic optimisation protocols, and personalised lifestyle interventions grounded in individual biomarker data. Longevity tourism is where preventive medicine, regenerative science, and high-end health travel converge. Its patients are not ill. They are investing in not becoming ill, and they are willing to travel and pay substantially to do it right. The sub-sector sits at the clinical end of the wellness tourism spectrum, with significantly higher medical complexity than standard wellness retreats and in some cases overlapping with experimental medicine. Treatments such as stem cell therapy, peptide protocols, and novel diagnostic technologies occupy regulatory grey areas in many home countries but are available in jurisdictions with more permissive frameworks for experimental or emerging therapies. Longevity tourism is distinct from both medical tourism, which treats existing illness, and wellness tourism, which focuses on general health maintenance. Its defining characteristic is proactive clinical investment in future health, typically by patients who are already in good health by conventional measures and whose goal is to extend the period of vigorous, high-functioning life. ### The Science and the Speculation The longevity medicine field spans a wide continuum of scientific rigour. At one end sit evidence-based interventions with robust clinical trial data: continuous glucose monitoring, advanced lipid panels, whole genome sequencing, and hormonal optimisation within therapeutic ranges. At the other sit commercially marketed interventions whose claimed benefits significantly outpace the available evidence. Patients entering this market need to distinguish between the two, as providers do not always make this easy. Three tiers, sold as one What the evidence actually shows Strong evidence base Coronary calcium scoring, ApoB and Lp(a), CT angiography, continuous glucose monitoring, DEXA, VO2 max Emerging but promising Epigenetic biological age clocks, NAD+ precursors, hormonal optimisation within therapeutic ranges Ahead of the evidence Stem cell therapies for anti-ageing, peptide protocols: limited peer-reviewed human trial data Tiers and their contents are the page's own, from the section of the same name. Being in the lowest tier is not evidence that something does not work; it means the human trial data supporting the claim is not there yet. Download this chart PNG, free to republish with attribution Section 02 ## Common Longevity Tourism Treatments Longevity tourism programmes vary considerably in depth, clinical rigour, and cost. The following categories represent the major treatment modalities currently offered across leading destinations. Advanced Diagnostics Full-body MRI, whole genome sequencing, advanced blood panels (ApoB, Lp(a), hs-CRP), continuous glucose monitoring, biological age testing, DEXA scanning Regenerative Medicine Stem cell therapy (autologous and allogeneic), exosome treatments, platelet-rich plasma, NAD+ infusions, senolytic protocols Hormonal Optimisation Hormone replacement therapy (HRT), testosterone replacement, thyroid optimisation, growth hormone protocols, DHEA supplementation Peptide Therapy BPC-157, TB-500, Epitalon, Thymosin Alpha-1, Sermorelin, CJC-1295, ipamorelin combinations Metabolic and Nutritional Medicine IV micronutrient therapy, personalised nutrition protocols, metabolic health optimisation, gut microbiome analysis and intervention Cognitive and Neural Optimisation Neurofeedback, transcranial magnetic stimulation (TMS), cognitive performance testing, sleep architecture optimisation, brain health screening Epigenetic Testing Biological age clocks (Horvath, GrimAge, DunedinPACE), epigenome-wide association studies, lifestyle intervention response tracking Physical Optimisation VO2 max testing and training, grip strength and muscle quality assessment, flexibility and mobility programmes, cryotherapy, hyperbaric oxygen therapy Cardiovascular Prevention Coronary calcium scoring, carotid IMT measurement, advanced cardiac imaging, lipid management, hypertension optimisation Section 03 ## Who Travels for Longevity Medicine The longevity tourism patient profile is among the most clearly defined in health tourism. Patients are predominantly aged 35-65, predominantly male, and in the top income decile of their home market. A significant proportion come from the technology, finance, and professional services sectors, reflecting a demographic that applies an engineering and optimisation mindset to health. The motivations break into three overlapping categories. The first is early disease detection: patients who want to know as early as possible whether they carry risk factors for cancer, cardiovascular disease, or neurodegenerative conditions that conventional annual health checks will not identify. The second is performance: patients who want to maintain and extend peak cognitive and physical function beyond conventional age-related norms. The third is longevity proper: patients following the science of ageing biology and seeking to intervene in the cellular and systemic processes that drive biological ageing. Longevity tourism patients typically arrive with more research behind them than any other patient type in health travel. They have read the literature, followed the leading researchers, and come with specific questions. The best longevity clinics are built to match that level of engagement. A secondary and growing cohort, as these programmes are marketed and staffed, is younger, roughly 25 to 40, and motivated primarily by performance optimisation and preventive screening rather than anti-ageing in the traditional sense. This cohort is more price-sensitive and is driving demand for accessible longevity programmes at lower price points than the premium clinic model. Section 04 ## Top Longevity Tourism Destinations Longevity tourism destinations are fewer and more concentrated than other health tourism sub-sectors, reflecting the high infrastructure requirements and specialist staffing demands of the sector. DestinationPrimary OfferingsKey Source MarketsPositioning SwitzerlandPrecision medicine, executive health programmes, cellular therapy, advanced diagnosticsGCC, UK, Russia, USA, Asia-PacificPremium global benchmark; discretion and trust; long history of providing high-end health programmes to global elites GermanyRegenerative medicine, integrative oncology, hormonal optimisation, advanced diagnosticsGCC, Russia, Eastern Europe, UKStrong clinical rigour; integration of conventional and complementary approaches; trusted by high-acuity patients AustriaMedical wellness, metabolic health, thermal therapy, integrative medicineGermany, Russia, GCC, Eastern EuropeIntersection of medical tradition and contemporary longevity science; strong hospitality infrastructure UAEDiagnostics, longevity clinics, biohacking, executive healthGCC, South Asia, East Africa, RussiaRapidly developing hub; government strategic priority; hub positioning for regional patients ThailandIntegrated longevity resorts, stem cell programmes, wellness-longevity hybridsUSA, UK, Australia, GCC, ChinaCombining longevity medicine with high-end wellness infrastructure; cost advantage over European destinations South KoreaAdvanced diagnostics, stem cell research, precision oncology, anti-ageing dermatologyChina, USA, Southeast Asia, JapanTechnology-led; strong in diagnostics and cellular medicine; K-Medicine emerging brand USA (selected states)Full longevity programme, cutting-edge trials, regenerative medicine, executive healthGlobal high-net-worthAccess to the most advanced longevity science globally; highest cost; some treatments available only here MexicoStem cell therapy, peptide protocols, regenerative treatmentsUSA, CanadaCost advantage for North American patients; permissive regulatory environment for experimental therapies Section 05 ## What the Evidence Actually Shows The longevity medicine field has a mixed evidence base that patients need to navigate carefully. Some interventions are grounded in decades of research with clear clinical utility. Others are commercially marketed ahead of the evidence that would justify their use. Understanding which is which is the central challenge for any longevity tourist. ### Strong Evidence Base Advanced cardiovascular screening, including coronary artery calcium scoring, ApoB and Lp(a) measurement, and coronary CT angiography, has robust evidence for detecting subclinical disease and for stratifying risk. The 2019 ACC/AHA primary prevention guideline gives calcium scoring a Class IIa recommendation, narrowly scoped to adults at intermediate risk where a statin decision is genuinely uncertain, and a 2025 systematic review pooling 53 studies and more than 240,000 participants finds detectable calcium strongly associated with events and mortality. It is worth separating that from a claim these clinics often make on top of it. Detecting disease is not the same as improving an outcome, and on the second question the evidence is thinner than the marketing. A 2022 systematic review in JAMA Internal Medicine found that adding a calcium score to a standard risk calculator improves discrimination only modestly and concluded, in its own words, that no evidence suggests this provides clinical benefit. The US Preventive Services Task Force grades exactly this use, in asymptomatic adults, as insufficient evidence. DANCAVAS, the one large randomised trial of a screening programme built around calcium scoring, did not significantly reduce all-cause mortality. The test is well evidenced for what it measures. Whether measuring it makes you live longer is a different question and not a settled one. ### Emerging but Promising Biological age clocks based on epigenetic methylation patterns are scientifically legitimate tools for assessing biological versus chronological age, and the research field is advancing rapidly. Epigenetic clocks predict mortality and disease risk at population level across multiple systematic reviews, which is what puts them in this tier; whether an individual can move their clock score and benefit from doing so is not established. ### Ahead of the Evidence Stem cell therapies for anti-ageing purposes, peptide protocols for longevity, NAD+ precursor supplementation, and several other interventions marketed heavily in the longevity tourism sector have limited peer-reviewed human trial data supporting their claimed benefits. NAD+ has moved into this tier since this page was first written, and the reason is worth stating: that nicotinamide riboside and nicotinamide mononucleotide raise NAD+ levels is well established, but that raising them delivers the rejuvenation, energy or healthspan benefit clinics sell is not. Those are two different claims and only the first has good evidence behind it. This does not mean they are ineffective, but it means patients should approach marketing claims with proportionate scepticism and ensure they understand the difference between what has been demonstrated in controlled trials and what is being extrapolated from animal models or small observational studies. Section 06 ## How to Evaluate a Longevity Tourism Provider Provider quality in longevity tourism varies more than in most health tourism sub-sectors, and the gap between the best and worst operators is substantial. The following criteria provide a framework for evaluation. Confirm the medical director's qualifications, research background, and specific expertise in the interventions being offered, not just general medicine Ask which interventions are evidence-based and which are experimental, and expect transparent, referenced answers Request a preliminary consultation before any financial commitment, and assess whether the clinical team engages seriously with your specific health history and goals Be cautious of programmes that offer identical protocols to all patients: legitimate longevity medicine is highly personalised to individual biomarker profiles Confirm which diagnostic tests are included in the programme and which laboratory systems are used for analysis Ask how findings will be communicated and what follow-up support is provided after you return home Understand the regulatory status of any experimental therapies being offered in the destination country and in your home country Obtain a full written protocol, including all interventions, dosing, and monitoring schedule, before travel Confirm that your home country physician will receive a complete clinical report and can support ongoing implementation of any protocols after your return Frequently Asked Questions ## Longevity Tourism: Common Questions What is longevity tourism? Longevity tourism is travel for advanced preventive medicine, biological age optimisation, and life extension therapies. It encompasses cutting-edge diagnostics to detect disease risk early, regenerative treatments, hormonal and metabolic optimisation, and personalised health protocols grounded in individual biomarker data. It is the newest and fastest-growing sub-sector of health tourism, attracting patients who are already healthy by conventional measures but want to extend their healthy lifespan through clinical intervention. How is longevity tourism different from wellness tourism? Wellness tourism is lower clinical intensity and focuses on health maintenance through lifestyle, movement, and mindfulness. Longevity tourism is clinically driven: it involves physicians, diagnostic laboratories, biomarker analysis, and in many cases pharmacological or biological interventions. A yoga retreat and a biological age assessment with stem cell therapy may both be described as longevity-oriented, but they occupy very different positions on the clinical intensity spectrum and carry different risk profiles and regulatory implications. Where are the best longevity clinics in the world? Switzerland and Germany lead globally for medically rigorous longevity programmes with a strong evidence base. Switzerland's premium positioning and long history of providing discreet high-end healthcare to wealthy international patients makes it the natural first choice for cost-no-object programmes. Germany's strength is in integrating conventional and regenerative medicine under rigorous clinical oversight. Thailand offers a growing range of longevity programmes at lower price points. The UAE is rapidly developing as a regional hub for longevity medicine, with significant government investment and an expanding clinic ecosystem. For cutting-edge experimental approaches, some of the most advanced work is being done in the US, where the longevity science community is most concentrated. How much does longevity tourism cost? Costs vary enormously by destination and programme depth. A comprehensive longevity assessment at a premium Swiss or German clinic, including advanced diagnostics, physician consultations, and a personalised protocol, typically costs between 5,000 and 30,000 for a multi-day programme. Advertised stem cell programmes start in the low thousands and run well into five figures, and the quoted floor varies enough between operators that any single range would be misleading; treat an advertised starting price as the least you could pay for complex multi-infusion protocols. Longevity programmes in Thailand or Mexico advertise broadly similar diagnostics at materially lower cost, though no independent source prices these programmes on comparable terms, so the gap is not one we can put a figure on. Simple biomarker packages and biological age testing programmes at the lower end of the market start from a few hundred dollars. Is stem cell therapy for longevity safe? Stem cell therapy for anti-ageing is an area where commercial marketing has significantly outpaced the clinical evidence. Safety varies by cell type, administration route, source, and the clinical oversight under which the treatment is delivered. Autologous treatments, using the patient's own cells, carry a different risk profile from allogeneic treatments. The regulatory status of stem cell therapies differs substantially between countries, and many are offered in destinations with permissive frameworks precisely because they have not cleared the approval process in more stringent regulatory environments. Patients should ask specifically what peer-reviewed evidence supports the claimed benefits of any stem cell protocol being proposed and ensure the treating physician can answer that question in detail. What tests are included in a longevity assessment? A comprehensive longevity assessment typically includes advanced blood panels covering lipids, inflammatory markers, hormones, metabolic function, and nutrient status; cardiovascular imaging such as coronary calcium scoring or coronary CT angiography; body composition assessment via DEXA scanning; VO2 max testing; cognitive performance assessment; genetic and epigenetic analysis; gut microbiome profiling; and biological age testing. The most comprehensive programmes also include full-body MRI, cancer screening panels, and detailed ophthalmological and dental assessment. The specific tests included vary by clinic and programme tier. Who is longevity tourism for? Longevity tourism is primarily for individuals who are already in reasonably good health, have the financial means to invest in advanced preventive care, and want to extend the period of healthy, high-functioning life. The typical patient is aged 35-65, is in a demanding professional environment, has a family history of a condition they want to monitor closely, or has become interested in the science of ageing and wants to act on it. The sub-sector is not limited to the ultra-wealthy: a growing range of programmes at more accessible price points is bringing longevity medicine to a wider patient population. Can longevity treatments be continued at home? Some longevity interventions initiated during a travel programme can be continued at home, and the best programmes are designed with this in mind. Hormonal optimisation, nutritional protocols, and targeted supplementation can typically be managed by a home country physician working from the longevity clinic's protocol. Others, such as IV therapies or in-clinic regenerative treatments, require repeat visits. Patients should confirm before travel which elements of a proposed programme can realistically be continued domestically and which require a return visit, and factor this into their overall planning and cost assessment. ## Sources The tier placements on this page are editorial judgements about the state of the human trial evidence, and each is now cited. Two moved when we checked them, which is recorded in the corrections log. Prices on this page remain advertised starting figures published by operators, not a surveyed panel: unlike our treatment guides, this sub-sector has no Health Tourism News price panel behind it, and where we could not state a range honestly we have said so instead of estimating. Coronary artery calcium, the guideline position. Arnett DK, Blumenthal RS, Albert MA, et al. "2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease." Class IIa, Level B-NR, for adults at intermediate risk where a statin decision is uncertain. pmc.ncbi.nlm.nih.gov/articles/PMC7685565 Coronary artery calcium, prognostic strength. Al Hennawi H, et al. "Impact of coronary artery calcium scores on cardiovascular risk and preventive therapies: a systematic review and meta-analysis." Global Cardiology Science & Practice, 2025. 53 studies, over 240,000 participants. pmc.ncbi.nlm.nih.gov/articles/PMC13070238 Coronary artery calcium, the counterweight. Bell KJL, White S, Hassan O, et al. "Evaluation of the Incremental Value of a Coronary Artery Calcium Score Beyond Traditional Cardiovascular Risk Assessment." JAMA Internal Medicine, 2022. Concludes that no evidence suggests the added discrimination provides clinical benefit. pmc.ncbi.nlm.nih.gov/articles/PMC9039826 Coronary artery calcium, the randomised evidence. Sogaard R, Lindholt JS, Diederichsen ACP, et al. "User-defined outcomes of the Danish cardiovascular screening (DANCAVAS) trial." PLoS Medicine, 2024. The screening programme did not reduce all-cause mortality. pmc.ncbi.nlm.nih.gov/articles/PMC11132442 Lipoprotein(a). "Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement", 2022. pmc.ncbi.nlm.nih.gov/articles/PMC9639807 Epigenetic clocks. Chen BH, Marioni RE, Colicino E, et al. "DNA methylation-based measures of biological age: meta-analysis predicting time to death", Aging, 2016; and Fransquet PD, et al. "The epigenetic clock as a predictor of disease and mortality risk: a systematic review and meta-analysis", Clinical Epigenetics, 2019. PMC5076441 and PMC6458841 Cardiorespiratory fitness. Ross R, Blair SN, Arena R, et al. "Importance of Assessing Cardiorespiratory Fitness in Clinical Practice", American Heart Association scientific statement, 2016; and Kodama S, et al. on cardiorespiratory fitness as a quantitative predictor of all-cause mortality, 2009. PMID 27881567 and PMID 19454641 Continuous glucose monitoring outside diabetes. "Continuous glucose monitoring in non-diabetic populations: a systematic review", European Journal of Medical Research, 2026, and expert-interpretation work on CGM reports from people without diabetes. pmc.ncbi.nlm.nih.gov/articles/PMC11822776 NAD+ precursors. "NAD+ supplementation for anti-aging and wellness: a PRISMA-guided systematic review", 2026; and a 2025 meta-analysis of nicotinamide mononucleotide and riboside on skeletal muscle mass and function. The precursors raise NAD+; the anti-ageing benefit is not established. pmc.ncbi.nlm.nih.gov/articles/PMC12022230 Peptides and stem cell protocols. "Therapeutic peptides in gerontology: mechanisms and applications for healthy ageing", 2026; and "Regeneration or Risk? A narrative review of BPC-157 for musculoskeletal healing", 2025. PMC13095733 and PMC12446177 ## Related coverage Update July 1, 2026 Nigeria, Iran And Seoul Redraw Medical Tourism News June 23, 2025 Why Longevity Tourism Is the Future of Health Travel Update August 30, 2026 This Week in Medical Tourism: 20–26 August 2026 Update August 29, 2026 This Week in Medical Tourism: 13–19 August 2026 Update August 22, 2026 South Korea Undercuts America but Not Turkey Update August 22, 2026 Spain and Greece Report IVF Success Differently Update August 22, 2026 Mexico and Turkey Price Against Different Home Markets Update August 22, 2026 Turkey's Deepest Discounts Sit on Its Safest Procedures --- # The HTN Knowledge Hub URL: https://health-tourism-news.com/knowledge-hub/ Reference & Definitions The HTN Knowledge Hub A living reference built from industry expertise - definitions, frameworks, and sector intelligence for health tourism professionals worldwide. Umbrella Term ## Health Tourism Health Tourism is the umbrella term for traveling across borders to enhance or restore physical, mental, or spiritual well-being. It spans the full spectrum from complex medical procedures to lifestyle-focused wellness experiences, encompassing six distinct sub-sectors. Read the complete Health Tourism Overview ### Sub-Sector Guides Medical Tourism Crossing borders for medical services - surgery, diagnostics, rehabilitation, and specialist care. Wellness Tourism Active pursuit of health maintenance through yoga, fitness, nutrition, and spiritual programmes. Dental Tourism Traveling for preventive, restorative, and cosmetic dental care at significant cost savings. Fertility Tourism Cross-border reproductive care - IVF, donor programmes, surrogacy, and fertility preservation. Cosmetic Tourism Elective surgical and non-surgical aesthetic procedures performed by medical professionals abroad. Longevity Tourism Emerging segment focused on life extension, biological age optimisation, and regenerative therapies. ### Related Articles Weekly Digest This Week in Medical Tourism: 20–26 August 2026 August 30, 2026 Weekly Digest This Week in Medical Tourism: 13–19 August 2026 August 29, 2026 Medical Tourism Mexico and Turkey Price Against Different Home Markets August 22, 2026 Sub-Sector ## Medical Tourism Part of Health Tourism Medical tourism is the practice of travelling outside one's country of residence to receive medical services, bearing direct or indirect costs. It is the largest and most commercially significant sub-sector of health tourism, covering everything from elective surgery to complex oncology treatment abroad. Read the complete Medical Tourism Guide ### Related Articles Medical Tourism Mexico and Turkey Price Against Different Home Markets August 22, 2026 Medical Tourism Turkey's Deepest Discounts Sit on Its Safest Procedures August 22, 2026 Medical Tourism Why Medical Tourism to Germany Declined August 11, 2026 Sub-Sector ## Wellness Tourism Part of Health Tourism Wellness tourism is the active pursuit of health maintenance and improvement through travel. It sits at the enhancement end of the health tourism spectrum, encompassing yoga retreats, fitness camps, nutrition programmes, Ayurveda, and spiritual experiences. Read the complete Wellness Tourism Guide ### Related Articles Weekly Digest Medical Tourism Records Concentrate In Penang And Seoul July 8, 2026 Weekly Digest Nigeria, Iran And Seoul Redraw Medical Tourism July 1, 2026 Weekly Digest Health Tourism As Badge, Escape Hatch And Disguise June 24, 2026 Sub-Sector ## Dental Tourism Part of Health Tourism Dental tourism is one of the most established segments of health tourism, driven by significant price differentials for procedures ranging from implants and crowns to full smile makeovers. Leading destinations include Turkey, Hungary, Mexico, and Poland. Read the complete Dental Tourism Guide ### Related Articles Cosmetic Tourism South Korea Undercuts America but Not Turkey August 22, 2026 Medical Tourism Mexico and Turkey Price Against Different Home Markets August 22, 2026 Medical Tourism Turkey's Deepest Discounts Sit on Its Safest Procedures August 22, 2026 Sub-Sector ## Fertility Tourism Part of Health Tourism Also known as Cross-Border Reproductive Care (CBRC), fertility tourism involves travelling to access IVF, donor programmes, surrogacy, and other reproductive treatments shaped by differing legal frameworks and cost structures. It is one of the fastest-growing and most ethically complex segments of health tourism. Read the complete Fertility Tourism Guide ### Related Articles Fertility Tourism Spain and Greece Report IVF Success Differently August 22, 2026 Sub-Sector ## Cosmetic Tourism Part of Health Tourism Cosmetic tourism encompasses patients travelling internationally for aesthetic procedures - from rhinoplasty and body contouring to non-surgical treatments - driven by competitive pricing and the rise of leading cosmetic surgery destinations. It sits at the intersection of medical and wellness tourism. Read the complete Cosmetic Tourism Guide ### Related Articles Cosmetic Tourism South Korea Undercuts America but Not Turkey August 22, 2026 Medical Tourism Turkey's Deepest Discounts Sit on Its Safest Procedures August 22, 2026 Weekly Digest Medical Tourism Records Concentrate In Penang And Seoul July 8, 2026 Emerging Sub-Sector ## Longevity Tourism Part of Health Tourism Longevity tourism is an emerging segment focused on life extension, biological age optimisation, and advanced preventive medicine. Patients travel for cutting-edge diagnostics, regenerative therapies, and personalised anti-aging protocols at clinics in Switzerland, Germany, Thailand, and the UAE. Read the complete Longevity Tourism Guide ### Related Articles Weekly Digest Nigeria, Iran And Seoul Redraw Medical Tourism July 1, 2026 Longevity Tourism Longevity Travel Market Valued at $18 Billion, $48.2 Billion by 2033 May 19, 2026 Longevity Tourism Grenada Expands Wellness Tourism With Two Resorts May 18, 2026 --- # Health Tourism Guides URL: https://health-tourism-news.com/guides/ HTN Guides Health Tourism Guides Health tourism is a field that rewards precision and punishes loose talk, and these guides exist to supply the first. Each takes a clear position on its part of the industry, from the broad question of what health tourism is to the particular logic of its six sub-sectors. They are written for professionals, though anyone trying to understand the field properly will find them useful. Health Tourism The umbrella. What the field is, how it fits together, and where the lines actually fall. Read the guide Medical Tourism Travel for surgery, diagnostics, oncology, cardiac and orthopaedic care, and rehabilitation. The largest and most serious sub-sector. Read the guide Wellness Tourism Travel to maintain or improve a state of health that is already sound. By revenue it dwarfs every other sub-sector. Read the guide Dental Tourism Travel for implants, full-mouth work and restorative dentistry, driven almost entirely by price. Read the guide Fertility Tourism Cross-border reproductive care, shaped as much by what a patient's home law forbids as by cost. Read the guide Cosmetic Tourism Elective aesthetic procedures abroad, the sub-sector that moves with fashion rather than medicine. Read the guide Longevity Tourism Diagnostics, biological-age testing and preventive medicine for people who are not ill and want to stay that way. Read the guide --- # This Week In Health Tourism 08.06.26 - 15.06.26 URL: https://health-tourism-news.com/news/080626-150626/ Weekly Digest June 15, 2026 Weekly DigestCosmetic TourismWellness TourismMedical TourismHealth Tourism This Week In Health Tourism 08.06.26 - 15.06.26 This is the Health Tourism News roundup for the week of 8 June 2026, and the clearest signal across it is that the contest in medical tourism has moved past... Christian El-Khouri Editor-in-Chief Published June 15, 2026 · 7 min read This is the Health Tourism News roundup for the week of 8 June 2026, and the clearest signal across it is that the contest in medical tourism has moved past price toward control of the whole patient journey. Governments spent the week building the administrative layer that clinical quality alone never solved: South Korea legalised telemedicine for foreign patients, Telangana put its public hospitals into the trade, Thailand moved to lengthen its medical visa, and a new service centre opened in China’s Hainan pilot zone. A harder story ran underneath, set out by Medscape and US health officials: who pays when the journey is left unmanaged. The week rewarded coordination over capacity. ## China’s advanced-treatment play in medical tourism The Business Times reported the case of Stuart Lye, a 58-year-old New Zealander who travelled to Shanghai for CAR-T therapy that cost about US$65,000 including airfare, against more than A$500,000 in Australia. While Thailand, South Korea and Malaysia compete on cosmetic surgery, fertility care and screening, China is selling procedures few others offer: a CAR-T infusion runs US$300,000 to US$475,000 in the United States against US$150,000 to US$180,000 in China, which already has seven approved commercial therapies and more trials under way than anywhere else. PR Newswire reported a new full-chain service centre at the Boao Lecheng pilot zone in Hainan, which drew nearly 10,000 foreign medical tourists from 14 countries in 2025 and has cleared more than 560 innovative drugs and devices. The science is not the constraint; regulators are. pharmaphorum’s point, that cancer patients care only that a breakthrough reaches them, is the bottleneck: China’s ivonescimab took the first China-developed plenary slot at the ASCO meeting, yet the United States declined a China-only trial for sintilimab in 2022 over how far the data carried. Agencies such as Joyful Medical and SinoUnited Health will shape this early market, but the missing medical-visa scheme and fragmented services flagged by China Renaissance Securities are the openings Thai and Singaporean operators should press now. ## India, Thailand and Egypt build medical tourism infrastructure Three governments treated medical tourism as infrastructure to build, not a slogan to market. EdexLive and The Hans India reported that Telangana has formed a high-level committee, ordered on 6 June, to bring international patients into Hyderabad’s state-run hospitals: a dedicated block at TIMS Sanathnagar, procedures with fixed package rates, translators and attendant services, with recommendations due within a month. Nation Thailand described a parallel push by the Department of Health Service Support to lengthen the medical visa and amend the 1998 Medical Facilities Act so private hospitals can run their own research centres, alongside a global insurance-claims platform aimed at the longevity market. Thailand already counts more than 500 private hospitals, many internationally accredited. Clinical capacity stopped being the binding constraint years ago; the work that wins referrals now sits in pricing transparency, visa duration and dispute resolution. Telangana’s one-month deadline is the near-term thing to watch, since a public-hospital pricing schedule that undercuts private rivals would reset expectations across southern India. The hazard of moving fast showed in Egypt, where Al Manassa reported the health ministry launching its national platform under a name, “Tour for Cure”, already used by a Turkish competitor, after quietly treating around 250 patients in a pilot. Nomad Lawyer noted a different lever in Portugal, where Lagoa used a 1,500-delegate internal medicine congress to push into year-round medical-conference tourism. ## Telemedicine and integrated care redraw the patient journey South Korea made the week’s most consequential regulatory change. Digital Health News reported an amendment letting registered providers consult, diagnose and prescribe for foreign patients remotely, including first-timers, both before they fly in and after they return home. With foreign patient visits near two million a year, it attacks the structural weakness of medical travel: the short stay that ends the moment a patient boards the plane. The demand shows in the data: The Asia Business Daily reported Korean medical tourism spending up 48.7% year on year in April, Chinese spending alone up 141.5%; in Malaysia, BIMB Securities Research read first-quarter results the same way, IHH Healthcare’s core earnings up 8% and revenue per inpatient up 12%. Continuity of care ran through the week’s commercial stories too. Vietnam Investment Review reported that Taipei Fertility Center, a cross-border fertility care specialist, has treated more than 2,300 international families, the over-40s now near 30%, using a one-stop remote model. Business Insider Africa described Medicana’s Nigeria strategy in similar terms, an international patient department handling second opinions, costs, accommodation and post-return contact. Newsweek carried the same account from Colombia’s Hospital Internacional de Colombia, where an integrated model and a Mayo Clinic Care Network tie-up are turning Bucaramanga, an intermediate city, into a destination for complex cardiac and paediatric cases. The margin is moving to whoever owns the consultation before and the follow-up after. ## The safety reckoning in cosmetic surgery tourism The counterpoint to all that coordination came from the operating theatre. Medscape, translating its French edition, reported plastic surgeon Flore Delaunay telling the French Society of Aesthetic and Plastic Surgeons’ congress in Biarritz that cheap cosmetic surgery in Tunisia, Turkey or Thailand hides a chain of failures: no mandatory waiting period, thin consent, untraceable implants, and flights taken days after surgery that raise the risk of clots. A breast augmentation averaging €4,500 in France costs about €2,000 in Tunisia, and Turkey’s cosmetic-tourism market, valued near $3.5 billion, is projected to reach $17 billion by 2035. When it fails, patients come home in sepsis with multidrug-resistant infections, and a Marseille team put the average cost of complications at €8,500 per patient, increasingly billed back by French Social Security. Nomad Lawyer relayed the same pattern from the United States, where a health alert linked a surge of drug-resistant infections in Los Angeles to cut-price cosmetic surgery abroad. Unmanaged cosmetic surgery tourism pushes its costs onto home health systems, and destinations that lead on volume, Turkey most of all, carry a reputational liability they cannot discount away. The remedy is unglamorous: implant traceability and a real aftercare pathway. The integrated-care operators above are, in effect, selling the absence of this exact risk. ## Wellness tourism borrows the clinic’s tools Wellness tourism kept closing the gap to medicine. Nine.com.au pointed to Saint Haven in Sydney and Melbourne, where city dwellers book short urban recovery stays built on hyperbaric oxygen, cryotherapy, infrared saunas and nutrient drips, clinical kit in a spa wrapper. The Traveler made the case for Puerto Rico, whose pitch rests on a medical base: as a United States territory it offers care to US standards, English-speaking clinicians and familiar insurance, with new sites such as Sabanera Health in Dorado pairing advanced medicine with resort comfort, which is what lets it outpace Belize, Saint Lucia and Barbados. Travel Daily Media traced the same convergence across the Asia Pacific, from Thailand’s Chiva-Som, open since 1995, to the Philippines’ Farm at San Benito. The spa and the clinic are merging into one product, and the high-spend traveller goes to operators with a clinical spine. Puerto Rico’s regulatory umbrella and the Farm’s medical staffing are the moat, not a detail. Destinations selling wellness tourism without that depth will keep the casual visitor and lose the patient who actually spends. ## What This Means The single thread through every one of these stories is that medical tourism is being re-priced around coordination rather than the procedure itself. China can offer a therapy no one else has and still lose patients at the visa desk. Korea, Medicana and a hospital in Bucaramanga win not on surgical skill alone but on owning the weeks before and after. And the cosmetic-surgery casualties filling French and Californian wards are what an uncoordinated journey produces. For the back half of 2026, watch whether the new state-backed entrants, Telangana, Thailand and Egypt, can build the dull administrative layer, pricing, visas, follow-up and mediation, fast enough to turn clinical capacity into trusted referrals, because that, not another accredited hospital, is what now separates a destination patients reach from one they only read about. Sources (20) Businessinsider Nationthailand Newsweek Digitalhealthnews Prnewswire Businesstimes Manassa Traveldailymedia Thetraveler Thestar Nomadlawyer Pharmaphorum Medscape Geneonline Edexlive Vir Thehansindia Nomadlawyer Nine Asiae TürkiyeNigeriaThailandPortugalSpainUnited Arab EmiratesAsiaAustralia ### The Wire Aug 30This Week in Medical Tourism: 20–26 August 2026 Aug 29This Week in Medical Tourism: 13–19 August 2026 Aug 22South Korea Undercuts America but Not Turkey All coverage ### Newsletter Get weekly health tourism intelligence in your inbox. Subscribe ### Knowledge Hub Medical Tourism Wellness Tourism Dental Tourism Fertility Tourism Cosmetic Tourism Longevity Tourism Explore the Hub Stay informed on the latest in global health tourism. Subscribe to our Newsletter ## Related Articles Weekly Digest 30 AUG 2026 Weekly Digest ### This Week in Medical Tourism: 20–26 August 2026 August 30, 2026 Weekly Digest 29 AUG 2026 Weekly Digest ### This Week in Medical Tourism: 13–19 August 2026 August 29, 2026 Cosmetic Tourism 22 AUG 2026 Cosmetic Tourism ### South Korea Undercuts America but Not Turkey August 22, 2026 --- # This Week In Health Tourism 31.05.26 - 07.06.26 URL: https://health-tourism-news.com/news/310526-070626/ Weekly Digest June 14, 2026 Weekly DigestCosmetic TourismWellness TourismMedical TourismHealth Tourism This Week In Health Tourism 31.05.26 - 07.06.26 This is the Health Tourism News roundup for May 31–June 7, 2026. This week's signals highlight a dual trend: destinations are aggressively pursuing growth in... Christian El-Khouri Editor-in-Chief Published June 14, 2026 · 8 min read This is the Health Tourism News roundup for May 31–June 7, 2026. This week’s signals highlight a dual trend: destinations are aggressively pursuing growth in medical and wellness tourism through strategic initiatives, while simultaneously, the industry faces increasing scrutiny over patient safety and the critical role of trust. Policymakers and providers must balance ambitious expansion plans with robust patient protection measures to sustain long-term sector development. ## Strategic Expansion and Digitalisation Drive Medical Tourism Medical tourism destinations globally are intensifying efforts to attract international patients through strategic investments in infrastructure, digital solutions, and integrated patient services. Malaysia, for example, demonstrated strong demand at its Malaysia Fair 2026 in Jakarta, reporting RM2.2 billion in revenue from Indonesia in 2025, a 23% year-on-year increase, with over 970,000 Indonesian healthcare travellers, up 16% from 2024. The Malaysia Healthcare Travel Council (MHTC) views Jakarta as a crucial high-potential market, an initiative supported by MHTC’s brand ambassador, national songstress Siti Nurhaliza Tarudin, as Freemalaysiatoday reported. In the Middle East, Jordan’s Health Minister Ibrahim Al Bdour highlighted continuous royal support for the healthcare sector, establishing the country as a regional hub for medical treatment and education. Istiklal Hospital, marking its 25th anniversary, has treated patients from 97 nationalities and launched an “Istiklal Medical Tourism Platform” to bolster Jordan’s reputation, according to Petra. This illustrates how national commitment and private sector investment are vital for developing regional leadership. Further east, Ethiopia is executing an extensive plan to digitise over 80% of its government hospitals and clinics by 2030, aiming to become a premier medical tourism centre in the Horn of Africa. Dereje Duguma, the State Minister for Health, noted that more than 50 facilities have already adopted paperless systems and are implementing AI-based digital radiology and diagnostic tools, TV BRICS reported. This digital push seeks to elevate service quality and attract patients from nearby nations. Dubai is also advancing its patient journey with a ‘smart medical visa,’ a collaboration between the General Directorate of Identity and Foreigners Affairs and the Dubai Health Authority. This agreement seeks to create a cohesive experience for medical tourists, encompassing visa, residency, and healthcare services from pre-arrival to post-treatment, Khaleej Times stated. Such policy integration, including companion visas and sponsorship via licensed healthcare facilities, is fundamental for streamlining access. Meanwhile, Bangkok Health Service in Thailand has introduced a USD pricing page for its medical tourism packages, providing US and international patients with clearer cost estimates for a range of procedures, from health checks to cardiovascular surgeries, as reported by The National Law Review and Businessinsider. This transparency in pricing, though initially estimated, is a key factor in patient decision-making. Beyond general medical tourism, specialisation drives significant growth. Belarus is emerging as a leading medical tourism hub in the Commonwealth of Independent States (CIS), appealing to Russian citizens with its innovative treatments, according to State Secretary Sergei Glazyev. BelTA News Agency indicated plans to double tourism’s share in the national GDP and open a second Union State tourist information centre by 2027. Similarly, Turkey’s hair transplant sector exemplifies highly specialised medical tourism, generating $3 billion from 1.3 million medical tourists in 2025. Streamlinefeed detailed how Turkey achieved global leadership through aggressive innovation, accessible pricing, and the standardisation of microsurgical techniques, transforming corporate hospitals into advanced medical academies. These varied approaches demonstrate that both broad strategic investments and focused specialisation are effective pathways for national and regional medical tourism development, requiring operators and policymakers to adapt strategies to their specific market strengths. ## Prioritising Patient Trust and Safety Amidst Growing Risks While the medical tourism market is projected to exceed $100 billion by 2032, expanding at 15% to 25% annually, growth in awareness has not translated proportionally into patient conversion, according to Business Insider. This publication highlights that 97.2% of medical tourists consider trust paramount in their decision-making, yet many programmes focus on visibility rather than trust-building systems. A new advisory service from JCH Digital, drawing on nursing leadership experience, aims to help policymakers and healthcare organisations strengthen patient trust and improve international positioning by framing it as a clinical credibility exercise rather than solely a branding effort. This approach is critical given that 5% of US medical tourists report unexpected outcomes from care abroad, with 67% of those seeking follow-up treatment upon return, reinforcing hesitation among prospective patients, Business Insider noted. Concerns over patient safety are further underscored by new research from the Centers for Disease Control and Prevention (CDC). The CDC documented serious complications, including difficult-to-treat infections and, in some cases, deadly outcomes, tied to cosmetic surgeries performed during medical tourism trips. A study published in the CDC’s Emerging Infectious Diseases journal reviewed reports spanning a decade, identifying 21 reports involving approximately 145 patients who experienced adverse outcomes, including four patient deaths, between 2014 and 2024. Lead author Kiara McNamara, a CDC nurse epidemiologist, emphasised the importance of patients being informed and prepared before seeking cosmetic surgery abroad, Laredo Morning Times reported. The study also highlighted infection-control concerns at some facilities, citing shortcomings in cleaning, hand hygiene, personal protective equipment use, and surgical instrument processing. British surgeons have issued a stark warning regarding individuals travelling overseas for procedures such as leg-lengthening, noting the significant burden placed on the National Health Service (NHS) for extensive follow-up care. A study by specialist limb reconstruction surgeons at the Royal National Orthopaedic Hospital NHS Trust calculated that addressing complications from just seven cases cost the NHS over £36,000, with the true financial impact likely far greater, reported The Independent. Complications observed include implant failure, inadequate bone healing, and severe limb deformities. Most patients sought these procedures abroad due to lower costs and availability, with five of the seven studied cases travelling to Turkey, one to Russia, and one to South Africa. The Royal College of Surgeons of England noted a growing trend of patients seeking surgical treatments outside the UK, with the incidence almost doubling from 230,000 patients in 2021 to over 430,000 in 2023. These findings collectively urge policymakers and healthcare providers to collaborate on stronger surveillance efforts, enhance patient education on risks, and prioritise clinical credibility and safety measures to mitigate adverse outcomes and build enduring trust in cross-border care. ## The Expanding Scope of Wellness Travel Beyond traditional medical treatments, the wellness travel sector is gaining considerable momentum, shifting focus towards preventative health and holistic wellbeing. Preventative wellness travel is increasingly replacing conventional leisure vacations, driven by a broader recognition among employers, insurers, and healthcare decision-makers that employee health outcomes are influenced by lifestyle, stress, sleep, and recovery practices. As reported by Corporate Wellness Magazine, this trend addresses issues like burnout and chronic stress, offering structured activities such as stress reduction programmes, sleep optimisation, mindfulness, and nutrition education, distinct from acute medical interventions. This reflects a proactive approach to longevity and aligns with evolving workforce expectations for experiences that contribute to mental clarity and emotional resilience. South Korea is capitalising on this trend by deploying legislative and financial support to position itself as a premier global wellness destination. Under its newly enacted Healing Tourism Industry Act, the Ministry of Culture, Sports and Tourism has selected 20 premier wellness sites nationwide, providing each with up to 50 million won (approximately $36,300) in government funding. This initiative, detailed by The Korea Times, aims to institutionalise and regulate the domestic sector, establishing an official bureaucratic framework to manage service quality, train professionals, and designate specialised “healing tourism zones.” The funding will support multilingual digital infrastructure, global advertising campaigns, and localised content across areas like traditional Korean medicine, high-tech beauty spas, and forest retreats, reflecting Korea’s unique blend of modernity and ancient tradition. In Southeast Asia, Bintan is strengthening its position as a wellness and sports travel hub. Safariindia reported on the return of the Bintan Triathlon 2026, an event that attracts professional athletes, fitness enthusiasts, and wellness travellers seeking to combine endurance activities with a tropical island escape. The triathlon, just a 60-minute ferry ride from Singapore, exemplifies how destinations are curating experiences that blend movement, relaxation, and nature immersion, aligning with modern travel preferences for physical activity and mental wellbeing. These developments indicate a clear industry shift: wellness travel is not merely a leisure pursuit, but a strategic component of health tourism, demanding tailored infrastructure, regulatory frameworks, and integrated experiences to meet sophisticated consumer and corporate demands. Investors and operators should look to these examples for models of sustainable, high-value tourism development. ## What This Means The industry is clearly at a crossroads, balancing ambitious growth with the imperative of patient confidence. While countries like Malaysia, Jordan, Ethiopia, and Dubai are making strategic investments in digital infrastructure, specialised services, and policy reforms to attract medical tourists, the persistent warnings from bodies like the CDC and the Royal College of Surgeons highlight critical gaps in patient safety and trust. The rise of preventative wellness travel, as seen in South Korea and Bintan, offers a complementary path, but it too requires careful regulation and credible offerings. The overarching message is that sustained expansion in health tourism, whether medical or wellness-focused, will depend less on aggressive marketing and more on demonstrable clinical credibility, robust patient protection, and transparent, integrated service models that prioritise the traveller’s wellbeing at every stage. Industry stakeholders must now focus on harmonising these diverse elements to build a truly resilient and reputable global health tourism offering. Sources (13) Freemalaysiatoday Belta Lmtonline Independent Khaleej Times Natlawreview Petra Corporatewellnessmagazine Businessinsider Tvbrics Koreatimes Streamlinefeed Safariindia IndonesiaMalaysiaBelarusRussiaNorth AmericaU.S.ColombiaCanada ### The Wire Aug 30This Week in Medical Tourism: 20–26 August 2026 Aug 29This Week in Medical Tourism: 13–19 August 2026 Aug 22South Korea Undercuts America but Not Turkey All coverage ### Newsletter Get weekly health tourism intelligence in your inbox. Subscribe ### Knowledge Hub Medical Tourism Wellness Tourism Dental Tourism Fertility Tourism Cosmetic Tourism Longevity Tourism Explore the Hub Stay informed on the latest in global health tourism. Subscribe to our Newsletter ## Related Articles Weekly Digest 30 AUG 2026 Weekly Digest ### This Week in Medical Tourism: 20–26 August 2026 August 30, 2026 Weekly Digest 29 AUG 2026 Weekly Digest ### This Week in Medical Tourism: 13–19 August 2026 August 29, 2026 Cosmetic Tourism 22 AUG 2026 Cosmetic Tourism ### South Korea Undercuts America but Not Turkey August 22, 2026 --- # Düsseldorf Strengthens Its Position in Health Tourism URL: https://health-tourism-news.com/news/7th-dusseldorf-health-marketing-forum-s-resounding-success/ Medical Tourism Düsseldorf Strengthens Its Position in Health Tourism 7th Health Marketing Forum Sets New Impulse for Medical Tourism and Global Healthcare Christian El-Khouri Editor-in-Chief Editor-in-Chief of Health Tourism News. Twelve-plus years across international patient services, healthcare consulting, and destination development in Europe, the Middle East, and beyond. Co-Founder and Vice President of the European Health and Medical Tourism Association (EHMTA). Read more Published November 26, 2025 · 3 min read **DÜSSELDORF - ** More than 120 international experts from medicine, health services, and tourism gathered for the 7th Düsseldorf Health Marketing Forum, confirming Düsseldorf’s growing relevance as a leading destination in health tourism, medical tourism, and global healthcare. Organized by Visit Düsseldorf, the event delivered forward-looking insights, strategic discussions, and a landmark announcement for the city’s health travel ecosystem. ## A Premium Setting for Health and Medical Tourism Dialogue The forum took place at the prestigious Steigenberger Icon Parkhotel, a flagship of Düsseldorf’s luxury hospitality sector. Hosted by General Manager Stefan Winkler, the hotel’s refined atmosphere and central location provided an ideal environment for high-level discussions on the future of international patient travel and global healthcare offerings. ## Strategic Outlook for Düsseldorf’s Health Tourism Growth The program highlighted several key developments shaping the city’s health and medical tourism strategy: Health Marketing Strategy 2025/26: Jens Ihsen, Director of Visit Düsseldorf, unveiled the city’s upcoming strategic framework designed to strengthen Düsseldorf’s position in the European and global health tourism market. Longevity as a Growth Segment: Dr. med. Thomas B. Fischer delivered a compelling keynote on Longevity, reflecting the increasing global demand for preventive medicine, lifestyle optimization, and long-term health management. **Industry Panel on Future Trends: **A dynamic panel discussion brought together Dimitri Belov, Anna Kobrya (radprax Vorsorge-Institut), Dr. Fischer, and Stefan Winkler. Moderated by Angela Julie Wadenpohl, the conversation explored new opportunities in medical tourism, patient expectations, digital transformation, and the evolving role of clinics and facilitators in global healthcare. ## Major Milestone: Visit Düsseldorf Joins the European Health and Medical Tourism Association (EHMTA) A defining moment of the evening was the official signing of the membership agreement between Visit Düsseldorf and the European Health and Medical Tourism Association (EHMTA).The agreement was signed live on stage by Jens Ihsen and EHMTA President Ivan Rendulić. Joining EHMTA strengthens Düsseldorf’s integration into the European health tourism network and provides access to: international patient facilitators, cross-border cooperation initiatives, global healthcare market intelligence, and relevant medical tourism industry data. This step positions Düsseldorf even more strongly within Europe’s competitive landscape for high-quality medical care, wellness travel, and international patient services. ## Düsseldorf’s Growing Role in Global Healthcare The 7th Health Marketing Forum clearly demonstrated that Düsseldorf is ready to take a leading role in shaping the future of global healthcare travel. With its internationally recognized clinics, strong hospitality infrastructure, and strategic partnerships, the city is steadily expanding its profile as a premium destination for both health and medical tourism. As the forum concluded, Visit Düsseldorf and its partners emphasized their commitment to advancing innovation, strengthening international networks, and driving sustainable growth in the region’s health tourism ecosystem. ### The Wire Aug 30This Week in Medical Tourism: 20–26 August 2026 Aug 29This Week in Medical Tourism: 13–19 August 2026 Aug 22South Korea Undercuts America but Not Turkey All coverage ### Newsletter Get weekly health tourism intelligence in your inbox. Subscribe ### Knowledge Hub Medical Tourism Wellness Tourism Dental Tourism Fertility Tourism Cosmetic Tourism Longevity Tourism Explore the Hub Stay informed on the latest in global health tourism. Subscribe to our Newsletter ## Related Articles Medical Tourism 22 AUG 2026 Medical Tourism ### Mexico and Turkey Price Against Different Home Markets August 22, 2026 Medical Tourism 22 AUG 2026 Medical Tourism ### Turkey's Deepest Discounts Sit on Its Safest Procedures August 22, 2026 Medical Tourism ### Why Medical Tourism to Germany Declined August 11, 2026 --- # Addressing Concerns About Medical Tourism: Cost Savings vs. Quality of Care URL: https://health-tourism-news.com/news/addressing-concerns-about-medical-tourism-cost-savings-vs-quality-of-care/ Medical Tourism Addressing Concerns About Medical Tourism: Cost Savings vs. Quality of Care Global Healthcare at a Fraction of the Cost - Without Compromising Standards Kevin Ciresi Contributor A career spanning the operating room to the boardroom. Former surgeon who founded and led multiple U.S. healthcare facilities, now focused on transparent frameworks for international care and blue-zone wellness destinations. Read more Published September 30, 2025 · 11 min read Reviewed by Christian El-Khouri, Editor-in-Chief Global Healthcare at a Fraction of the Cost - Without Compromising Standards Imagine needing a major medical procedure that you can’t afford at home, but a hospital overseas offers the same treatment for a fraction of the cost. Critics might warn that “cheaper means worse care,” arguing that medical tourism compromises safety and quality in favor of savings. In reality, cost savings do not have to mean compromised care. Let’s break down the common concerns and examine what the evidence - and authentic patient experiences - reveal. ## Common Criticisms of Medical Tourism Safety Risks Complications: Detractors worry about subpar safety standards abroad. Standards can indeed vary, and poor infection control can lead to complications like surgical infections or even exposure to drug-resistant “superbugs”. Past outbreaks (e.g. infections after cosmetic surgery in the Dominican Republic) underscore these risks. Travel itself can add risk - flying soon after surgery increases the chances of blood clots (DVT/PE). Critics also note that many medical tourists lack legal recourse if malpractice occurs abroad. These safety concerns are real, and any medical travel requires careful research and precautions. Quality of Care and Standards: Opponents argue that overseas hospitals may offer lower-quality care or employ unqualified staff. They point out that not all countries have the same accreditation or oversight. Some facilities abroad may lack Western-standard accreditation or fail to rigorously track outcomes (cdc.gov). Standards can vary widely between (and within) countries. The American Medical Association notes that “issues of safety and quality can loom large” when patients leave the U.S. system. Additionally, patients may unknowingly choose clinics that use medications or devices not vetted by U.S. regulators. In short, critics fear “you get what you pay for” - that lower cost comes at the expense of medical quality and patient safety Continuity of Care Challenges: Another primary concern is what happens after the procedure. Critics highlight gaps in continuity of care - for example, patients often return home without proper medical records or clear follow-up plans, as noted. The AMA observes that many returning medical tourists lack records of the treatments they received abroad, leaving their hometown doctors in the dark. If complications arise back home, local physicians may struggle to “make right what went wrong” without information. There’s also the concern that foreign providers may not be readily available for questions or follow-ups. This discontinuity can jeopardize recovery and long-term outcomes, say critics. Essentially, the journey doesn’t end when the patient flies home, and skeptics worry medical tourism providers won’t be there for the long haul. Ethical and Systemic Concerns: Beyond the individual patient, critics raise ethical issues. Some practices associated with medical tourism are troubling - for instance, “transplant tourism” (traveling for organ transplants) can involve illegal or exploitative organ trading. Patients may access procedures abroad that are illegal or unapproved in their home country (e.g., specific experimental stem cell treatments, unregulated reproductive procedures). There’s also a public health angle: a Canadian study warned that if patients come home with complications or resistant infections, it can burden the home healthcare system and even pose public health risks. On the other hand, in destination countries, critics worry that catering to foreign patients might siphon resources from local citizens or create a two-tier system. In short, some argue that the cost incentives of medical tourism create ethical trade-offs, both for vulnerable patients and in terms of healthcare equity. ## Why Cost Savings Don’t Have to Mean Lower Quality While the concerns above are valid, they don’t tell the whole story. **Medical tourism can be conducted safely and with excellent outcomes **when patients make informed choices. Here are key counterpoints that show affordable care can also be high-quality: World-Class Hospitals and Accreditation: Many international hospitals are highly accredited and internationally recognized. For example, over 1,000 healthcare organizations in more than 70 countries have earned the coveted Joint Commission International (JCI) Gold Seal, meeting rigorous U.S.-level standards, as noted on a. Top hospitals in popular medical tourism destinations undergo rigorous accreditation and boast outcomes that rival those of Western facilities. Thailand’s famed Bumrungrad International Hospital was the first in Asia to earn JCI accreditation in 2002 and has maintained it through five consecutive renewals, according to its website. Bumrungrad reports some of the highest clinical success rates and lowest infection rates globally, thanks to its consistent standards. Visit for more information. Newsweek recently ranked Bumrungrad among the world’s top 100 hospitals (the only Thai hospital on the list) - a testament to its world-class quality. The key takeaway: Many overseas centers are internationally accredited, audited, and held to high standards. Accreditation bodies and medical societies recommend that patients seek out these vetted facilities, as shown, which indicates that high-quality care is achievable abroad. Highly Trained Doctors and Staff: The image of “unqualified quacks” abroad is an outdated stereotype. In reality, leading medical travel destinations employ experts with impressive credentials. At Bumrungrad, **the majority of its 1,300+ physicians hold international board certifications (e.g., from the US, UK, or Australia) **. Likewise, many hospitals in India, Turkey, Mexico, and other countries have surgeons who were trained or have practiced in North America or Europe. Some facilities partner with top U.S. institutions - for instance, Anadolu Medical Center in Turkey is affiliated with Johns Hopkins Medicine. These partnerships and credentials ensure that patients get care from doctors who adhere to the latest standards and techniques. The quality of medical staff often earns praise from patients. One extensive review found that medical tourists were “most satisfied with [the] medical staff quality,” rating the doctors and nurses very highly.  In other words, patients often find compassionate, skilled caregivers abroad - the kind who inspire confidence just as much as those at home (sometimes even more, given the personalized attention many international hospitals provide). Successful Outcomes Patient Satisfaction: What do the results say? According to many accounts, medical tourists often achieve outcomes comparable to those in their home country. Success stories abound. For example, Dr. Cristy Kessler, an American patient, famously said, “Medical* tourism saved my life.”* Facing a lethal autoimmune illness, she obtained a stem cell transplant in Turkey that she couldn’t get in the U.S., and it gave her a new lease on life. Her treating hospital was JCI-accredited and had partnered with Johns Hopkins, highlighting that her “affordable” foreign care met top-notch standards. Beyond anecdotes, broader research indicates high satisfaction rates: patients traveling abroad often perceive great value for their money and the quality of care. In one review, tourists felt that the value of the treatment was high - they received excellent care at a significantly lower cost - and this positive experience drove high satisfaction and a willingness to recommend it. To be clear, not every story is perfect; complications can happen anywhere. But overall, tens of thousands of patients safely undergo procedures overseas each year and return home healthy and happy. The growing volume of repeat medical tourists and personal testimonials is evidence that, when executed correctly, medical tourism can meet* or exceed expectations*. Compelling Cost-Quality Comparisons: The cost differences in medical tourism are huge, but importantly, they often stem from economic factors (labor costs, administrative overhead, currency exchange), not from skimping on care. Consider this eye-opening comparison: a total knee replacement that might cost $35,000 - $60,000 in the U.S. (with insured Americans often still owing $10,000 - $20,000 out-of-pocket) can be performed in a top-tier Spanish hospital for approximately** $6,000 - $10,000.. That Spanish hospital isn’t “low quality” - Spain is a developed nation with excellent healthcare. The price is lower due to systemic cost differences, not because the surgeons or equipment are inferior in quality. Similarly, a cardiac bypass surgery that easily tops $100,000 in the U.S. can cost a tenth of that in India’s best heart hospitals, which boast outcomes comparable to U.S. hospitals. The renowned Narayana cardiac center in India, for instance, has pioneered high-volume, low-cost heart surgeries with survival rates similar to Western averages by innovating efficiencies rather than sacrificing quality. Bottom line: Cheaper doesn’t always mean worse - often it means the hospital operates in a more cost-efficient health system. Patients can save 50% - 80% or more on major procedures while still receiving safe and effective treatment**. These cost savings can enhance patient care in some cases (e.g., allowing a patient to afford a procedure they would otherwise have to forgo). Improvements in Continuity and Support: The industry has recognized the continuity-of-care issue and is working on solutions. Reputable medical tourism providers now emphasize providing patients with complete documentation of their treatment (sometimes even a digital record) to share with their home doctors. Many facilities offer follow-up services; for example, surgeons abroad may provide telemedicine check-ins, and some hospitals have partnerships for aftercare in the patient’s home country. Admittedly, follow-up remains a challenge, but awareness is growing. The American College of Surgeons and AMA urge patients and facilitators to coordinate with home physicians before and after the trip. In practice, many patients do plan ahead - consulting their home doctor, arranging sufficient recovery time abroad, and securing travel health insurance just in case. As medical travel becomes more common, we also see domestic providers becoming more understanding and experienced with treating returning patients. Millions** of U.S. residents now travel for care each year**, so it’s no longer an anomaly; health systems are adapting to ensure continuity. The key is that patients approach medical tourism responsibly - doing their homework on the facility’s quality and having a plan for post-op care, which more and more are doing. Growing Acceptance and Oversight: Medical tourism is no longer a fringe phenomenon; it has become a global industry with increasing oversight. There are international patient departments, concierge services, and even insurance options for medical travelers. Large employers and insurers in the U.S. have begun to include medical travel benefits, recognizing that it can be a cost-effective option for specific procedures. (In one 2022 survey, 44% of large employers said they already offer or plan to offer travel benefits for medical care.) This trend pressures overseas providers to maintain high quality to win contracts and referrals. Moreover, organizations such as the Joint Commission International and ISQua, among others, continue to monitor and accredit foreign hospitals. This means a patient can find, say, a JCI-accredited hospital in Costa Rica or Thailand with confidence that it meets the same core standards as a U.S. hospital. The presence of international standards and audits helps dispel the notion that going abroad = going “rogue” or unsafe. Medical tourism is increasingly about globalized healthcare, not “cheap hacks.” ## Conclusion: Informed Choices Make the Difference Medical tourism isn’t an all-or-nothing proposition. Yes, there are legitimate concerns - no one should gloss over risks to safety, quality, or ethics. However, those risks can be mitigated. Patients who choose accredited hospitals, experienced surgeons, and plan their follow-up carefully often receive outstanding care at a fraction of the price. Cost savings and quality care are not mutually exclusive: you can find modern hospitals abroad that resemble five-star hotels, surgeons with world-class credentials, and infection rates even lower than those in some U.S. hospitals (bumrungrad.com). The narrative that “affordable means inferior” doesn’t hold up in many cases. As one medical traveler put it, “I got better care overseas than I ever did at home - and I could afford it.” The **data support this, with high patient satisfaction and outcomes when proper precautions are taken **. Rather than dismissing medical tourism outright, a more productive approach is to educate patients on how to do it safely: verify credentials, ensure the facility is internationally accredited, have a clear follow-up plan, and keep your home doctors informed. When those boxes are checked, medical tourism can be a viable, high-quality, and affordable option, not a reckless bargain. In summary: Don’t let the word “tourism” fool you - this is healthcare, not a vacation, and it can be as safe as any local care if you’re an informed consumer. The goal for any patient is the best possible care within their means. Medical tourism, when conducted responsibly, helps thousands achieve that goal without compromising their health or financial savings. Sources (10) American Medical Association Medical Tourism Magazine US Centers for Disease Control and Prevention PubMed Central Joint Commission International Bumrungrad International Hospital BenefitsPRO Bloomberg PubMed Mercer ### The Wire Aug 30This Week in Medical Tourism: 20–26 August 2026 Aug 29This Week in Medical Tourism: 13–19 August 2026 Aug 22South Korea Undercuts America but Not Turkey All coverage ### Newsletter Get weekly health tourism intelligence in your inbox. Subscribe ### Knowledge Hub Medical Tourism Wellness Tourism Dental Tourism Fertility Tourism Cosmetic Tourism Longevity Tourism Explore the Hub Stay informed on the latest in global health tourism. Subscribe to our Newsletter ## Related Articles Medical Tourism 22 AUG 2026 Medical Tourism ### Mexico and Turkey Price Against Different Home Markets August 22, 2026 Medical Tourism 22 AUG 2026 Medical Tourism ### Turkey's Deepest Discounts Sit on Its Safest Procedures August 22, 2026 Medical Tourism ### Why Medical Tourism to Germany Declined August 11, 2026 --- # Airlines Move To The Centre Of Medical Tourism URL: https://health-tourism-news.com/news/airlines-move-to-the-centre-of-medical-tourism/ Health Tourism July 14, 2026 Health Tourism Airlines Move To The Centre Of Medical Tourism This is the Health Tourism News roundup for the week of 7 to 13 July 2026. Nobody opened a hospital this week. Instead, the announcements were about... Christian El-Khouri Editor-in-Chief Published July 14, 2026 · 8 min read This is the Health Tourism News roundup for the week of 7 to 13 July 2026. Nobody opened a hospital this week. Instead, the announcements were about distribution: an airline in Malaysia selling heart screenings with its boarding passes, a Thai campaign for Gulf travellers built on flight capacity, and a booking platform for Chinese hospitals cleared by two city governments. Wellness supplied the money figure, with data cited by USA Today putting wellness tourism at US$894 billion in 2024 and on course for US$1.4 trillion by 2029. In Dodoma, a Tanzanian clinic counted more than 28,000 patients in its first year. The sellers this week were airlines, tourism boards and platforms, and the hospitals stayed in the background. ## Malaysia puts medical tourism on the boarding pass Batik Air, the National Heart Institute of Malaysia and Tourism Malaysia have launched a year-long medical tourism partnership, according to an official statement issued in Kuala Lumpur and carried by The Island. Under the Fly High with a Healthy Heart campaign, which began on May 1 and runs until April 30, 2027, international passengers with a valid boarding pass receive 15 per cent off the institute’s essential heart screening, priced at RM765 (US$190). The first 1,000 international passengers get 20 per cent off a premier screening package at RM1,760 (US$430). Patients travelling for treatment, and family members travelling with them, get a 10 per cent airfare discount on showing an appointment letter. IJN, as the institute is known, performs more than 4,400 cardiothoracic surgeries and 17,000 cardiac catheterisations a year. Batik Air chief executive Datuk Chandran Rama Muthy said Malaysia welcomed about 1.85 million healthcare travellers in 2025, generating RM3.35 billion (US$820 million) in revenue. Thailand still leads the region with more than 3 million medical tourists a year, he noted. It runs alongside Visit Malaysia 2026 and the country’s Year of Medical Tourism. A tourism board on the other side of the Pacific worked the same seam. Los Angeles Tourism said it flew Australian lifestyle journalists to the city with Fiji Airways to present Los Angeles as a wellness hub. Part of the selling was done in the air, with the carrier’s FlyWell programme offering red-light therapy and wearable technology on the long-haul legs. A screening discount on a boarding pass and red-light therapy in a lie-flat cabin are versions of the same idea. The journey is being folded into the health product, and the carriers have noticed there is margin in it. ## Thailand aims Healing is the New Luxury at the Gulf The Tourism Authority of Thailand launched a campaign called Healing is the New Luxury this week, aimed at Gulf travellers, and expects more than 600,000 GCC visitors by the end of 2026, Khaleej Times reported. More than 150,000 of them are expected from the UAE. Governor Thapanee Kiatphaibool said Thailand is “ready to welcome visitors from across the region with confidence” as the Middle East high season begins. Capacity is already in place. More than 140 flights a week link Dubai, Abu Dhabi and Sharjah with Thai destinations, and flydubai’s new daily Dubai to Don Mueang service goes double daily from July 18, Biz Today reported. GCC visitors stay between 10 days and three weeks, UAE travellers spend more than 100,000 baht (US$3,000) per trip, and medical travellers from the region average 107,662 baht (US$3,200). Thailand counts more than 400 internationally accredited hospitals and clinics, and its health tourism sector generated about 125 billion baht (US$3.7 billion) in 2025. The Tourism Authority of Thailand is also promoting Khao Yai, Kanchanaburi, Chanthaburi and Trat to stretch trips beyond Bangkok, Phuket, Krabi and Chiang Mai. Ten days to three weeks is the detail that matters. A guest staying that long buys the treatment, the recovery, the resort and a second city, which is why the campaign bundles them, and why destinations chasing Gulf patients should measure length of stay rather than arrivals. That is what turns 600,000 GCC visitors into a health economy rather than a beach season. ## China adds booking rails to its medical tourism pull China supplied the medical tourism case study for the third week running. China Daily reported that Harrison James, an Australian diagnosed with a malignant pancreatic tumour, travelled to Chongqing for high-intensity focused ultrasound treatment after failing to find a surgical option at home, and was discharged the day after the procedure. “I never expected the surgery to be so quick and painless, without any incisions,” James said. China Daily credited the country’s 240-hour visa-free transit policy, which covers citizens of 55 countries, and the growing number of international insurers billing Chinese hospitals directly. Booking rails are being formalised too. City News Service, a Shanghai-based expat outlet, reported that MediPath China, a cross-border platform built by New Frontier, the owner of United Family Healthcare, launches officially this month. Shanghai and Beijing officials approved trial operations in June, the outlet said. The platform coordinated robotic surgery and tomotherapy across two Shanghai hospitals for a 60-year-old Canadian prostate cancer patient, whose main biomarker fell from 42.5 to 0.03. Managing director David Zeng said it matches international patients with “top public medical institutions primarily in Shanghai and Beijing”. Readers of this digest will recognise the sequence: a New Zealander flying to Shanghai for CAR-T therapy in June, another beginning a solid-tumour first last week, and now the booking rails. The missing medical visa and the fragmented services that securities analysts flagged in June are being worked around piece by piece, and the pace deserves more attention from rival Asian hubs than it is getting. ## Wellness tourism heads for US$1.4 trillion USA Today sent a reporter to Hilton Head Health in South Carolina, an all-inclusive resort where seven-night stays start at just over US$3,900 and the programming now includes GLP-1 support seminars alongside a longevity-focused Blue Zones Experience. It cited Global Wellness Institute data, analysed by PhocusWright, showing wellness tourism more than doubled from US$438 billion in 2012 to US$894 billion in 2024, with US$1.4 trillion by 2029 projected. Region Illawarra reported Destination Wollongong citing Booking.com research that 42 per cent of travellers now seek trips focused on mental and physical wellbeing. Destination Wollongong has made wellness tourism a strategic priority while admitting it is short of eco-focused places to stay. Moneycontrol ran the consumer version of the same story, holidays judged by how rested people come home. Supply is moving upmarket to meet it. The Ozen Collection said in a statement that its two Maldives resorts now offer DNA-based wellness profiling with Muhdo Health and what the company calls bioenergetic scanning. It framed the move around longevity and pointed to the newly created Dubai Longevity Authority. AD HOC News profiled OneSpaWorld, the listed operator of spa facilities across cruise fleets and resorts, whose revenue rises and falls with passenger volumes and onboard spending. A detail worth keeping: the GLP-1 seminar. Weight-loss drugs were widely expected to hurt the wellness trade; instead the resorts are building programming around them, which is what a US$894 billion market tends to do with a disruption. ## Tanzania counts its first year as India studies trust Benjamin Mkapa Hospital in Dodoma marked the first anniversary of its international patients clinic on Friday, and Tanzania’s Daily News reported that the unit treated more than 28,000 patients in its first year, over 200 of them from abroad. Opened in July 2025 by the late health minister Jenista Mhagama, the clinic gets patients in front of a specialist within 15 minutes and keeps diagnostics, pharmacy and payment under one roof. “The services were fast and well coordinated,” said Sara Lenday, who travelled from Iringa with her mother and returned home the same day. Two hundred international patients is a modest number, and a believable one. India examined the softer end of the trade. The Economic Times reported a study by Payal Mehra of IIM Lucknow and Himanshu Tyagi, an orthopaedics director at Fortis in New Delhi, published in the Asia Pacific Journal of Health Management. It found India’s medical tourism market skewed towards neighbouring countries with low cultural distance. Its authors recommended structured intercultural communication training for hospital staff, and Mehra told PTI the work sits where healthcare, culture and international business meet. A warning from the mature end of the market came from Seoul, where Nikkei Asia reported that record numbers of foreigners arriving for cosmetic procedures are adding to concerns about imbalances in Korean medical care, with doctors drawn away from hospital work. ## What This Means One thread connects the week: distribution. Malaysia put a screening discount on a boarding pass, Thailand measured its campaign in weekly flights, China switched on a booking platform, and the wellness industry priced the journey itself into the product. Hospitals used to wait for patients. The sellers of seats and platforms now go out and fetch them, and they own the customer relationship earlier than any clinic does. Three things to watch over the coming months: whether flydubai’s double daily Bangkok service holds past the Middle East high season, how many patients MediPath China reports once formal operations begin, and whether the first 1,000 international passengers take up IJN’s discounted screenings before the campaign ends in April. Sources (14) Island Nikkei Discoverlosangeles Dailynews Liangjiang Indexbox Usatoday Regionillawarra Biztoday Khaleej Times Indiatimes Citynewsservice Moneycontrol Ad Hoc News South KoreaTanzaniaAustraliaChinaUSRussiaUKUAE ### The Wire Aug 30This Week in Medical Tourism: 20–26 August 2026 Aug 29This Week in Medical Tourism: 13–19 August 2026 Aug 22South Korea Undercuts America but Not Turkey All coverage ### Newsletter Get weekly health tourism intelligence in your inbox. Subscribe ### Knowledge Hub Medical Tourism Wellness Tourism Dental Tourism Fertility Tourism Cosmetic Tourism Longevity Tourism Explore the Hub Stay informed on the latest in global health tourism. Subscribe to our Newsletter ## Related Articles Weekly Digest 30 AUG 2026 Weekly Digest ### This Week in Medical Tourism: 20–26 August 2026 August 30, 2026 Weekly Digest 29 AUG 2026 Weekly Digest ### This Week in Medical Tourism: 13–19 August 2026 August 29, 2026 Weekly Digest 14 AUG 2026 Weekly Digest ### This Week in Medical Tourism: 6–12 August 2026 August 14, 2026 --- # Asia Pacific Medical Tourism: Growth, But Not Everywhere Equally URL: https://health-tourism-news.com/news/asia-pacific-medical-tourism-market-set-for-explosive-growth-driven-by-value-and-advanced-care/ Cosmetic Tourism April 5, 2026 Cosmetic TourismMedical Tourism Asia Pacific Medical Tourism: Growth, But Not Everywhere Equally The regional forecast says 15.53 percent a year through 2031. The country ledgers tell a more uneven story: Korea doubled on dermatology, Malaysia grew 14 percent, and Thailand is planning around fewer, richer patients. Christian El-Khouri Editor-in-Chief Published April 5, 2026 · Updated July 4, 2026 · 6 min read Mordor Intelligence prices the Asia-Pacific medical tourism market at USD 70.77 billion for 2026 and projects USD 145.66 billion by 2031, a compound annual growth rate of 15.53 percent. That is the headline number doing the rounds in press releases, and taken alone it flattens more than it explains. Over the past year Korea, Malaysia and Thailand have all published their own patient and revenue figures, and read side by side they describe very different businesses growing at very different speeds. The regional average is real. It just is not happening everywhere, or to everyone, in the same way. ## What the forecast says, and what it hides Start with what the report actually contains, because the detail is better than the headline. Mordor attributes the region’s pull to a durable price gap - elective procedures in Bangkok or Chennai cost 40 to 80 percent less than in the United States, the United Kingdom or Australia - and to an accreditation build-out that has taken the region past 1,100 JCI-accredited facilities, up from roughly 800 in 2020. India is the largest single market with 25.13 percent of regional revenue in 2025, on the back of 635,000 medical visas processed in 2023. Vietnam is the fastest riser, at an 18.51 percent annual clip through 2031. The segment data is where it gets interesting. Cosmetic and aesthetic work is the largest treatment category at 28.55 percent of 2025 revenue, orthopedics is the fastest-growing at 18.25 percent, and ambulatory surgical centres are the fastest-expanding provider type at 19.85 percent. Put plainly, the centre of gravity of this market is outpatient, discretionary and paid in cash, not the complex tertiary surgery on the conference brochures. Keep that in mind for the country numbers below, because it explains how a national patient count can double in twelve months. ## Korea doubled its patient count, mostly on dermatology Korea’s Ministry of Health and Welfare counted 2.01 million international patients from 201 countries in 2025, the first time the figure has crossed two million since tracking began in 2009 and nearly double the 1.17 million of 2024. Chinese patients made up 30.8 percent and Japanese 29.8 percent, with Taiwan at 9.2 percent and the United States at 8.6 percent after a 70.4 percent jump to about 173,000 American patients. More than 62 percent of all foreign patients were treated at dermatology clinics, 11.2 percent had plastic surgery, and 87.2 percent were seen in Seoul. The Korea Institute for Industrial Economics and Trade estimates those patients and their companions spent 12.5 trillion won, about USD 8.4 billion, of which 3.3 trillion won went to medical services. No hospital system doubles its complex caseload in a year; retail does that. Roughly three out of every four won were spent outside the clinic, on hotels, flights and shopping, and the typical patient in this dataset is a short-haul visitor having a skin procedure between other stops. It is a genuinely lucrative model and Korea runs it better than anyone. It is also fragile in a specific way: nearly nine in ten of those patients pass through one city, and the flow depends on visa policy and the travel mood in Beijing and Tokyo. What doubled in a year can halve in a year. ## Malaysia and Thailand are not even counting the same thing Malaysia’s numbers come straight from the Malaysia Healthcare Travel Council. The country received 1.6 million healthcare travellers in 2024, up 14 percent on the year before, and MHTC puts 2025 revenue at RM3.35 billion with volume running at about 1.85 million travellers a year. The council’s stated goal is RM12 billion in annual revenue by 2030, and the government has declared 2026 the Malaysia Year of Medical Tourism, a campaign launched in July 2025 under health minister Datuk Seri Dr Dzulkefly Ahmad, who chairs MHTC. Thailand’s tourism authority frames its market in almost opposite terms. TAT expected around 580,000 medical tourists in 2025, about 1.74 percent of international arrivals, generating roughly 125 billion baht. Its deputy governor for tourism products, Nat Kruthasoot, described a deliberate pursuit of high-income patients from Qatar, Oman and Kuwait alongside nearer markets like Cambodia and Bangladesh, pitched on 61 JCI-certified hospitals. The traveller TAT wants earns over 2 million baht a year and spends about 107,662 baht per trip, a little over USD 3,000. Do the arithmetic on Malaysia and the model shows itself. RM3.35 billion across roughly 1.85 million travellers is under RM2,000 a head, around USD 400, so the typical Malaysian healthcare traveller is a regional outpatient, not a surgical admission. Thailand is selling the inverse: a fraction of Korea’s headline volume at several times Malaysia’s revenue per visit. And note the measurement problem hiding in plain sight. Mordor’s own report credits Thailand with 1.2 million medical travellers in 2024, roughly double the figure TAT plans around. When the report publisher and the country’s own tourism authority differ by a factor of two, the field has no common unit; patients, visits, travellers and visas are being added up as if they were the same thing. My read on Malaysia’s RM12 billion target is that it cannot be reached by adding more of the same travellers. Quadrupling revenue in five years means shifting the case mix toward complex, high-ticket work, which is exactly the ground India and Thailand already hold. ## What This Means Strip the label off and the Asia-Pacific market is at least three distinct products. Korea sells high-volume outpatient aesthetics to short-haul visitors and had a spectacular 2025 doing it. Malaysia sells affordable routine care to its neighbours and compounds at a steady mid-teens rate. India and Thailand sell complex or premium treatment to patients who fly further and pay far more per case. Mordor’s 15.53 percent regional growth rate is a weighted average across businesses that barely compete with one another, which is why I think it is the least useful number in the report for anyone making an actual decision. The growth itself is not in doubt; every national ledger cited here is up. What differs is who captures it, in which specialty, and under which definition of a patient. Through 2026 I would watch two things: whether Korea’s dermatology boom survives its dependence on Seoul and on short-haul goodwill, and whether Malaysia’s 2030 target pushes it upmarket into territory where the competition is no longer on price. The regional headline will keep compounding either way. The country ledgers are where the story is. Sources (6) Mordor Intelligence Korea Times Korea Herald Malaysia Healthcare Travel Council Nation Thailand PR Newswire (MHTC) Asia-PacificThailandMalaysiaSouth KoreaIndia ### The Wire Aug 30This Week in Medical Tourism: 20–26 August 2026 Aug 29This Week in Medical Tourism: 13–19 August 2026 Aug 22South Korea Undercuts America but Not Turkey All coverage ### Newsletter Get weekly health tourism intelligence in your inbox. Subscribe ### Knowledge Hub Medical Tourism Wellness Tourism Dental Tourism Fertility Tourism Cosmetic Tourism Longevity Tourism Explore the Hub Stay informed on the latest in global health tourism. Subscribe to our Newsletter ## Related Articles Cosmetic Tourism 22 AUG 2026 Cosmetic Tourism ### South Korea Undercuts America but Not Turkey August 22, 2026 Medical Tourism 22 AUG 2026 Medical Tourism ### Mexico and Turkey Price Against Different Home Markets August 22, 2026 Medical Tourism 22 AUG 2026 Medical Tourism ### Turkey's Deepest Discounts Sit on Its Safest Procedures August 22, 2026 --- # Ayurveda Tourism: India's Traditional Medicine Goes Global URL: https://health-tourism-news.com/news/ayurvedas-global-moment/ Wellness Tourism Ayurveda Tourism: India's Traditional Medicine Goes Global How India's 3,000-year-old medical tradition is becoming a pillar of global wellness travel. Ivan Rendulic Contributor Founder of ZagrebMed and President of the European Health and Medical Tourism Association (EHMTA). Over a decade facilitating international patients and shaping cross-border healthcare initiatives from Croatia. Read more Published July 7, 2025 · Updated July 2, 2026 · 3 min read Reviewed by Christian El-Khouri, Editor-in-Chief There’s something profoundly powerful happening in global healthcare, and it’s not coming from a gleaming lab in Silicon Valley or a luxury clinic in Switzerland. It’s coming from ancient roots, from the deep heritage of India, and from a medical tradition that has been healing humans for over 3,000 years: Ayurveda. This past week, India took a landmark step that could shift how traditional medicine is seen, practiced, and accessed around the world. The Ministry of Ayush signed a Memorandum of Understanding with the World Health Organization (WHO) to develop a dedicated module on traditional Indian medicine as part of the International Classification of Health Interventions (ICHI). This isn’t just paperwork. It’s policy with the power to redefine legitimacy. ## Two Realities for One Ancient Tradition For years, Ayurveda has lived in two realities: one where it thrives locally in India as part of everyday wellness, and another where it is often treated as an alternative, fringe option in the West. But global health is changing. People are no longer satisfied with reactive medicine - they are seeking balance, prevention, and personalization. And Ayurveda offers all three in abundance. ## What ICHI Recognition Unlocks The inclusion of Ayurvedic interventions into the ICHI framework means that its therapies - everything from Panchakarma detox to Rasayana rejuvenation - can soon be coded, classified, and tracked within global health systems. That may sound technical, but it’s a big deal. It paves the way for insurance reimbursement, research integration, and cross-border referrals. It gives doctors, payers, and policymakers a common language to engage with Ayurveda - not as mysticism, but as medicine. ## From Cure to Resilience This recognition comes at the right moment. As the world emerges from a pandemic, we are not just looking for cures - we’re looking for resilience. From immune-boosting tonics to stress-reducing rituals, Ayurveda doesn’t just treat disease. It helps us not get sick in the first place. This is the essence of health tourism’s next evolution: not flying out for surgery, but traveling for sustainable well-being. ## India’s Opportunity and Its Homework India, with its robust network of Ayurvedic clinics, wellness retreats, and medical colleges, is uniquely positioned to lead. But this moment is also a call to action: standardize the practices, ensure international quality benchmarks, and make Ayurveda understandable to the modern patient. The interest is growing - now it’s time to meet it with infrastructure. This WHO-Ayush partnership could be the tipping point. It puts Ayurveda on the map, literally and institutionally. It invites global patients to explore ancient healing in a modern framework - one where diagnostics meet doshas, and prevention sits alongside prescription. ## Integrating the Best of Both As someone deeply immersed in health travel and innovation, I see this not as a nostalgic nod to the past, but as a forward-looking strategy. Ayurveda can offer what high-tech medicine often lacks: context, continuity, and care rooted in nature. It’s not about East versus West. It’s about integrating the best of both. The world is ready. Let’s make sure Ayurveda is too. ### The Wire Aug 30This Week in Medical Tourism: 20–26 August 2026 Aug 29This Week in Medical Tourism: 13–19 August 2026 Aug 22South Korea Undercuts America but Not Turkey All coverage ### Newsletter Get weekly health tourism intelligence in your inbox. Subscribe ### Knowledge Hub Medical Tourism Wellness Tourism Dental Tourism Fertility Tourism Cosmetic Tourism Longevity Tourism Explore the Hub Stay informed on the latest in global health tourism. Subscribe to our Newsletter ## Related Articles Weekly Digest 08 JUL 2026 Weekly Digest ### Medical Tourism Records Concentrate In Penang And Seoul July 8, 2026 Weekly Digest 01 JUL 2026 Weekly Digest ### Nigeria, Iran And Seoul Redraw Medical Tourism July 1, 2026 Weekly Digest 24 JUN 2026 Weekly Digest ### Health Tourism As Badge, Escape Hatch And Disguise June 24, 2026 --- # Types of Integrative Medicine: TCM, Ayurveda and More URL: https://health-tourism-news.com/news/broad-spectrum-of-integrative-medicine-approaches/ Wellness Tourism Types of Integrative Medicine: TCM, Ayurveda and More From conventional-alternative hybrids to TCM and Ayurveda: the approaches shaping integrative care and wellness tourism. Kevin Ciresi Contributor A career spanning the operating room to the boardroom. Former surgeon who founded and led multiple U.S. healthcare facilities, now focused on transparent frameworks for international care and blue-zone wellness destinations. Read more Published January 7, 2026 · Updated July 2, 2026 · 10 min read Reviewed by Christian El-Khouri, Editor-in-Chief Integrative medicine encompasses a diverse range of therapeutic approaches and healing philosophies. In the global trends of 2019-2025, several modalities have seen notable growth and integration into both clinical practice and wellness tourism. Here we outline the broad spectrum of approaches and how they are evolving: ## Conventional - Alternative Hybrids Many clinics and health centers now consciously blend conventional Western medicine with complementary and alternative medicine (CAM), creating accurate “hybrid” care models. This might mean a team where MDs, naturopaths, acupuncturists, nutritionists, and other providers work in concert. Hospitals have established integrative medicine departments, providing services such as acupuncture for pain management, massage therapy for hospital inpatients, and mindfulness training for individuals with chronic diseases. For example, the Whole Health model in U.S. VA hospitals coordinates physicians with yoga instructors and health coaches to develop personalized health plans. In Europe, some public hospitals (in countries like Germany or Italy) incorporate homeopathy or acupuncture within standard care for certain conditions, while private integrative clinics proliferate. The unifying principle is to utilize the best of both worlds - patients may receive conventional diagnostics and pharmaceuticals alongside herbal medicine and mind-body therapy, thereby treating the person more comprehensively and safely. Evidence-based integration is emphasized; reputable integrative centers now routinely base their alternative treatment recommendations on scientific research or clinical guidelines (e.g., using acupuncture for chemotherapy-induced nausea, which is supported by substantial evidence). This marks a maturation of the field from the early 2000s, when “alternative” treatments were often used haphazardly. As one editorial noted, *integrative medicine emphasizes using evidence in integration to facilitate health and healing, *. Professional societies and academic programs have also emerged to train providers in how to combine modalities judiciously. ## Mind-Body Practices Approaches such as meditation, mindfulness-based stress reduction (MBSR), yoga, tai chi, qigong, guided imagery, and breathing techniques have become cornerstone therapies in integrative medicine. The growth in research in this area is remarkable - by 2021, keywords such as yoga, acupuncture, and mindfulness were among the most common in top integrative medicine journals. The evidence base for mind-body interventions in managing chronic pain, anxiety, depression, and even hypertension has solidified, leading to their wider acceptance. Clinicians report that teaching patients simple practices such as mindful breathing or meditation improves outcomes by engaging patients in self-regulation of stress and pain. On the wellness tourism front, nearly every destination retreat now offers some form of mind-body activity, from sunrise yoga classes on the beach to multi-day silent meditation retreats in monasteries. Meditation retreats are especially popular post-pandemic, as people seek to improve mental resilience. Traditional mind-body arts, such as tai chi and qigong (once considered niche in the West), are now offered in resort programs and even recommended by physicians for older adults to improve balance and reduce stress. This mainstreaming of mind-body modalities reflects both ancient wisdom and modern science, as research confirms their benefits, health consumers eagerly embrace these practices for their low risk and holistic rewards. ## Traditional Chinese Medicine (TCM) and Acupuncture TCM, encompassing acupuncture, Chinese herbal medicine, cupping, and other practices, has seen greater integration worldwide. Acupuncture has been incorporated into conventional guidelines for pain management (e.g., many European pain clinics and physiotherapy centers have an acupuncturist on staff). The WHO notes that some methods like acupuncture have “very good evidence” for efficacy in specific indications. Across Europe, acupuncture is among the most accepted CAM modalities - it is practiced by physicians and non-physicians, often regulated or certified, and used by millions of patients for musculoskeletal pain, migraines, fertility, and more. China has actively promoted TCM globally through initiatives and clinics abroad. In 2022, the WHO included a chapter on traditional medicine in its global diagnostic compendium, further legitimizing TCM. However, the integration of herbal medicine is more cautious due to regulatory and safety considerations; countries vary widely in their approval of TCM herbal products. In wellness tourism, elements of TCM are frequently incorporated: e.g., luxury resorts might offer acupuncture sessions, qigong classes at dawn, herbal consultations, or TCM-inspired spa treatments (like moxibustion or gua sha facials). This blending of Eastern medicine with Western wellness is especially evident in places like Thailand, Singapore, and increasingly Europe - for instance, Greek retreat programs have even paired Greek and Chinese healing philosophies together. The trend is toward complementarity: using TCM approaches alongside Western ones in a coherent manner, which, if done carefully, can enhance patient care (as long as providers heed the evidence and prioritize safety). ## Ayurveda and Yoga Therapy Ayurveda, the traditional medicine of India, has been rapidly gaining traction across Europe and globally as a holistic wellness system. European spas and retreats have added Ayurvedic massages, Panchakarma detox programs, and Ayurvedic nutrition consultations to their offerings. Resorts dedicated entirely to Ayurveda have opened in Europe - examples include Engel Ayurpura in Italy, Ayurveda Sonnhof in Austria, and Parkschlösschen in Germany, all pioneering authentic Ayurvedic retreat experiences in a Western context. Ayurveda’s emphasis on balance, preventive cleansing, and lifestyle routines resonates strongly with today’s wellness consumers. Industry experts report double-digit growth in demand for Ayurvedic services each year through 2028. The modality is seen as addressing modern ailments like stress, burnout, and toxin exposure through natural means (diet, herbal remedies, yoga, meditation). Indeed, Ayurveda and yoga are closely linked; yoga therapy, which utilizes yogic practices specifically for health conditions, is now commonly integrated into treatment plans (for example, yoga for back pain or pranayama breathing for asthma). The “yoga boom” of the past decade has spilled into medicine: doctors increasingly “prescribe” yoga or meditation classes, and hospitals might host yoga sessions for patients or staff. In Europe, an executive of a leading Ayurveda resort noted that people are “longing for holistic approaches” and recognize that traditional methods can prevent disease and support a healthy, fulfilling life, not just treat illness. This captures why Ayurveda and yoga have become so popular - they offer a comprehensive approach to living a well-being-focused life. Many wellness tourists from Western countries now even travel to India or Sri Lanka specifically for immersive Ayurvedic retreats, indicating a high level of interest in these ancient practices when delivered in credible settings. ## Functional and Integrative Nutrition Nutrition has always been a pillar of CAM, but the concept of “food as medicine” has gone mainstream. Consumers are increasingly seeking personalized dietary guidance as a therapeutic tool, whether for managing chronic conditions (such as anti-inflammatory diets for autoimmune diseases) or for promoting longevity (intermittent fasting, Blue Zone diets, etc.). Functional medicine, a subset of integrative medicine that focuses on identifying root causes (often through detailed nutritional and metabolic analysis), has experienced significant growth in popularity. Thousands of clinicians worldwide have trained in functional medicine protocols, which typically involve extensive nutrition interventions, supplement regimens, and lifestyle changes tailored to an individual’s biochemistry. Patients are drawn to the thoroughness and personalization of this approach, notably when conventional medicine offers no clear answers for complex, chronic issues. The focus on gut health is a prime example: conditions like dysbiosis or SIBO (small intestinal bacterial overgrowth) are now recognized by functional/integrative practitioners and addressed with targeted diets, probiotics, and herbal antimicrobials. There is rising awareness of SIBO among consumers; one report predicts the global SIBO diagnostics market (like at-home breath tests) will grow steadily (4%+ CAGR) through 2028, indicating more patients and providers are investigating gut-related root causes. More broadly, nutritional supplements and functional foods are in high demand. Sales of supplements for mood, immunity, and general wellness have seen double-digit annual growth. Integrative providers meet this demand by staying current with nutrition science - for instance, advising on anti-inflammatory diets for brain health (the field of nutritional psychiatry) or on nutraceuticals for metabolic syndrome. Wellness retreats also emphasize cuisine: the “healthfulness of food” is now expected at wellness hotels, with organic farm-to-table menus, juice detox options, and educational cooking classes being commonplace. Data shows that consumers are indeed treating food as medicine to combat chronic conditions. In response, we are seeing an increase in functional beverage bars, medicinal mushroom coffees, herbal tonics, and dietitian-led programs, both in clinical and travel settings. This nutritionally centered approach is one area where the line between healthcare and wellness tourism blurs - an executive health check-up package might include personalized diet advice, while a yoga retreat might feature an Ayurvedic meal plan; both reflect the integration of nutrition into an overall health strategy. ## Regenerative and Advanced Therapies At the cutting edge of integrative wellness are the regenerative medicine therapies - treatments aiming to repair or regenerate cells and tissues. These include stem cell therapies, platelet-rich plasma (PRP) injections, bioidentical hormone replacement therapy, ozone therapy, exosome treatments, and others. Once confined to experimental labs, some regenerative treatments have entered upscale wellness clinics and medical tourism destinations. For example, stem cell therapy for joint injuries or anti-aging purposes is offered in countries like Germany, Switzerland, Japan, Mexico, and Thailand, where either regulation permits it or specialized clinics have emerged. Patients with means are traveling to access these therapies if they are not available at home, a phenomenon dubbed “stem cell tourism.” The draw is the promise of healing chronic degenerative conditions (like osteoarthritis, neurodegenerative diseases) by using the body’s own cells. However, the evidence for many regenerative therapies is still catching up, and regulatory oversight varies greatly (with some concern over unproven or unsafe practices in certain markets). Policymakers are in a bind to balance innovation with patient safety; as a result, we see strict protocols in places like Germany and Japan for approved cell therapies, versus a more laissez-faire approach in parts of Latin America. Nonetheless, the luxury wellness sector is embracing “regen” treatments as a frontier offering. E.g. some high-end retreats now incorporate PRP facials, stem-cell banking, or NAD IV infusions as part of longevity packages. The global medical tourism industry reports regenerative medicine as a rising niche, with patients motivated by access to advanced technology, shorter wait times, and sometimes lower costs abroad. ## Preventive Diagnostics Another aspect is preventive diagnostics, which involves the use of genomic testing, continuous glucose monitors, wearable trackers, and AI health analytics to personalize prevention. Many integrative medicine practices offer genomic wellness panels or microbiome analyses to fine-tune interventions. Wearable health tech has gone mainstream - even healthy individuals are using continuous glucose monitors to optimize diet and exercise. Integrative providers can leverage these tools to create data-driven, personalized programs. In summary, regenerative and advanced therapies sit at the intersection of biotech and holistic health. While not “traditional” CAM, they are being adopted by the integrative wellness industry as part of a comprehensive approach to rejuvenation and prevention. Their growth will depend on ongoing research and sensible regulation to ensure safety and efficacy. In covering this spectrum of approaches, it’s clear that integrative medicine is not a single entity, but rather a framework that draws on multiple modalities. From ancient practices like Ayurveda and TCM to modern innovations like stem cells and digital health, the unifying goal is improving patient outcomes and well-being by broadening the toolkit of healing. The key is to apply these modalities in an individualized, evidence-guided manner - an area where the field has made significant strides (e.g., establishing clinical guidelines for integrative oncology or conducting trials on yoga for heart failure). As integrative methods continue to prove their worth, we can expect a deeper incorporation into both conventional healthcare and the wellness tourism offerings worldwide. Sources (7) PubMed Central European Spa Magazine Fullscript Child Neurology Society Health Policy Watch Medical Tourism Magazine To Vima ### The Wire Aug 30This Week in Medical Tourism: 20–26 August 2026 Aug 29This Week in Medical Tourism: 13–19 August 2026 Aug 22South Korea Undercuts America but Not Turkey All coverage ### Newsletter Get weekly health tourism intelligence in your inbox. Subscribe ### Knowledge Hub Medical Tourism Wellness Tourism Dental Tourism Fertility Tourism Cosmetic Tourism Longevity Tourism Explore the Hub Stay informed on the latest in global health tourism. Subscribe to our Newsletter ## Related Articles Weekly Digest 08 JUL 2026 Weekly Digest ### Medical Tourism Records Concentrate In Penang And Seoul July 8, 2026 Weekly Digest 01 JUL 2026 Weekly Digest ### Nigeria, Iran And Seoul Redraw Medical Tourism July 1, 2026 Weekly Digest 24 JUN 2026 Weekly Digest ### Health Tourism As Badge, Escape Hatch And Disguise June 24, 2026 --- # China's Medical Tourism Bet on Traditional Chinese Medicine URL: https://health-tourism-news.com/news/chinese-traditional-medicine/ Wellness Tourism China's Medical Tourism Bet on Traditional Chinese Medicine While rivals race for surgical patients, China is building its medical tourism sector around Traditional Chinese Medicine. Ivan Rendulic Contributor Founder of ZagrebMed and President of the European Health and Medical Tourism Association (EHMTA). Over a decade facilitating international patients and shaping cross-border healthcare initiatives from Croatia. Read more Published August 5, 2025 · Updated July 2, 2026 · 3 min read Reviewed by Christian El-Khouri, Editor-in-Chief Let’s talk about China. While the rest of the world is racing to attract patients with robotic surgery suites, dental tourism discounts, and stem cell therapy, China is quietly and quite strategically doing something very different. It’s not just developing its medical tourism sector. It’s turning its deepest cultural heritage into a global health asset. Traditional Chinese Medicine (TCM) is not just an add-on to China’s healthcare system. It’s a pillar. And from where I stand, it’s also the low-hanging fruit in China’s medical tourism efforts. I’ve spent years watching countries try to find their unique health travel edge. China already has one. It’s thousands of years old, trusted by millions, and now being positioned as a global offering with serious weight behind it. ## Medical Tourism Zones in Hainan and Yunnan In places like Hainan and Yunnan, the government has developed dedicated medical tourism zones. These aren’t window-dressing initiatives. They have infrastructure, policy support, foreign patient services, and crucially, a focus on TCM. Acupuncture, herbal therapies, tuina massage, and lifestyle-based healing are being packaged as high-value services for international patients. And the demand is real, especially from Southeast Asia, Russia, and increasingly Africa, where there’s cultural openness to this type of care. ## Creating Its Own Lane What I find clever is how China is choosing not to copy the West. Instead of fighting for the same ground like cosmetic surgery, IVF, or joint replacements, it’s creating its own lane. TCM isn’t trying to be an alternative to biomedicine. It’s presenting itself as a complementary path, one that treats chronic issues, improves resilience, and takes the long view of health. In a world exhausted by overmedication and rushed diagnoses, this is resonating more than ever. ## Blending Ancient Medicine With AI But here’s where it gets really interesting. It’s not just old wisdom being exported. China is layering its traditional medicine approach with cutting-edge AI and data science. According to a recent paper on arXiv, China is leveraging artificial intelligence to accelerate healthcare reform, personalize treatment plans, and support clinical decision-making. This includes everything from AI-powered diagnostics in rural hospitals to intelligent TCM platforms that integrate centuries of herbal knowledge with patient biometrics. It’s the fusion of ancient medicine and machine learning, and China is betting on it big time. That tells me this isn’t nostalgia. It’s strategy. China knows it can’t outspend the U.S. or outbrand Europe in terms of hospitals. But it can lead with what’s unique and then support it with serious tech. And to their credit, they’re working on safety, regulatory alignment, and global perception. They’re building trust, not just awareness. ## A Scalable, Exportable Model As someone who’s worked in this industry for years, I see China’s TCM push not as a niche, but as a scalable, differentiating model. They’re creating clinics abroad, training international practitioners, and developing policy bridges with countries who want a different kind of healthcare partnership. Kenya and Uzbekistan are already part of that vision. More will follow. ## The Remaining Challenges Challenges? Of course. Western patients are still cautious about qi, meridians, and herbal formulas. But with AI translating and validating outcomes, that gap will shrink. If anything, digital transparency and algorithmic guidance could be the bridge that finally brings TCM into more mainstream health tourism flows. So is traditional medicine the low-hanging fruit for China? No doubt. But it’s also a long-term bet. And they’re playing it smart, blending heritage, innovation, and soft power into a medical tourism package the world hasn’t seen before. ### The Wire Aug 30This Week in Medical Tourism: 20–26 August 2026 Aug 29This Week in Medical Tourism: 13–19 August 2026 Aug 22South Korea Undercuts America but Not Turkey All coverage ### Newsletter Get weekly health tourism intelligence in your inbox. Subscribe ### Knowledge Hub Medical Tourism Wellness Tourism Dental Tourism Fertility Tourism Cosmetic Tourism Longevity Tourism Explore the Hub Stay informed on the latest in global health tourism. Subscribe to our Newsletter ## Related Articles Weekly Digest 08 JUL 2026 Weekly Digest ### Medical Tourism Records Concentrate In Penang And Seoul July 8, 2026 Weekly Digest 01 JUL 2026 Weekly Digest ### Nigeria, Iran And Seoul Redraw Medical Tourism July 1, 2026 Weekly Digest 24 JUN 2026 Weekly Digest ### Health Tourism As Badge, Escape Hatch And Disguise June 24, 2026 --- # Cosmetic Tourism Hospitalization Increases by 94% URL: https://health-tourism-news.com/news/cosmetic-tourism-hospitalization-increases-by-94/ Cosmetic Tourism Cosmetic Tourism Hospitalization Increases by 94% Data compiled by the British Association of Plastic and Aesthetic Surgeons (BAAPS) causes concern Christian El-Khouri Editor-in-Chief Editor-in-Chief of Health Tourism News. Twelve-plus years across international patient services, healthcare consulting, and destination development in Europe, the Middle East, and beyond. Co-Founder and Vice President of the European Health and Medical Tourism Association (EHMTA). Read more Published October 4, 2024 · Updated July 2, 2026 · 2 min read The landscape of cosmetic tourism has seen a dramatic shift, with the British Association of Aesthetic Plastic Surgeons (BAAPS) recently highlighting a concerning trend. There’s been a 94% increase over three years in the number of UK residents requiring hospitalization after undergoing cosmetic surgery abroad, particularly in Turkey, accounting for over three-quarters of these cases. This surge underscores the risks associated with seeking cosmetic procedures overseas, driven primarily by cost considerations but often leading to severe complications like wound healing issues or life-threatening sepsis. ## Consumer Guidelines and Surgeon Credentials BAAPS, alongside the Turkish Society of Plastic Reconstructive and Aesthetic Surgeons (TSPRAS), has taken proactive steps by issuing consumer guidelines. These guidelines emphasize the importance of surgeon credentials, aftercare plans, and awareness of what should be considered standard care. For instance, ensuring your surgeon is a member of reputable bodies like TSPRAS or has an EBOPRAS certification can offer a layer of assurance regarding their expertise. The collaboration between BAAPS and TSPRAS aims to mitigate the risks by informing potential patients about what to look for in a surgeon and clinic abroad, advocating for transparency and accountability. ## The Cost to the NHS Moreover, the discussion extends beyond individual patient safety to the economic implications on the NHS, with each corrective surgery costing roughly £15,000. This financial burden, coupled with the health risks, prompts a broader conversation on regulatory frameworks and patient education. BAAPS’s efforts to dialogue with governmental bodies and the Advertising Standards Authority aim at addressing misleading advertising that minimizes the risks of cosmetic tourism. ## The Case for International Standards This situation underscores a critical need for more stringent international standards in medical tourism, particularly in cosmetic surgery, where the allure of lower costs must be weighed against potential health risks and postoperative complications. As the industry grows, so does the necessity for informed decision-making, backed by clear, accessible information about what constitutes safe practice in cosmetic surgery abroad. Sources (2) British Association of Aesthetic Plastic Surgeons BAAPS and TSPRAS joint consumer guidelines ### The Wire Aug 30This Week in Medical Tourism: 20–26 August 2026 Aug 29This Week in Medical Tourism: 13–19 August 2026 Aug 22South Korea Undercuts America but Not Turkey All coverage ### Newsletter Get weekly health tourism intelligence in your inbox. Subscribe ### Knowledge Hub Medical Tourism Wellness Tourism Dental Tourism Fertility Tourism Cosmetic Tourism Longevity Tourism Explore the Hub Stay informed on the latest in global health tourism. Subscribe to our Newsletter ## Related Articles Cosmetic Tourism 22 AUG 2026 Cosmetic Tourism ### South Korea Undercuts America but Not Turkey August 22, 2026 Medical Tourism 22 AUG 2026 Medical Tourism ### Turkey's Deepest Discounts Sit on Its Safest Procedures August 22, 2026 Weekly Digest 08 JUL 2026 Weekly Digest ### Medical Tourism Records Concentrate In Penang And Seoul July 8, 2026 --- # Dental Implant Prices Abroad Hide Three Different Units URL: https://health-tourism-news.com/news/dental-implant-prices-abroad-hide-three-different-units/ Dental Tourism August 22, 2026 Dental Tourism Dental Implant Prices Abroad Hide Three Different Units Across six Health Tourism News country guides a single implanted tooth runs from $270 to $3,150. Part of that spread is price. A good part of it is that the six markets do not headline the same thing. Christian El-Khouri Editor-in-Chief Published August 22, 2026 · 7 min read Health Tourism News now runs six country guides on dental implants. Read across them and a single implanted tooth costs anywhere from $270 to $3,150. Some of that spread is genuine price. A good part of it is not price at all. The six markets do not headline the same product, and the number a clinic puts at the top of its list decides whether any comparison that follows means anything. Three units circulate. The implant alone, which is a titanium post and no tooth. The restored or complete tooth, which is the post, the abutment and the crown. And the arch, which is a bridge on four or more implants and may or may not be the final one. Quotes from different countries routinely put all three under the same word. ## What each market puts on the front of its price list Turkey prices by implant brand rather than by city, and the published panel figures are per implant with the crown on it. Entry-tier systems ran $270 to $535 in mid-2026, mid-tier brands $605 to $805, and premium Swiss and Swedish systems $940 to $1,140, as set out in the Turkish implant guide. Poland does the same, headlining the restored tooth at $535 to $940 for standard systems and $735 to $1,340 for premium ones, which the Poland guide breaks down by brand. Croatia and Hungary work the other way. Croatian lists usually headline the post, at $775 to $935, or $905 to $1,110 for a Swedish system, and the abutment and crown add $275 to $790 on top. The restored tooth lands at $1,050 to $1,715, which is the figure the Croatia guide uses. Hungarian lists run from $370 for a budget post to $1,415 for a Straumann one, with the restored mainstream tooth at $950 to $1,460 in the Hungary guide. Mexico advertises a sub-$900 figure that is the surgical post alone. Border-town lists run $750 to $890 for it, and the restoration adds $450 to $720, so the complete tooth is $1,200 to $1,610 in the border cities and $1,730 at one Mexico City provider, as the Mexico guide records. Thailand mostly publishes complete-tooth rate cards, $1,050 to $1,950 for economy brands and $1,950 to $3,150 for premium ones, but two providers on the panel headline the implant body alone at $870 to $1,770 with the crown adding $750 to $900, a trap the Thailand guide flags. CountryWhat the headline price usually coversRestored or complete tooth Turkeyimplant with crown, by brand tier$270 - $1,140 entry tier to premium Polandrestored tooth$535 - $1,340 Hungarythe post alone$950 - $1,460 mainstream systems Croatiathe post alone$1,050 - $1,715 Mexicothe post alone$1,200 - $1,730 Thailandcomplete tooth, two panel exceptions$1,050 - $3,150 by brand tier UK referencerestored tooth$3,355 median £2,500, 1,125-practice sample US referencecomplete tooth$3,500 - $5,500 Panel prices from the six Health Tourism News country guides, each with its own methodology note and dated exchange rate. UK median from TreatCompare’s 2026 sample. Line them up on the same unit and the ranking changes. A Croatian post at $775 and a Turkish premium tooth at $940 look about twenty per cent apart, and they are not comparable at all: put a crown on the Croatian post and the Croatian tooth costs more than the Turkish one. Poland, quoting restored teeth from $535, is the cheapest whole tooth on the panel outside Turkey’s entry tier, which no headline suggests, because Poland is quoting the finished article while three of its competitors are quoting a component. ## The arch quotes are worse All-on-4 is the least comparable number in this market, because one label covers several different products. The Turkish panel makes the point on its own: one provider publishes an arch at $2,150 with a temporary bridge, another publishes $7,500 for both jaws in porcelain. A reader comparing the two without checking the unit is off by more than a factor of three, part unit and part material. CountryAll-on-4, per archNote Turkeyfrom $2,150budget brand, acrylic, temporary bridge Poland$5,700 - $8,900a zirconia arch in Kraków near $6,750 Hungary$6,965 - $11,400low end leaves the final bridge unstated Croatia$7,550 - $8,750all-inclusive lists; full band $5,150 - $10,950 Mexico$8,110 - $9,900border towns; Cancun resort packages $10,000 - $13,500 Thailand$9,900 - $13,200premium brand; one budget Korean system at $6,300 UK$16,100 - $33,500per jaw, 2026 lists US$25,000 - $35,000as reported by comparison guides Units as each provider publishes them. Full methodology in each country guide. The cheap floors have something in common across all six countries: they leave the final bridge unstated. The transparent lists name the bridge, its material and the visit it arrives on. That single difference explains more of the spread in the table above than the country does. ## What does not vary The biology is the same in all six markets, and so is what the literature says about it. An implant fuses to the jaw over three to six months, which is why every one of the six guides describes two trips separated by months rather than one. Teeth in a day describes a temporary bridge, not the result. Ten-year survival sits at 93 to 96 per cent in the review literature wherever the work is done, and peri-implantitis, the inflammation that takes implants out later, is not a destination-specific risk either. What does vary, apart from the unit, is the paperwork. A named implant system with lot numbers can be serviced by a dentist at home; an unbranded fixture can mean removal and replacement at domestic prices. Warranty terms that say who pays for a redo, and where it happens, are worth more than a lower floor. The General Dental Council’s guidance for British patients going abroad makes the same point in blunter language. ## Three questions that make a quote comparable Ask whether the price is the restored tooth or the post alone, and get the answer in writing with the abutment and crown itemised. Ask whether an arch price is per jaw or both, and which bridge and material arrive on which visit. Ask which implant system, by name, and whether lot numbers come home in the records. A patient who asks those three questions can put six countries on one line. A patient who compares headlines is comparing a post in Croatia with a tooth in Turkey and an arch in Thailand, and the cheapest number on that list is usually the one that covers the least. The six guides sit under the dental implants section, each with the panel, the methodology and the local licence checks. Health Tourism News is a trade publication and sells no treatment. Prices are the figures clinics publish, held on file, with the limits of each panel stated in the country guide. Sources (4) TreatCompare, UK dental implant cost sample of 1,125 practices, 2026 Howe, Keys, Richards. Long-term (10-year) dental implant survival, Journal of Dentistry, 2019 Soto-Penaloza et al. The all-on-four treatment concept: systematic review, 2017 General Dental Council, Going abroad for dental treatment dental implantsTurkeyPolandHungaryCroatiaThailandMexicoprices ### The Wire Aug 30This Week in Medical Tourism: 20–26 August 2026 Aug 29This Week in Medical Tourism: 13–19 August 2026 Aug 22South Korea Undercuts America but Not Turkey All coverage ### Newsletter Get weekly health tourism intelligence in your inbox. Subscribe ### Knowledge Hub Medical Tourism Wellness Tourism Dental Tourism Fertility Tourism Cosmetic Tourism Longevity Tourism Explore the Hub Stay informed on the latest in global health tourism. Subscribe to our Newsletter ## Related Articles Cosmetic Tourism 22 AUG 2026 Cosmetic Tourism ### South Korea Undercuts America but Not Turkey August 22, 2026 Medical Tourism 22 AUG 2026 Medical Tourism ### Mexico and Turkey Price Against Different Home Markets August 22, 2026 Medical Tourism 22 AUG 2026 Medical Tourism ### Turkey's Deepest Discounts Sit on Its Safest Procedures August 22, 2026 --- # Dubai Bolsters Medical Tourism with New Strategic Partnership URL: https://health-tourism-news.com/news/dubai-bolsters-medical-tourism-with-new-strategic-partnership/ Medical Tourism Dubai Bolsters Medical Tourism with New Strategic Partnership Dubai DHA and DET sign MoU Christian El-Khouri Editor-in-Chief Editor-in-Chief of Health Tourism News. Twelve-plus years across international patient services, healthcare consulting, and destination development in Europe, the Middle East, and beyond. Co-Founder and Vice President of the European Health and Medical Tourism Association (EHMTA). Read more Published October 3, 2024 · Updated July 2, 2026 · 4 min read In a move to solidify its reputation as a premier destination for medical tourism, Dubai has seen the Dubai Health Authority (DHA) and the Dubai Department of Economy and Tourism (DET) sign a Memorandum of Understanding (MoU). This partnership aims to integrate health services into Dubai’s broader tourism strategy, enhancing the city’s appeal as a place not only for leisure but also for world-class medical care. The agreement is notable less for any single measure it introduces than for what it signals: two government bodies that have traditionally worked in separate lanes - one overseeing healthcare, the other economy and tourism - formally coordinating their efforts. In practice, that means treating a patient’s medical visit and their stay in the city as parts of the same experience rather than unrelated transactions. ## Linking Healthcare to the Tourism Engine Medical tourism depends on more than clinical quality. A patient travelling abroad for treatment also needs visas, accommodation, transport, and often a companion, and the smoothness of those arrangements can be as decisive as the reputation of the hospital itself. By bringing the tourism department into the conversation, Dubai is acknowledging that the non-medical parts of the journey shape whether patients choose the city and whether they come back. This collaboration focuses on achieving operational efficiency, transparency, and competitiveness in healthcare services, aligning with global standards. Coordinating across the two authorities is intended to reduce friction at each of those touchpoints, from the moment a prospective patient researches options to the follow-up care after they return home. ## Dubai’s Existing Medical Tourism Foundations Dubai has spent years building the underlying assets that a strategy like this relies on. The emirate is home to a large number of internationally accredited facilities, including hospitals that hold Joint Commission International (JCI) accreditation, a benchmark that international patients often look for when choosing where to travel. Its position as a global aviation hub places much of Asia, Africa, and Europe within a few hours’ flight, and it has developed medical visa processes intended to ease travel for patients and their families. The city also operates the Dubai Health Experience (DXH), an online platform designed to help international patients find providers, compare services, and arrange treatment packages. Initiatives like these give the new partnership an existing base to build on rather than a standing start. ## What the Partnership Aims to Achieve The MoU’s stated objectives include making Dubai the best place globally to visit, live, and work, thereby reinforcing the emirate’s economic stability and role as a global hub. That framing ties medical tourism to broader goals of livability and competitiveness rather than treating it as a standalone niche. The initiative reflects Dubai’s ambition to leverage its advanced medical infrastructure and strategic location to attract more medical tourists, promising both quality care and a unique travel experience. This strategic alignment between the healthcare and tourism sectors is expected to drive growth in medical tourism and contribute to the emirate’s ongoing economic diversification, reinforcing its position as a leading destination for health-related travel. ## Positioning in a Competitive Regional Market Dubai is not alone in courting international patients. Across the Gulf and the wider region, governments have identified healthcare as a growth industry and are investing to attract patients who might otherwise travel to Europe or Asia. That competition raises the value of coordination: destinations that can offer a seamless end-to-end experience hold an advantage over those with strong hospitals but fragmented logistics. By formalising the link between its health and tourism authorities, Dubai is betting that integration itself will be a differentiator. Whether the partnership delivers measurable growth will depend on execution, but the direction of travel reinforces the emirate’s stated goal of standing among the world’s leading destinations for health-related travel. Sources (1) Dubai Media Office ### The Wire Aug 30This Week in Medical Tourism: 20–26 August 2026 Aug 29This Week in Medical Tourism: 13–19 August 2026 Aug 22South Korea Undercuts America but Not Turkey All coverage ### Newsletter Get weekly health tourism intelligence in your inbox. Subscribe ### Knowledge Hub Medical Tourism Wellness Tourism Dental Tourism Fertility Tourism Cosmetic Tourism Longevity Tourism Explore the Hub Stay informed on the latest in global health tourism. Subscribe to our Newsletter ## Related Articles Medical Tourism 22 AUG 2026 Medical Tourism ### Mexico and Turkey Price Against Different Home Markets August 22, 2026 Medical Tourism 22 AUG 2026 Medical Tourism ### Turkey's Deepest Discounts Sit on Its Safest Procedures August 22, 2026 Medical Tourism ### Why Medical Tourism to Germany Declined August 11, 2026 --- # Event: Global Health Exhibition in Riyadh URL: https://health-tourism-news.com/news/event-global-health-exhibition-in-riyadh/ Medical Tourism Event: Global Health Exhibition in Riyadh Why you should visit one of the most anticipated global healthcare events Christian El-Khouri Editor-in-Chief Editor-in-Chief of Health Tourism News. Twelve-plus years across international patient services, healthcare consulting, and destination development in Europe, the Middle East, and beyond. Co-Founder and Vice President of the European Health and Medical Tourism Association (EHMTA). Read more Published October 10, 2024 · Updated July 2, 2026 · 3 min read The Global Health Exhibition in Riyadh is set to be a landmark event in the healthcare sector, scheduled from October 21 to 23, 2024, at the Riyadh Convention Exhibition Centre in Malham, Saudi Arabia. This exhibition has grown from its modest beginnings post-World War II into a global symposium that mirrors the world’s increasing focus on health equity and international collaboration in healthcare. This year, the event, themed “Invest in Health,” will feature over 1,200 exhibitors showcasing everything from the latest in medical devices to revolutionary digital health solutions. These exhibitors represent significant growth, highlighting the event’s rising importance in the global health community. Attendees can expect to engage with innovations and solutions at the forefront of medical advancement. ## Five Forums and Over 100 Hours of Education The exhibition will be a hub for knowledge exchange with an impressive lineup of speakers across five dedicated forums, including the Leader’s Summit and the Medical Excellence Forum, offering over 100 hours of educational content. This content not only serves as a learning platform but also provides Continuing Professional Development (CPD) credits for professionals. ## A Global Gathering of 40 Countries The international appeal of the event is evident, with an anticipated participation from over 40 countries, fostering a melting pot of ideas and fostering global health strategies. Last year alone, the exhibition welcomed over 40,000 visitors, a figure that speaks volumes about its significance in the healthcare industry. ## Why You Should Visit Visiting the Global Health Exhibition offers numerous benefits. It’s an opportunity for networking and connecting healthcare professionals, policymakers, and innovators from around the globe. For those looking to expand their knowledge, the event provides insights from thought leaders and hands-on workshops. Moreover, it’s a prime venue for witnessing the future of healthcare technology, potentially influencing health policies worldwide. For investors, the exhibition presents a golden opportunity to discover and invest in emerging health startups and technologies. ## Saudi Arabia’s Vision 2030 and the Inbound Ambition Saudi Arabia has a special state where health and medical tourism are concerend. For the longest time, the Kingdom has been an outbound stakeholder, with patients from the Kingdom visiting healthcare destinations for over half a century now. Amongst the goals of the ambitious Vision 2030 is also the wish to change that and develop Saudi Arabia into an inbound market, intending to provide health and medical services to patients from all over the globe. For anyone interested in the prospects of this ambition, health- and medical tourism oldtimer Christian El-Khouri has written a thought provoking piece on the subject titled “Saudi Arabia: A future Medical Tourism Destination” on the MESC blog. The Global Health Exhibition in Riyadh is more than just an event; it’s a movement towards a more integrated, innovative, and investment-friendly future in global health. Whether your interest lies in learning, investing, or innovating, this exhibition stands out as an essential destination in 2024 for anyone serious about the trajectory of global health. For further information about the event visit: https://www.globalhealthsaudi.com/en/home.html Sources (1) Global Health Exhibition ### The Wire Aug 30This Week in Medical Tourism: 20–26 August 2026 Aug 29This Week in Medical Tourism: 13–19 August 2026 Aug 22South Korea Undercuts America but Not Turkey All coverage ### Newsletter Get weekly health tourism intelligence in your inbox. Subscribe ### Knowledge Hub Medical Tourism Wellness Tourism Dental Tourism Fertility Tourism Cosmetic Tourism Longevity Tourism Explore the Hub Stay informed on the latest in global health tourism. Subscribe to our Newsletter ## Related Articles Medical Tourism 22 AUG 2026 Medical Tourism ### Mexico and Turkey Price Against Different Home Markets August 22, 2026 Medical Tourism 22 AUG 2026 Medical Tourism ### Turkey's Deepest Discounts Sit on Its Safest Procedures August 22, 2026 Medical Tourism ### Why Medical Tourism to Germany Declined August 11, 2026 --- # Does Integrative Medicine Work? Evidence and Outcomes URL: https://health-tourism-news.com/news/evidence-and-outcomes/ Wellness Tourism Does Integrative Medicine Work? Evidence and Outcomes A growing body of research now measures integrative medicine on effectiveness, cost and patient satisfaction. Here is what the evidence shows. Kevin Ciresi Contributor A career spanning the operating room to the boardroom. Former surgeon who founded and led multiple U.S. healthcare facilities, now focused on transparent frameworks for international care and blue-zone wellness destinations. Read more Published January 14, 2026 · Updated July 2, 2026 · 7 min read Reviewed by Christian El-Khouri, Editor-in-Chief A crucial aspect of the evolution from alternative to integrative medicine is the emphasis on evidence-based outcomes. Early skepticism toward CAM stemmed from a lack of rigorous data; however, the past decade has seen a growing body of research evaluating the effectiveness, cost impact, and patient-reported outcomes of integrative therapies. For policymakers and investors, in particular, demonstrating value through evidence is crucial to the broader acceptance and funding of integrative modalities. Here, we highlight some of the notable findings on outcomes and effectiveness (2019-2025): ## Clinical Effectiveness Multiple meta-analyses and trials have consistently demonstrated that certain integrative therapies can enhance clinical outcomes for specific conditions. For example, there is solid evidence that mindfulness meditation and cognitive-behavioral techniques reduce symptoms of anxiety, PTSD, and depression, sometimes on par with medications for mild-moderate cases. Acupuncture’s standing is narrower than it is often presented. NICE recommends considering a single course of acupuncture for chronic primary pain, but its separate guideline on low back pain and sciatica does not recommend it, and it does not form part of the osteoarthritis recommendations. The distinction matters: a therapy supported for one pain category is not thereby supported for all of them. Herbal medicines have mixed evidence - some (e.g., ginger for nausea, butterbur for migraines) are supported by clinical trials, while others lack robust data or have quality issues. Nevertheless, the integrative field increasingly winnows therapies based on evidence: those with positive risk-benefit profiles are promoted, whereas ineffective or unsafe ones are dropped. A systematic review in 2022 found that complementary and integrative health (CIH) therapies overall have positive effects on quality of life and well-being for various populations, with firm support for reducing pain and stress. Additionally, integrative lifestyle programs (combining diet, exercise, stress management) have shown ability to reverse disease progression in some cases - a notable example being the Ornish Lifestyle trial which demonstrated regression of coronary artery disease with intensive lifestyle change, leading to long-term cost savings. More recently, the Diabetes Prevention Program found lifestyle intervention to be more effective than metformin in preventing diabetes onset (a 58% risk reduction compared to 31% with metformin), and it was also more cost-effective. These kinds of outcomes bolster the argument that integrative, preventive approaches are not just “nice add-ons” but can be front-line interventions with superior results for chronic disease management. ## Cost Savings and Healthcare Utilization For health systems and payers, one of the most compelling findings is that integrative care models can reduce healthcare utilization and costs. The previously mentioned Chicago HMO study (Alternative Medicine, Inc.) is a case in point: integrative care led to over 40% reductions in hospital admissions and surgeries, and halved drug costs. The sustained 7-year outcomes (60-85% reductions in various utilization measures) suggest that when patients receive integrative primary care focusing on prevention and non-invasive therapies, they experience fewer complications and require fewer high-cost interventions. Another evaluation of almost 700 patients in Iowa under a multicomponent integrative program saw four-year total medical expenditures 57-59% lower than matched controls or state averages. These are dramatic savings that, if scaled, could relieve pressure on healthcare budgets. Even smaller-scale interventions show savings: health coaching for high-risk patients yielded significant reductions in monthly healthcare expenditures per person. Integrative cardiology programs (like Dr. Dean Ornish’s heart disease reversal program) have demonstrated fewer procedures and rehospitalizations, leading some insurers to cover them as a cost-saving measure. The general trend in studies is that upfront spending on integrative therapies (such as time with practitioners and lifestyle workshops) is offset by downstream savings from avoided surgeries, hospital stays, or complications from chronic diseases. Policymakers in some countries (e.g., Switzerland and Germany) have noted this and supported CAM integration partly for economic reasons. However, rigorous cost-effectiveness research is still needed in many areas to convince national health systems. ## Patient Satisfaction and Health Behaviors Integrative approaches tend to score high on patient satisfaction and engagement metrics. Patients often appreciate the extended consultation times and the attention to their overall well-being. Surveys in integrative clinics frequently report patients feeling that their “health concerns were more thoroughly addressed” compared to previous conventional visits. Because integrative medicine often involves coaching patients in self-care practices (such as diet changes, exercise, and stress management), it can improve patients’ health behaviors and self-efficacy. For instance, participants in integrative programs have shown greater adherence to healthy diets and exercise regimens due to the support and education received. In one study of an integrative health course for providers, those providers improved their wellness behaviors, including stress management, exercise, and personal reflection, which likely translates to better patient counseling as well. High patient satisfaction can also be a proxy for better outcomes, as engaged patients are more likely to follow treatment plans and maintain long-term wellness routines. For wellness tourism operators, guest satisfaction is similarly critical: retreats now solicit extensive feedback and often track improvements (e.g., the percentage of guests who report reduced stress or weight loss by the end of the week). Many wellness resorts boast repeat visitor rates, indicating that clients perceive real benefit and are motivated to return. While scientific outcome data from wellness tourism are limited, anecdotal evidence and small studies suggest improvements in mental health scores, jump-starts in fitness, and sustained smoking cessation after intensive retreats. ## Safety and Risk Management Another component of “evidence-based” integrative practice is ensuring safety and managing risks of combined therapies. Research has helped identify where sure CAM might be harmful or interact with medications. For example, studies have highlighted that some herbal supplements (like St. John’s Wort) can interfere with pharmaceuticals, or that improper use of essential oils can cause side effects in children. Responsible integrative providers now screen patients for supplement use, guide them on quality products, and educate them about potential adverse effects. The WHO’s 2025-2034 Traditional Medicine Strategy underscores that integration must be scientifically valid and evidence-based to prevent misinformation and unsafe practices. It calls for more research and regulatory oversight to weed out harmful or ineffective approaches. Encouragingly, evidence reviews show that many integrative modalities have low incidence of adverse effects when delivered by trained professionals. For instance, acupuncture’s complication rate is extremely low, and mind-body therapies are inherently safe. But continuous monitoring is needed. Policymakers are paying attention: the European Union voiced concerns at the World Health Assembly that WHO and countries must remain vigilant against “harmful and/or inefficient practices disguised as alternative medicine.” In Europe, regulatory bodies in some countries have tightened rules on CAM provider credentialing and product safety in recent years, precisely to ensure that as integrative medicine expands, it does so without compromising patient safety or public trust. ## What the Evidence Adds Up To In summary, the growing evidence base has both strengthened the case for integrative medicine and provided guidelines for its implementation. We now have concrete data that a holistic approach can improve outcomes in areas like chronic disease, mental health, and patient satisfaction, while also potentially lowering costs, outcomes of great interest to healthcare policymakers and payers. At the same time, evidence has allowed integrative medicine to mature by discarding approaches that don’t work or are unsafe. The trajectory from 2019 to 2025 is one of increasing validation: Integrative medicine is transitioning from the realm of anecdotal evidence into the realm of science-backed medicine, which in turn encourages health systems and investors to support its growth. That said, experts agree more research is needed, particularly whole-system studies (beyond single therapy trials) to understand the synergistic effects of multimodal integrative care. If such research continues and expands, it will pave the way for integrative medicine to be not just an optional add-on, but a foundational approach in 21st-century healthcare. Sources (7) MDPI Health Policy Watch Child Neurology Society PubMed Central NICE guideline NG193, chronic pain in over 16s Diabetes Prevention Program Research Group, New England Journal of Medicine Ornish et al., Lifestyle Heart Trial, JAMA ### The Wire Aug 30This Week in Medical Tourism: 20–26 August 2026 Aug 29This Week in Medical Tourism: 13–19 August 2026 Aug 22South Korea Undercuts America but Not Turkey All coverage ### Newsletter Get weekly health tourism intelligence in your inbox. Subscribe ### Knowledge Hub Medical Tourism Wellness Tourism Dental Tourism Fertility Tourism Cosmetic Tourism Longevity Tourism Explore the Hub Stay informed on the latest in global health tourism. Subscribe to our Newsletter ## Related Articles Weekly Digest 08 JUL 2026 Weekly Digest ### Medical Tourism Records Concentrate In Penang And Seoul July 8, 2026 Weekly Digest 01 JUL 2026 Weekly Digest ### Nigeria, Iran And Seoul Redraw Medical Tourism July 1, 2026 Weekly Digest 24 JUN 2026 Weekly Digest ### Health Tourism As Badge, Escape Hatch And Disguise June 24, 2026 --- # Founding of the European Health and Medical Tourism Association URL: https://health-tourism-news.com/news/founding-of-the-european-health-and-medical-tourism-association/ Medical Tourism Founding of the European Health and Medical Tourism Association A New Era for European Health and Medical Tourism Christian El-Khouri Editor-in-Chief Editor-in-Chief of Health Tourism News. Twelve-plus years across international patient services, healthcare consulting, and destination development in Europe, the Middle East, and beyond. Co-Founder and Vice President of the European Health and Medical Tourism Association (EHMTA). Read more Published January 15, 2025 · 5 min read ## EHMTA: A New Era for European Health and Medical Tourism The European Health and Medical Tourism Association (EHMTA) has officially launched, setting the stage for transformative growth in the health and medical tourism industry across Europe. This groundbreaking initiative marks a pivotal moment, bringing together diverse stakeholders to create a unified platform for excellence in healthcare, patient safety, and global collaboration. ## The Vision Behind EHMTA Established with the mission to position Europe as the premier destination for health and medical tourism, EHMTA is driven by a commitment to transparency, quality, and innovation. As a centralized hub, the association connects healthcare providers, medical tourism facilitators, insurance companies, government bodies, and wellness centers under a single umbrella. “Our mission is to create a unified platform that strengthens Europe’s position as a global leader in health and medical tourism,” stated Ivan Rendulic, President of EHMTA. “By bringing together stakeholders, we aim to set benchmarks for quality and trust, benefiting both providers and patients.” EHMTA’s focus on collaboration and shared knowledge reflects the growing need for cohesive strategies in a rapidly expanding global market. With health tourism projected to experience unprecedented growth, Europe’s world-class facilities, skilled professionals, and diverse cultural offerings make it uniquely positioned to lead the charge. ## Key Objectives of the Association EHMTA’s strategic goals address both immediate and long-term needs within the industry. Among its primary objectives are: Representing the interests of Europe’s health and medical tourism industry to policymakers and global stakeholders. Establishing industry-wide standards for healthcare and patient safety. Driving the expansion and development of Europe as a top-tier destination for medical and wellness travel. Facilitating the exchange of knowledge and best practices among members. Enhancing transparency, ethical practices, and trust within the sector. This multifaceted approach ensures that EHMTA not only promotes Europe’s competitive edge but also fosters sustainable growth and patient-centric care. ## Launching at a Crucial Time EHMTA’s formation comes at a time when health and medical tourism is evolving at a rapid pace. The post-pandemic recovery has highlighted the importance of cross-border healthcare access, sustainable practices, and the integration of technology in medical tourism. Europe, with its advanced healthcare infrastructure, commitment to sustainability, and reputation for high-quality care, is ideally suited to take a leadership role. EHMTA aims to capitalize on this momentum, ensuring that the continent remains at the forefront of global health tourism. ## A Strong Presence at ITB Berlin 2025 The association’s participation in ITB Berlin 2025, the world’s leading travel trade show, underscores its commitment to building a strong global presence. By engaging with industry leaders, tourism boards, and healthcare providers, EHMTA seeks to create meaningful opportunities for collaboration. “Being part of ITB Berlin 2025 is a significant step in our mission to transform health and medical tourism in Europe,” Rendulic said. “Our partnership with ITB underscores the importance of collaboration in driving innovation and creating meaningful opportunities for all stakeholders in the sector.” EHMTA’s presence at the Medical Tourism Pavilion will include discussions on developing global standards, fostering patient mobility, and promoting Europe as a leader in sustainable wellness tourism. ## Advancing the Health Tourism Industry One of EHMTA’s critical initiatives includes the development of certifications and benchmarks to ensure that providers adhere to high standards of care and sustainability. This effort not only enhances patient safety but also boosts Europe’s reputation as a reliable and responsible destination for health tourism. ## Connecting Stakeholders for a Unified Vision A cornerstone of EHMTA’s approach is fostering a strong network of stakeholders across the industry. The association provides a platform for healthcare providers, insurance companies, and tourism leaders to collaborate on addressing shared challenges. By streamlining patient referrals, harmonizing regulatory frameworks, and encouraging innovation, EHMTA ensures that every link in the health tourism chain is optimized for efficiency and excellence. ## Bridging Healthcare and Tourism EHMTA recognizes the unique intersection of healthcare and tourism in its mission. Europe’s unparalleled cultural heritage, scenic landscapes, and wellness offerings provide a compelling backdrop for medical travelers seeking high-quality care. By aligning healthcare services with tourism experiences, the association enhances the patient journey, offering both physical and mental well-being. This holistic approach reflects EHMTA’s dedication to comprehensive and compassionate care. ## Membership Opportunities As a member-driven organization, EHMTA offers healthcare providers, facilitators, and industry leaders an opportunity to shape the future of health tourism in Europe. Membership benefits include access to exclusive events, knowledge-sharing platforms, and the ability to influence industry standards and policies. EHMTA’s website, serves as a gateway for information, collaboration, and updates on the association’s initiatives. ## A Collaborative Path Forward The launch of EHMTA heralds a new chapter for Europe’s health and medical tourism industry. By fostering collaboration, setting high standards, and promoting innovation, the association is poised to drive sustainable growth and excellence in the sector. As EHMTA takes its place on the global stage, stakeholders across the industry are invited to join this transformative journey. Together, they can ensure that Europe remains a beacon of quality, trust, and leadership in health tourism. Next week we will begin a series of articles, introducing the EHMTA’s founding team. Sources (1) European Health and Medical Tourism Association ### The Wire Aug 30This Week in Medical Tourism: 20–26 August 2026 Aug 29This Week in Medical Tourism: 13–19 August 2026 Aug 22South Korea Undercuts America but Not Turkey All coverage ### Newsletter Get weekly health tourism intelligence in your inbox. Subscribe ### Knowledge Hub Medical Tourism Wellness Tourism Dental Tourism Fertility Tourism Cosmetic Tourism Longevity Tourism Explore the Hub Stay informed on the latest in global health tourism. Subscribe to our Newsletter ## Related Articles Medical Tourism 22 AUG 2026 Medical Tourism ### Mexico and Turkey Price Against Different Home Markets August 22, 2026 Medical Tourism 22 AUG 2026 Medical Tourism ### Turkey's Deepest Discounts Sit on Its Safest Procedures August 22, 2026 Medical Tourism ### Why Medical Tourism to Germany Declined August 11, 2026 --- # Global Landscape of Integrative Medicine and Wellness Tourism URL: https://health-tourism-news.com/news/global-landscape-of-integrative-medicine-and-wellness-tourism/ Wellness Tourism Global Landscape of Integrative Medicine and Wellness Tourism Integrative Medicine and Wellness Tourism: Global Trends and the Evolving Provider-Patient Relationship Kevin Ciresi Contributor A career spanning the operating room to the boardroom. Former surgeon who founded and led multiple U.S. healthcare facilities, now focused on transparent frameworks for international care and blue-zone wellness destinations. Read more Published December 14, 2025 · 4 min read Reviewed by Christian El-Khouri, Editor-in-Chief ## Introduction In recent years, integrative medicine and wellness tourism have moved from the fringes of healthcare and travel into the mainstream, driven by rising consumer demand for holistic well-being. Integrative medicine (IM) refers to a patient-centered, holistic approach that combines conventional medical care with evidence-informed complementary therapies, emphasizing prevention, wellness, and the whole person ( and childneurologysociety.org). Meanwhile, wellness tourism - travel to maintain or improve health - has become one of the fastest-growing segments in the travel industry, accelerated by a global shift toward self-care and preventive health, especially in the wake of the COVID-19 pandemic and hospitalityinsights.ehl.edu. This report offers a comprehensive analysis of global trends in integrative medicine and wellness tourism from 2019 to 2025, with a particular focus on Europe (notably Italy, Sicily, and Greece). It examines how the provider - patient relationship is evolving in tandem with the changing needs of clients and how providers are responding. Key considerations for policymakers, healthcare investors, and wellness travelers are highlighted, including patient demand trends, emerging business models, evidence-based outcomes, regulatory implications, and destination-based innovations, all supported by recent data and literature. *The global wellness economy by sector, highlighting the significant roles of wellness tourism ($830 billion) and traditional and complementary medicine ($553 billion) in 2023. *. The wellness industry (totaling $6.3 trillion in 2023) has rebounded significantly post-pandemic, with wellness tourism and preventive health services among its fastest-growing components. Globally, interest in integrative health has surged. The number of research publications on integrative medicine doubled between 2012 and 2021, reflecting increased scientific attention and legitimization. Countries such as the United States, China, Germany, the United Kingdom, and Italy have been leading contributors to IM research output. More importantly, public uptake of integrative and traditional remedies remains vast: the World Health Organization (WHO) estimates that over 80% of the world’s population in 170+ countries uses some form of conventional or complementary medicine, and in high-income countries like France and Canada nearly half the population has utilized such therapies. By 2018, roughly 26% of Europeans had used at least one complementary or alternative medicine (CAM) therapy in the past year, and long-term surveys show CAM use climbing (for example, in Denmark usage grew from 10% in 1987 to 24% in 2021). This widespread adoption signals that integrative approaches addressing nutrition, mind-body practices, herbal medicine, and other complementary therapies have resonated with consumer needs across diverse cultures. The wellness economy reached new heights by 2023 - valued at $6.3 trillion, about 6% of global GDP - with virtually all wellness sectors exceeding their pre-2019 size. Within this economy, wellness tourism has been a standout driver of growth. After pandemic lows, wellness travel rebounded by over 30% from 2022 to 2023, reaching a $830 billion market in 2023. Forecasts indicate that wellness tourism will continue to grow at ~10% annually, outpacing overall travel, as people increasingly prioritize health-centric getaways ( and tovima.com). Another booming segment is “public health, prevention, and personalized medicine”, encompassing preventive and functional medicine services, which have grown 15-16% annually in recent years. By 2023, the prevention/personalized medicine sector accounted for over $ 780 billion (approximately 12% of all wellness spending) - now the fifth-largest wellness segment globally. In parallel, the traditional complementary medicine market (spanning herbal supplements, acupuncture, Ayurveda, etc.) is substantial - estimated at over $550 billion in 2023 and expected to see double-digit annual growth through mid-decade. These figures make it clear that holistic health modalities and wellness travel are no longer niche interests, but rather major components of the global health landscape. Crucially, growth is not limited to one region. Europe, North America, and the Asia-Pacific region are all robust markets, although each has distinct strengths. Europe leads in the sheer volume of wellness trips - in 2019, Europeans took an estimated 333 million wellness trips (more than any other region), reflecting the continent’s long tradition of spa and health tourism. North America, by contrast, leads in per-trip expenditures and overall market value of wellness tourism, owing to higher spending patterns. The Middle East and Asia are also emerging, often blending traditional healing cultures with luxury wellness resorts. However, across the board, the common denominator is that wellness has become a universal consumer value, transcending age and geography. As two senior researchers at the Global Wellness Institute put it, “No matter your politics or beliefs, who doesn’t desire the knowledge, tools, and opportunities to build a healthy life for yourself and your family?”. That sentiment, intensified by the pandemic, is fueling sustained expansion in both integrative medicine utilization and wellness-focused travel. Sources (5) To Vima PubMed Central Global Wellness Institute CBI, Netherlands Enterprise Agency Health Policy Watch ### The Wire Aug 30This Week in Medical Tourism: 20–26 August 2026 Aug 29This Week in Medical Tourism: 13–19 August 2026 Aug 22South Korea Undercuts America but Not Turkey All coverage ### Newsletter Get weekly health tourism intelligence in your inbox. Subscribe ### Knowledge Hub Medical Tourism Wellness Tourism Dental Tourism Fertility Tourism Cosmetic Tourism Longevity Tourism Explore the Hub Stay informed on the latest in global health tourism. Subscribe to our Newsletter ## Related Articles Weekly Digest 08 JUL 2026 Weekly Digest ### Medical Tourism Records Concentrate In Penang And Seoul July 8, 2026 Weekly Digest 01 JUL 2026 Weekly Digest ### Nigeria, Iran And Seoul Redraw Medical Tourism July 1, 2026 Weekly Digest 24 JUN 2026 Weekly Digest ### Health Tourism As Badge, Escape Hatch And Disguise June 24, 2026 --- # Health Tourism As Badge, Escape Hatch And Disguise URL: https://health-tourism-news.com/news/health-tourism-as-badge-escape-hatch-and-disguise/ Weekly Digest June 24, 2026 Weekly DigestDental TourismCosmetic TourismWellness TourismMedical TourismHealth Tourism Health Tourism As Badge, Escape Hatch And Disguise This Week In Health Tourism 16.06.26 - 23.06.26. Three governments spent the week calling medical tourism a pillar of national economic strategy, while a... Christian El-Khouri Editor-in-Chief Published June 24, 2026 · 7 min read This Week In Health Tourism 16.06.26 - 23.06.26. Three governments spent the week calling medical tourism a pillar of national economic strategy, while a sitting US Congresswoman said she had flown to Mexico for stem cell therapy because she carries no health insurance. Together, those two facts tell one story: the supply side keeps dressing up as triumph what the demand side lives as failure. Every patient gained is, somewhere else, a system that lost them. ## Egypt, Jordan and medical tourism as state policy Three states put medical tourism on the balance sheet this week. At the fifth Africa Health ExCon in Cairo, Egypt’s health minister Khaled Abdel Ghaffar told delegates Egypt had built a National Council for Medical Tourism and a national digital platform meant to act, as Daily News Egypt reported, as the official gateway for international patients. Jordan put a figure on the same idea: AGBI reported, citing the Jordan Times, that it earned almost a billion dollars from 230,000 foreign patients in 2025, up four per cent on the year, with Fawzi Hammouri of the country’s private hospitals body naming obesity surgery, orthopaedics and IVF as the draws. Uzbekistan went looking for the machinery, sending a delegation to Suzhou to talk pharmaceutical plants and patient flow with Chinese partners, UzDaily reported. A gateway is only as good as what waits behind it. A next step could be to publish outcomes and complication rates by procedure, so it becomes more than a brochure with a login. These are early bets, and the receipts are real enough. The trust takes longer to build than the platform. ## Dental tourism and the American escape hatch The clearest demand signal of the week came from Washington, not from a clinic. Marjorie Taylor Greene said on X, as The American Bazaar reported, that she had travelled to Mexico for stem cell therapy, that she has no health insurance, and that rising costs are pushing more Americans abroad. A member of the United States Congress could not get a treatment at home and left for it. That is the symptom thesis in one news cycle. People do not cross borders for fun; they cross because home failed them on price, on access, or on what the law there allows. Mexico catches much of that traffic. Vocal, citing Renub Research, put the country’s dental implant market at 87.88 million dollars in 2024, rising to a forecast 161.02 million by 2033, with an implant costing roughly 650 dollars against nearly 5,000 in the United States. Two of the five drivers are doing the work: cheaper, and unavailable at home. A warning sits inside that. An implant is well understood and well evidenced. The stem cell therapy Greene described is, by the US regulator’s own account, unapproved for most uses. The risk for Mexico’s clinics is letting the sound bargain and the unproven punt ride on the same trust. The CDC already named what counts: regulation, infection control, and continuity of care once the patient is home. That list is the floor, and the price does not move it. ## Singapore, wellness tourism and the cost of being premium While Mexico sells cheaper, Singapore spent the week selling the opposite. At the ITIC APAC conference, as ITIJ reported, the chief executive of one of the city’s largest private hospital groups argued that Singapore wins international patients not because they lack alternatives, but because its private hospitals compete against some of the world’s best public ones. He pointed to the country’s compactness and tourism receipts above thirty billion Singapore dollars a year. The counterweight came from the insurance side of the room. An assistance-industry executive walked delegates through the bill: specialist fees that can exceed hospital charges, and a laparoscopic appendectomy costing several times more in Singapore or Hong Kong than in Thailand or Malaysia for a clinically similar result. Set that beside the wellness figures. VnExpress, citing the Global Wellness Institute, reported Singapore’s wellness economy above 23 billion dollars, with spending of 3,845 dollars a head. Singapore’s pitch is best, not cheaper, and that holds only as long as outcomes justify the multiple. Insurers will keep steering clinically identical cases to cheaper neighbours, and they are right to. If Singapore’s operators want the premium, they must publish the outcome data that earns it. An address is not evidence. ## K-aesthetic medicine becomes an export engine South Korea posted a record month with a quieter, more interesting trend underneath it. The Asia Business Daily, citing DB Financial Investment, reported foreign medical tourism spending of 251.2 billion won in May, up 44 per cent on the year across 597,000 cases, dermatology taking the largest share. The number that should catch an operator’s eye is pharmacy spending, up 172 per cent year on year to a record share of the total. Korea is no longer just treating visitors; it is selling them a brand that follows them home, in creams and cosmetics bought after the procedure. Exports of medical and aesthetic products hit 480 million dollars in May, fillers alone 336 million. The inbound spend is the shop window; the export line is the till, and that is the number to model. ## AI and the experience layer in medical tourism Two stories cast technology as the thing patients will next judge destinations on, with mixed credibility. Nomad Lawyer described a humanoid robot called Alter-Ego, tested in a Milan rehabilitation hospital, that guides patients and fetches supplies, and attached a global market figure of around 130 billion dollars to the trend; treat that as the source’s, not settled fact. CBN’s Cyprus story was steadier, the country’s chief scientist Demetris Skourides and the head of the global thalassaemia patients’ federation, Androulla Eleftheriou, on using AI to put trusted information within reach of patients who would otherwise go without. The real thread is not the robot. Experience technology differentiates only where the clinical basics are already trusted, and a machine in the corridor does nothing for a thin outcomes record. Operators buying the shiny layer before the boring one have the order backwards. ## The organ trafficking case wearing the industry’s name The week’s ugliest story is also its most important. India’s Enforcement Directorate alleged, as Telangana Today reported, that an organ trafficking racket in Kerala ran for five years behind a registered medical tourism company. The agency says the network paid financially distressed donors five to fifteen lakh rupees, charged recipients twenty to thirty-five lakh or more, forged altruism certificates, and arranged illegal transplants at hospitals in Ernakulam. Several people have been arrested, accounts frozen, six police cases registered. The same two words three governments wore as a badge this week, a criminal network used as a costume. That is the trouble with a label that means everything and guarantees nothing. The industry’s representative bodies cannot prosecute fraud, but they can stop pretending the term protects anyone. Backing donor-protection registries and withholding the medical tourism label from unverified operators would cost little and say a great deal. Do nothing, and the next such case is already being written. ## What This Means One phrase did three jobs this week. Health tourism was a badge in Cairo, Amman and Tashkent, an escape hatch in Washington and Tijuana, and a disguise in Kerala. It stretched that far because the industry still has no shared floor, no agreed standard of proof separating a Singapore outcomes claim from a Mexican price tag from a forged altruism certificate. Everyone sells trust; almost no one publishes it. So, what to watch: which government pairs its glossy booking platform with real outcome data, procedure by procedure. The first to publish that gradient, from genuine care to salesmanship, will own something no rival can buy with a conference stage. Sources (11) Uzdaily Nomadlawyer Telanganatoday Asiae Americanbazaaronline Itij Vocal Agbi Cbn Dailynewsegypt Vnexpress UzbekistanRepublic of UzbekistanPeople's Republic of ChinaItalyPortugalCosta RicaMexicoThailand ### The Wire Aug 30This Week in Medical Tourism: 20–26 August 2026 Aug 29This Week in Medical Tourism: 13–19 August 2026 Aug 22South Korea Undercuts America but Not Turkey All coverage ### Newsletter Get weekly health tourism intelligence in your inbox. Subscribe ### Knowledge Hub Medical Tourism Wellness Tourism Dental Tourism Fertility Tourism Cosmetic Tourism Longevity Tourism Explore the Hub Stay informed on the latest in global health tourism. Subscribe to our Newsletter ## Related Articles Weekly Digest 30 AUG 2026 Weekly Digest ### This Week in Medical Tourism: 20–26 August 2026 August 30, 2026 Weekly Digest 29 AUG 2026 Weekly Digest ### This Week in Medical Tourism: 13–19 August 2026 August 29, 2026 Cosmetic Tourism 22 AUG 2026 Cosmetic Tourism ### South Korea Undercuts America but Not Turkey August 22, 2026 --- # Report Projects Healthcare ERP Market At $13.38bn By 2035 URL: https://health-tourism-news.com/news/healthcare-erp-market-poised-for-strategic-growth-driving-efficiency-in-global-patient-care-to-1338-billion-by-2035/ Health Tourism April 6, 2026 Health Tourism Report Projects Healthcare ERP Market At $13.38bn By 2035 Precedence Research projects the global healthcare ERP market will grow from USD 7.09 billion in 2025 to USD 13.38 billion by 2035, a vendor forecast worth reading with care. Christian El-Khouri Editor-in-Chief Published April 6, 2026 · Updated July 9, 2026 · 4 min read Precedence Research has put the global healthcare enterprise resource planning market at USD 7.09 billion in 2025 and projected it to reach USD 13.38 billion by 2035, the firm said in a press release. That path works out at a growth rate of 6.56 per cent a year between 2026 and 2035. Precedence Research sells market research, and the release is a promotional one, so the figure reads best as a vendor projection rather than a hard measure of what hospitals spend on software. ## What the projection counts as growth Healthcare ERP is the software that hospitals and clinics use to run billing, supply chains and patient records on one system, Precedence Research reported. The firm said the growth would come from demand for digital tools, from automating office work, and from adding artificial intelligence to how data is sorted and read. It also named the need to move data between hospital departments, the release said, along with more chronic illness and the extra admissions that brings. Each of those is a supply-side gain rather than a count of patients. None of them measures demand for medical tourism, and the release did not say it did. ## The segments the firm ranks Precedence Research ranked the market in several ways. The finance and billing segment held the largest share in 2025, which the firm tied to handling patient payments, insurance claims and financial rules. Inventory came next, driven by the volume of medical supplies a hospital has to track, and within hospitals the firm expects material management to grow fastest. On-premises systems led in 2025, the release said, because hospitals wanted their own control of patient data and a closer fit with local rules. Cloud systems should grow faster over the period on lower upfront cost and easier access. Hospitals were the biggest buyers in 2025. ## Where the firm expects the money North America led the market in 2025, which Precedence Research put down to early use of digital tools, heavy health spending, strong hospital infrastructure and government efforts to go paperless. Asia Pacific should grow fastest over the period, the firm said. The firm pointed to rising government spending, ageing populations, bigger patient numbers, more private hospitals and staff shortages that push providers toward one shared system. The release named one recent move, Zoho Corporation’s entry into the ERP market on 23 January 2026 with an AI-driven platform that carries predictive analytics and built-in banking. Zoho’s launch was cast as a sign of the wider turn toward AI-assisted systems. ## A projection, not a measurement A ten-year software forecast like this is an announcement, not a measurement, and it sits in the same file as the other headline numbers that circulate in medical tourism. Health Tourism News traced one of them, a forecast putting Singapore’s medical tourism market at USD 15.4 billion by 2035, back to its publisher and found it harder to stand up than its wide use suggested. The healthcare ERP forecast rests on the same kind of modelling. What it is worth to a hospital lies less in the headline total than in whether the software shortens a patient’s billing and scheduling. The patient-facing side of the same technology is easier to see. Health Tourism News reported that CureMeAbroad raised 600,000 US dollars in pre-seed funding to build an AI cost estimator and match patients to hospitals across borders. That is a dated deal, not a projection to 2035, and it shows where money is really moving in the software medical tourism runs on. ## What operators can check The test, for an operator, is narrow and near. It will show in whether cloud take-up across Asia Pacific turns into shorter admission and billing times at the hospitals that treat foreign patients, and in whether the finance and billing systems the firm ranks first cut the payment delays that stall cross-border care. A projection to 2035 settles none of that. A year of hospital results, and the first customer numbers for platforms like Zoho’s, will say more than the forecast does. Sources (3) Precedence Research Market Research Future Entrackr Healthcare ERPHealth TechnologyArtificial IntelligenceNorth AmericaAsia PacificMarket Research ### The Wire Aug 30This Week in Medical Tourism: 20–26 August 2026 Aug 29This Week in Medical Tourism: 13–19 August 2026 Aug 22South Korea Undercuts America but Not Turkey All coverage ### Newsletter Get weekly health tourism intelligence in your inbox. Subscribe ### Knowledge Hub Medical Tourism Wellness Tourism Dental Tourism Fertility Tourism Cosmetic Tourism Longevity Tourism Explore the Hub Stay informed on the latest in global health tourism. Subscribe to our Newsletter ## Related Articles Weekly Digest 30 AUG 2026 Weekly Digest ### This Week in Medical Tourism: 20–26 August 2026 August 30, 2026 Weekly Digest 29 AUG 2026 Weekly Digest ### This Week in Medical Tourism: 13–19 August 2026 August 29, 2026 Weekly Digest 14 AUG 2026 Weekly Digest ### This Week in Medical Tourism: 6–12 August 2026 August 14, 2026 --- # India Medical Tourism Market Size: The 13 Billion Dollar Question URL: https://health-tourism-news.com/news/india-s-medical-tourism-sector-poised-for-13-billion-surge-by-2026-a-deep-dive-into-growth-drivers/ Medical Tourism March 3, 2026 Medical Tourism India Medical Tourism Market Size: The 13 Billion Dollar Question Everyone quotes 13 billion dollars for India's 2026 medical tourism market. The figure is a four-year-old projection, and the government's own arrivals data spent 2025 moving the other way. Christian El-Khouri Editor-in-Chief Published March 3, 2026 · Updated July 4, 2026 · 6 min read Ask how big India’s medical tourism market will be in 2026 and nearly every answer lands on the same figure: 13 billion US dollars. It sits on FICCI’s sector page, it anchors ministerial speeches, and it headlines most press coverage of the industry. The figure deserves closer inspection than it usually gets, because it is not a measurement. It is a projection, roughly four years old, and the Indian government’s own arrivals data spent 2025 moving in the opposite direction. ## Where the 13 billion dollar figure comes from The most quotable source is the Federation of Indian Chambers of Commerce and Industry. FICCI’s medical value travel page states that the Indian market, estimated at around 6 billion dollars in 2022, is projected to grow to 13 billion dollars by 2026, on a compound growth rate of 21.1 percent between 2020 and 2027. The Ministry of Tourism’s National Strategy and Roadmap for Medical and Wellness Tourism, published in 2022, carried the same trajectory. Union Tourism Minister Gajendra Singh Shekhawat repeated it this February at the 6th FICCI Medical Value Travel Awards, held during Advantage Healthcare India in Greater Noida, telling delegates the sector would cross 13 billion dollars this year. A Grant Thornton report covered by The Tribune in March 2025 put the number slightly higher, at 13.42 billion dollars, and the wire services carried it without much interrogation. What none of these citations contain is a method. The projection dates from the post-pandemic recovery years, when arrivals were rebounding fast off a collapsed base, and it has been restated ever since without adjustment. More telling is what the Ministry of Tourism said in a written Lok Sabha reply on 9 February 2026: that it has not conducted any study of the sector’s current status, key challenges or growth potential, and that it does not maintain state-wise data on arrivals or on the revenue medical tourism earns. The ministry promoting the 13 billion dollar target told Parliament, in the same month its minister restated that target, that it holds no revenue data to check it against. That is the first honest thing to say about India’s medical tourism market size: nobody in government is measuring it. ## What the arrivals data shows The one official series that exists is the Bureau of Immigration’s count of foreign tourist arrivals for medical purposes, published through the Press Information Bureau. It runs: 697,453 in 2019, 182,945 in 2020, 323,748 in 2021, 474,798 in 2022, 659,356 in 2023 and 644,387 in 2024. The provisional figure for January to November 2025 is 450,633, about 5.7 percent of all foreign arrivals in the period. Even with a strong December, 2025 will close somewhere near half a million, more than a fifth below 2024 and getting on for 30 percent below the 2019 peak. India’s medical arrivals never fully recovered their pre-pandemic level; they came close in 2023 and have fallen since. Set those counts against the revenue claims and the arithmetic turns uncomfortable. Take FICCI’s own pairing: 6 billion dollars earned from 474,798 arrivals in 2022 implies about 12,600 dollars per arriving patient. Reaching 13 billion dollars in 2026 on anything like current volumes would require roughly 26,000 dollars per arrival, a doubling of per-patient billing in four years. For scale, Apollo Hospitals’ results material puts its average revenue per inpatient, across all payers, near 171,000 rupees, about 2,000 dollars. International patients buy costlier procedures and longer stays, and the immigration count misses people who travel on ordinary tourist visas, so the real market is larger than crude multiplication suggests. But a market that doubles in dollar terms while its patient count falls by a fifth is a market someone should be able to document. Nobody has. ## Bangladesh is the fault line The arrivals table hides a concentration problem. In 2024, 482,336 of India’s 644,387 medical arrivals came from Bangladesh, three out of every four. The next largest source, Iraq, sent 32,008. When the Hasina government fell in August 2024 and India tightened visa issuance in Dhaka, the sector’s largest corridor narrowed, and the 2025 decline followed almost mechanically. Apollo Hospitals, the country’s largest listed hospital chain, shows what that looks like on an income statement. Its fourth-quarter FY25 investor material quantified the drag from fewer Bangladeshi patients at 1.2 percent of inpatient volumes, with international patient services the smallest of its four payer categories, a mid-single-digit share of inpatient revenue. Financial press coverage through the year described the group rebuilding that book with patients from Africa, West Asia and South East Asia. Two readings of Apollo’s numbers are available, and I think both are correct. The reassuring one: even for India’s most internationally visible hospital group, foreign patients are a single-digit slice of revenue, so the Bangladesh shock dents growth rather than solvency. The awkward one: if international work is a mid-single-digit business at the listed flagship of Indian private medicine, a sector-wide claim of 13 billion dollars implies a great deal of revenue that no listed operator can show on its books. ## Heal in India and the supply-side wager The government’s response runs through the Heal in India umbrella. The Ministry of Health and Family Welfare is building capacity for it through public-private partnerships, and the e-medical visa and e-medical attendant visa now extend to nationals of 171 countries. The Services Export Promotion Council runs an accredited-provider portal that the tourism ministry links from its own sites. The biggest commitment came in the Union Budget for 2026-27, presented on 1 February, when Finance Minister Nirmala Sitharaman announced a scheme to support states in establishing five Regional Medical Hubs with the private sector, integrated complexes combining treatment, teaching and research with AYUSH centres and medical value travel facilitation desks. Everything on that list adds supply. Almost nothing on it addresses why demand fell. India’s 2025 problem was not a shortage of beds or accredited hospitals; it was a visa regime that closed the biggest patient corridor for political reasons, and a source-market mix so lopsided that one border decision erased a fifth of national volume. Five new medical hubs will not fill themselves while that remains true. If I were allocating the budget line, I would spend it on the dull plumbing instead: visa processing in second-tier source markets, bilateral patient-referral agreements, and a published revenue series so the sector can be steered by data rather than by slogan. ## What This Means The 13 billion dollar figure is a target, not a tally. It originated as a projection around 2022, survives on repetition by FICCI, ministers and consultants, and is checked by no official revenue series, because none exists. The measurable record points the other way: arrivals peaked in 2019, slipped in 2024 and fell hard in 2025 after the Bangladesh corridor narrowed. My own reading is that the true 2026 market lands well short of 13 billion dollars, and the burden of proof sits with anyone claiming otherwise. Rather than the headline number, watch whether Dhaka-Delhi visa traffic normalises and whether the Ministry of Tourism starts publishing revenue data. The day it does, India’s medical tourism market will finally have a size instead of a slogan. Sources (7) Pib (Arrivals Data) Pib (Source Countries) Pib (Union Budget) Ficci Asianhospitality Tribuneindia Apollohospitals IndiaBangladeshFICCIApollo HospitalsHeal in India ### The Wire Aug 30This Week in Medical Tourism: 20–26 August 2026 Aug 29This Week in Medical Tourism: 13–19 August 2026 Aug 22South Korea Undercuts America but Not Turkey All coverage ### Newsletter Get weekly health tourism intelligence in your inbox. Subscribe ### Knowledge Hub Medical Tourism Wellness Tourism Dental Tourism Fertility Tourism Cosmetic Tourism Longevity Tourism Explore the Hub Stay informed on the latest in global health tourism. Subscribe to our Newsletter ## Related Articles Medical Tourism 22 AUG 2026 Medical Tourism ### Mexico and Turkey Price Against Different Home Markets August 22, 2026 Medical Tourism 22 AUG 2026 Medical Tourism ### Turkey's Deepest Discounts Sit on Its Safest Procedures August 22, 2026 Medical Tourism ### Why Medical Tourism to Germany Declined August 11, 2026 --- # Iran Crisis Cuts Gulf Medical Travel to Asia URL: https://health-tourism-news.com/news/iran-crisis-halts-gulf-patient-flows-to-asia-india-hospitals-see-50-75-drop/ Medical Tourism May 21, 2026 Medical Tourism Iran Crisis Cuts Gulf Medical Travel to Asia A conflict in West Asia has closed air corridors and cut Gulf medical tourism to Asia, with India reporting the steepest fall in patient arrivals. Christian El-Khouri Editor-in-Chief Published May 21, 2026 · Updated July 9, 2026 · 5 min read A sharp escalation of the conflict in West Asia has cut into cross-border medical travel across more than thirty countries, Nomad Lawyer reported. Closed airspace and rerouted flights over the region have reduced patient arrivals in South Korea, Japan, India and Thailand, the report said, as Gulf patients postpone planned procedures rather than travel through disrupted corridors. Bookings for oncology, cardiac, orthopaedic and paediatric care have slipped alongside the cosmetic surgery and fertility work that first built these corridors. ## India reports the steepest fall The fall was steepest in India. Hospitals in Delhi, Mumbai, Bangalore and Hyderabad reported drops of 50 to 75 per cent in patients from West Asia, Nomad Lawyer reported, with oncology, cardiac and orthopaedic bookings the most affected. Nomad Lawyer is a general-interest publication rather than a medical-travel data source, and the 50 to 75 per cent figure should be read as indicative rather than audited. Slower arrivals reached South Korea, where clinics in Seoul and Busan handle cosmetic surgery and fertility treatment for Gulf patients, and Japan, where oncology and regenerative medicine centres in Tokyo, Osaka and Fukuoka logged postponements. In Thailand the recovery resorts of Bangkok and Phuket recorded the same postponements, and in China the diagnostics and fertility centres of Beijing, Shanghai and Guangzhou began steering their outreach toward Southeast Asia. India’s own hospitals put similar numbers on the fall. The New Indian Express reported medical tourism arrivals down 30 to 40 per cent across the country’s principal medical hubs. Those hubs run from the National Capital Region to Maharashtra, Tamil Nadu, Karnataka and Telangana, and at some hospital chains overseas inflow dropped 50 to 75 per cent over a single fortnight, the paper said. The same contraction was reported across India’s medical hubs as the conflict widened, and the two accounts agree on the direction and the scale. ## Gulf source markets slow The Gulf source markets carried much of the fall. Outbound medical travel from Oman, Saudi Arabia, the United Arab Emirates and Qatar slowed as families delayed surgery, fertility treatment and paediatric care, the report said. Volatility around the Strait of Hormuz and rising conflict-risk premiums on travel insurance made the journeys expensive and uncertain. Iran itself turned inward, its hospitals absorbed by conflict-related care while foreign bookings froze, and patients in Iraq and Yemen who depend on hospitals in India and Turkey lost their route out. Some diverted demand moved toward Turkey, though the report described that flow as unstable. The disruption widened beyond the operating theatre. Airspace closures and rerouted flights lengthened and raised the price of long-haul journeys for patients with urgent needs, Nomad Lawyer reported, and travel insurers added conflict-risk premiums to policies covering the affected corridors. The secondary trade that medical tourism carries with it, the recovery hotels, the interpreters, the private transfers and the rehabilitation services, saw the same fall in occupancy as the clinics they serve. ## The fourth risk of medical travel There is a settled way to read a quarter like this. Medical tourism carries four standing risks, and most coverage names only the first three: the clinical risk that the treatment goes wrong, the legal risk that redress is hard to win abroad, and the continuity risk that follow-up care falls to a home system that never saw the operation. The fourth is the one on display now. It is the logistical risk that the corridor itself closes, and the patient never reaches the accredited clinic at all, whether the booking is orthopaedic, oncological or paediatric. A cardiac programme in Delhi can be excellent and still lose 50 to 75 per cent of its Gulf patients to an airspace map over the Strait of Hormuz that it does not control. That fourth risk is really a concentration problem. The destinations most exposed this quarter are the ones that built their medical tourism arrivals on a single source market, and across Asia that source market has been the Gulf. When one region supplies a large share of the high-paying patients, its politics become the destination’s politics. The pressure reaches the demand side as well as the supply side: Thailand’s tourism ministry expects up to three million fewer foreign visitors in 2026, blaming the Middle East conflict and the cost of fuel, a shortfall its operators are answering by pivoting toward luxury and regional markets. Nomad Lawyer reported the standard remedies, that hospitals diversify their source markets toward Southeast Asia, Africa and Central Asia and lean on telemedicine for the parts of care that do not need a flight. Telemedicine covers the consultation and the follow-up, but telemedicine does not fly a patient to a cardiac theatre, and a source market is not built in a quarter. ## What operators should watch The test is measurable and close. Destinations that widened their source markets before this quarter will show it in their next arrival figures, and destinations that leaned on the Gulf will show the gap. For operators the specific move is dull and correct: hold the deposits, keep the scheduling flexible, and count how much of the book depends on a single corridor before the next corridor closes. A hospital that cannot answer that last question does not yet know how exposed it is to the fourth risk. Sources (3) Nomad Lawyer The New Indian Express ScandAsia IranIndiaSaudi ArabiaSouth KoreaThailandMiddle East ### The Wire Aug 30This Week in Medical Tourism: 20–26 August 2026 Aug 29This Week in Medical Tourism: 13–19 August 2026 Aug 22South Korea Undercuts America but Not Turkey All coverage ### Newsletter Get weekly health tourism intelligence in your inbox. Subscribe ### Knowledge Hub Medical Tourism Wellness Tourism Dental Tourism Fertility Tourism Cosmetic Tourism Longevity Tourism Explore the Hub Stay informed on the latest in global health tourism. Subscribe to our Newsletter ## Related Articles Medical Tourism 22 AUG 2026 Medical Tourism ### Mexico and Turkey Price Against Different Home Markets August 22, 2026 Medical Tourism 22 AUG 2026 Medical Tourism ### Turkey's Deepest Discounts Sit on Its Safest Procedures August 22, 2026 Medical Tourism ### Why Medical Tourism to Germany Declined August 11, 2026 --- # Lebanon Conflict Puts Its Medical Tourism Hopes at Risk URL: https://health-tourism-news.com/news/lebanons-healthcare-under-siege-escalating-conflict-endangers-medical-tourism-aspirations/ Medical Tourism April 6, 2026 Medical Tourism Lebanon Conflict Puts Its Medical Tourism Hopes at Risk A strike near Lebanon's largest public hospital and a run of verified attacks on health facilities have left the country unable to promise foreign patients a safe route to care. Christian El-Khouri Editor-in-Chief Published April 6, 2026 · Updated July 9, 2026 · 4 min read An Israeli strike about 100 metres from Rafik Hariri University Hospital, Lebanon’s largest public medical facility, killed four people and injured 39, The Tribune India reported, and drew condemnation from the head of the World Health Organisation. The hospital was not hit, the report said, though the blast caused major damage to a nearby residential area. WHO Director-General Tedros Adhanom Ghebreyesus condemned the strike, which came as Israel widened its military operations inside Lebanon. ## WHO records repeated attacks on health facilities Tedros said the WHO had verified 11 attacks on Lebanese health facilities between 28 March and 31 March, The Tribune India reported, an average of about two a day, with five recorded on 28 March alone. Those attacks struck facilities in Kfar Tibnit, Ghandouriyeh, Zawtar Al Gharbiyeh, Kfar Dajal and Jazzine, the report said, and they killed nine people and injured five. A wider count was larger still. Since 28 February the WHO had verified 92 attacks on health facilities, medical vehicles, personnel and warehouses, Tedros said, attacks that together killed 53 people and injured 137. He wrote that governments should treat the protection of healthcare as an obligation rather than a choice, and that “healthcare is #NotATarget”. ## A security posture that promises to hold The military pressure behind those figures is not presenting itself as temporary. The Times of Israel reported that the Israeli military’s chief of staff, Lieutenant-General Eyal Zamir, told the mayor of Nahariya, a city on the northern border, that Israeli forces would remain in southern Lebanon until the threat from Hezbollah was removed. “We hold the area and will not leave it,” Zamir said, describing that aim as the top of his priority list. Israeli forces holding ground in the south, and the WHO logging attacks on hospitals through the same weeks, together describe a country that a foreign patient cannot plan a treatment around. ## Why the figures matter beyond the war Medical tourism runs on a promise that a country under fire cannot make: that an international patient can reach an accredited hospital, be treated and travel home on a schedule. A West Asia conflict has already cut Gulf medical travel to Asia, with Indian hospitals reporting falls of 50 to 75 per cent in patients from the region. The same instability has reshaped medical tourism across the Middle East. Lebanon sits inside that instability rather than beside it. That strike near Rafik Hariri University Hospital did not need to hit the building to make its point. A blast 100 metres away that kills four and wrecks nearby housing tells a prospective patient what proximity to the fighting means. A hospital in Beirut can hold accreditation and skilled staff and still count for little to a foreign patient while the WHO is verifying attacks on health facilities at a rate of about two a day in the same country. The point is a standing one about how destinations get chosen. Safety is not one feature among many that a medical tourism destination advertises; it is the precondition the rest of the pitch depends on. Cost, quality of care and specialty depth start to matter only once a patient believes the journey is survivable and the schedule will hold. The 92 verified attacks on health facilities since 28 February settle that prior question before price or specialty is reached. Beirut’s hospitals face that arithmetic now. Damage to a destination’s name is slow to undo, too. Confidence in a healthcare destination falls in the weeks of a bombing campaign and returns over years. It comes back well after any ceasefire, because the record of attacks on hospitals outlasts the fighting that produced it. ## What to watch The measurable test is whether the WHO’s verified attack count in Lebanon stops climbing. Tedros put the running tally at 92 since 28 February and 11 in the last four days of March, and a fall in that daily rate, held across a full quarter, is the first sign that Lebanese hospitals can schedule foreign patients again. For operators the reading stays simple for now, and the daily count keeps rising. Until that happens, any pitch for Lebanon as a medical tourism or wellness tourism destination describes a future the current attack figures do not support, and the number to check is the WHO’s count of verified attacks, not the brochure. Sources (2) The Tribune India The Times of Israel LebanonIsraelWHOMiddle EastMedical Tourism ### The Wire Aug 30This Week in Medical Tourism: 20–26 August 2026 Aug 29This Week in Medical Tourism: 13–19 August 2026 Aug 22South Korea Undercuts America but Not Turkey All coverage ### Newsletter Get weekly health tourism intelligence in your inbox. Subscribe ### Knowledge Hub Medical Tourism Wellness Tourism Dental Tourism Fertility Tourism Cosmetic Tourism Longevity Tourism Explore the Hub Stay informed on the latest in global health tourism. Subscribe to our Newsletter ## Related Articles Medical Tourism 22 AUG 2026 Medical Tourism ### Mexico and Turkey Price Against Different Home Markets August 22, 2026 Medical Tourism 22 AUG 2026 Medical Tourism ### Turkey's Deepest Discounts Sit on Its Safest Procedures August 22, 2026 Medical Tourism ### Why Medical Tourism to Germany Declined August 11, 2026 --- # Longevity Tourism Reshapes Global Healthcare URL: https://health-tourism-news.com/news/longevity-tourism-reshapes-global-healthcare/ Wellness Tourism Longevity Tourism Reshapes Global Healthcare Elite travelers seek advanced anti-aging in emerging cross-border health markets. Christian El-Khouri Editor-in-Chief Editor-in-Chief of Health Tourism News. Twelve-plus years across international patient services, healthcare consulting, and destination development in Europe, the Middle East, and beyond. Co-Founder and Vice President of the European Health and Medical Tourism Association (EHMTA). Read more Published April 8, 2026 · Updated September 1, 2026 · 13 min read The global pursuit of extended “healthspan” - the duration of life lived in optimal health - rather than merely lifespan, is rapidly redefining the landscape of medical and wellness tourism. This strategic shift has catalyzed the emergence of longevity tourism, a high-growth segment where discerning individuals travel internationally for advanced anti-aging and regenerative therapies. The market for longevity retreats is projected to reach an estimated $11.08 billion in 2026, demonstrating a robust compound annual growth rate (CAGR) of 12.9% from 2025, according to recent industry analyses. This expansion indicates a profound reorientation of consumer priorities towards proactive health management and personalized vitality. The demand for a specialized longevity clinic abroad is a key driver in this evolving sector, attracting significant investment and innovation. This article provides an analytical framework for understanding longevity tourism, examining its market dynamics, strategic geographical advantages, technological drivers, and the operational models of leading providers. We assess the convergence of luxury hospitality with advanced medical science, focusing on integrated programs that span preventive health, regenerative medicine, and holistic well-being. Our analysis highlights the critical role of Blue Zones and integrated medicine clinics in shaping this emerging cross-border healthcare segment, offering insights for industry stakeholders navigating this transformative period. ## What Macroeconomic Forces Are Driving the Longevity Tourism Market Expansion? The growth trajectory of longevity tourism is fundamentally influenced by several interlocking macroeconomic and demographic factors. A primary driver is the increasing global wealth coupled with an aging demographic in developed economies, where individuals possess the financial capacity and desire to invest in their long-term health. The global Longevity Clinic Tourism market, a more specific subset, was valued at USD 17.8 billion in 2024 and is forecast to reach USD 48.2 billion by 2033, growing at a robust CAGR of 14.2% from 2025. This indicates a significant upward trend that transcends traditional wellness offerings. ### How is the Shift from Lifespan to Healthspan Influencing Consumer Demand? The conceptual pivot from merely extending life to enhancing “healthspan” - the quality and vitality of those extended years - is a critical demand-side catalyst. Consumers are no longer satisfied with reactive medicine; they seek proactive, aspirational interventions aimed at optimizing physical and cognitive function, regardless of age. This drives demand for sophisticated diagnostics, personalized prevention strategies, and regenerative therapies. The Global Wellness Institute, which measures this field, put wellness tourism expenditure at $894 billion in 2024. It draws a firm line between wellness tourism and medical tourism, describing them as operating largely in separate domains and meeting different consumer needs, which is worth holding on to here: longevity travel sits awkwardly across that line rather than neatly inside either side of it. ### What Role Do Affluence and Discretionary Spending Play in Market Development? The clientele for a premium longevity clinic abroad typically represents high-net-worth individuals who view health as an investable asset. Melanie Brandman, founder and CEO of Brandman Agency, noted that for the “uber, uber wealthy,” longevity centers are becoming a new form of private club membership, signifying a move beyond conventional luxury. This demographic possesses significant discretionary income, enabling them to access cutting-edge, often expensive, treatments and immersive wellness experiences not readily available through standard healthcare channels. The availability of advanced diagnostics and bespoke programs, often requiring travel, positions longevity tourism as a distinct segment within global healthcare, catering to an exclusive demand curve. ## Why Are Blue Zones and Integrated Medicine Clinics Becoming Strategic Hubs for Longevity Tourism? The strategic clustering of longevity tourism offerings, particularly within or inspired by “Blue Zones,” represents a deliberate market positioning. These regions, renowned for their inhabitants’ exceptional longevity and vitality, provide a powerful narrative and an evidence-based framework for health optimization. The editorial guidance indicates a notable expansion into longevity treatments anticipated for 2026, especially among properties located in these Blue Zones. ### How Do Blue Zone Principles Translate into Health Retreat Programs? Blue Zones - such as Okinawa, Japan; Sardinia, Italy; Nicoya, Costa Rica; Icaria, Greece; and Loma Linda, California - are characterized by common lifestyle denominators, including natural movement, a strong sense of purpose, effective stress reduction, plant-based diets, and robust social connections. Wellness resorts are increasingly integrating these “Power 9” principles into their programs, offering guests immersive experiences that blend local culture, diet, and habits with modern scientific interventions. For example, Halekulani Okinawa will host a Blue Zones retreat in October 2026, featuring plant-based cooking classes and meditation. Similarly, the Andaz Costa Rica Resort at Peninsula Papagayo plans its second Blue Zones retreat in February 2025, unveiling longevity secrets. These programs offer more than a vacation; they provide a structured pathway to adopt sustainable, longevity-enhancing behaviors, differentiating them from generic wellness offerings. ### What Constitutes an Integrated Medicine Clinic in a Longevity Context? Integrated medicine clinics within longevity tourism represent a convergence of conventional Western medicine with complementary and alternative therapies, all orchestrated under a personalized, preventive umbrella. These facilities move beyond single-modality treatments, offering comprehensive programs covering nutrition, coaching, and rehabilitation. They often feature: Advanced Diagnostics: Utilizing AI-powered tools, DNA sequencing, blood biomarker analysis, full-body MRIs, and DEXA scans to create highly personalized health profiles. Personalized Nutrition: Data-driven, often plant-forward menus tailored to individual metabolic and genetic needs. Biohacking Suites: Incorporating cryotherapy, hyperbaric oxygen therapy (HBOT), infrared saunas, and red-light therapy to optimize cellular health and cognitive function. Regenerative Therapies: Including stem cell therapy, PRP treatments, EBO₂ to boost blood oxygen, exosome treatments for tissue regeneration, and peptide therapy. Mental and Emotional Well-being: Programs focused on nervous system regulation, stress management through breathwork, somatic practices, and neuromodulation technologies. This integrated approach ensures a holistic focus on physical, mental, and emotional health, critical for sustained healthspan extension. Properties like Clinique La Prairie and Lanserhof exemplify this model, merging luxury hospitality with deep medical expertise to deliver tangible results. ## Who Are the Key Players and What Emerging Business Models Are Shaping Longevity Tourism? The competitive landscape of longevity tourism is characterized by established luxury wellness brands, innovative new entrants, and strategic partnerships, all vying to capture a growing, affluent clientele. These players are adopting diverse business models, from exclusive retreats to expansive residential projects, reflecting the segment’s rapid evolution. ### Which Established Brands Lead the Longevity Market, and How Are They Innovating? Established players such as Clinique La Prairie (Switzerland), Lanserhof (Austria and Germany), and SHA Wellness Clinic (Spain and Mexico) have long been pioneers in advanced wellness and preventive medicine. Clinique La Prairie, founded in 1931, is a historical leader, known for its cellular regeneration therapies and Longevity Master Assessment programs. The company has ambitious plans to open approximately 50 spa-clinic destinations worldwide, signifying a global expansion strategy. Lanserhof, renowned for metabolic optimization, is set to open a fourth property in Marbella, Spain, by 2026, expanding its European footprint. SHA Wellness Clinic, with its integrative East-West approach, has successfully expanded to Mexico, bringing its European model to new markets. These brands are continually innovating, integrating new scientific discoveries and technologies to maintain their leadership in a competitive market. ### What New Entrants and Partnerships Are Disrupting the Sector? The market is also seeing significant disruption from new entrants and strategic alliances. The Estate, a new hotel brand, plans to launch its first four longevity-focused hotels in St. Kitts, the U.K., northern Italy, and Montreux, Switzerland, by 2026. Their ultimate goal is to create the “world’s biggest network of longevity-focused resorts and residential projects.” These properties will partner with preventative diagnostics brands like Fountain Life, offering advanced diagnostic tools. This model, integrating hospitality with medical diagnostics, exemplifies the convergence trend. Other notable developments include Six Senses RoseBar in Ibiza, venturing into medical wellness, and Canyon Ranch’s “Longevity8” program, a four-day intensive diagnostic and consultation package. These new models often emphasize personalized health optimization programs supported by cutting-edge technology and data analytics, reflecting a strategic response to evolving consumer expectations. ## How Are Technology and Regenerative Medicine Reshaping Longevity Clinic Offerings? Technology is a foundational pillar of modern longevity tourism, enabling personalized, data-driven interventions that were previously unattainable. The integration of advanced diagnostics, AI, and regenerative medicine is transforming the efficacy and appeal of a longevity clinic abroad, moving beyond generalized wellness to precision health. ### What Advanced Diagnostic Tools Are Being Utilized for Personalized Longevity Plans? Modern longevity clinics leverage a suite of sophisticated diagnostic tools to create a granular understanding of an individual’s health status. This includes: AI-Powered Diagnostics: These tools complement clinicians’ expertise in interpreting biomarkers and lab results, enhancing early detection capabilities and providing real-time, personalized guidance for nutrition, fitness, and sleep. The healthcare predictive analytics market is booming, with major players like IBM and Cerner Corporation advancing capabilities (openPR.com). Similarly, healthcare data monetization is a growing field, with companies like Oracle and Epic Systems developing solutions (openPR.com). Genomic Sequencing: DNA analysis to identify predispositions to certain conditions and tailor interventions accordingly. Blood Biomarker Analysis: Comprehensive panels assessing inflammation, metabolic health, hormone levels, and cellular aging markers. Advanced Imaging: Full-body MRIs and DEXA scans for detailed assessments of organ health, body composition, and bone density. Wearable Technology: Continuous monitoring of vital signs, sleep patterns, and activity levels to inform real-time adjustments to personalized plans. These technologies enable a proactive, rather than reactive, approach to health, allowing for early detection and intervention to mitigate age-related decline. Abu Dhabi, for instance, is advancing towards a proactive and precision healthcare model, shifting from reacting to disease to anticipating it, and from standardized treatment to personalized care (Economy Middle East). ### What Regenerative Medicine Therapies Are Integrated into Longevity Programs? Regenerative medicine is at the forefront of longevity treatments, offering innovative solutions for tissue repair, cellular revitalization, and functional optimization. These therapies are redefining medical tourism, attracting patients seeking advanced interventions for age-related conditions. Key regenerative therapies include: Stem Cell Therapy: Utilized for various applications, including joint repair, anti-inflammatory effects, and general cellular rejuvenation. Platelet-Rich Plasma (PRP) Treatments: Concentrated platelets from the patient’s own blood are used to stimulate healing and regeneration in tissues and joints. Exosome Treatments: Involving extracellular vesicles that facilitate cell-to-cell communication, promoting tissue repair and reducing inflammation. Peptide Therapy: Administering specific amino acid chains to stimulate various physiological functions, such as hormone balance, muscle growth, and immune modulation. EBO₂ Therapy: Extracorporeal Blood Oxygenation and Ozonation, a procedure designed to boost blood oxygen levels and improve circulation, often used for detoxification and anti-aging. These treatments, often combined with lifestyle interventions, aim to reverse or slow down the biological processes of aging, significantly enhancing healthspan. The convergence of these advanced medical techniques with luxurious, integrated wellness settings creates a compelling value proposition for longevity tourism. ## What Challenges and Future Opportunities Define the Longevity Tourism Landscape? While the growth trajectory for longevity tourism is steep, the segment faces challenges related to regulation, ethical considerations, and market differentiation. Understanding these factors is crucial for strategic planning and sustainable growth. ### What Regulatory and Ethical Considerations Impact the Longevity Sector? The rapid advancement of regenerative medicine and anti-aging therapies often outpaces regulatory frameworks. This creates a complex environment for a longevity clinic abroad, where varying national regulations regarding experimental treatments, stem cell therapies, and genetic interventions can influence patient flow. Ensuring patient safety, efficacy of treatments, and ethical practice is paramount. Industry observers suggest that robust accreditation standards and transparent communication about treatment outcomes will be critical for building trust and ensuring the long-term viability of the sector. The C3 Davos of Healthcare™ Silicon Valley Summit, convening global leaders, underscores the importance of strategic dialogue on the intersection of medical innovation and economic competitiveness, implicitly addressing these complex issues (PR Newswire). ### What Future Market Insights and Growth Areas Are Expected by 2026 and Beyond? Looking towards 2026 and beyond, several key trends are anticipated to shape the longevity tourism market: Increased Specialization and Niche Offerings: Clinics will likely develop even more specialized programs targeting specific aspects of aging, such as cognitive longevity, metabolic health, or musculoskeletal regeneration. Digital Health Integration: AI tools will become more sophisticated in personalizing care, offering real-time guidance, and facilitating remote monitoring and follow-up, reducing the need for extended stays abroad. Telemedicine is already playing a larger role in pre- and post-operative care. Residential Longevity Communities: The Estate’s model of combining resorts with residential projects indicates a trend towards integrating longevity services into daily living, moving beyond short-term retreats. This aligns with broader trends in high-end real estate and wellness living. Accessibility through Technology: While currently catering to the ultra-wealthy, advancements in technology and economies of scale may eventually make some longevity interventions more accessible, expanding the market base. This is consistent with the general push for global healthcare improvements, as evidenced by initiatives like the IAEA supporting global health through nuclear science (International Atomic Energy Agency). Focus on Mental Acuity: With nervous system regulation becoming a central focus, therapies supporting autonomic stability, such as breathwork and neuromodulation, will gain prominence, recognizing chronic stress’s impact on aging. These developments suggest a future where longevity tourism is not merely a luxury but a sophisticated, data-driven approach to maximizing human potential, deeply integrated into global healthcare ecosystems. ## Key Takeaways for Industry Stakeholders Strategic Market Positioning: Longevity tourism is a high-growth segment driven by affluent consumers seeking healthspan optimization. Operators must position their offerings as an investment in long-term vitality, not merely luxury leisure. Integrated Care is Paramount: Success hinges on combining advanced medical diagnostics and regenerative therapies with holistic wellness programs encompassing nutrition, coaching, and rehabilitation. This creates a compelling and differentiated value proposition. Blue Zones Offer Strategic Advantage: Locations within or inspired by Blue Zones provide a powerful, evidence-based narrative and unique cultural immersion opportunities that resonate with the target demographic. Technological Imperative: Continuous investment in AI-powered diagnostics, personalized medicine, and cutting-edge regenerative therapies is essential for competitive differentiation and delivering measurable outcomes. Navigating Regulatory Complexities: Proactive engagement with regulatory bodies and a commitment to ethical practices and transparent reporting will be crucial for building trust and ensuring sustainable growth in this rapidly evolving cross-border healthcare sector. ## Conclusion The emergence of longevity tourism signifies a pivotal transformation in global healthcare, moving beyond traditional sick care towards an aspirational model of proactive health optimization. The strategic convergence of luxury hospitality, advanced medical science, and culturally rich Blue Zone philosophies positions this segment for sustained, exponential growth. As we approach 2026, the market is poised for significant expansion, driven by technological innovations in regenerative medicine and AI, alongside an enduring consumer desire for a longer, healthier, and more fulfilling life. For industry leaders, the imperative is clear: invest in integrated, data-driven, and ethically sound longevity solutions to capture this burgeoning market. By aligning incentives with client outcomes and building capabilities that empower individuals, as Bain Company advocates for business leaders, the longevity tourism sector can deliver true results, enhancing not only individual healthspans but also the value proposition of global medical travel as a whole.” } Sources (3) Research and Markets, Longevity Retreats Market Report 2026 Growth Market Reports, Longevity Clinic Tourism Market Global Wellness Institute ### The Wire Aug 30This Week in Medical Tourism: 20–26 August 2026 Aug 29This Week in Medical Tourism: 13–19 August 2026 Aug 22South Korea Undercuts America but Not Turkey All coverage ### Newsletter Get weekly health tourism intelligence in your inbox. Subscribe ### Knowledge Hub Medical Tourism Wellness Tourism Dental Tourism Fertility Tourism Cosmetic Tourism Longevity Tourism Explore the Hub Stay informed on the latest in global health tourism. Subscribe to our Newsletter ## Related Articles Weekly Digest 08 JUL 2026 Weekly Digest ### Medical Tourism Records Concentrate In Penang And Seoul July 8, 2026 Weekly Digest 01 JUL 2026 Weekly Digest ### Nigeria, Iran And Seoul Redraw Medical Tourism July 1, 2026 Weekly Digest 24 JUN 2026 Weekly Digest ### Health Tourism As Badge, Escape Hatch And Disguise June 24, 2026 --- # Medical Tourism and Family Offices URL: https://health-tourism-news.com/news/medical-tourism-and-family-offices-a-new-wave-in-international-healthcare/ Medical Tourism Medical Tourism and Family Offices Private wealth management firms serving ultra-high-net-worth families are becoming an important force in international healthcare and medical travel. Christian El-Khouri Editor-in-Chief Editor-in-Chief of Health Tourism News. Twelve-plus years across international patient services, healthcare consulting, and destination development in Europe, the Middle East, and beyond. Co-Founder and Vice President of the European Health and Medical Tourism Association (EHMTA). Read more Published February 24, 2025 · Updated July 2, 2026 · 5 min read Over the past few years, the intersection of healthcare, travel, and wealth management has spawned the development of medical tourism. Within this fast-growing sector, family offices - private wealth management firms serving ultra-high-net-worth families - are becoming an important force. ## What is Medical Tourism? Medical tourism is the process of crossing borders to receive medical treatment, typically in other nations that offer quality care at a lower cost than one’s native country. Drivers of the international medical tourism industry include rising healthcare costs in developed nations, the ease of specialized care elsewhere, and the ability to receive treatment while still on vacation. Some popular countries include Thailand, South Korea, Mexico, and India. As the industry grows, the reasons people go for medical tourism are increasingly diverse. While cost savings continue to be a primary driver, many patients are also attracted to those places that have highly qualified specialists, state-of-the-art equipment, and greater quality of care. These latter considerations are more applicable to the concerns of the family office. ## The Role of Family Offices in Medical Tourism Family offices have traditionally focused on investments, estate planning, and legacy management. With medical tourism becoming more popular, however, family offices are now also involved in counseling their clients on healthcare options, including receiving medical treatment abroad. Family offices are not only responsible for managing financial portfolios but also for enhancing the overall well-being of their clients in this context. Family offices should be able to get through the web of medical tourism by having direct service such as: ### Research and Recommendations Family offices provide personalized advice that is specially tailored to meet the unique needs of their clients. This could mean exploring the world’s top medical centers, locating trustworthy doctors or specialists, and evaluating the standards of care at various medical tourism hubs. Family offices leverage their connections to bring their clients the best treatment options available, typically in coordination with concierge healthcare services to facilitate it. ### Synchronizing Travel and Logistics Medical tourism is not just about the receiving of healthcare - it’s the entire experience. For high-net-worth individuals, receiving medical care abroad is usually paired with luxury accommodations, travel arrangements, private transportation, and personalized care during recovery. Family offices become an important aspect in arranging these logistics so that clients can experience hassle-free transitions in their medical experience. This may include reserving personal assistants, translators, or private nurses to ensure a comfortable and stress-free experience. ### Financial Management Family offices are ideally suited to take care of the finances of medical tourism. Being experienced in financial planning, family offices can take care of the expense of medical treatment, travel, and stay. They can help clients decipher insurance policies, determine whether medical tourism is a good financial option, and even arrange payment plans or funds specifically for healthcare. ### Risk Management and Due Diligence When seeking medical treatment abroad, patients must consider aspects such as the level of care received, security of the healthcare delivery system, and qualifications of healthcare professionals. Family offices mitigate such risks by conducting an intensive due diligence on healthcare professionals to confirm that the institutions and doctors involved meet international standards. Moreover, family offices can also offer legal counsel to protect their clients’ interests in case they are traveling to countries with special regulations or medical procedures. ## Why Family Offices Are Getting Involved in Medical Tourism Globalization and Ease of Travel: As travel has gotten easier and the world has become smaller, more families are thinking about healthcare options beyond their native countries. Family offices are well-positioned to take advantage of this growing demand by facilitating travel arrangements and advising clients on the optimal global healthcare options. Client Well-being: High net worth individuals will desire the best for themselves and their loved ones, not just in the context of wealth generation but also health. By arranging access to the best medical treatment and making the medical tourism experience easier, family offices are improving the overall well-being of their clients, a core aspect of their service capability. Holistic** Lifestyle Management:** Since family offices aim to make whole-life wealth management a reality, health naturally finds its place in the grand design. With the rapidly growing phenomenon of medical tourism, family offices are taking healthcare management to their more holistic lifestyle packages. This entails establishing access to wellness treatments, mental health care, and preventive medical services. ## Challenges and Considerations While the marriage of family offices and medical tourism has numerous advantages, there are issues to be addressed. First, there are differences in medical standards and practices across cultures, which may affect the patient’s experience and results. A lot of due diligence is needed to ensure that medical procedures overseas are done safely and effectively. Besides, it requires experience to manage the complexities of international healthcare regulations, travel bans, and linguistic differences. Family offices must develop good relationships with credible medical networks worldwide and stay updated on the latest healthcare trends, legal considerations, and travel procedures to ensure the process is smooth for their clients requirements to ensure a smooth process for their clients. ### The Wire Aug 30This Week in Medical Tourism: 20–26 August 2026 Aug 29This Week in Medical Tourism: 13–19 August 2026 Aug 22South Korea Undercuts America but Not Turkey All coverage ### Newsletter Get weekly health tourism intelligence in your inbox. Subscribe ### Knowledge Hub Medical Tourism Wellness Tourism Dental Tourism Fertility Tourism Cosmetic Tourism Longevity Tourism Explore the Hub Stay informed on the latest in global health tourism. Subscribe to our Newsletter ## Related Articles Medical Tourism 22 AUG 2026 Medical Tourism ### Mexico and Turkey Price Against Different Home Markets August 22, 2026 Medical Tourism 22 AUG 2026 Medical Tourism ### Turkey's Deepest Discounts Sit on Its Safest Procedures August 22, 2026 Medical Tourism ### Why Medical Tourism to Germany Declined August 11, 2026 --- # Medical Tourism Industry Size Projections URL: https://health-tourism-news.com/news/medical-tourism-industry-size-projections/ Medical Tourism Medical Tourism Industry Size Projections Why They Should Be Approached With Caution Christian El-Khouri Editor-in-Chief Editor-in-Chief of Health Tourism News. Twelve-plus years across international patient services, healthcare consulting, and destination development in Europe, the Middle East, and beyond. Co-Founder and Vice President of the European Health and Medical Tourism Association (EHMTA). Read more Published February 10, 2025 · 6 min read The medical tourism industry has become a booming global market as increasing numbers of patients seek affordable, high-quality medical care abroad. As such, this sector’s growth and size projections are being widely discussed. While these forecasts often depict a promising future, it is essential to approach them with caution. Relying solely on optimistic predictions of growth may overlook the complexities and uncertainties that shape the trajectory of the medical tourism market. Here are key reasons why the projected growth figures should be treated with scepticism. ## 1. Overreliance on Assumptions and Past Trends Market projections, particularly in emerging industries like medical tourism, often rely heavily on past trends and assumptions about future behaviours. However, this approach can be problematic because it assumes that past growth patterns will continue in the same trajectory without accounting for unpredictable shifts in global circumstances. For example, medical tourism has been steadily growing, driven by globalization, internet access, and the ability to travel easily across borders. However, unforeseen global events like the COVID-19 pandemic show that market forces can change quickly and dramatically, disrupting travel patterns, medical practices, and patient demand. Projections that ignore these kinds of risk factors can mislead investors and stakeholders into expecting a consistent upward growth curve, even in the face of unforeseen disruptions. ## 2. Exclusion of Market Saturation As the medical tourism industry matures, new destinations may enter the market, leading to a situation of market saturation. While the initial growth in the industry may appear promising, projections often fail to account for the limits of expansion. The more countries and regions that enter the medical tourism space, the more fragmented the market becomes. New providers compete for a finite number of patients, and prices can fluctuate as countries battle for market share. Projections that do not consider the likelihood of saturation can be overly optimistic. They may lead to expectations of endless growth in an increasingly competitive environment. As more players enter the market, particularly in countries with lower healthcare standards, the industry’s value proposition could diminish, and expected growth rates may not materialize as predicted. ## 3. Exclusion of Regulatory and Political Risks The medical tourism industry is deeply interconnected with the global political landscape, including visa regulations, trade policies, and healthcare regulations. As political dynamics shift, so too can the ease with which patients can travel to their desired medical destinations. Market growth projections often overlook the possibility of regulatory changes that could curtail the flow of medical tourists. For example, changes in visa policies, economic sanctions, or heightened geopolitical tensions can significantly affect the number of patients travelling abroad for treatment. A major political crisis or regulatory overhaul could lead to sudden and unpredictable shifts in demand, derailing forecasts that don’t adequately consider such risks. ## 4. Failure to Account for Economic Fluctuations The broader economic climate also significantly influences the growth of industries like medical tourism. Economic downturns, inflation, and currency devaluation can reduce individuals’ disposable income, making foreign medical treatments less accessible. Conversely, during times of economic growth, there may be more disposable income for international healthcare. However, the medical tourism market is vulnerable to economic cycles, and projections based solely on optimistic forecasts of global prosperity fail to account for recessions or financial instability. Moreover, global economic factors impacting different regions could cause unexpected volatility in patient flows. For example, a recession in the United States could lead to a decline in medical tourists travelling from the U.S., which may not be fully captured in broad, global market projections. ## 5. Lack of Granular Regional Insights Many medical tourism growth projections tend to aggregate global figures without providing sufficient detail about regional variations. While some regions may see substantial growth due to improvements in infrastructure, rising healthcare costs, and increased accessibility, others may face significant barriers, such as limited healthcare quality or political instability, that prevent them from capitalizing on the opportunity. For example, countries with low-cost healthcare offerings may experience different dynamics than those with more developed healthcare systems. Projections that treat the industry as a homogeneous global market ignore these regional differences, leading to an overly simplistic view of the future. The lack of nuanced insights could lead businesses to miscalculate where investments should be made or where demand for medical tourism will genuinely grow. ## 6. Underestimating Technological Disruption The healthcare industry is undergoing significant technological disruption, with innovations like telemedicine, robotic surgeries, and AI-assisted diagnostics transforming the landscape. Depending on how the technology is applied, these technological advances could either bolster or reduce the need for cross-border medical travel. Projections that fail to consider technology’s impact on the industry may underestimate the speed with which domestic healthcare providers can innovate, potentially reducing the need for patients to travel abroad. For instance, the rise of telehealth could allow patients to receive consultations or post-operative care remotely, reducing the travel demand. On the other hand, new medical technologies could make specific treatments more widely available and affordable, accelerating growth in medical tourism. Accurately forecasting this technological shift remains a challenge for analysts and could significantly affect future market projections. ## 7. Extrapolation of Short-Term Success into Long-Term Trends Another flaw in some medical tourism growth projections is the tendency to extrapolate short-term successes into long-term trends. The early growth phases of the industry, driven by rising interest in affordable healthcare options and the appeal of exotic destinations, may skew projections. However, just as quickly as demand surged, it could plateau or decline as medical tourists realize that the risks associated with foreign healthcare are not always worth the savings. Over time, consumer awareness and concerns about healthcare quality, ethics, and safety may dampen the industry’s growth. Projections that extend these short-term trends indefinitely could set up unrealistic expectations in the long run. This can mislead stakeholders and investors into making decisions based on overly optimistic expectations. ## 8. Complexity in Patient Decision-Making Projections often simplify the decision-making process of medical tourists by assuming that cost is the only significant factor driving their choices. While affordability is indeed a key factor, the reality is more complex. Medical tourists may also consider the reputation of healthcare providers, the availability of specialized treatments, the quality of post-procedure care, and the overall patient experience. Projections that do not account for the complexity of decision-making may overlook subtle shifts in patient preferences or changes in the factors that drive demand for international medical care. For instance, rising concerns over patient safety and ethical issues may shift demand from low-cost destinations to those with better reputations or more stringent regulations, impacting the projections of growth in certain regions. All in all these factors should be kept in mind before paying to much heed to market reports that are only inteneded to create sales rather than inform accurately. ### The Wire Aug 30This Week in Medical Tourism: 20–26 August 2026 Aug 29This Week in Medical Tourism: 13–19 August 2026 Aug 22South Korea Undercuts America but Not Turkey All coverage ### Newsletter Get weekly health tourism intelligence in your inbox. Subscribe ### Knowledge Hub Medical Tourism Wellness Tourism Dental Tourism Fertility Tourism Cosmetic Tourism Longevity Tourism Explore the Hub Stay informed on the latest in global health tourism. Subscribe to our Newsletter ## Related Articles Medical Tourism 22 AUG 2026 Medical Tourism ### Mexico and Turkey Price Against Different Home Markets August 22, 2026 Medical Tourism 22 AUG 2026 Medical Tourism ### Turkey's Deepest Discounts Sit on Its Safest Procedures August 22, 2026 Medical Tourism ### Why Medical Tourism to Germany Declined August 11, 2026 --- # Medical Tourism Records Concentrate In Penang And Seoul URL: https://health-tourism-news.com/news/medical-tourism-records-concentrate-in-penang-and-seoul/ Weekly Digest July 8, 2026 Weekly DigestCosmetic TourismWellness TourismMedical Tourism Medical Tourism Records Concentrate In Penang And Seoul This is the Health Tourism News roundup for the week of June 29 to July 7 2026. Malaysia and South Korea both reported record medical tourism figures this... Christian El-Khouri Editor-in-Chief Published July 8, 2026 · 8 min read This is the Health Tourism News roundup for the week of June 29 to July 7 2026. Malaysia and South Korea both reported record medical tourism figures this week, and both governments spent the week worrying about how concentrated those figures are. Penang alone generated 45 per cent of Malaysia’s medical tourism revenue, while Seoul received 87.2 per cent of South Korea’s 2.01 million foreign patients. Private equity firms moved on Malaysian hospital assets, and new hospitals in Abuja, Hanoi and Tashkent reported early progress in keeping patients at home. A cancer centre in Shanghai began treating its first international patient with a therapy available nowhere else. ## Penang supplies 45 per cent of Malaysia’s medical tourism revenue Penang’s tourism chairman Wong Hon Wai said in a statement on Tuesday that Malaysia had been ranked the world’s sixth best medical tourism destination by Travel and Tour World, behind Turkey, Thailand, India, Mexico and South Korea, The Star reported. National medical tourism revenue rose 23.2 per cent to RM3.35 billion in 2025, and the number of foreign patients grew from 1.6 million to 1.85 million. Penang remained the country’s largest centre. Its 16 participating private hospitals treated 527,176 foreign patients last year, up 25.94 per cent, and earned RM1.14 billion in medical tourism revenue, according to the Penang Centre of Medical Tourism. The state is already looking for new markets. PenangToday reported that a Qatari delegation led by Ambassador Salah bin Mohammed Al-Sorour toured Island Hospital, Northern Heart Hospital Penang and Sunway Medical Centre Penang after Qatar Airways resumed its Doha to Penang service under its winter schedule. Wong said the Middle East would reduce Penang’s dependence on Indonesian patients. The Business Times reported that Bain Capital, KKR and KV Asia Capital have been shortlisted for a minority stake in Avisena Healthcare, valuing the Malaysian hospital group at about US$368 million, citing two people with direct knowledge of the matter. Binding bids are due by the end of July. CodeBlue, a Malaysian health policy site, published an anonymous piece asking what share of the cost of hotel-style lobbies, concierge services and premium suites is carried by Malaysian patients. Those costs, the author argued, are folded into room rates and bundled charges rather than shown on the bill. The site withheld the author’s name because civil servants are barred from writing to the press. The questions are reasonable ones, and whether the Malaysia Healthcare Travel Council engages with them will show how seriously the industry takes the point. ## South Korea records 2.01 million foreign patients South Korea counted 2.01 million foreign patients last year, the highest figure since records began in 2009, and the industry spent the week discussing what to do with them. The Korea Times reported that the K-Medical Tourism Roundtable met on Thursday to examine the shape of the sector. The Korea Institute for Industrial Economics and Trade says the industry generated 22.8 trillion won, about US$14.6 billion, in wider economic effects last year. Kim Jin-kuk, who heads the country’s medical tourism promotion body, told the paper in a separate interview that Seoul alone received 87.2 per cent of foreign patients and that language remains their biggest obstacle. “There is a strong desire among foreigners to go to Korea and become beautiful,” Kim said. He proposed certified medical interpreters and a tiered qualification that would let foreign beauty professionals refer patients from their home countries. Hong Seung-wook of the Korea Health Industry Development Institute told the roundtable that dermatology and plastic surgery account for 68 per cent of foreign patients, and the greater Seoul area for 90 per cent of visits, a structure he called fragile. The Korea Times reported that foreign card spending passed 2 trillion won in May for the first time, with pharmacy spending up 206.1 per cent and dermatology clinics up 85.5 per cent on a year earlier. A sector in which two procedures account for two thirds of patients and one urban area for nine tenths of visits can be upset by a single policy change or a diplomatic row. Of the reforms discussed at the roundtable, the interpreter shortage is the cheapest to fix, and whether Kim’s scheme is running before next year’s figures appear will be a fair test of intent. ## Abuja, Hanoi and Tashkent report progress on keeping patients at home Businessday reported that George Elombi, the president of Afreximbank, visited the African Medical Centre of Excellence in Abuja on Friday, a year after the hospital opened with backing from the bank and King’s College Hospital, London. The centre has treated more than 5,000 patients from over 20 countries, delivered West Africa’s first stereotactic body radiotherapy for lung cancer, completed its first triple bypass and processed 40,000 laboratory tests. “The success of this Centre reflects the depth of talent assembled here,” Elombi said. Laodong reported that Hanoi intends to retain the US$2 billion to US$3 billion that Vietnamese patients spend abroad each year. Its health department plans cancer, heart and dental care packages and a coordinating office. In Tashkent, President Shavkat Mirziyoyev toured the US$30 million Global International Hospital and told officials to “combine medical and tourism services in a balanced way” and to build more hotels near hospitals, Trend reported. The projects are small against the sums their governments hope to keep, but radiotherapy delivered in Abuja removes one of the procedures that once required a flight to London. The limit of every such plan appeared in the same week. Jiahui Health announced that a 59-year-old New Zealander with advanced gastroduodenal cancer had become the first international patient to begin Satri-cel, the first approved CAR-T therapy for a solid tumour, which is available only in China. He is the second New Zealander in a month to travel to Shanghai for CAR-T treatment. Programmes like these can compete on price and quality. They have no answer yet to a therapy that exists in one country. ## Cosmetic tourism grows faster than its safeguards The Bali Sun reported research from the medical device firm idsMED showing Indonesia’s aesthetic market growing at about 15 per cent a year, led by skin tightening. One clinic in Surabaya performed about 500 treatments in the three months after installing a Korean radio-frequency device, the paper said. Türkiye’s health tourism sector received about 1.4 million foreign visitors in 2025 and earned US$3.3 billion, the country’s tourism ministry told a D-8 webinar, according to APP. Türkiye Today published a detailed warning for prospective patients: a before-and-after photograph is not a medical evaluation, a package price says nothing about who performs the procedure or what a free revision covers. Patients who pay foreign intermediaries with no Turkish authorisation, it warned, may find no clear legal party to sue if the work fails. It advised patients to verify the clinic, the doctor and the intermediary through the Turkish Ministry of Health before paying anyone. The advice applies well beyond Türkiye. Unlicensed intermediaries who collect payment abroad are a known weakness of the trade. Destinations arriving late to the boom, Bali among them, could make verified providers their selling point rather than repeat the familiar cycle of growth, scandal and regulation. ## Wellness travel demand keeps growing A Priority Pass survey of 12,000 travellers in 20 countries, carried by CBN, found that 47 per cent now travel for wellness at least once a year and that a third combine wellness with sporting events. Just over half said the journey itself shapes their view of a holiday. The wellness travel market is projected to pass £718 billion by 2030. Nomad Lawyer published an enthusiastic account of a thermal bath revival across Hungary, the Czech Republic and Slovakia, claiming savings of 40 to 60 per cent against Switzerland, though the piece named few sources and its figures could not be verified. When nearly half of travellers report at least one wellness trip a year, wellness has stopped being a niche. ## What This Means The week’s pattern is plain enough. Success in medical tourism concentrates, and the governments and investors who hold it are working to spread it before it turns into a liability. Penang is recruiting new source markets, Korea wants patients beyond Seoul and beyond dermatology and plastic surgery, and private equity is buying into the operators that concentration has already rewarded. Three things over the coming months will show how far this goes: the binding bids for Avisena due by the end of July, whether Korea’s interpreter and visa reforms move from roundtable to regulation, and the second-year figures from the African Medical Centre of Excellence in Abuja. Sources (17) Thestar Businessday Newswire Galencentre Trend Laodong Businesstimes Thebalisun Koreatimes Penangtoday Koreatimes Nst Nomadlawyer App Turkiyetoday Cbn Koreatimes MalaysiaThailandIndiaMexicoSouth KoreaSingaporeAfricaNigeria ### The Wire Aug 30This Week in Medical Tourism: 20–26 August 2026 Aug 29This Week in Medical Tourism: 13–19 August 2026 Aug 22South Korea Undercuts America but Not Turkey All coverage ### Newsletter Get weekly health tourism intelligence in your inbox. Subscribe ### Knowledge Hub Medical Tourism Wellness Tourism Dental Tourism Fertility Tourism Cosmetic Tourism Longevity Tourism Explore the Hub Stay informed on the latest in global health tourism. Subscribe to our Newsletter ## Related Articles Weekly Digest 30 AUG 2026 Weekly Digest ### This Week in Medical Tourism: 20–26 August 2026 August 30, 2026 Weekly Digest 29 AUG 2026 Weekly Digest ### This Week in Medical Tourism: 13–19 August 2026 August 29, 2026 Cosmetic Tourism 22 AUG 2026 Cosmetic Tourism ### South Korea Undercuts America but Not Turkey August 22, 2026 --- # Medical Tourism Trends 2026: What Is Actually Changing URL: https://health-tourism-news.com/news/medical-tourism-s-evolving-landscape-key-trends-for-2026/ Medical Tourism January 25, 2026 Medical TourismWellness Tourism Medical Tourism Trends 2026: What Is Actually Changing Nobody agrees how big medical tourism is - estimates for the same year run from US$35 billion to US$312 billion. What is actually changing in 2026 is easier to pin down, from second-tier treatment hubs to accreditation with real teeth. Christian El-Khouri Editor-in-Chief Published January 25, 2026 · Updated July 4, 2026 · 7 min read Most trend pieces about medical tourism are copies of copies: the same five predictions and the same unsourced numbers, passed from one listicle to the next. This page is meant to be the version you can check. I have gone through the reporting from Travel Daily Media, the February 2026 market study from Future Market Insights, the Medical Tourism Association’s own magazine, Joint Commission International’s new hospital standards and the Global Wellness Institute’s latest economy data, and kept only what survives contact with a source. Here is what is actually changing in 2026, and what is conference talk. ## Nobody agrees how big this market is Start with the number everyone quotes and nobody can defend. Travel Daily Media put the sector at roughly US$35 billion at the close of 2025, growing 16.8 percent a year, with Asia-Pacific taking 46.43 percent of revenue and Thailand, Singapore, India and Malaysia carrying most of it. Future Market Insights, in a report dated 7 February 2026, values the same industry at US$312.5 billion this year and projects US$1,000.2 billion by 2036 at a 12.3 percent compound rate. That is not a rounding disagreement. It is a nine-fold gap between two serious publications describing the same trade in the same year. The gap has a boring explanation: nobody agrees on what counts. Count only what foreign patients pay hospitals and you get a small number. Add flights, hotels, companions and recovery stays and it triples. Fold in wellness travel and you reach whatever figure your report needs. My advice is to ignore the levels and trust the direction, because on that every source agrees: double-digit growth, driven by healthcare inflation in the rich world pushing patients toward markets that can do the same operation for a tenth of the price. ## The map is spreading beyond the capitals The more useful story is where patients go once they land. Travel Daily Media reports Türkiye consolidating its position in cardiology, oncology and IVF, while in India the traffic is spilling out of Delhi and Mumbai into Jaipur, Amritsar, Lucknow and Chandigarh, second-tier cities offering the same procedures with shorter queues and lower bills. The report sees the same pattern starting in Thailand and Malaysia. The infrastructure is following the patients: Future Market Insights notes that India extended its e-medical visa to citizens of 171 countries as of August 2025, and that IHH Healthcare plans 2,000 new hospital beds in India by 2028. Diversification is the trend I would bet on, because it compounds. Every second-tier city that lands an accredited hospital and an airport connection undercuts the capital that trained its surgeons. The first-tier hubs will keep the complex cases. The volume work, the hips and the dental restorations, will keep drifting to wherever the queue is shortest and the hotel is cheapest. ## The consultation now happens before the flight The pandemic’s telehealth reflex has hardened into a workflow. Travel Daily Media describes telemedicine moving past the introductory video call toward virtual hospital models: remote expert opinions and patient monitoring at the front of the journey, so the flight is booked only after the doctors agree there is something worth flying for. The same report expects AI across the administrative spine of the trip, from triage of incoming inquiries and appointment scheduling to laboratory analysis and post-operative follow-up. I take the teleconsult trend more seriously than the AI one, for a simple reason: the accreditor has already moved. Joint Commission International’s 8th edition hospital standards, mandatory for every accreditation survey since 1 January 2025, added an entire Healthcare Technology chapter covering electronic records, telehealth and cybersecurity. Regulators do not write chapters for experiments. AI triage will matter eventually, but in 2026 much of what is sold under that label is routing software with a new name. The teleconsult is different. It moves patient selection to before the ticket is bought, and bad patient selection is where most medical travel disasters begin. ## Payers keep circling, slowly The perennial promise is that insurers will industrialise this market. The Medical Tourism Association’s magazine has documented the pilots: UnitedHealth plans covering more than 200,000 Americans with access to Bumrungrad International in Bangkok and Apollo Hospitals in India, BlueCross BlueShield of South Carolina building its own network of partner hospitals in Thailand, Türkiye, Singapore and Costa Rica, and Californian plans from Blue Shield and Health Net covering over 20,000 patients in Mexican hospitals. The arithmetic behind all of it has not changed: the magazine cites a hip replacement at US$75,000 in the United States against US$9,000 in India. Here is the honest reading. Most of those pilots are old, and if payer-funded medical travel were going to take off on its own it would have done so by now. What keeps the trend on this list is the direction of the spread: every year of medical inflation in the West widens the gap that a self-funded employer has to explain to its finance director. I would not watch the insurers’ press releases. I would watch their renewal spreadsheets. ## Accreditation grows teeth this year Quality scrutiny is the quietest trend and the most concrete. JCI published the 8th edition of its hospital standards in July 2024 and made it the basis of every survey from 1 January 2025: roughly 10 to 15 percent fewer standards after consolidation, the new technology chapter above, and a set of environmental sustainability requirements that become fully mandatory on 1 January 2026. Future Market Insights calls the decade’s underlying shift the “formalization of cross-border patient pathways through government visa frameworks and global accreditation standards”, with competition moving from cost arbitrage to quality assurance. For the traveling patient this is the trend with immediate practical use. The badge in the hospital lobby now says something about whether your records are protected and whether the telehealth follow-up meets a standard, not just whether the operating theatre is clean. In a market where every clinic’s website claims excellence, accreditation remains one of the few claims a patient can independently verify, and in 2026 it is a harder badge to hold. ## Wellness and medicine keep merging The wellness economy is now the gravitational field the whole sector orbits. The Global Wellness Institute’s November 2025 data puts it at a record US$6.8 trillion for 2024, double its 2013 size and up 7.9 percent in a year, with a forecast of US$9.8 trillion by 2029; wellness tourism specifically grew 13.8 percent between 2023 and 2024. On the medical side, Travel Daily Media describes the rise of the healthcation: properties like Chiva-Som in Hua Hin and The Farm at San Benito in the Philippines pairing resort recovery with integrated medicine clinics, hospital affiliations and clinical staff, with longevity programmes the expected next step. The convergence runs in both directions, and I find the resort-to-clinic direction the more interesting one. A hospital adding a recovery wing is an amenity. A resort hiring physicians and buying diagnostic equipment is entering the medical market with hotel margins and hotel marketing, and the accreditation regime described above does not yet reach most of it. The patient wins when clinical accountability arrives with the equipment. Until then, the sharpest question to ask a longevity retreat is the one you would ask a hospital: who is responsible when something goes wrong? ## What This Means Strip out the numbers nobody agrees on and 2026 resolves into one word: formalization. Visa frameworks built specifically for patients, an accreditation edition with new requirements, telehealth written into hospital standards, insurers running quiet arithmetic instead of loud pilots. The market’s size is unknowable; its direction is not, and the machinery around it is hardening. For a patient, two of these trends are usable today: insist on a teleconsult before you book, and check when the accreditation was issued, not just whether the badge exists. For destinations, the lesson cuts harder. The winners of the next five years will not be the countries with the best beaches or even the lowest prices, but the ones that make the paperwork, the data and the follow-up boring and reliable. Everything else on this list is downstream of that. Sources (5) Travel Daily Media Future Market Insights Medical Tourism Magazine PR Newswire Global Wellness Institute ThailandIndiaTürkiyeMalaysiaAsia-Pacific ### The Wire Aug 30This Week in Medical Tourism: 20–26 August 2026 Aug 29This Week in Medical Tourism: 13–19 August 2026 Aug 22South Korea Undercuts America but Not Turkey All coverage ### Newsletter Get weekly health tourism intelligence in your inbox. Subscribe ### Knowledge Hub Medical Tourism Wellness Tourism Dental Tourism Fertility Tourism Cosmetic Tourism Longevity Tourism Explore the Hub Stay informed on the latest in global health tourism. Subscribe to our Newsletter ## Related Articles Medical Tourism 22 AUG 2026 Medical Tourism ### Mexico and Turkey Price Against Different Home Markets August 22, 2026 Medical Tourism 22 AUG 2026 Medical Tourism ### Turkey's Deepest Discounts Sit on Its Safest Procedures August 22, 2026 Medical Tourism ### Why Medical Tourism to Germany Declined August 11, 2026 --- # Mexico and Turkey Price Against Different Home Markets URL: https://health-tourism-news.com/news/mexico-and-turkey-price-against-different-home-markets/ Medical Tourism August 22, 2026 Medical TourismDental Tourism Mexico and Turkey Price Against Different Home Markets Tijuana quotes in US dollars. Istanbul quotes in sterling. Neither quotes in its own currency, and the multiple each corridor lands on says more about the patient than about the local cost of surgery. Christian El-Khouri Editor-in-Chief Published August 22, 2026 · 5 min read A Tijuana hospital publishes its gastric sleeve package in US dollars, though it pays its staff in pesos. An Istanbul clinic publishes an itemised implant list in pounds sterling, though it buys its fixtures in lira. Hungarian and Polish clinics quote foreign patients in euros while their domestic prices sit in forint and złoty. In every case the currency on the page belongs to the buyer rather than the seller, and that is the first clue to how these prices are set. Health Tourism News runs country guides on both corridors. Read the Mexican and Turkish ones side by side and the same pattern shows in the numbers. ## Two corridors, one multiple ProcedureMexicoUS referenceTurkeyUK reference Gastric sleeve, all-inclusive package$4,150 - $5,000 typical; market $3,900 - $7,500$15,000 - $25,000$3,600 - $4,500 panel median $3,850$13,000 - $18,000 Single implant, finished tooth$1,200 - $1,730$3,500 - $5,500$940 - $1,140 premium brand$3,355 median All-on-4, per arch$8,110 - $9,900 border towns$25,000 - $35,000from $2,150 budget brand, acrylic$16,100 - $33,500 Panel prices from the four Health Tourism News country guides, each with its own methodology note and dated exchange rate. Do the arithmetic on the sleeve and both corridors land in the same band. In Mexico, $15,000 against $5,000 is three times and $25,000 against $4,150 is six; the guide settles on a factor of three to five for the typical package. In Turkey, $13,000 against $4,500 is under three times and $18,000 against $3,600 is five. Different countries, different absolute prices, near-identical ratios. The finished tooth does the same thing. The Mexican implant guide puts the complete tooth at roughly a third of the American price. The Turkish implant guide puts a premium-brand fixture at roughly a third of the British median. Two markets with no reason to agree, agreeing to within a rounding error. The obvious reading is that both are pricing against the number the patient already carries, rather than up from a local cost base. Mexico’s dollar prices sit consistently above Turkey’s because the American benchmark sits consistently above the British one, not because surgery in Tijuana costs more to deliver than surgery in Istanbul. The Mexican bariatric guide and the Turkish one describe the same operation, the same registry mortality near 0.1 per cent, and two price lists denominated for two different audiences. ## Where the pattern breaks Two places, and both are instructive. The first is Cancun. All-on-4 in the Mexican border towns runs $8,110 to $9,900 an arch; the same operation in Cancun’s resort packages runs $10,000 to $13,500 with travel services bundled in. Same country, same benchmark, twenty to fifty per cent more. That market is pricing against convenience and a holiday rather than against a Phoenix dental quote. The second is Turkey’s entry tier. An implanted tooth at $270 to $535 is a sixth to a twelfth of the British median, not a third. No home benchmark explains that. It is a brand-tier decision, an Osstem or Neodent fixture rather than a Straumann one, and it is the point at which the price stops describing the same product. That is worth holding onto, because the multiple is only meaningful while both sides of it name the same thing. ## What the multiple never prices The ratio covers a list price in one country against a list price in another. It does not cover the second flight, and implants need one: osseointegration takes three to six months in both countries, and no pricing tier hurries it. It does not cover the complication that surfaces after the package ends, which for a sleeve means a leak in the days or weeks after a patient has flown, and aviation guidance sets about ten days after abdominal surgery against packages of five to seven. Above all it does not cover what happens at home. Most US dental plans stop at the border, though some preferred-provider schemes reimburse 50 to 80 per cent of out-of-network work against an itemised receipt carrying standard procedure codes, which is worth asking for in English before leaving the chair. US insurers frequently exclude complications of elective surgery obtained overseas. In Britain, the NHS treats emergencies from surgery abroad and does not fund revision or cosmetic correction, and the British bariatric society has published its own statement on going abroad for weight-loss surgery. Both corridors leave the return trip and the aftercare as the patient’s line item, and neither prices it. ## What this means for patients A three-to-five multiple is a description of how a market quotes, not a measure of what a patient receives. The number is honest as far as it goes, and it goes as far as the list price. Everything the guides spend their length on, the finished unit rather than the component, the named surgeon and licensed hospital, the extra inpatient night, the second trip and the plan for the year after, sits outside it. Patients who spend part of the saving on the parts the multiple ignores get the deal the arithmetic describes. Patients who treat the multiple as the deal are buying a list price. Health Tourism News is a trade publication and sells no treatment. Prices are the figures providers publish, held on file, with the limits of each panel stated in the guide it comes from. Sources (7) CareQuest Institute for Oral Health, Crossing Borders for Care: dental tourism among US adults, June 2026 American Dental Association, CEBJA statement on dental tourism, 2009 (rev. Nov 2009) GENEVA collaborative study, 30-day outcomes of sleeve gastrectomy, 2021 In-hospital and post-discharge mortality after bariatric surgery in England (HES/NBSR analysis), BJS Open, 2017 TreatCompare, UK dental implant cost sample of 1,125 practices, 2026 BOMSS statement on going abroad for weight loss surgery, September 2023 European Central Bank, euro foreign exchange reference rates, 10 July 2026 MexicoTurkeygastric sleevedental implantspricesTijuana ### The Wire Aug 30This Week in Medical Tourism: 20–26 August 2026 Aug 29This Week in Medical Tourism: 13–19 August 2026 Aug 22South Korea Undercuts America but Not Turkey All coverage ### Newsletter Get weekly health tourism intelligence in your inbox. Subscribe ### Knowledge Hub Medical Tourism Wellness Tourism Dental Tourism Fertility Tourism Cosmetic Tourism Longevity Tourism Explore the Hub Stay informed on the latest in global health tourism. Subscribe to our Newsletter ## Related Articles Cosmetic Tourism 22 AUG 2026 Cosmetic Tourism ### South Korea Undercuts America but Not Turkey August 22, 2026 Medical Tourism 22 AUG 2026 Medical Tourism ### Turkey's Deepest Discounts Sit on Its Safest Procedures August 22, 2026 Dental Tourism 22 AUG 2026 Dental Tourism ### Dental Implant Prices Abroad Hide Three Different Units August 22, 2026 --- # Middle East Turmoil Reshapes Medical Tourism URL: https://health-tourism-news.com/news/middle-east-turmoil-reshapes-medical-tourism/ Medical Tourism Middle East Turmoil Reshapes Medical Tourism Geopolitical instability forces global healthcare providers to pivot, impacting international patient flows and revenue streams. Christian El-Khouri Editor-in-Chief Editor-in-Chief of Health Tourism News. Twelve-plus years across international patient services, healthcare consulting, and destination development in Europe, the Middle East, and beyond. Co-Founder and Vice President of the European Health and Medical Tourism Association (EHMTA). Read more Published March 16, 2026 · 27 min read In the dynamic and often precarious landscape of global healthcare, geopolitical shifts can send profound ripples through established industries. Recent reports from Travel and Tour World indicate that India’s medical tourism sector, a significant global player, has experienced an alarming 50% to 75% reduction in international patient arrivals from the Middle East due to ongoing regional conflicts. This dramatic downturn underscores how rapidly evolving geopolitical situations in the Middle East are not merely regional issues but are fundamentally reshaping the contours of global medical tourism, compelling healthcare providers and nations reliant on international patients to recalibrate their strategies. This phenomenon, where individuals traverse national borders to access medical, surgical, or dental treatments, is intrinsically linked to global healthcare disparities. As we have previously asserted, medical tourism often exists as a symptom of an imperfect world, a necessity born from unequal access to affordable, timely, or competent care. The current instability in the Middle East exacerbates these underlying issues, creating new barriers for those already seeking solutions beyond their domestic systems and forcing a re-evaluation of what constitutes a stable and accessible healthcare destination. The impact extends beyond mere patient numbers, touching upon the financial viability of major hospital networks, the logistical complexities of cross-border healthcare, and the strategic planning of entire nations positioning themselves as health tourism hubs. Understanding these intricate dynamics is crucial for industry stakeholders, policymakers, and prospective international patients alike, as the ripple effects continue to unfold across continents. ## How Does Geopolitical Instability Disrupt Global Medical Travel and Patient Access? The persistent geopolitical instability in the Middle East has created an unprecedented environment of uncertainty, directly impacting the fundamental premise of medical tourism: the ability to travel safely and reliably. Historically, countries like Oman, Saudi Arabia, Iran, Iraq, and Yemen have been significant sources of international patients for destinations renowned for advanced medical interventions, such as India. These patients frequently sought specialized treatments including intricate cancer therapies, complex cardiac surgeries, vital organ transplants, and sophisticated orthopedic procedures, driven primarily by the substantial cost savings offered abroad compared to their home nations. However, the current conflicts, particularly the U.S.-Israel-Iran war, have severely hampered air travel, leading to widespread flight cancellations, airspace restrictions, and a pervasive sense of insecurity that deters patient mobility. Leading healthcare entities, including India’s Apollo Hospitals, Fortis Healthcare, and Manipal Hospitals, have publicly reported a significant reduction in the influx of international patients from the Middle East. For instance, Fortis Healthcare, which previously received five to six new patients daily from Iran and Iraq before the conflict intensified, has seen these numbers plummet to a near standstill. This dramatic slowdown is not merely anecdotal; industry analysts, such as Aryaman Tandon, managing partner for healthcare and life sciences at Praxis Global Alliance, affirm that India’s $7-8 billion Medical Value Travel (MVT) industry relies majorly on patients from the Middle East. The disruption of these established patient corridors forces a re-evaluation of accessibility and the very definition of a reliable healthcare journey. Beyond the immediate conflict zones, the repercussions stretch across the region and beyond, affecting major aviation hubs like Dubai International Airport, Qatar’s Hamad International Airport, and Zayed International Airport in Abu Dhabi. These airports serve as critical stopover points for international patients traveling from Africa and Central Asia to destinations like India and Southeast Asia. With these hubs experiencing partial closures or significant disruptions, patients from multiple regions are facing increased travel complexities, longer transit times, and heightened risks of cancellations. This interconnectedness means that instability in one region can trigger a cascade of logistical challenges across the broader global healthcare network, impacting patient travel originating far from the immediate conflict zones. The psychological impact on prospective international patients is also profound. A prevailing sense of uncertainty mounts, leading numerous individuals to delay or entirely cancel their planned medical journeys. This decision-making process is often driven by concerns over personal safety during transit, the reliability of travel itineraries, and the potential for complications while abroad in an unstable environment. For many, seeking medical care abroad is already a vulnerable undertaking, and the added layer of geopolitical risk can make the prospect insurmountable. The situation highlights that for medical tourism to thrive, or even merely function, a baseline of perceived safety and stability in both the origin and destination regions, as well as along the travel routes, is absolutely paramount. ### What are the Financial Repercussions for Key Healthcare Destinations? The financial repercussions of the Middle East’s geopolitical situation on medical tourism destinations are substantial and multifaceted. Patients from the Middle East often represent a high-value segment for healthcare providers, frequently opting for premium accommodation, advanced medical procedures, and specialized care packages. This demographic typically incurs higher expenditures on treatments, contributing disproportionately to the profitability margins of hospitals. The sharp decline in patient arrivals from this region, therefore, impacts not just top-line revenue but also the overall financial health of major hospital networks. KIMSHEALTH Al-Shifa in Kerala, for instance, has publicly warned that its international revenue could fall by 10 to 15 percent if the situation persists, illustrating the tangible financial strain experienced by individual institutions. According to Salil Kallianpur, managing director of market intelligence firm ARKS Knowledge Consulting, even a temporary disruption in the flow of these high-value international patients can materially impact the revenue mix and profitability. The preference for enhanced amenities and cutting-edge medical procedures by Middle Eastern patients means their absence creates a significant gap that is challenging to fill with other patient segments. This financial pressure is particularly acute for countries like India, where medical value travel from the Middle East accounted for nearly 18% of total foreign medical arrivals in 2024, as per the tourism ministry’s Tourism Data Compendium 2025 report. Beyond direct patient revenue, the broader ecosystem of health tourism also suffers. This includes associated services such as medical travel facilitation agencies, hospitality providers catering to international patients and their families, and ancillary businesses like specialized transport and translation services. When patient numbers decline, these supporting industries face reduced demand, leading to job losses and economic contraction within the medical tourism sector. The interconnectedness of this ecosystem means that financial strain on hospitals quickly translates into wider economic challenges for destination countries that have invested heavily in positioning themselves as global healthcare hubs. Furthermore, the need to adapt to these disruptions requires significant investment. Hospitals are expanding teleconsultation services and platforms for remote second opinions, which, while crucial for maintaining patient engagement, also represent new operational costs. Developing new market strategies and establishing patient corridors in alternative regions like Southeast Asia, Africa, and Central Asia also demands considerable financial outlay for market research, marketing campaigns, and infrastructure adjustments. These unforeseen expenditures, coupled with reduced revenue, place a dual burden on healthcare providers, forcing them to balance immediate financial stability with long-term strategic reorientation in an unpredictable global environment. ## India’s Strategic Pivot: Navigating Disruption and Forging New Medical Travel Corridors In direct response to the prevailing crisis in the Middle East, India’s robust medical tourism industry is undergoing a significant strategic pivot. Historically, India has been a preferred choice for international patients seeking affordable and high-quality healthcare, particularly for advanced treatments in cardiology, orthopedics, oncology, and cosmetic procedures. However, with the dramatic reduction in patient flow from its traditional Middle Eastern markets, Indian healthcare providers are vigorously exploring alternative international markets to mitigate potential financial setbacks. This adaptability underscores the industry’s agility in maintaining its position as a global healthcare destination amidst crises. Regions such as Southeast Asia, Africa, and Central Asia have emerged as promising territories for medical travel. These markets are characterized by their increasing demand for quality healthcare, often facing similar challenges of cost and access to advanced treatments as those that traditionally drove Middle Eastern patients to India. India already possesses a strong appeal for patients from these areas, primarily due to its compelling cost advantage - with major surgeries being 60 to 80 percent cheaper than comparable treatments in many developed nations - and its renowned clinical expertise. Within Africa, countries such as Nigeria, Kenya, and South Africa are increasingly referring patients to India for specialized medical interventions. Similarly, several nations across Central Asia are developing into potential markets as their economies expand and their populations’ demand for advanced healthcare services grows, presenting new avenues for patient travel and wellness tourism. This strategic reorientation, however, is not without its challenges. India encounters stiff competition from well-established medical tourism hubs like Thailand and Malaysia, which have meticulously cultivated strong reputations within the global medical travel market, offering sophisticated facilities and services. Nevertheless, India maintains a significant competitive edge, attributed to its extensive network of state-of-the-art hospitals, a vast pool of highly experienced medical specialists, and consistently lower treatment costs. Furthermore, many international patients place considerable trust in India for managing complex medical conditions and delivering comprehensive, long-term treatment plans, reinforcing its position as a preferred international patient care provider. To facilitate this pivot, Indian hospitals are actively engaging in fresh market research and new market development initiatives. This involves understanding the specific healthcare needs and preferences of patients in these emerging markets, tailoring service offerings, and establishing new partnerships. The goal is to build new patient corridors beyond the Gulf, ensuring a more diversified and resilient international patient sourcing strategy. This proactive approach is critical for the industry’s long-term sustainability, transforming a crisis into an opportunity for strategic expansion and market diversification. ### What Role Do Teleconsultation and Remote Services Play in Sustaining International Patient Care? In the face of disrupted patient travel, teleconsultation and remote second-opinion services have become indispensable tools for sustaining international patient care. These digital platforms allow international patients to consult with Indian specialists without the immediate necessity of physical travel, effectively bridging geographical and logistical barriers. For patients in regions affected by travel advisories or flight disruptions, teleconsultations offer a vital lifeline, enabling them to initiate consultations, receive preliminary diagnoses, and discuss treatment plans remotely. This adaptation highlights the industry’s agility in maintaining international patient engagement amidst crises, ensuring continuity of care even when cross-border travel is challenging. Many major Indian hospital chains, including Fortis Healthcare, have significantly expanded their teleconsultation services. This expansion serves multiple purposes: it keeps potential patients engaged with Indian healthcare providers, builds trust, and allows for pre-travel assessments. Patients can obtain expert opinions, understand their treatment options, and even schedule procedures in anticipation of a more stable travel environment. This remote engagement is particularly crucial for complex cases requiring multiple consultations or for patients seeking second opinions before committing to extensive medical travel. By leveraging technology, hospitals can continue to provide value and maintain relationships with their international patient base, even when physical presence is not immediately possible. However, the role of teleconsultation is primarily a preparatory or interim measure rather than a complete substitute for physical medical travel, especially for invasive procedures. While it facilitates initial assessments and ongoing follow-ups, the core of medical tourism - the actual delivery of surgical or specialized treatments - still necessitates travel. Nevertheless, these remote services are critical for maintaining patient pathways and ensuring that when geopolitical situations stabilize, patients are ready and informed to undertake their medical journeys. They reduce the burden of uncertainty and provide a structured approach to planning medical interventions, making the overall experience of cross-border healthcare more manageable for international patients. ## Ripple Effects Across the Global Healthcare Landscape: Beyond India’s Borders The geopolitical instability in the Middle East, while immediately impacting regional patient flows, has far-reaching ripple effects across the entire global healthcare landscape, extending far beyond India’s borders. The interconnected nature of international travel and healthcare infrastructure means that disruptions in one critical region can create cascading challenges for medical tourism destinations worldwide. This highlights the inherent vulnerabilities in a globalized medical travel market that often relies on specific transit hubs and established travel corridors. Consider the situation with Thailand, a nation rapidly cementing its position as a global hub for medical and wellness travel. While Thailand has seen robust growth and rising interest from markets like Russia, its leading private hospital networks, such as Bangkok Dusit Medical Services (BDMS), are navigating a challenging landscape. Their reliance on medical tourism for a significant revenue slice means that shifts in global travel patterns, including those influenced by Middle Eastern instability, can introduce headwinds. Although not directly reliant on Middle Eastern patients to the same extent as India, the broader slowdown in global tourism recovery and mounting operational costs, exacerbated by any widespread travel apprehension, can affect even well-established destinations. Furthermore, the internal dynamics of the Middle East itself are being reshaped. Countries like Turkey, which have emerged as prominent hubs for medical tourism, particularly for cosmetic surgery and dental procedures, face heightened scrutiny. Recent reports from the U.K.’s Foreign, Commonwealth and Development Office (FCDO) have issued comprehensive travel alerts for Turkey, specifically addressing health and medical care for travelers. These advisories highlight growing concerns about overseas medical consultations and link directly to a distressing tally of at least seven British citizens who tragically died in Turkey during 2025 as a direct consequence of medical procedures. While these concerns predate the current geopolitical flare-up, sustained instability in the broader region can amplify perceptions of risk, potentially deterring patients who might otherwise seek affordable care in such destinations. The intertwining of safety, quality, and geopolitical stability becomes increasingly critical for patient decision-making. The impact also extends to emerging markets. Moldova, for instance, is increasingly recognized as a budget-friendly alternative for medical tourism in Eastern Europe, attracting international patients with low prices and shorter waiting times. Similarly, Albania is exploring its potential as a regional hub for medical and health tourism in Southeast Europe, leveraging strategic collaborations. While these nations may not be directly impacted by Middle Eastern patient flows, the global re-shuffling of patient traffic could present both opportunities and challenges. On one hand, patients seeking alternatives to disrupted traditional routes might consider these emerging destinations. On the other, a general climate of global uncertainty and reduced international travel could dampen growth prospects across the board, even for those not directly in the path of the conflict. ### How Does Middle Eastern Airspace Disruption Impact Broader Medical Travel Logistics? The disruption of Middle Eastern airspace, a direct consequence of ongoing geopolitical conflicts, poses significant logistical challenges that extend far beyond the immediate region. Major aviation hubs such as Dubai, Abu Dhabi, and Doha serve as crucial transit points for a vast network of international flights, connecting continents from Africa to Asia and Europe. For medical tourism, these hubs are indispensable, often acting as the primary gateways for patients traveling from diverse origins to their chosen healthcare destinations. When these routes are compromised, the entire infrastructure of cross-border healthcare is affected. A considerable number of international patients from Africa and Central Asia, for example, rely on flight connections operated by Middle Eastern airlines, which typically involve layovers in these major Gulf aviation hubs. If these routes are disrupted due to airspace restrictions, flight cancellations, or perceived safety risks, hospitals in destination countries like India could lose patients from multiple regions simultaneously. Fortis Healthcare’s cluster head for international markets, Ganapati Hegde, noted that if these connecting flights via the Gulf are canceled, it creates a dual challenge, affecting patient inflow not just from the Middle East but also from Africa and Central Asia. This highlights a systemic vulnerability in the global medical travel ecosystem, where a localized conflict can trigger widespread logistical bottlenecks. The implications are far-reaching. Patients face longer and more expensive travel itineraries, often necessitating multiple connections through alternative, less direct routes. This adds to the already considerable stress of seeking medical treatment abroad, potentially deterring individuals from undertaking necessary journeys. Furthermore, increased airfares and travel complexities can render medical tourism less affordable, eroding one of its primary appeals. For healthcare providers, managing these logistical hurdles becomes an added operational burden, requiring constant adaptation to flight changes and patient re-routing, which can strain resources and impact the patient experience. The call from industry players, such as Hegde, to approach governments for more direct flights from other countries underscores the urgent need for resilient and diversified air travel options to sustain international patient flow. ## The Evolving Dynamics of Medical Tourism: Quality, Risk, and Accessibility The geopolitical situation in the Middle East is fundamentally altering the dynamics of medical tourism, forcing a re-evaluation of the interplay between quality, risk, and accessibility. While the pursuit of affordable and high-quality healthcare remains a primary driver for international patients, the escalating risks associated with travel, coupled with concerns about the stability of destination regions, are introducing new complexities into decision-making. This evolving landscape necessitates a deeper understanding of how perceived safety influences patient choices and whether medical tourism can truly be a sustainable solution to global healthcare disparities in an increasingly volatile world. As noted in our previous coverage, medical tourism is often a symptom of global health inequality, a necessity rather than a choice for many seeking essential care. The reasons for this inequality are diverse, ranging from political incompetence and resource distribution to outright conflict or fundamental distrust in domestic healthcare systems. The current Middle Eastern conflicts amplify these factors, creating new layers of necessity while simultaneously introducing significant barriers. Patients might face a stark choice: either delay crucial treatments due to travel risks or navigate perilous journeys to access care that is unavailable or unaffordable at home. This ethical dilemma underscores the profound challenges inherent in relying on cross-border healthcare in times of instability. The industry is also grappling with the ethical and legal concerns that arise when patients travel abroad. Issues such as quality assurance, the risk of counterfeit drugs (a concern highlighted in pharmaceutical tourism), and legal implications of importing medications across borders are compounded by geopolitical instability. When regulatory oversight might be strained in conflict-adjacent regions or when travel disruptions make follow-up care challenging, the risks to patient well-being escalate. This necessitates a heightened focus on transparency, robust accreditation, and comprehensive pre- and post-travel patient support to mitigate these evolving dangers. The industry, therefore, must continually demonstrate integrity and responsibility, especially when operating in a world that, in our view, necessitates its existence due to systemic healthcare imperfections. Furthermore, the rise of wellness tourism as a related segment also experiences indirect impacts. While often focused on preventive care, relaxation, and lifestyle improvements rather than acute medical interventions, the general climate of travel apprehension caused by geopolitical tensions can deter individuals from undertaking any form of international travel. Destinations like Thailand, which are rapidly cementing their reputation as global hubs for medical and wellness travel, must navigate this broader sentiment, even as they attract new segments of international patients from regions like Russia. The overall perception of a region’s stability and safety becomes a crucial determinant for all forms of health-related travel. ### How Do Geopolitical Risks Influence Patient Perceptions of Safety and Quality of Care? Geopolitical risks profoundly influence patient perceptions of both safety and the quality of care in medical tourism destinations. When a region is characterized by conflict, political instability, or widespread insecurity, prospective international patients are naturally hesitant to travel there for medical procedures. This apprehension is not merely about the direct danger of being caught in a conflict zone; it extends to concerns about the reliability of infrastructure, the availability of essential medical supplies, and the potential for disruptions to healthcare services. The perception of safety during transit, in the destination city, and within the healthcare facility itself becomes paramount, often overshadowing considerations of cost or clinical expertise. Reports such as the UK’s FCDO warnings for Turkey, which explicitly address health and medical care for travelers and highlight fatalities, illustrate how governmental advisories can solidify negative perceptions. Even if a specific hospital maintains high standards, the broader narrative of risk in the country or region can deter patients. This is particularly true for elective procedures, where patients have more flexibility to choose alternative destinations. For critical, life-saving treatments, the decision becomes an agonizing balance between urgent medical need and perceived travel risks, often leading to delays or cancellations. Moreover, geopolitical instability can subtly erode trust in the quality of care. Patients may fear that in a crisis, healthcare resources could be diverted, medical staff might be overstretched, or the focus on international patient care might diminish. Concerns about post-operative care and emergency repatriation also intensify. If travel routes are disrupted, the ability to return home safely or access follow-up care becomes a significant worry. This holistic view of risk, encompassing travel, treatment, and recovery, shapes patient decision-making and can lead to a shift in preference towards destinations perceived as more stable, even if they come at a higher cost or with longer waiting times. ### Is Medical Tourism a Sustainable Solution to Global Healthcare Disparities? In an ideal world, medical tourism would be obsolete, as healthcare would be universally accessible, affordable, and equitable. However, as we have often contended, medical tourism exists as a symptom of global health inequality, a necessary recourse for individuals facing immense distrust in their domestic healthcare systems, prohibitive costs, or prolonged waiting times. The question of its sustainability as a solution to these disparities is complex, particularly in light of geopolitical volatility. While medical tourism offers immediate relief to individual international patients by providing access to otherwise unattainable care, its systemic sustainability is debatable. The current Middle Eastern conflicts vividly demonstrate that reliance on cross-border healthcare is inherently vulnerable to external shocks. When travel is disrupted, or perceived risks escalate, the very pathways designed to address disparities can become inaccessible. This fragility suggests that medical tourism, while vital for many, cannot be the sole or primary long-term solution to fundamental healthcare inequalities. It addresses the symptom, not the root cause. Sustainable solutions would necessitate systemic reforms within national healthcare systems, including improved resource distribution, more equitable pricing strategies for medications and treatments, and robust regulatory frameworks that prioritize patient access and safety. The pharmaceutical industry, for instance, despite being heavily lobbied, can quickly adapt to changes in regulation, as it primarily involves importing products. However, changing entire healthcare delivery systems and behaviors is a far more arduous task. Therefore, while medical tourism will undoubtedly continue to serve a critical function for individuals, its sustainability as a solution to global healthcare disparities will remain limited until the underlying systemic issues that necessitate such travel are adequately addressed by national and international bodies. The industry’s role, in our view, is to operate with the highest integrity and responsibility within this imperfect world, providing a crucial service while advocating for a future where its necessity diminishes. ## Future Trajectories: Adapting to Instability in International Patient Care The ongoing geopolitical instability in the Middle East serves as a stark reminder that the future of international patient care, encompassing medical tourism, health tourism, and wellness tourism, will be defined by adaptability and resilience. The industry cannot afford to operate with static models; instead, it must proactively anticipate and respond to global shifts. This forward-looking perspective requires significant investment in infrastructure, technology, and strategic partnerships, all aimed at mitigating risks and ensuring continuity of care for international patients. One critical trajectory involves the further integration and sophistication of digital health solutions. While teleconsultations have already proven invaluable during the current crisis, future advancements will likely see more comprehensive virtual care models, remote monitoring technologies, and AI-driven diagnostic tools becoming standard components of the medical travel journey. These innovations can reduce the need for initial physical travel, facilitate pre- and post-operative care, and offer ongoing support regardless of geographical barriers. Such technological advancements will not only enhance patient convenience but also build a more resilient system less susceptible to physical travel disruptions. The ability to consult with specialists, receive second opinions, and even manage aspects of recovery remotely will be key to sustaining cross-border healthcare in an unpredictable global environment. Another crucial aspect of future adaptation lies in market diversification and the establishment of robust, redundant patient corridors. As seen with India’s pivot towards Southeast Asia, Africa, and Central Asia, relying heavily on a single region for patient sourcing is a significant vulnerability. Healthcare providers and destination nations must actively cultivate relationships and marketing efforts across a broader spectrum of countries, ensuring that disruptions in one area do not cripple their international patient programs. This involves understanding diverse cultural needs, establishing local representation, and forging partnerships with referral networks in multiple geographies. Furthermore, advocating for direct flight routes that bypass volatile transit hubs will be essential for creating more resilient travel pathways for international patients. Finally, the industry must continue to champion ethical practices, transparent pricing, and verifiable quality standards. In a landscape where geopolitical risks amplify patient anxieties, trust becomes an even more precious commodity. Robust accreditation, clear communication about potential risks, comprehensive pre-travel information, and strong patient advocacy will be paramount. By adhering to the highest standards of integrity and responsibility, the medical tourism sector can reinforce its value proposition, assuring international patients that even in an imperfect world, their well-being remains the utmost priority. The future of international patient care is not merely about adapting to instability but about building a more trustworthy, accessible, and resilient global healthcare ecosystem. ### What Innovations and Policy Changes Could Mitigate Geopolitical Impacts on Health Tourism? Mitigating the impacts of geopolitical instability on health tourism demands a multi-pronged approach involving both technological innovations and strategic policy changes. On the innovation front, the rapid advancement of telemedicine and remote care platforms is paramount. Moving beyond simple teleconsultations, the development of sophisticated virtual care ecosystems that can support diagnostics, treatment planning, and even post-operative monitoring will significantly reduce the necessity for initial physical travel. Technologies like augmented reality (AR) for remote surgical assistance or virtual reality (VR) for pre-surgical patient education could enhance the quality of remote engagement. Furthermore, blockchain technology could be leveraged to create secure, interoperable health records, ensuring seamless transfer of patient data across borders, which is crucial when traditional travel documents or physical records might be compromised. From a policy perspective, governments and international bodies have a critical role to play. There is an urgent need for bilateral and multilateral agreements that facilitate medical travel during crises, such as fast-track visa processes for international patients seeking urgent care or agreements that guarantee medical evacuation routes. Policies promoting direct flight connectivity between patient-source and destination countries, bypassing volatile transit hubs, would also enhance resilience. Regulatory bodies could also establish international standards for medical tourism, ensuring quality assurance and patient safety regardless of geopolitical shifts. This includes harmonizing medical liability laws and creating clear frameworks for cross-border medical claims, which would instill greater confidence in international patients. Furthermore, incentivizing healthcare providers to invest in crisis-resilient infrastructure, such as redundant power supplies and secure communication networks, could be crucial. ### How Can Destinations Build Resilience in an Unpredictable Global Environment? Building resilience in medical tourism destinations within an unpredictable global environment requires a strategic blend of diversification, technological integration, and robust risk management. Firstly, destinations must actively diversify their patient sourcing markets, avoiding over-reliance on any single region, as exemplified by India’s pivot. This involves targeted marketing and outreach to emerging markets, coupled with cultural sensitivity and language support tailored to new patient demographics. Such diversification acts as a buffer against regional downturns, ensuring a more stable inflow of international patients. Secondly, investing heavily in digital infrastructure for telemedicine and remote patient management is no longer optional but essential. This includes secure data management systems, high-speed internet connectivity, and platforms that support comprehensive virtual consultations and follow-up care. These technologies not only enhance accessibility but also reduce the impact of travel disruptions, allowing continuity of care even when physical movement is restricted. Moreover, fostering local medical expertise and research capabilities can reduce dependence on external resources, making the healthcare system more self-sufficient and resilient. Finally, robust risk management and crisis communication strategies are vital. This involves developing clear protocols for responding to geopolitical events, including contingency plans for patient travel, accommodation, and emergency medical services. Destinations should establish transparent communication channels with international patients, providing real-time updates on travel advisories, safety measures, and alternative arrangements. Collaborating with international travel insurance providers and medical assistance companies can also enhance patient security and peace of mind. By proactively addressing potential risks and building adaptable systems, medical tourism destinations can better navigate the complexities of an unpredictable global landscape and maintain their appeal for international patients. ## Key Takeaways for Global Medical Tourism Stakeholders The impact of the Middle East’s geopolitical situation on global medical tourism is profound and multifaceted, necessitating strategic adaptation from all industry stakeholders. Here are the critical takeaways: Disrupted Patient Flows: Geopolitical instability, particularly in the Middle East, directly hampers patient travel, leading to significant reductions in international patient arrivals for major medical tourism destinations like India, which has seen a 50-75% drop from the region. Financial Strain: Middle Eastern patients often represent a high-value segment, making their absence a significant financial blow to hospitals, impacting revenue and profitability margins. Some hospitals anticipate 10-15% revenue drops. Strategic Diversification: Healthcare providers are actively pivoting to new markets such as Southeast Asia, Africa, and Central Asia to mitigate losses and build more resilient patient sourcing strategies. Logistical Challenges: Disruptions in major Middle Eastern aviation hubs affect not only regional patients but also those from other continents who rely on these hubs for connecting flights, creating widespread logistical hurdles. Rise of Telemedicine: Teleconsultation and remote second-opinion services are crucial for maintaining patient engagement and continuity of care when physical travel is constrained. Heightened Risk Perception: Geopolitical instability amplifies patient concerns about safety, quality of care, and post-operative support, influencing destination choices and potentially deterring medical travel. Sustainability Questioned: While medical tourism addresses individual healthcare disparities, its systemic sustainability as a solution is vulnerable to global shocks, highlighting the need for broader healthcare reforms. Need for Resilience: Future success hinges on technological innovation (advanced virtual care), market diversification, robust risk management, and strong ethical practices to build a more adaptable and trustworthy global healthcare ecosystem. ## Conclusion: Navigating a New Era for International Patient Care The geopolitical turbulence emanating from the Middle East has unequivocally ushered in a new era for international patient care, fundamentally challenging the established paradigms of medical tourism. The dramatic slowdown in patient flows, particularly from the high-value Middle Eastern markets, underscores the inherent fragility of a globalized healthcare system reliant on stable international travel. This situation has not merely presented a temporary setback but has ignited a profound re-evaluation of how medical tourism destinations, healthcare providers, and international patients navigate an increasingly unpredictable world. In our view, the events of recent months serve as a potent reminder that medical tourism, while a vital necessity for many, is a symptom of deeper global healthcare inequities. Its continued existence demands not only operational excellence but also a constant, ethical vigilance. The industry’s rapid pivot towards new markets in Africa, Southeast Asia, and Central Asia, coupled with the accelerated adoption of teleconsultation services, demonstrates an impressive capacity for adaptation. However, these shifts also highlight the urgent need for more resilient logistical frameworks and diversified patient corridors that are less susceptible to regional conflicts and airspace disruptions. Looking forward, the future of health tourism will be shaped by a continuous interplay of technological innovation, strategic policy-making, and an unwavering commitment to patient safety and quality. For stakeholders across the global healthcare spectrum, the imperative is clear: invest in robust digital health infrastructure, advocate for international agreements that facilitate safe medical travel, and foster a culture of transparency and trust. By doing so, the industry can build a more resilient and equitable system, ensuring that even amidst global uncertainties, the fundamental human need for accessible and competent medical care can continue to be met across borders. The journey of medical tourism is evolving, and its path forward requires collective foresight and unwavering dedication to its core mission. Sources (1) Travel And Tour World ### The Wire Aug 30This Week in Medical Tourism: 20–26 August 2026 Aug 29This Week in Medical Tourism: 13–19 August 2026 Aug 22South Korea Undercuts America but Not Turkey All coverage ### Newsletter Get weekly health tourism intelligence in your inbox. Subscribe ### Knowledge Hub Medical Tourism Wellness Tourism Dental Tourism Fertility Tourism Cosmetic Tourism Longevity Tourism Explore the Hub Stay informed on the latest in global health tourism. Subscribe to our Newsletter ## Related Articles Medical Tourism 22 AUG 2026 Medical Tourism ### Mexico and Turkey Price Against Different Home Markets August 22, 2026 Medical Tourism 22 AUG 2026 Medical Tourism ### Turkey's Deepest Discounts Sit on Its Safest Procedures August 22, 2026 Medical Tourism ### Why Medical Tourism to Germany Declined August 11, 2026 --- # Nigeria, Iran And Seoul Redraw Medical Tourism URL: https://health-tourism-news.com/news/nigeria-iran-and-seoul-redraw-medical-tourism/ Weekly Digest July 1, 2026 Weekly DigestDental TourismLongevity TourismWellness TourismMedical Tourism Nigeria, Iran And Seoul Redraw Medical Tourism This is the Health Tourism News roundup for the week of 24 to 30 June 2026, and it read less like a sales pitch than a stocktake of leaks. Nigeria wants its... Christian El-Khouri Editor-in-Chief Published July 1, 2026 · 7 min read This is the Health Tourism News roundup for the week of 24 to 30 June 2026, and it read less like a sales pitch than a stocktake of leaks. Nigeria wants its people to stop leaving. Iran wants to sell abroad instead of waiting at home. A British man’s ruined teeth supplied the week’s price tag for getting it wrong. The word I kept waiting for was cost, and it barely came up; the talk was all workforce, quality and digital plumbing. ## Nigeria moves to stop its medical tourism outflow Nigeria spent the week trying to plug an outflow rather than chase an inflow. Vanguard reported Professor Smaranda Olarinde, Vice Chancellor of Afe Babalola University, using the hospital’s 50th kidney transplant to argue that medical tourism shrinks only when health workers are paid, protected and given room to grow, not when another scanner arrives. Her hospital also signed a deal with Manipal Hospitals of India, where urologist Dr Rajeev Sood recalled the pandemic teaching governments that flying a patient out can vanish overnight. Akwa Ibom made the bigger gesture, covered by Businessday. Governor Umo Eno unveiled a 100-hectare medical city, a ten-storey block of 62 specialities, built expressly to keep patients from boarding planes. The state says it has hired 2,844 health workers since March 2025 and will train 100 more abroad before the doors open. Nobody on the podium said the awkward part out loud. A tower full of equipment is worthless if the people meant to run it have already emigrated, and Olarinde was the only speaker pointing at that risk instead of the ribbon. Copy the partnership, skip the tower. Manipal drops skills into a hospital that already works, costs a sliver of a medical city, and any state could do the same next year. Concrete is the easy part. Keeping the surgeon is the hard one. ## Iran, Korea and Malaysia turn medical tourism outward Three other governments looked outward, not in. Tehran Times reported Iran’s chamber of commerce tourism commission, through Seyyed Mostafa Mousavi, arguing the country has run the import model too long. The new plan is to export: build joint clinics in Iraq, Afghanistan, Azerbaijan and Pakistan, post Iranian specialists abroad, and consult patients before they cross a border. Mousavi admits Iran is bleeding share of the Iraqi market, its biggest, for want of a local presence. His colleague Mohammad Jahangiri sketched a Shiraz, Mashhad and Qom golden triangle aimed at the Muslim-majority pilgrimage-and-treatment market, citing meeting-floor figures that put the global sector above $50 billion in 2024 and near $200 billion within a decade. Two more deals pointed the same way. The Asia Business Daily reported the first Korea-China service trade council in Beijing, which pledged to smooth medical-tourism information for rising Chinese patient numbers, while DayakDaily caught Malaysia and Vietnam in Macau agreeing to push medical and halal tourism together. So which of these is real strategy, and which is a press release? Iran’s reads like strategy. Exporting clinicians hedges against the two things that strand its inbound model, sanctions and shut borders, and any facilitator working Iraqi patients can expect an Iranian-run clinic nearby within a year or two. Halal is the part worth watching. Pair certified halal hospitality with a credible operating theatre and you reach a devout, high-spending market the big Asian hubs barely court. ## Dental tourism’s £40,000 warning and the workforce answer The week’s grimmest number came from dental tourism. Streamlinefeed told the story of Danny Tomlinson, 47, from Southend-on-Sea, who flew abroad in 2020 to have healthy teeth filed to pegs for a set of Turkey Teeth crowns. The £3,900 he paid became a £40,000 rebuild at home, after nine return trips and a parting £12,500 quote to patch work already failing. Kenya’s dental regulator, the report noted, keeps warning as East Africans chase cut-price cosmetic work in Turkey, India and the Middle East. Bulgaria went the slow way instead. BTA covered a cooperation memorandum between the country’s rheumatology professionals and its balneology and spa-tourism union, signed in Sofia, to lift staff qualifications to European standards and make proper use of its mineral springs. Tomlinson’s final bill settles the argument. It does not land on the clinic that filed his teeth down. It lands on him, then on the home system that has to rebuild his mouth. Every cut-price cosmetic destination is quietly subsidised this way. Is the saving worth the gamble? Is the clinic still there when the work fails? Who pays when it does? Tomlinson now knows all three answers. Dr Vladimira Boyadzhieva’s pitch in Sofia, certify the workforce before you sell the springs, is slower, less photogenic, and the only version of this trade that survives a complication. ## Wellness tourism climbs the longevity and luxury ladder Wellness tourism kept climbing the price ladder. Luxury Travel Magazine pegged the global wellness economy at $6.8 trillion, twice its 2013 size, the travel slice growing about a tenth a year to 2028, as high-end retreats swap scented candles for genetic testing, metabolic profiling and hyperbaric oxygen. The premium guest, it argued, now treats health as an investment rather than a luxury. The same trend reached the cabin. BriefGlance reported EVA Air winning a drinks award in a brand-new wellness, no and low category for a non-alcoholic sparkling, courting the sober-curious traveller as the Taiwanese carrier opens a Washington route. The longevity push quietly changes who a wellness resort is up against. A spa that sells massage competes with the spa next door. A retreat that sells diagnostics, a resident physician and a healthspan programme is competing with clinics, and prices like one. Without that clinical backbone, a property keeps the weekend guest and loses the high-value patient to one that hands them data. EVA Air’s small trophy sits in the same logic. In-flight wellness is becoming a booking reason, and a carrier on long-haul treatment routes would do well to treat the cabin as part of the cure. ## Jordan and Seoul bet on AI-driven medical tourism The digital layer is where the contenders separated this week. Ammon News ran an opinion piece by Lubna Hanna Ammari arguing Jordan could become the region’s smart medical-tourism hub by marrying AI, with a nod to diagnostic studies in The Lancet Digital Health, to its assets at the Dead Sea and Ma’in Hot Springs. The Korea Times reported Seoul readying its International Tourism Forum, where some 900 delegates will debate a turn from sheer visitor volume toward higher-yield trade, medical tourism among it, on the back of faster visas, quicker payments and AI-run event marketing, while keeping the overtourism that hollowed out Kyoto and Venice at bay. Ammari’s piece is an aspiration, and that is its weakness. Any ministry can commission the same essay. Whoever ships working software first wins; the prose counts for nothing. Seoul is further along because it named the dull obstacle, the visa queue and the payment that will not clear, instead of the scenery. That is the unglamorous part of it. The destinations that moved this week were fixing paperwork and data pipes, and a health ministry still selling mountains and low prices is a decade behind. ## What This Means One thread holds the week together, and it is not price: medical tourism has stopped being a simple race to gather the most patients. Nigeria is trying to keep its own. Iran is trying to sell abroad. Korea wants to vet who arrives, Seoul wants fewer and richer visitors, and a man in Essex is the warning stapled to all of it. Everyone is steering the flow, in opposite directions, with the same instrument: the quality of their people and their systems. Price has slipped to the back of the room. I would watch the next six months for which wager clears first, Akwa Ibom’s tower, Iran’s clinics in Iraq, or Seoul’s faster visa lane. I would put money on the country that fixes the dull machinery over the one that opens the grandest building. Sources (11) Bta Koreatimes Tehrantimes Vanguard Dayakdaily Streamlinefeed Luxurytravelmagazine Ammonnews Businessday Briefglance Asiae BulgariaIranIraqAfghanistanAzerbaijanPakistanNigeriaIndia ### The Wire Aug 30This Week in Medical Tourism: 20–26 August 2026 Aug 29This Week in Medical Tourism: 13–19 August 2026 Aug 22South Korea Undercuts America but Not Turkey All coverage ### Newsletter Get weekly health tourism intelligence in your inbox. Subscribe ### Knowledge Hub Medical Tourism Wellness Tourism Dental Tourism Fertility Tourism Cosmetic Tourism Longevity Tourism Explore the Hub Stay informed on the latest in global health tourism. Subscribe to our Newsletter ## Related Articles Weekly Digest 30 AUG 2026 Weekly Digest ### This Week in Medical Tourism: 20–26 August 2026 August 30, 2026 Weekly Digest 29 AUG 2026 Weekly Digest ### This Week in Medical Tourism: 13–19 August 2026 August 29, 2026 Cosmetic Tourism 22 AUG 2026 Cosmetic Tourism ### South Korea Undercuts America but Not Turkey August 22, 2026 --- # Assocham Symposium Pitches Northern India Wellness URL: https://health-tourism-news.com/news/northern-india-assocham-symposium-2026-discusses-health-tourism-and-wellness/ Wellness Tourism May 7, 2026 Wellness TourismMedical Tourism Assocham Symposium Pitches Northern India Wellness Assocham's third Health, Beauty and Wellness Symposium in Chandigarh talked up medical tourism and AYUSH but announced no funding. Christian El-Khouri Editor-in-Chief Published May 7, 2026 · Updated July 9, 2026 · 4 min read Assocham organised the third Health, Beauty and Wellness Symposium in Chandigarh, bringing officials, health experts and industry figures together to discuss health care, wellness and medical tourism, Devdiscourse reported. The event was pitched as a platform for regional and national health priorities, and its speakers returned again and again to preventive care, wellness and the AYUSH systems of traditional medicine. No investment figure and no funded programme were announced, and the report named none. ## Government priorities at the symposium Punjab Governor and Union Territory Administrator Gulab Chand Kataria attended as chief guest. Kataria called for “collective efforts towards building a TB-Free India” and for a drug-free Punjab, Devdiscourse reported. He acknowledged Assocham’s support for Chandigarh’s TB-Free drive and urged stakeholders to help tuberculosis patients through awareness, nutrition and treatment programmes. He also honoured industry members for their work in the sector, the report said. The public-health themes Kataria raised were domestic ones. TB control and drug-addiction campaigns sit inside India’s own health system, and neither was tied in the reporting to a plan for foreign patients. That gap ran through the day. The symposium talked up medical tourism as a goal and preventive care as a selling point, but it set out no costed route from the one to the other. ## Industry speakers and the northern India pitch Manik Batra, who chairs the Assocham JK council, made the sharpest medical tourism case, pointing to health tourism and wellness across northern India. Other council figures spoke on jobs and investment in preventive care and pressed for closer work between industry and government, and an Ayurveda expert argued for holistic wellness. The northern India framing matters because the region is trying to position itself against established hubs further south. Uttar Pradesh has made a comparable pitch, pushing wellness and medical tourism alongside MICE events, and the Chandigarh symposium leaned on the same combination of traditional medicine and preventive care. Whether any of it converts into arrivals depends on capacity that a conference cannot supply. ## AYUSH, sessions and the accreditation question The symposium ran three sessions, Devdiscourse reported. One covered wellness policies and AYUSH, one the role of artificial intelligence and startups in preventive care, and one women’s leadership and enterprise. AYUSH, India’s umbrella for traditional medicine, was the thread through the day, offered as the thing that sets India’s wellness pitch apart from the cheaper surgical hubs in the rest of Asia. That pitch is not new. India’s traditional-medicine systems have been marketed abroad for years, and Ayurveda in particular has gone global as a wellness draw. The harder part is trust. Foreign patients and their insurers weigh accreditation, and AYUSH clinics that want foreign custom face the same questions on quality as any hospital. A symposium can name the opportunity. It cannot certify a single treatment room. There is a settled way to read events like this one. In medical tourism an announcement is not capacity, and a conference is the cheapest announcement of all. India’s headline numbers are large, with the country’s medical tourism market projected to nearly double to 16.2 billion US dollars by 2030 on the strength of AYUSH and easier medical visas, but those forecasts rest on hospitals, accreditation and air links rather than on the count of symposiums held. The Chandigarh event produced dialogue and an awards ceremony. It did not produce a bed, a certification or a funded corridor. ## What to watch The test is whether the talk in Chandigarh leaves a paper trail. Watch for a costed northern India wellness or medical tourism scheme with a budget line, rather than another symposium. Watch for AYUSH facilities in the region seeking NABH or equivalent accreditation aimed at foreign patients. And watch whether Assocham or the state governments publish arrival or revenue figures for northern India, because until they do, the region’s medical tourism case rests on the speeches its own councils gave. Sources (2) Devdiscourse TravTalk India IndiaChandigarhPunjabWellness TourismAYUSHMedical TourismAssocham ### The Wire Aug 30This Week in Medical Tourism: 20–26 August 2026 Aug 29This Week in Medical Tourism: 13–19 August 2026 Aug 22South Korea Undercuts America but Not Turkey All coverage ### Newsletter Get weekly health tourism intelligence in your inbox. Subscribe ### Knowledge Hub Medical Tourism Wellness Tourism Dental Tourism Fertility Tourism Cosmetic Tourism Longevity Tourism Explore the Hub Stay informed on the latest in global health tourism. Subscribe to our Newsletter ## Related Articles Medical Tourism 22 AUG 2026 Medical Tourism ### Mexico and Turkey Price Against Different Home Markets August 22, 2026 Medical Tourism 22 AUG 2026 Medical Tourism ### Turkey's Deepest Discounts Sit on Its Safest Procedures August 22, 2026 Medical Tourism ### Why Medical Tourism to Germany Declined August 11, 2026 --- # Aging Populations Will Drive Medical Travel Worldwide URL: https://health-tourism-news.com/news/not-just-canada/ Medical Tourism Aging Populations Will Drive Medical Travel Worldwide Canada's record surgery wait times are an early warning: aging populations will push patients across borders in most developed health systems. Ivan Rendulic Contributor Founder of ZagrebMed and President of the European Health and Medical Tourism Association (EHMTA). Over a decade facilitating international patients and shaping cross-border healthcare initiatives from Croatia. Read more Published July 23, 2025 · Updated July 2, 2026 · 2 min read Reviewed by Christian El-Khouri, Editor-in-Chief I’ve been closely following the healthcare headlines coming out of Canada recently. Record wait times. Backlogs in hip and knee surgeries. An overwhelmed system trying to keep up with an aging population. For those of us in medical tourism, this isn’t just another news cycle. It’s a sign of something much bigger and much more global. Canada is not an exception. It’s the early warning. ## A Predictable Pattern Across Aging Nations Across the world, countries with aging populations are witnessing a predictable yet complex pattern. More people are living longer, which is undeniably a success story. But with longevity comes a rise in chronic conditions, joint replacements, and time-sensitive surgeries. The result? Overstretched healthcare systems, resource bottlenecks, and growing delays for care that can’t wait. The trend is clear. It starts with demographics: lower birth rates and higher life expectancy. Then comes increased demand for orthopedic, cardiac, and ophthalmologic interventions. Then it hits hard limits: not enough surgeons, not enough beds, not enough time. The COVID pandemic only worsened the backlog. ## Not Just Canada: A Worldwide Trend OECD research shows it’s not just Canada. The UK’s NHS has over six million people waiting. Australia’s elective surgery queues are stretched thin. Sweden, Norway, New Zealand - all are reporting similar stories. Even in high-tech healthcare systems like Japan and South Korea, aging is moving faster than infrastructure can adapt. ## Why This Could Fuel Outbound Medical Travel I believe this shift could directly fuel the next wave of outbound medical travel. It’s no longer about affordability alone. Now it’s also about time. Patients aren’t just priced out. They’re timed out. When waiting six months for a knee replacement in your home country becomes the norm, a three-week trip abroad starts to make sense. Not as a luxury, but as a necessity. ## A Responsibility for the Medical Tourism Industry For those of us in this industry, this is our moment to act responsibly. To build trust, quality standards, and cultural bridges. Patients don’t want to feel like tourists. They want to feel cared for, seen, and understood. That’s where we come in. As aging continues to challenge domestic systems, cross-border care will evolve from an alternative into a parallel track. Efficient, high-quality, human-centered. And more important than ever. ### The Wire Aug 30This Week in Medical Tourism: 20–26 August 2026 Aug 29This Week in Medical Tourism: 13–19 August 2026 Aug 22South Korea Undercuts America but Not Turkey All coverage ### Newsletter Get weekly health tourism intelligence in your inbox. Subscribe ### Knowledge Hub Medical Tourism Wellness Tourism Dental Tourism Fertility Tourism Cosmetic Tourism Longevity Tourism Explore the Hub Stay informed on the latest in global health tourism. Subscribe to our Newsletter ## Related Articles Medical Tourism 22 AUG 2026 Medical Tourism ### Mexico and Turkey Price Against Different Home Markets August 22, 2026 Medical Tourism 22 AUG 2026 Medical Tourism ### Turkey's Deepest Discounts Sit on Its Safest Procedures August 22, 2026 Medical Tourism ### Why Medical Tourism to Germany Declined August 11, 2026 --- # Priced Out: Tariffs Could Push Americans Abroad for Care URL: https://health-tourism-news.com/news/priced-out/ Medical Tourism Priced Out: Tariffs Could Push Americans Abroad for Care US tariffs on medical imports are adding new cost pressure to the world's most expensive healthcare system, and more Americans are weighing treatment abroad. Ivan Rendulic Contributor Founder of ZagrebMed and President of the European Health and Medical Tourism Association (EHMTA). Over a decade facilitating international patients and shaping cross-border healthcare initiatives from Croatia. Read more Published June 30, 2025 · Updated July 2, 2026 · 3 min read Reviewed by Christian El-Khouri, Editor-in-Chief ## Priced Out: How Tariffs Could Push Americans Abroad for Care America’s healthcare system has always walked a tightrope between innovation and cost. With some of the most advanced facilities in the world, the U.S. also bears the weight of the highest healthcare prices globally. And now, with new tariffs on medical imports entering the picture, we may be watching the final straw take shape - one that nudges more Americans to seek care beyond their own borders. But let me be clear: this shift isn’t just about price. I’ve worked with many American patients over the years, and the truth is, price is rarely the sole motivator. Yes, it matters - but it’s never enough. What they need - what anyone needs - is presence, trust, precision, and delivery. And right now, the U.S. system is offering less of that and charging more for it. The 2025 introduction of a 10% universal import tariff (with even higher rates on goods from specific countries) has cast a long shadow over medical devices and supplies. Pharmaceuticals were exempt, but equipment and materials critical to surgery, diagnostics, and rehabilitation were not. The result? Increased costs for hospitals, clinics, and eventually, patients. It’s a ripple effect that touches everything from knee replacements to imaging equipment to the instruments in an operating room. But here’s where things get nuanced. Every country targeting international patients has the U.S. on its radar - it’s the big game. The outbound medical tourism market from North America is projected to exceed $600 billion by 2032. Yet despite that figure, fewer than half of Americans even have a passport. The real opportunity lies not in volume, but in depth - in how you show up for the patients who do choose to leave home for care. Throwing price differentials in their face doesn’t work. That’s a tired pitch. Instead, what resonates is a provider who listens, anticipates, and guides. Americans expect responsiveness, structure, and authenticity. You have to be proactive. You have to care about the details before they even bring them up. And in the end, you have to deliver more than promised. That’s not just the American market - that’s every patient, everywhere. So, while these tariffs might escalate the cost equation and turn more heads toward global options, the real game-changer won’t be economic. It will be experiential. Providers who understand this - who focus less on undercutting prices and more on overdelivering trust - are the ones who will win in the long run. This moment, in all its complexity, might finally be what shifts medical travel from a contingency plan into a considered decision for more Americans. And not just because care is cheaper somewhere else - but because it might actually feel better, be better, and deliver better. Sources (1) Future Market Insights ### The Wire Aug 30This Week in Medical Tourism: 20–26 August 2026 Aug 29This Week in Medical Tourism: 13–19 August 2026 Aug 22South Korea Undercuts America but Not Turkey All coverage ### Newsletter Get weekly health tourism intelligence in your inbox. Subscribe ### Knowledge Hub Medical Tourism Wellness Tourism Dental Tourism Fertility Tourism Cosmetic Tourism Longevity Tourism Explore the Hub Stay informed on the latest in global health tourism. Subscribe to our Newsletter ## Related Articles Medical Tourism 22 AUG 2026 Medical Tourism ### Mexico and Turkey Price Against Different Home Markets August 22, 2026 Medical Tourism 22 AUG 2026 Medical Tourism ### Turkey's Deepest Discounts Sit on Its Safest Procedures August 22, 2026 Medical Tourism ### Why Medical Tourism to Germany Declined August 11, 2026 --- # Recap: SITMMT 2024 in Seoul, South Korea URL: https://health-tourism-news.com/news/recap-sitmmt-2024-in-seoul-south-korea/ Medical Tourism Recap: SITMMT 2024 in Seoul, South Korea Guest contributor Christian El-Khouri on how Korea continues to advance their medical tourism leadership Christian El-Khouri Editor-in-Chief Editor-in-Chief of Health Tourism News. Twelve-plus years across international patient services, healthcare consulting, and destination development in Europe, the Middle East, and beyond. Co-Founder and Vice President of the European Health and Medical Tourism Association (EHMTA). Read more Published October 1, 2024 · 5 min read It was a privilege to have been invited to the Seoul International Travel Mart for Medical Tourism this September. An event, with a strong focus on Korean healthcare providers and their connections to foreign markets. Organized by the Seoul Tourism Organisation and the Seoul Metropolitan Government, the event certainly was something the organizers should take pride in. Korean healthcare providers are lucky to have the backing of official stakeholders that use their resources to promote the domestic health and medical tourism infrastructure. ## South Korea as a medical tourism destination I am preparing a longer piece on the rise of Korea in health and medical tourism and the approach they have chosen to get to and stay at the pinnacle of the industry. For this piece, a few details shall give readers new to the industry and region a good idea about where South Korea stands. Within a bit more than 10 years, South Korea has managed to 10x their inbound medical tourists, a feat not accomplished by many destinations. This would not have been possible without a determined strategic approach and careful implementation of the chosen techniques and systems. The next graph sheds some light on the origin of the most common medical tourists in South Korea. ## About SITMMT 2024 It’s easy to tell that South Korea certainly delivered on their ambition to become a leading medical tourism destination - something I also eluded to in my remarks and toast as the buyer’s representative during the first evening’s dinner. My follow-up piece on national medical tourism strategies will go into the larger-scale efforts and mechanisms that drove the destination’s success. Still, it makes sense to look at SITMMT 2024 in isolation and derive conclusions as to what makes it a great event. Clear target and understanding of successThe event intends to promote local healthcare providers to international stakeholders, medical tourism facilitators and travel agencies. Promoting domestic providers is the target; this is made clear to all participants. The event is unambiguous in what visitors can and should expect, ensuring an alignment of expectations. It also allows attendees to plan and prepare accordingly. The conference design follows the targetThe conference design is heavily informed by the organizer’s aim. International buyers are invited to meet with local sellers primarily*. Every buyer is placed in their own booth, and appointments are made prior to the event through an online platform. The platform, albeit a bit slow, serves is purpose to let both sides search for counterparts in the industries and regions they are interested in and lets them schedule meetings during the conference times.Buyers won’t have to find their way through the booths, they can stay in place while every 20 minutes another seller presents themselves to them. It is enough time for mutual introductions, establish initial interest in cooperation and discuss follow-up engagements.The organizers also provide an interpreter to each buyer who stays with them throughout all meetings and aids in communication. Great planning and follow-throughAnyone who has experienced a well-organised event will understand the point I am making here. Having a team of diligent staffers that keep conference guests appraised of all details and next steps to ensure nobody misses any relevant events or gets left behind is worth so much. It ensures that the plans that have been established are followed through with and thus capture the goal of the event in its execution. The organizers of SITMMT 24 understood the task and delivered on it. Any questions I had before or during the event were swiftly responded to and taken care of. Willingness to investThe organizers of SITMMT 24 understand return on investment (ROI). Besides general conference expenditures, they also financed the attendance of a couple of choice buyers. By doing so, they succeeded in at least two ways. First, the obvious one is to attract as many foreign buyers as possible. On another level, they manifest South Korea as a serious place for business with high intent and reflect positively on their companies. They have managed to do both, and they understand that this investment will be returned manifold in the future through the various cooperations that will be established as a consequence of their approach. Their investment will pay off through future medical tourism and general tourism returns. Motivated and keen organisersI had the chance to speak with the organizers of the event, the Seoul Metropolitan Government and Seoul Tourism Organisation. The sincerity of their ambition and conviction in the country’s ambitions were tangible. Great leadership is often a prerequisite to success in large-scale efforts, and without building conviction amongst every rung, it is hardly achieved. I had the chance to meet and chat with the event organisers, the Seoul Metropolitan Government and Seoul Tourism Organisation. A fantastic set of ambitious people with significant convictions. The only things I missed during the event were opportunities and presentations on medical tours in general, best practices, outstanding cases and the industry’s systems and techniques. This could have been done without compromising the event’s goals. But at the same time it also depends on the attendees, whether they are interested in hearing and engaging in these conversations. Even in light of that, the event was outstanding. SITMMT 24 was a success. Both, I am sure for the attendees, but also for the organizers. The vision South Korea has manifested a bit over a decade ago is being continuously and tirelessly pursued and upheld. The event was a best-practice example of a medical tourism event. I was delighted that no “fake” awards were handed out - a phenomenon now all too common and most accurately described as a scam. *I am not a friend of the industry’s usage of “buyer” and “seller” in medical tourism. Generally, a seller refers to healthcare providers (hospitals, clinics, etc.) and buyers to those commissioning their healthcare services (patients, agencies, facilitators, insurance companies). While this allows for clear definitions and definitions, I think it misses the nuances. ### The Wire Aug 30This Week in Medical Tourism: 20–26 August 2026 Aug 29This Week in Medical Tourism: 13–19 August 2026 Aug 22South Korea Undercuts America but Not Turkey All coverage ### Newsletter Get weekly health tourism intelligence in your inbox. Subscribe ### Knowledge Hub Medical Tourism Wellness Tourism Dental Tourism Fertility Tourism Cosmetic Tourism Longevity Tourism Explore the Hub Stay informed on the latest in global health tourism. Subscribe to our Newsletter ## Related Articles Medical Tourism 22 AUG 2026 Medical Tourism ### Mexico and Turkey Price Against Different Home Markets August 22, 2026 Medical Tourism 22 AUG 2026 Medical Tourism ### Turkey's Deepest Discounts Sit on Its Safest Procedures August 22, 2026 Medical Tourism ### Why Medical Tourism to Germany Declined August 11, 2026 --- # Wellness Tourism Trends: What Clients Actually Want URL: https://health-tourism-news.com/news/rising-patient-demand/ Wellness Tourism Wellness Tourism Trends: What Clients Actually Want Today's wellness travelers are informed, proactive seekers of measurable well-being. These are the demand trends reshaping wellness tourism. Kevin Ciresi Contributor A career spanning the operating room to the boardroom. Former surgeon who founded and led multiple U.S. healthcare facilities, now focused on transparent frameworks for international care and blue-zone wellness destinations. Read more Published January 2, 2026 · Updated July 2, 2026 · 6 min read Reviewed by Christian El-Khouri, Editor-in-Chief On the consumer side, there has been a discernible shift in what patients and wellness travelers want and need. Today’s clients are informed, proactive seekers of well-being rather than passive recipients of care or generic spa services. Several demand trends have shaped integrative medicine and wellness tourism offerings in the past 5+ years: ## Prevention and Longevity Lead the Way Preventive Health and Longevity: Perhaps the strongest driver is the desire to maintain health and prevent disease before it develops. Extensive surveys show that an overwhelming majority of people (over 80% in the U.S., for example) now rank wellness and preventive self-care as a top life priority, according to hospitalityinsights.ehl.edu. This has led to a surge in interest in longevity medicine, anti-aging therapies, and regular health retreats. Consumers are asking not just “how do I treat this ailment?” but “how do I optimize my vitality and lifespan?” In response, clinics and resorts are offering longevity assessments, biological age testing, hormone optimization, and other preventive services. The anti-aging and longevity market was valued at around $37 billion in 2020 and is projected to grow by 22% annually through 2028, as patients increasingly request interventions like NAD+ supplements, nutraceuticals (e.g., resveratrol, CoQ10), and regenerative therapies to support healthy aging. Even wellness tourists are booking trips focused on life extension, for example, “Blue Zones”-inspired retreats that teach the lifestyle secrets of centenarians (more on this below). ## A New Focus on Mental Wellness Mental Wellness and Stress Relief: The mental health fallout from the pandemic and modern lifestyles has made stress reduction and emotional well-being a central concern for consumers. Anxiety and depression rates globally jumped ~25% during COVID’s peak. Travelers and patients alike are now seeking mindfulness, meditation, and other mind-body modalities to cope. **“Burnout travel” **and “recovery retreats” are trending, where guests engage in digital detoxes, nature therapy, and resilience workshops. Sales of mood-support supplements and demand for nutritional psychiatry consultations (using diet to improve mental health) have surged as well. For many wellness tourists, the ability to disconnect from technology, practice yoga or breathwork, and reset mentally is a primary motivation for their trip. In clinical settings, integrative practitioners report more patients asking about non-drug approaches for anxiety, chronic stress, and insomnia, reflecting a broader quest for mind-body balance. Providers have responded by integrating services such as meditation training, breathwork (e.g., box breathing exercises), and yoga therapy into their treatment plans. ## Active, Personalized, and Evidence-Based Care Active and Personalized Wellness Experiences: There is a notable shift away from the traditional notion of wellness travel as purely passive pampering (such as lying on a beach or receiving a basic massage). Instead, clients want immersive, active wellness experiences that yield personal growth or tangible health benefits. A recent industry study found a “newly emerging shift from traditional relaxation activities to active wellness” among travelers. This means more people are choosing vacations which includes fitness coaching, hiking in nature, healthy cooking classes, and learning mind-body skills, rather than just idle relaxation. Wellness tourists also crave authenticity and education - for example, retreats centered around learning yoga philosophy, practicing meditation in a monastery, or participating in local healing rituals. As one Greek wellness retreat planner put it, people come not just to de-stress but “to learn new things, evolve. and integrate newfound knowledge into everyday life”. Customization is key: travelers expect programs tailored to their individual needs (whether it’s a detox diet, a strength-training regimen, or a focus on spiritual counseling). This aligns with the broader healthcare trend of personalized medicine, as seen in functional medicine and genomic wellness programs that offer diet and supplement plans based on an individual’s metabolism or DNA. Evidence and Results: Another demand shift is that clients increasingly seek evidence-based offerings. The wellness space, historically plagued by fads, is experiencing a rise in consumer sophistication. Many wellness tourists now research destinations that can demonstrate credible outcomes - e.g., medical wellness resorts staffed by licensed doctors, or retreat programs designed by reputable experts. Savvy travelers ask about the science behind a program: Does this weight-loss retreat have data on average weight change? Can this clinic provide references or studies on the outcomes of their integrative cancer support? Likewise, patients in integrative clinics often inquire about clinical evidence for recommended supplements or therapies, reflecting a higher level of health literacy. This trend forces providers to raise the bar and incorporate outcome tracking and scientific validation into their services. It also explains the popularity of concepts like Blue Zone retreats (which market the fact that they’re based on epidemiological research of longevity hotspots) and the partnership of some resorts with academic institutions to study results. In short, today’s wellness consumers want results, not just vague promises - whether it’s measurable stress reduction, improved biometrics, or sustainable lifestyle changes when they return home. ## Higher Spending for Quality Results Higher Spending for Quality: Importantly, many consumers are willing to spend significantly more for these integrative, high-quality wellness experiences. In 2022, wellness tourists globally spent, on average, 175% more per trip than the typical international tourist. Luxury travel advisors report that nearly half of wellness-focused travelers are comfortable paying $5,000 - $10,000 or more for a single wellness vacation if it delivers transformative value. This willingness to invest in one’s health is also seen in medical contexts (patients paying out-of-pocket for functional medicine consults, advanced labs, or integrative oncology services not covered by insurance). For investors and providers, this underscores that the market segment of health-conscious consumers is relatively price-insensitive - they prioritize efficacy, safety, and comprehensiveness over bargain pricing. Particularly, Millennials and Gen Z cohorts are redefining spending norms: they outspend older groups on health and wellness products/services and place substantial value on experiences over material goods, hospitalityinsights.ehl.edu. This generational shift means the demand for integrative wellness is likely to continue rising in the coming decade, as these younger cohorts enter their peak earning years and continue to channel their disposable income into wellbeing. In summary, patients and wellness travelers today seek holistic, preventive, personalized, and meaningful health experiences. They want to actively participate in improving their well-being, prefer natural and lifestyle-based interventions when possible, and expect credible results. This demand profile is driving the industry toward more sophisticated, integrative offerings that blend medical expertise with spa hospitality and cultural authenticity. Sources (3) Fullscript To Vima Child Neurology Society ### The Wire Aug 30This Week in Medical Tourism: 20–26 August 2026 Aug 29This Week in Medical Tourism: 13–19 August 2026 Aug 22South Korea Undercuts America but Not Turkey All coverage ### Newsletter Get weekly health tourism intelligence in your inbox. Subscribe ### Knowledge Hub Medical Tourism Wellness Tourism Dental Tourism Fertility Tourism Cosmetic Tourism Longevity Tourism Explore the Hub Stay informed on the latest in global health tourism. Subscribe to our Newsletter ## Related Articles Weekly Digest 08 JUL 2026 Weekly Digest ### Medical Tourism Records Concentrate In Penang And Seoul July 8, 2026 Weekly Digest 01 JUL 2026 Weekly Digest ### Nigeria, Iran And Seoul Redraw Medical Tourism July 1, 2026 Weekly Digest 24 JUN 2026 Weekly Digest ### Health Tourism As Badge, Escape Hatch And Disguise June 24, 2026 --- # Saudi Arabia's Leap in Medical Tourism with World's First Fully Robotic Heart Transplant URL: https://health-tourism-news.com/news/saudi-arabia-s-leap-in-medical-tourism-with-world-s-first-fully-robotic-heart-transplant/ Medical Tourism Saudi Arabia's Leap in Medical Tourism with World's First Fully Robotic Heart Transplant Achievements in healthcare with impact beyond borders Christian El-Khouri Editor-in-Chief Editor-in-Chief of Health Tourism News. Twelve-plus years across international patient services, healthcare consulting, and destination development in Europe, the Middle East, and beyond. Co-Founder and Vice President of the European Health and Medical Tourism Association (EHMTA). Read more Published October 4, 2024 · Updated July 2, 2026 · 4 min read King Faisal Specialist Hospital Research Centre (KFSHRC) in Riyadh, Saudi Arabia, has etched its name in medical history by performing the world’s first fully robotic heart transplant on a 16-year-old patient with end-stage heart failure. Led by Dr. Feras Khaliel, the surgery, which lasted about two and a half hours, represents not just a technological breakthrough but also signifies a monumental shift in medical tourism implications for Saudi Arabia. The operation replaced the open-chest approach that has defined cardiac transplantation for decades with a minimally invasive, robot-assisted technique. For a procedure as demanding as replacing a failing heart, that shift is significant: it points toward a future in which some of the most complex surgeries carry less physical trauma for the patient. The case has been widely reported as a first of its kind, and it arrives as the Kingdom works to reposition itself on the global healthcare map. ## Why Robotic Surgery Matters for Transplant Patients Conventional heart transplants require a sternotomy, in which the surgeon divides the breastbone to reach the chest cavity. The approach is effective but traumatic, and recovery can be long and painful. Robotic systems let surgeons operate through much smaller incisions, guiding instruments with a level of precision that the unaided hand cannot match. For transplant recipients, the reported benefits of the less invasive approach - reduced recovery times, lower complication rates, and improved quality of life - carry particular weight. Transplant patients depend on immunosuppressant drugs that raise the risk of infection, so smaller wounds and shorter hospital stays can meaningfully lower that risk. The hospital has framed the procedure as evidence that robotic techniques, already common in fields such as urology and general surgery, can be extended to the most delicate cardiac work. ## KFSHRC’s Standing in Transplant Medicine KFSHRC is one of the region’s most established referral centres and has long ranked among the leading hospitals in the Middle East for complex and specialised care. It has built a particular reputation in organ transplantation and cardiac services, running programs that have treated patients from across the Gulf and beyond. That track record matters for context. A single landmark operation draws headlines, but it is the surrounding infrastructure - research capacity, specialist teams, and the experience to manage rare cases - that turns a one-off achievement into a sustainable capability. The robotic transplant sits on top of that base rather than standing alone, which is part of why the hospital’s announcement drew attention beyond the immediate clinical result. ## A Building Block in Vision 2030 The achievement aligns with Vision 2030, Saudi Arabia’s plan to diversify an economy long dependent on oil. Healthcare is one of the sectors targeted for transformation, both to improve services for residents and to build industries capable of attracting investment and spending from abroad. Within that framework, high-profile medical firsts serve a dual purpose. They advance domestic clinical capability while generating the kind of international attention that shapes perceptions of a country’s healthcare system. Positioning the Kingdom as a place where cutting-edge procedures are pioneered, rather than imported, is central to that ambition. ## What It Means for Saudi Medical Tourism This groundbreaking procedure underscores Saudi Arabia’s growing prowess in advanced medical technology, potentially positioning it as a key destination for medical tourism. The success of the operation, performed without the traditional invasive chest opening, promises reduced recovery times, lower complication rates, and improved quality of life for patients - factors that are highly attractive to international patients seeking high-quality yet less invasive treatments. The global recognition of this feat, highlighted by coverage from major international news outlets, not only boosts Saudi Arabia’s reputation for innovation and excellence in healthcare but also enhances its medical tourism profile. The ripple effect of such an advancement may not be imminent, but it will very likely draw medical tourists seeking cutting-edge treatments, fostering economic growth through healthcare. For Saudi Arabia, this marks not only a medical milestone but also a strategic step toward becoming a hub for medical tourism, leveraging its state-of-the-art healthcare facilities and forward-looking approach to health services. Sources (2) Saudi Press Agency King Faisal Specialist Hospital & Research Centre ### The Wire Aug 30This Week in Medical Tourism: 20–26 August 2026 Aug 29This Week in Medical Tourism: 13–19 August 2026 Aug 22South Korea Undercuts America but Not Turkey All coverage ### Newsletter Get weekly health tourism intelligence in your inbox. Subscribe ### Knowledge Hub Medical Tourism Wellness Tourism Dental Tourism Fertility Tourism Cosmetic Tourism Longevity Tourism Explore the Hub Stay informed on the latest in global health tourism. Subscribe to our Newsletter ## Related Articles Medical Tourism 22 AUG 2026 Medical Tourism ### Mexico and Turkey Price Against Different Home Markets August 22, 2026 Medical Tourism 22 AUG 2026 Medical Tourism ### Turkey's Deepest Discounts Sit on Its Safest Procedures August 22, 2026 Medical Tourism ### Why Medical Tourism to Germany Declined August 11, 2026 --- # Saudi Arabia Bets Vision 2030 Money On Medical Tourism URL: https://health-tourism-news.com/news/saudi-arabia-s-medical-tourism-sector-poised-for-explosive-growth-driven-by-vision-2030-and-ai-integration/ Medical Tourism January 29, 2026 Medical Tourism Saudi Arabia Bets Vision 2030 Money On Medical Tourism IMARC Group projects Saudi Arabia's medical tourism market will grow from $1.6 billion in 2025 to $8.9 billion by 2034. The forecast deserves scrutiny. The spending behind it deserves more. Christian El-Khouri Editor-in-Chief Published January 29, 2026 · Updated July 4, 2026 · 6 min read IMARC Group values Saudi Arabia’s medical tourism market at USD 1,633.5 million for 2025 and projects USD 8,887.9 million by 2034, a compound annual growth rate of 20.71 percent. Those numbers have been doing the rounds in recycled press releases, so it is worth separating the forecast from the facts underneath it. The forecast asks you to believe a market Saudi Arabia barely had a decade ago will more than quintuple. The facts are a state health budget being rebuilt from the ground up, one flagship hospital with genuinely strong inbound numbers, and a virtual-care network no other country in the region can match. ## Two research houses, one market, an eightfold gap IMARC’s list of growth drivers is plausible enough: patients from the region who would rather be treated closer to home, wellness services sold alongside procedures, widely available health insurance, hospitals holding international accreditation, and government moves to simplify the medical visa process. The trouble starts when you put the forecast next to a rival one. Research and Markets valued the same market at USD 0.20 billion in 2024 and expects USD 0.68 billion by 2030, growing at 22.50 percent a year. IMARC’s 2025 base of USD 1.63 billion is roughly eight times larger. Both houses cannot be right, and my reading is that neither is measuring a settled thing. One is almost certainly counting a broad basket of health and wellness travel while the other counts a narrow definition of inbound treatment. When two estimates of one national market differ by a factor of eight, the honest conclusion is that the market is too young to measure well. What is telling is that the growth rates nearly agree: both firms assume a steep climb from wherever their base happens to sit. Take the direction from the research and treat the size with suspicion. ## Vision 2030 money is real, and mostly domestic The engine behind every Saudi health headline is the Health Sector Transformation Program, one of the Vision 2030 realization programs, which commits the state to wider access, digital care and prevention rather than treatment. The US International Trade Administration’s commercial guide puts hard numbers on the effort: more than USD 65 billion earmarked for health infrastructure, a plan to privatize 290 hospitals and 2,300 primary health centers, and a reorganization of care into 21 health clusters, the first two of which are already operating in Riyadh. The 2024 health allocation alone was SAR 214 billion, about USD 57 billion, roughly 17 percent of the entire state budget. The same guide expects the total Saudi health market to reach about USD 102 billion by 2035. Look at what that money is actually for, though, and almost none of it targets foreign patients. This is a domestic overhaul: the state is converting a public health service into a regulated market and inviting private operators to run most of it. Medical tourism rides along on the side. Privatized hospital clusters will need revenue beyond what the state pays them, and international patients are the obvious top-up. That is precisely why I take the sector seriously despite the messy market research. The hospitals get built and staffed whether or not a single foreign patient arrives; the forecasts are really a bet on who fills the beds afterwards. ## The flagship already has inbound numbers King Faisal Specialist Hospital and Research Centre used Arab Health 2025 in Dubai to show its books. Deputy chief executive Dr Bjorn Zoega reported 46,476 new patients in 2024 and a 47.39 percent rise in medical tourism cases, with patients arriving from 17 countries. The institution runs 2,443 beds across three cities and places on Newsweek’s and Brand Finance’s global hospital rankings, unusual territory for the region. A 47 percent jump is easier to post when the base is small, and 17 source countries points to a mostly regional draw: Gulf neighbours, diaspora families, patients from nearby markets with thin specialist care. Even so, this is the first Saudi institution publishing inbound growth figures rather than ambitions, and that distinction matters. Turkey and Thailand both built their trade on a handful of flagship hospitals that proved the model before anyone else followed. KFSHRC is being groomed for exactly that role, and its willingness to publish patient numbers is the surest sign the ministry believes them. ## A virtual hospital is the sharpest tool in the kit The original version of the growth story leaned heavily on artificial intelligence, and most of those claims dissolve on contact with a source. One does not. The Ministry of Health’s Seha Virtual Hospital now supports more than 242 hospitals across 48 main specialties and 68 sub-specialties, with capacity for over 597,000 patients a year, and Guinness World Records lists it as the largest virtual healthcare provider in the world. For medical travel the value is concrete rather than futuristic. A prospective patient in Cairo or Karachi can have local imaging reviewed by a Riyadh consultant before anyone books a flight, which removes the most expensive uncertainty in the whole exercise: travelling for a treatment you may not need or cannot get. Writing in Arab News, health tourism specialist Saad Majdy Baslom argued that the kingdom sits within a six-to-eight-hour flight of Europe, Africa and much of Asia and should compete on quality and innovation rather than price. The geography argument cuts both ways, since the same flight radius reaches Istanbul, Dubai and Delhi, all established competitors with decade-long head starts. Quality plus a working referral pipeline is the better pitch, and Seha is the pipeline. ## What This Means Strip the press-release gloss off this story and what remains is still substantial. The state is spending on health at a scale no regional rival matches, the flagship hospital has real double-digit inbound growth, and the referral infrastructure exists today rather than in a rendering. What does not exist is an agreed measure of the market: when research firms disagree by a factor of eight, every headline figure deserves a raised eyebrow, including the USD 8.9 billion one. My read is that Saudi Arabia becomes a serious treatment centre for Gulf and Muslim-majority markets well before it troubles Bangkok or Istanbul on volume, because that is the demand its geography, religious travel flows and referral network actually serve. I would watch whether the newly privatized clusters start reporting international patient numbers the way KFSHRC now does, and whether the promised medical visa simplification ships as working software rather than a slide. The forecasts will follow the plumbing, not the other way around. Sources (7) IMARC Group Saudi Vision 2030 Saudi Ministry of Health International Trade Administration KFSHRC Research and Markets Arab News Saudi ArabiaVision 2030GCCMiddle East ### The Wire Aug 30This Week in Medical Tourism: 20–26 August 2026 Aug 29This Week in Medical Tourism: 13–19 August 2026 Aug 22South Korea Undercuts America but Not Turkey All coverage ### Newsletter Get weekly health tourism intelligence in your inbox. Subscribe ### Knowledge Hub Medical Tourism Wellness Tourism Dental Tourism Fertility Tourism Cosmetic Tourism Longevity Tourism Explore the Hub Stay informed on the latest in global health tourism. Subscribe to our Newsletter ## Related Articles Medical Tourism 22 AUG 2026 Medical Tourism ### Mexico and Turkey Price Against Different Home Markets August 22, 2026 Medical Tourism 22 AUG 2026 Medical Tourism ### Turkey's Deepest Discounts Sit on Its Safest Procedures August 22, 2026 Medical Tourism ### Why Medical Tourism to Germany Declined August 11, 2026 --- # Singapore HSA Reaches WHO Top Tier For Medical Device Regulation URL: https://health-tourism-news.com/news/singapores-hsa-achieves-global-first-in-medical-device-regulation-setting-a-new-benchmark-for-quality-healthcare/ Health Tourism March 10, 2026 Health Tourism Singapore HSA Reaches WHO Top Tier For Medical Device Regulation The WHO has rated Singapore's HSA at Maturity Level 4 for medical device regulation, a global first. What the rating actually covers, how the four risk classes work, and why the announcement arrived bundled with an industry sales brief. Christian El-Khouri Editor-in-Chief Published March 10, 2026 · Updated July 4, 2026 · 7 min read Singapore’s Health Sciences Authority is now the first regulator anywhere to hold the World Health Organization’s top rating for medical device oversight. The WHO confirmed on 10 March 2026 that the HSA had reached Maturity Level 4, the highest classification in its benchmarking system for national authorities, after assessing how the agency handles devices from first approval through to post-market policing. Health Minister Ong Ye Kung broke the news in his opening speech at the 29th session of the International Medical Device Regulators Forum, which Singapore was hosting and chairing that same week. The venue was chosen for effect. The substance underneath it is real. ## The first regulator to clear WHO’s top bar for devices The rating comes out of the WHO Global Benchmarking Tool Plus for medical devices, or GBT+MD, an extension of the framework the organization already uses to grade national systems for medicines and vaccines. A team of international experts, working with WHO staff from headquarters and the Regional Office for the Western Pacific, assessed the HSA in February 2026 against more than 260 indicators. Those cover the whole span of a device’s life: product registration and market authorization, laboratory testing, clinical trials oversight, post-market surveillance, and the inspection and licensing of manufacturers and distributors. Maturity Level 4 means the system runs at an advanced level of performance and keeps improving itself, rather than just clearing a minimum bar. Dr Yukiko Nakatani, WHO Assistant Director-General for Health Systems, Access and Data, framed the stakes plainly: “Effective regulation is essential to ensure that health products, including medical devices, reaching patients are safe, effective and of assured quality.” The WHO attached a number that deserves more attention than the award itself: only 32% of regulatory authorities worldwide have the capacity to fully ensure that medicines, vaccines and other health products meet required standards of safety, quality and effectiveness. That 32% figure is the real story. Two thirds of the world’s regulators cannot fully verify the products used in their own hospitals, so they borrow decisions from agencies that can. Every regulator that reaches the top of the WHO ladder becomes a lending library for the rest. Singapore just became the first one for devices, and that is worth considerably more than the plaque. ## What the rating covers, and what it does not One point is worth being precise about, because it trips up patients and procurement teams alike: ML4 is a verdict on the regulator, not a seal on any individual product. No device becomes “WHO approved” because of this. What the rating tells you is that the process behind Singapore’s approvals has been audited, end to end, at the highest grade the WHO applies. The process itself is worth knowing if you deal with the Singapore market. Devices there are regulated under the Health Products Act of 2007 and the Health Products (Medical Devices) Regulations of 2010, and sorted into four risk classes, from Class A for the lowest-risk products up to Class D for the highest. Devices in Classes B through D must be registered with the HSA before they can be supplied. Class A devices are exempt from product registration, a deliberate piece of proportionality, but the exemption is narrower than it sounds. Dealers still need a licence to manufacture, import or wholesale them, are assessed against Good Distribution Practice requirements, and stay on the hook for change notifications, adverse event reporting and field safety corrective actions if a health risk emerges after sale. For a patient flying in for treatment, the practical translation is modest but real. The scanners, implants and diagnostics used on you in a Singapore hospital pass through a system the WHO has now audited at its top grade. That does not rank the surgeon or the hospital. It does mean the narrower question, whether anyone competent vetted the device itself, has a better answer in Singapore than almost anywhere else. ## A credential stack a decade in the making The device rating slots into a longer sequence. The HSA reached ML4 for medicines and imported vaccines in 2022. The WHO designated it a Listed Authority for medicines in 2023, expanded that listing in 2024 to cover all regulatory functions for the medicines product stream, and has recognized it as a Stringent Regulatory Authority for high-risk in vitro diagnostics since 2023. In 2026 the agency chairs the Management Committee of the IMDRF, the club of major device regulators whose Singapore session ran from 9 to 13 March and drew over 400 regulators and industry delegates. HSA chief executive Adjunct Professor Raymond Chua kept his public reaction short: “It is a great honor for Singapore’s Health Sciences Authority to be recognized at the highest WHO Maturity Level (ML4) classification for medical device regulation.” The stack matters because of how regulation actually spreads. Reaching ML4 is the qualifying round for WHO Listed Authority status, the designation that lets other countries formally anchor their own approvals to yours. The HSA already holds it for medicines. If a device-stream listing follows, an HSA approval stops being a purely national decision and becomes something closer to an export product. Manufacturers can do this arithmetic too. With around 200 device makers in the country producing everything from in vitro diagnostics to software as a medical device, filing in Singapore first starts to look like the efficient route into every market that leans on HSA paperwork. ## The regulator picks up a sales brief What interests me most is what the HSA announced alongside the award. The same 10 March press release unveiled an expanded economic development role: a new industry development function run with the Economic Development Board, Enterprise Singapore, the research agency A*STAR and the Agency for Care Effectiveness. The numbers attached are not small. Singapore’s research and innovation plan, RIE2030, allocates S$37 billion, about US$29 billion, over the next five years. About 100 industry-sponsored clinical trials start in the country every year. Biopharmaceutical manufacturing output doubled over two decades to S$13.9 billion in 2023, while medtech output grew about tenfold over the same period, from S$1.8 billion in 2003 to S$18.9 billion in 2023. The HSA also launched AIHGle 2.0, revised AI-in-healthcare guidelines co-developed with the health ministry, and put out an AI-enabled tool for industry feedback that gives developers automated preliminary risk classification estimates while a product is still in development. A regulator formally taking on industry promotion is the kind of arrangement that normally earns a raised eyebrow, and it should here too. The referee has started selling tickets. Singapore’s wager is that the ML4 audit is precisely the counterweight that makes the dual role safe, and the sequencing supports it: the agency invited the WHO to grade its rigor in February, then announced the sales brief in March, in that order. The AI classification tool is the piece I would actually watch. A credible early read on whether your product lands in Class B or Class C is worth months to a small developer, and that sort of unglamorous plumbing decides where startups choose to file first. ## What This Means Strip away the ceremony and three things changed on 10 March. Patients who travel to Singapore for treatment now sit inside the only device regulation system the WHO has audited at its top grade, which will not pick their hospital for them but does close off one category of doubt. Manufacturers gained a reason to treat Singapore as a first-filing market, because HSA sign-off is on its way to becoming currency that other regulators accept. And every other WHO member state gained a working answer key, since the GBT+MD assessment Singapore passed is published methodology, not magic. Two open questions remain. Does a WHO device-stream listing follow the ML4 rating, and does the new industry development desk stay visibly separate from the people doing the evaluations? I would expect the first within a couple of years. The second is the one to hold them to. Sources (4) World Health Organization Health Sciences Authority HSA Regulatory Overview GovMedia SingaporeHSAMedical DevicesWHORegulation ### The Wire Aug 30This Week in Medical Tourism: 20–26 August 2026 Aug 29This Week in Medical Tourism: 13–19 August 2026 Aug 22South Korea Undercuts America but Not Turkey All coverage ### Newsletter Get weekly health tourism intelligence in your inbox. Subscribe ### Knowledge Hub Medical Tourism Wellness Tourism Dental Tourism Fertility Tourism Cosmetic Tourism Longevity Tourism Explore the Hub Stay informed on the latest in global health tourism. Subscribe to our Newsletter ## Related Articles Weekly Digest 30 AUG 2026 Weekly Digest ### This Week in Medical Tourism: 20–26 August 2026 August 30, 2026 Weekly Digest 29 AUG 2026 Weekly Digest ### This Week in Medical Tourism: 13–19 August 2026 August 29, 2026 Weekly Digest 14 AUG 2026 Weekly Digest ### This Week in Medical Tourism: 6–12 August 2026 August 14, 2026 --- # Singapore Medical Tourism Heads For USD 15.4 Billion By 2035 URL: https://health-tourism-news.com/news/singapores-medical-tourism-ascendancy-a-usd-154-billion-horizon-by-2035/ Medical Tourism February 14, 2026 Medical Tourism Singapore Medical Tourism Heads For USD 15.4 Billion By 2035 A USD 15.4 billion forecast for Singapore medical tourism is everywhere. Traced back to its publisher, the number falls apart; hospital accounts, MOH bill data and the regional race tell a sharper story. Christian El-Khouri Editor-in-Chief Published February 14, 2026 · Updated July 4, 2026 · 7 min read A forecast that Singapore’s medical tourism market will hit USD 15.4 billion by 2035 has been doing the rounds of aggregator sites for months, and an earlier version of this article passed it along at face value. That deserved a proper check rather than a quiet deletion. So I traced the number back to its publisher and set it against figures somebody actually audits: Ministry of Health bill data, the accounts of the listed hospital groups that dominate Singapore’s private wards, and what the competition in Kuala Lumpur and Bangkok reports. The forecast does not survive the trip. The market that emerges from the checkable numbers is smaller, slower and considerably more interesting. ## Where the USD 15.4 billion figure comes from The projection belongs to Market Research Future, a market research firm, and reached most readers through a press release syndicated on openPR: a Singapore medical tourism market of roughly USD 6.3 billion in 2024, compounding at 9.1 per cent a year to USD 15.4 billion by 2035. The internal arithmetic works. The provenance does not. Market Research Future’s own report page for the same market currently shows a 6.34 per cent growth rate, base and forecast values labelled 0.267 and 0.527 in units the page cannot keep consistent, and, further down, a claim that the market will reach USD 7.2 billion by 2035. Another syndicated release built on the same publisher’s Singapore report put the 2035 figure at USD 527.49 billion, more than thirty times the number this article once carried. None of these documents defines who counts as a medical tourist, which spending is in scope, or how the base year was measured. When one publisher’s projections for one small market span 7.2, 15.4 and 527 billion dollars depending on which page you load, the spread is the finding. These reports exist to be bought, and the press releases exist to sell them. I would not price a clinic, an insurance product or a paragraph of journalism on any of the three numbers. ## What the market measurably earns The checkable figures are two orders of magnitude smaller. A December 2024 feature in The Business Times cited RHB analysts putting Singapore’s medical tourism revenue for 2023 at US$250 million to US$270 million, behind Thailand at US$850 million and Malaysia at US$444 million. Official statistics cannot settle the matter, because there are none to consult: the Singapore Tourism Board’s receipts releases, totalling S$23.9 billion for January to September 2025, break out sightseeing and food and beverage but carry no medical line at all. The listed operators fill in some of the gap. IHH Healthcare, owner of Mount Elizabeth, Mount Elizabeth Novena, Gleneagles and Parkway East, said medical tourism made up 18 per cent of its Singapore top line as at the third quarter of 2024, against an average of 17 per cent from 2019 to 2023; the Singapore hospital segment booked RM4.7 billion, about S$1.4 billion, in revenue for the period. Raffles Medical Group closed FY2024 with group revenue of S$751.6 million, up 6.3 per cent, of which hospital services contributed S$345.7 million, and its results release concedes that “the strong Singapore dollar coupled with higher healthcare services costs has made Singapore a less attractive medical hub in the region”. Tay Wee Kuang of CGS International told the same Business Times feature that foreign patients supplied 25 to 30 per cent of local operators’ revenue before the pandemic, and 20 to 25 per cent since. Run the arithmetic and even the sober estimates refuse to reconcile: 18 per cent of IHH’s S$1.4 billion Singapore segment is roughly S$250 million on its own, which already approaches RHB’s figure for the entire country. Definitions differ, periods differ, and nobody outside the hospitals’ finance departments knows the true total. But every estimate that arrives with a methodology lands in the hundreds of millions of US dollars, growing at single digits, with the foreign share of revenue drifting down rather than up. USD 15.4 billion by 2035 would require the measured market to grow more than fiftyfold in a decade. Nothing in the accounts points anywhere near it. ## The Mount Elizabeth price tag Singapore’s price tier is public record, which is rare in this industry. The Ministry of Health publishes what patients actually paid: for a primary total knee replacement, the typical bill in a one bedded private ward is S$49,789 at Mount Elizabeth, S$49,314 at Mount Elizabeth Novena and S$45,610 at Gleneagles, GST included, before insurance. A subsidised public ward does the same operation for around S$7,285, but subsidies are for locals; the private tier is the market a foreign patient meets. Kuala Lumpur and Bangkok will do that knee for a fraction of the bill, and everyone in the industry knows it. What the premium buys is the top of the complexity curve. IHH opened a proton therapy centre for cancer care at Mount Elizabeth Novena in May 2023 and had treated more than 100 patients within a year. Thomson Medical, where medical tourists are about 10 per cent of Singapore patients, expects the regional hubs to specialise, “with Singapore doubling down on more complex care”, as group chief executive Melvin Heng put it. That is the honest pitch, and I think it is the right one. Nobody has flown to Singapore to save money in years. Patients fly in because the diagnosis is frightening and the system at home has run out of answers, and at that point the S$49,000 knee is not the reference point; the oncologist is. A market that has stopped competing on price competes on outcomes and trust, and those are slower to copy than a discount. ## Malaysia and Thailand are not waiting The volume, meanwhile, is being carved up next door. The Malaysia Healthcare Travel Council counted 1.6 million healthcare travellers in 2024, up 14 per cent, generating RM2.72 billion in revenue, up 21 per cent, with an official target of RM12 billion by 2030. Thailand loosened its medical visa rules in 2023, offering foreign patients a one year visa with multiple re-entry. The currency does the rest of the damage: Singapore Medical Group’s chief executive Beng Teck Liang says patient numbers from Vietnam, more than half of the group’s non-local base, fell 15 to 20 per cent from January 2024 as the dong weakened against the Singapore dollar. And the patients Malaysia is winning are mostly Indonesian, precisely the market Singapore leans on; the Singapore Tourism Board ranks Indonesia its second largest source of tourism receipts, at S$2.09 billion for January to September 2025. The most eloquent signal comes from IHH itself. The owner of Mount Elizabeth agreed to pay RM3.9 billion in cash for Island Hospital in Penang, and the foreign patient share of its Malaysian operations has climbed to 7 per cent of top line from a 3 per cent average across 2019 to 2023. When the group with the clearest view of regional patient flows writes its biggest cheque in Penang rather than off Orchard Road, it is telling you where it expects the growth in bodies to be. Singapore keeps the hardest cases and the highest margins, Malaysia takes the volume, Thailand holds the middle. That division of labour can hold for years. It is not a 9.1 per cent compounding story for Singapore. ## What This Means Strip out the press release arithmetic and Singapore’s medical tourism market looks like this: a few hundred million US dollars of measurable annual revenue, a foreign share of private hospital income around a fifth and no longer rising, prices published by the health ministry at levels no regional rival tries to match, and a moat built from complex oncology, cardiology and proton beams rather than package deals. USD 15.4 billion by 2035 is not a forecast so much as a headline engineered to be repeated, and this article repeated it once. The numbers worth watching instead are three: whether IHH’s Singapore medical tourism share holds near 18 per cent, whether Malaysia gets anywhere near its RM12 billion target by 2030, and what the Singapore dollar does against the rupiah, the dong and the baht. If those break the right way, Singapore’s market can double by 2035 on complexity and yield alone. Fifteen billion is a different universe, and nobody actually treating patients in Singapore is claiming to live in it. Sources (7) Market Research Future openPR The Business Times Raffles Medical Group Ministry of Health Singapore Singapore Tourism Board PR Newswire SingaporeMalaysiaThailandIndonesiaAsia ### The Wire Aug 30This Week in Medical Tourism: 20–26 August 2026 Aug 29This Week in Medical Tourism: 13–19 August 2026 Aug 22South Korea Undercuts America but Not Turkey All coverage ### Newsletter Get weekly health tourism intelligence in your inbox. Subscribe ### Knowledge Hub Medical Tourism Wellness Tourism Dental Tourism Fertility Tourism Cosmetic Tourism Longevity Tourism Explore the Hub Stay informed on the latest in global health tourism. Subscribe to our Newsletter ## Related Articles Medical Tourism 22 AUG 2026 Medical Tourism ### Mexico and Turkey Price Against Different Home Markets August 22, 2026 Medical Tourism 22 AUG 2026 Medical Tourism ### Turkey's Deepest Discounts Sit on Its Safest Procedures August 22, 2026 Medical Tourism ### Why Medical Tourism to Germany Declined August 11, 2026 --- # Skin Health Is a Global Priority, Not Just Cosmetic URL: https://health-tourism-news.com/news/skin-is-no-longer-just-cosmetic/ Wellness Tourism Skin Health Is a Global Priority, Not Just Cosmetic The WHO's new focus on skin conditions reframes skin as a global health priority, with real consequences for dermatology and wellness travel. Ivan Rendulic Contributor Founder of ZagrebMed and President of the European Health and Medical Tourism Association (EHMTA). Over a decade facilitating international patients and shaping cross-border healthcare initiatives from Croatia. Read more Published July 30, 2025 · Updated July 2, 2026 · 3 min read Reviewed by Christian El-Khouri, Editor-in-Chief For many, skin has long been seen as a cosmetic matter - face creams, wrinkles, acne, pigmentation. But with climate change, air pollution, UV radiation, stress, and a rising number of skin conditions worldwide, it is time to shift the narrative. That is exactly what the World Health Organization (WHO) has done by adopting a historic resolution that reframes skin diseases as a public health priority, not a cosmetic issue. Today, skin conditions affect more than 2 billion people around the world. At the same time, they remain among the least recognized and least funded health challenges. This is a contradiction we can no longer afford to ignore. This is not just about “clear skin” - it is about a broader approach to health. Our skin reflects much more than appearance. It reflects our immune system, our nutrition, our stress levels, and the environments we live in. ## Is Dermatology Set to Become a Core Pillar of Global Health Tourism? Within this new framework, dermatology is stepping beyond the traditional clinic and into the spotlight of health tourism. In a world where climate has a growing impact on skin health - with new inflammatory conditions, antibiotic-resistant infections, and increasing cases of skin cancer - destinations that offer dermatological programs in clean, healthy environments are becoming more relevant than ever. For patients from Africa, where access to dermatology is often limited and climate conditions intensify skin problems, traveling abroad for care is no longer a luxury - it is a necessity. The same is true for individuals living in polluted cities across Asia or South America, where skin damage from air quality, stress, and lifestyle factors is becoming more widespread. ## What Does “Dermatology Tourism” Actually Mean? It goes far beyond cosmetic treatments. It includes advanced diagnostics, chronic disease management, autoimmune and immunological skin therapy, treatment for post-COVID skin complications, phototherapy, microbiome balancing, food sensitivity testing, and personalized skincare tailored to each patient’s biology and environment. Health centers in countries such as Croatia, Portugal, and Turkey - and increasingly in Morocco, South Africa, and Kenya - are well-positioned to become international hubs for dermatological care. This is not about replacing local care, but complementing it. These destinations can offer clinical safety, personalized protocols, and high-level diagnostics in settings that support healing. ## A New Era of Skin Care - From Surface to Systemic Skin is now being recognized not only as the body’s largest organ, but also as a key signal of deeper systemic health. As environmental pressures rise and public awareness grows, dermatology is poised to become a central field within health tourism. Will it become one of the main pillars of global medical travel? All indicators say yes. Not just for the wealthy, but for anyone seeking treatment not available in their home country. In this sense, skin care is no longer a luxury. It is a necessity. In a time when health has become the world’s most valuable asset, perhaps the skin will lead the way in telling a new global story - one that begins on the surface, but reaches far deeper. Sources (1) World Health Organization, Seventy-eighth World Health Assembly ### The Wire Aug 30This Week in Medical Tourism: 20–26 August 2026 Aug 29This Week in Medical Tourism: 13–19 August 2026 Aug 22South Korea Undercuts America but Not Turkey All coverage ### Newsletter Get weekly health tourism intelligence in your inbox. Subscribe ### Knowledge Hub Medical Tourism Wellness Tourism Dental Tourism Fertility Tourism Cosmetic Tourism Longevity Tourism Explore the Hub Stay informed on the latest in global health tourism. Subscribe to our Newsletter ## Related Articles Weekly Digest 08 JUL 2026 Weekly Digest ### Medical Tourism Records Concentrate In Penang And Seoul July 8, 2026 Weekly Digest 01 JUL 2026 Weekly Digest ### Nigeria, Iran And Seoul Redraw Medical Tourism July 1, 2026 Weekly Digest 24 JUN 2026 Weekly Digest ### Health Tourism As Badge, Escape Hatch And Disguise June 24, 2026 --- # South Africa Medical Tourism: The Numbers Behind The Pitch URL: https://health-tourism-news.com/news/south-africa-s-medical-tourism-market-a-strategic-nexus-for-global-healthcare-and-wellness-innovation/ Wellness Tourism March 30, 2026 Wellness TourismMedical Tourism South Africa Medical Tourism: The Numbers Behind The Pitch South Africa's medical tourism pitch rests on a market forecast that more than quadruples by 2034. The country's own border data tells a much smaller story. We compare the two. Christian El-Khouri Editor-in-Chief Published March 30, 2026 · Updated July 4, 2026 · 7 min read South Africa’s medical tourism pitch is easy to summarise: good private hospitals, prices well below Europe, and a market forecast that more than quadruples inside a decade. The forecast comes from IMARC Group, and it circulates through press releases and aggregator sites, usually secondhand and usually without anyone checking it against South Africa’s own border statistics. I did the checking. The two sets of numbers do not describe the same country. ## What the market reports claim IMARC Group’s current report values the South Africa medical tourism market at $771.5 million in 2025 and projects $3,444.9 million by 2034, a compound annual growth rate of 17.55 percent. It segments the trade into cosmetic, dental, cardiovascular, orthopaedic, bariatric, fertility and ophthalmic work, concentrated in Gauteng, the Western Cape and KwaZulu-Natal. An earlier edition of the same report, still the version most derivative articles quote, put the market at $648.09 million in 2024 and $3,110.77 million by 2033, growing at 19.04 percent a year. The recent developments cited as evidence are modest: an April 2025 booking partnership between Satguru Travel Group and the medical travel platform Healthtrip, and a longevity summit in Durban. Two things are worth noticing before any of this reaches a business plan. First, the forecast moved between editions: the growth rate dropped by about a point and a half and the horizon shifted a year. That is normal in market research, and it is a useful reminder that these figures are model outputs, not measurements. Second, the evidence base is thin. A booking tie-up and a conference are what you cite when audited patient revenue does not exist. Nobody in this market publishes the number that would settle the question, so a projection fills the vacuum and hardens into fact through repetition. ## What the border data shows Statistics South Africa’s Tourism 2024 report, compiled from Department of Home Affairs immigration records, counted 8,919,370 foreign tourists in 2024, up 5.1 percent on 2023 and still 12.8 percent below the pre-pandemic peak. Of those, 96.9 percent came on holiday. Exactly 3,049 tourists, less than 0.1 percent, declared medical treatment as their purpose of visit: 1,957 from SADC countries, 628 from overseas and 447 from the rest of Africa. Another 204 same-day visitors crossed for treatment. The busiest months brought 334 and 309 medical arrivals respectively. Yet IMARC’s report states that 27,458 foreign visitors cited medical purposes when entering South Africa by July 2024, a figure that has been recycled through derivative coverage, including an earlier version of this article. I could not find it in any Stats SA publication, and the official monthly series contradicts it: at a peak rate of 334 arrivals a month, seven months gets you past 2,000, not past 27,000. Divide honestly and the problem gets worse. A $771.5 million market spread across 3,049 declared medical tourists is roughly $253,000 per patient, which is absurd. Even against the unsourced 27,458 it is about $28,000 per visitor, far above what dental work or cataract surgery in Johannesburg costs. The academic literature supplies the missing piece. Jonathan Crush and Abel Chikanda, writing in Social Science and Medicine, documented that patient movement into South Africa is overwhelmingly regional, much of it informal, driven by absent care at home, and large enough that the government has tried to formalise it through inter-country agreements with its neighbours. In other words, the official count is certainly too low, because most patients from the region never declare themselves at the border. But that cuts both ways: if the real flow is informal and uncounted, then any revenue figure quoted to two decimal places is a guess wearing a decimal point. ## The hospitals are real Whatever the patient numbers, the supply side checks out. Netcare, one of South Africa’s three big private hospital groups, lists 49 acute hospitals with 9,827 registered beds in its 2024 hospital listings, from Christiaan Barnard Memorial in Cape Town to Milpark in Johannesburg, plus another 1,007 mental health beds under its Akeso brand. Gauteng alone holds 5,585 of those acute beds, which matches IMARC’s claim that the province anchors the trade. Mediclinic and Life Healthcare run the other two large networks. I went looking for an international patient count in Netcare’s public reporting and did not find one. Beds are itemised hospital by hospital, down to the 21-bed Umhlanga Eye Institute; foreign patients are not counted anywhere. That absence is its own data point. For the groups that would actually treat medical travellers, the trade is evidently not material enough to report. The clinical capacity behind the pitch is real, the region’s patients demonstrably use it, and there is still no audited number connecting the two. Until one of the big three gives international revenue a line in its results, every market size for South African medical tourism is an estimate built on estimates. ## The wellness numbers are a different market Search interest often lands on the phrase “South Africa health and wellness market”, and that figure exists too: IMARC puts it at $27.9 billion in 2025, reaching $42.5 billion by 2034 at 4.56 percent a year. Read the segmentation before quoting it, because it covers functional foods and beverages, beauty and personal care, and preventive medicinal products. It is a consumer goods market, not a travel market, and gluing it onto a medical tourism story multiplies the sector thirtyfold by sleight of hand. South African Tourism, for its part, is selling wellness without the spreadsheet. In August 2025 it published “Wellness Reimagined: Soulful South African Journeys”, a campaign built on indigenous healing plants, mineral springs at Tshipise and the Caledon, and retreats like Sterrekopje Healing Farm. Three weeks later, South African Tourism and the KwaZulu-Natal Tourism and Film Authority hosted the 4th International Longevity Summit at Sibaya near Durban, drawing some 300 delegates under the theme “Future-Proofing Health: Africa’s Role in the Global Longevity Revolution”. The wellness pitch is, oddly, the more credible of the two. It sells what the country demonstrably has - landscape, springs, retreats and a tourism industry that moved almost nine million people in 2024 - and it does not depend on a patient count nobody can audit. A longevity summit is brand-building, but it is honest brand-building. If KwaZulu-Natal keeps stacking these events, the wellness traveller may end up doing more for provincial tourism revenue than the medical patient the market reports keep projecting. ## What This Means South Africa has real hospitals, real regional demand and soft numbers. The border data understates the trade because most of it is informal; the market reports overstate its precision because a forecast is all there is; and the 27,458 figure that launched a hundred articles has no visible source in the official statistics. If I were a facilitator or an investor, I would treat Stats SA’s 3,049 as the floor, treat IMARC’s projection as marketing, and watch for two signals that the market is maturing. The first is a proper count: the inter-country agreements Crush and Chikanda describe would give the government a reason to publish one. The second is a hospital group breaking out international patient revenue. The day Netcare or one of its rivals puts that line in its results, South African medical tourism will finally have a number worth quoting. Until then, the honest answer to “how big is the market” is: nobody has measured it. Sources (7) IMARC Group IMARC Group Statistics South Africa Netcare South African Tourism Getaway PubMed South AfricaAfricaWellness TourismSADC ### The Wire Aug 30This Week in Medical Tourism: 20–26 August 2026 Aug 29This Week in Medical Tourism: 13–19 August 2026 Aug 22South Korea Undercuts America but Not Turkey All coverage ### Newsletter Get weekly health tourism intelligence in your inbox. Subscribe ### Knowledge Hub Medical Tourism Wellness Tourism Dental Tourism Fertility Tourism Cosmetic Tourism Longevity Tourism Explore the Hub Stay informed on the latest in global health tourism. Subscribe to our Newsletter ## Related Articles Medical Tourism 22 AUG 2026 Medical Tourism ### Mexico and Turkey Price Against Different Home Markets August 22, 2026 Medical Tourism 22 AUG 2026 Medical Tourism ### Turkey's Deepest Discounts Sit on Its Safest Procedures August 22, 2026 Medical Tourism ### Why Medical Tourism to Germany Declined August 11, 2026 --- # South Korea Wellness And Dermatology Tourism Keep Climbing URL: https://health-tourism-news.com/news/south-korea-s-medical-tourism-surges-driven-by-wellness-and-dermatological-care/ Cosmetic Tourism January 18, 2026 Cosmetic TourismWellness TourismMedical Tourism South Korea Wellness And Dermatology Tourism Keep Climbing Foreign card spending at Korean clinics and pharmacies hit KRW 2.08 trillion in 2025, up 65.3% in a year, and the official patient count passed two million. Inside the dermatology-led engine behind Korea's wellness tourism market. Christian El-Khouri Editor-in-Chief Published January 18, 2026 · Updated July 4, 2026 · 7 min read South Korea’s health and wellness market keeps outrunning its own forecasts. Korea Tourism Organization Data Lab card records put foreign spending at Korean medical institutions and pharmacies at KRW 2.08 trillion for 2025, up 65.3% from KRW 1.25 trillion in 2024. The official patient count, released months later by the health ministry, crossed two million for the first time. Neither number was driven by the invasive surgeries Korea built its medical tourism reputation on. Both were driven by skin. ## What the card data shows KTO Data Lab tracks what foreign visitors actually charge to their cards inside Korea, and through 2025 the medical categories climbed with barely a pause. By September, foreign card spending at hospitals and pharmacies had already reached KRW 1.43 trillion, up 68% on the same period of 2024, before the full year closed at KRW 2.08 trillion. Dermatology took about 56% of that spending, with plastic surgery near a quarter, internal medicine around 10% and pharmacies most of the rest. The momentum carried straight into 2026. The Korea Times reported that total foreign card spending in Korea topped KRW 2 trillion in a single month for the first time in May 2026, up 67.1% year on year, with pharmacy spending up 206.1%, skin care and massage up 153.9% and dermatology clinics up 85.5%. Two caveats stop me taking the card series at face value, and they cut in opposite directions. It only captures card payments, so it misses cash and the Chinese app wallets many visitors prefer, which means the true figure is higher. It also cannot tell a patient from a tourist picking up sunscreen at a Seoul pharmacy, which flatters the medical label. A series that grows 65% in a year and accelerates into the next is still telling the truth about direction, whatever the exact level. ## Two million patients, one specialty The Ministry of Health and Welfare’s official tally, announced on 24 April 2026, counted 2,011,822 foreign patients in 2025 - the first time Korea passed two million since records began in 2009, after 610,000 in 2023 and 1.17 million in 2024. Dermatology accounted for 1.31 million of them, or 62.9%, with plastic surgery at 11.2% and internal medicine at 9.2%. China supplied 30.8% of patients and Japan 29.8%; Taiwan more than doubled to a 9.2% share and the United States rose 70.4% to 8.6%. The Korea Institute for Industrial Economics and Trade put total spending by those patients and their companions at KRW 12.5 trillion, about $8.4 billion, of which KRW 3.3 trillion went on treatment itself. The longer arc matters more than any single year. Korea Health Industry Development Institute figures cited by the South China Morning Post show 705,044 foreign dermatology patients in 2024, a 117-fold increase on 2009, when the specialty drew just over 6,000 people and 9.3% of foreign visits. It now takes more than half, and 87.7% of 2025 patient visits happened at clinic level rather than in hospitals. That is the most important fact for anyone sizing the South Korea wellness tourism market. The product has flipped from surgery you plan once to skin work you repeat, and repeat outpatient care behaves like retail rather than hospital medicine: less revenue per visit, far more visits. The gap between the KRW 3.3 trillion treatment figure and the KRW 12.5 trillion total - flights, hotels, food, shopping - is exactly why tourism officials now care more about laser clinics than transplant wards. ## Gangnam density and the K-beauty pull Seoul took 87.2% of foreign treatments in 2025, and inside Seoul the geography narrows further. The Seoul Metropolitan Government counted 999,642 international medical tourists in 2024, with Gangnam district alone receiving 377,073 of them across 1,034 registered international clinics and neighbouring Seocho another 288,475. Five districts accounted for about 92% of the city’s foreign patient visits, and Seoul has more than doubled its registered international clinics since 2020. The pull is the same engine that sells Korean skincare abroad. “K-beauty is creating new possibilities. It has evolved beyond the beauty industry to become one of Korea’s representative cultural contents,” Kang Jung-won, head of the KTO’s tourism policy bureau, told the Korea Times. The K-beauty adjacency is this market’s moat and its ceiling at once. A visitor primed by years of Korean skincare content arrives pre-sold; the clinic closes the sale and the pharmacy next door collects the follow-on basket, which is what a 206% jump in foreign pharmacy spending looks like on a chart. But a national industry this concentrated in a few districts of one city, selling mostly one specialty, inherits a single set of risks. A safety scandal in Gangnam or a diplomatic freeze with Beijing or Tokyo would touch most of the national number at once. ## The policy scaffolding is shifting Policy is being rebuilt around this new shape of demand, and not always in the industry’s favour. On 1 January 2026 the government let its 10% VAT refund on cosmetic procedures lapse, closing a scheme that had run since April 2016 and returned KRW 146.7 billion across more than 1.2 million claims by mid-2024, according to Korea Biomedical Review. Gangnam surgeons warned the decision invites price competition from cheaper rivals, and it lands hardest on Japanese patients, who made up 43.6% of foreign cosmetic clients between 2019 and 2023. In the other direction, a May 2026 amendment to the foreign patient law legalised telemedicine for international patients from 2027, covering remote consultations before travel and follow-up care after returning home. Entry itself is rarely the obstacle. Japan, Taiwan and the United States, together more than 47% of 2025 patients, can enter visa-free for short stays, while others use the C-3-3 medical visa, and facilitators designated by the Ministry of Justice can file electronic visas for their clients, per KHIDI’s Medical Korea portal. Read together, the two moves say the government thinks this market no longer needs subsidy, only plumbing. Letting a tax refund die while patient numbers double is a confidence bet, and probably a safe one at current growth rates. The telemedicine change is the one I would watch. Aftercare is the weakest link in a fly-in, fly-out skin business, and a legal channel for remote follow-up converts a one-off visitor into a patient a clinic can manage between trips. If Korean clinics use it that way rather than as a marketing funnel, it will do more for the market’s durability than the VAT refund ever did. ## What This Means Anyone researching the South Korea health and wellness market should be clear about what it actually is in 2026: a dermatology market wearing a wellness label, concentrated in a few square kilometres of southern Seoul and growing at rates no forecast predicted - 65.3% in card spending and about 72% in patient numbers in a single year. I would apply three tests over the next 18 months. Watch Japanese volumes through 2026 for the first clean read on whether losing the VAT refund dents the most price-conscious cohort. Watch whether telemedicine, once it takes effect in 2027, turns one-off visitors into returning patients. And watch Seoul’s 87.2% share: if it falls because regional clusters are winning patients, the market is maturing; if it falls because Gangnam stumbled, everything else will fall with it. Growth this fast in a market this narrow is real, and it is also fragile in a specific, mappable way. That is not a reason to doubt the KRW 2.08 trillion. It is a reason to remember that a number built on repeat visits can run in reverse just as quickly. Sources (10) KTO Data Lab Ministry of Health and Welfare Korea Herald Korea Times - Wellness Tourism Korea Times - Telemedicine Korea Biomedical Review Seoul Metropolitan Government Medical Korea South China Morning Post Akomnews South KoreaWellness TourismDermatologyK-BeautySeoul ### The Wire Aug 30This Week in Medical Tourism: 20–26 August 2026 Aug 29This Week in Medical Tourism: 13–19 August 2026 Aug 22South Korea Undercuts America but Not Turkey All coverage ### Newsletter Get weekly health tourism intelligence in your inbox. Subscribe ### Knowledge Hub Medical Tourism Wellness Tourism Dental Tourism Fertility Tourism Cosmetic Tourism Longevity Tourism Explore the Hub Stay informed on the latest in global health tourism. Subscribe to our Newsletter ## Related Articles Cosmetic Tourism 22 AUG 2026 Cosmetic Tourism ### South Korea Undercuts America but Not Turkey August 22, 2026 Medical Tourism 22 AUG 2026 Medical Tourism ### Mexico and Turkey Price Against Different Home Markets August 22, 2026 Medical Tourism 22 AUG 2026 Medical Tourism ### Turkey's Deepest Discounts Sit on Its Safest Procedures August 22, 2026 --- # South Korea Undercuts America but Not Turkey URL: https://health-tourism-news.com/news/south-korea-undercuts-america-but-not-turkey/ Cosmetic Tourism August 22, 2026 Cosmetic TourismDental Tourism South Korea Undercuts America but Not Turkey A Seoul rhinoplasty costs a quarter to a half of the American price. A Seoul veneer costs more than a British one and several times a Turkish one. The destination is not the unit of comparison. The procedure is. Christian El-Khouri Editor-in-Chief Published August 22, 2026 · 5 min read Medical travel is usually discussed a destination at a time. Turkey is cheap, Korea is expensive, Mexico is close. South Korea is the case that breaks the habit, because the country gives two opposite answers depending on which procedure you ask about, and both answers are correct. Health Tourism News runs two Seoul guides. One prices a procedure that undercuts the American equivalent by half. The other prices a procedure that costs more than the British equivalent and several times the Turkish one. Same city, same clinics district, same week of travel. ## Two procedures, two answers ProcedureSouth KoreaUS privateUK privateTurkey Primary rhinoplasty$2,100 - $7,000 $2,100 - $3,500 straightforward$8,000 - $15,000$8,000 - $13,400 £6,000 - £10,000not on this panel Revision or rib-cartilage rebuild$5,000 - $12,000$12,000 - $30,000from $10,700not on this panel Porcelain veneer, per tooth$720 - $1,500 ₩1.1m - ₩2.3m-$670 - $1,340 median £614$175 - $485 Composite veneer, per tooth$260 - $520-$270 - $670$95 - $270 Published Seoul clinic and platform prices from the two Health Tourism News guides, converted at about 1,530 won to the dollar, with UK and Turkish references from the corresponding country guides. The rhinoplasty guide puts a straightforward primary nose at $2,100 to $3,500 in Seoul, rising to $7,000 or more for complex primary work at premium clinics, against $8,000 to $15,000 in the United States. Platform averages across all types sit near $4,700 to $5,700. That is a genuine saving on a genuinely complex operation, and it is why Gangnam fills with foreign patients. The veneers guide reaches the opposite conclusion from the same city. Seoul porcelain at $720 to $1,500 a tooth sits at the top of the British range and above it, against a UK median of £614. Against Turkey the gap runs the other way and further: the Turkish veneers panel lists from under $100 to about $485 a tooth, and a 20-unit set at $2,900 to $6,050. A full smile of eight to ten porcelain veneers in Seoul works out at roughly $5,700 to $15,000. Nobody flies eleven hours to save money on a smile, and Korean clinics do not pretend otherwise. ## Why the same country prices two ways Korea’s dental sector competes on finish rather than fee. The larger Seoul clinics run their own laboratories, so design, shade matching and milling happen under one roof and inside one trip, and digital smile design is standard rather than an upsell. That is a coherent product with a reason to cost what it costs. It is not a discount, and a patient shopping on price is on the wrong continent. Rhinoplasty is a different market. Seoul runs the busiest cosmetic-surgery sector on earth, and the volume, the specialisation and the domestic competition do to the price what scale usually does. Korea still charges several times what Turkey or Thailand ask, and competes on precision and finish rather than on being cheapest. It simply happens to undercut America while doing so. Two things move the total that no price list shows. Foreign patients may be quoted above the domestic won figures through agency and facilitator markups, so the currency and the final total both belong in writing. And the 10 per cent VAT refund that once favoured foreign cosmetic patients ended on 1 January 2026, which takes a tenth off the saving that older comparisons still assume. ## The safeguard Korea legislated One thing the Seoul market has that others do not is a law written in response to its own scandal. Ghost surgery, the substitution of the chosen surgeon with a different and often junior operator once the patient is under anaesthetic, was reported by the country’s own plastic surgeons to have affected roughly 100,000 patients between 2008 and 2014, with around five deaths during ghost surgeries recorded between 2014 and 2022. Korea passed a law in 2021 requiring closed-circuit cameras in operating theatres, and since 2023 a patient under general anaesthesia has held a legal right to request that the operation is recorded. That is a usable defence rather than a reassurance: name the operating surgeon in the consent form, and exercise the right to the recording. The practice is now rare in registered, reputable clinics and concentrated in the high-volume operations that compete hardest on price for foreign patients, which is the same tier the harm concentrates in everywhere else in this trade. ## What this means for patients The question worth asking is never whether a country is cheap. It is what this procedure costs here against what it costs at home, and what the local market is competing on when it sets that price. On that test Seoul is a strong buy for a nose and a poor one for a smile, and the two conclusions sit a few streets apart. A patient who books a destination and then chooses a procedure has already made the decision backwards. Health Tourism News is a trade publication and sells no treatment. Prices are the figures clinics and platforms publish, held on file, with the limits of each panel stated in the guide it comes from. Sources (7) TreatCompare, UK veneer cost sample of 1,622 practices, May 2026 Systematic review of porcelain laminate veneer survival, Journal of Clinical Medicine, 2021 Library of Congress, Global Legal Monitor: South Korea, video cameras to be installed in operating rooms, 2021 Is the ghost surgery the subject of legal punishment in Korea? Journal of the Korean Medical Association / PMC, 2018 Medical Service Act of the Republic of Korea (English translation) Republic of Korea, Ministry of Health and Welfare and KHIDI: registration system for institutions attracting foreign patients European Central Bank, euro foreign exchange reference rates (crosses derived), 10 July 2026 South KoreaSeoulrhinoplastyveneersTurkeypricesghost surgery ### The Wire Aug 30This Week in Medical Tourism: 20–26 August 2026 Aug 29This Week in Medical Tourism: 13–19 August 2026 Aug 22Spain and Greece Report IVF Success Differently All coverage ### Newsletter Get weekly health tourism intelligence in your inbox. Subscribe ### Knowledge Hub Medical Tourism Wellness Tourism Dental Tourism Fertility Tourism Cosmetic Tourism Longevity Tourism Explore the Hub Stay informed on the latest in global health tourism. Subscribe to our Newsletter ## Related Articles Medical Tourism 22 AUG 2026 Medical Tourism ### Mexico and Turkey Price Against Different Home Markets August 22, 2026 Medical Tourism 22 AUG 2026 Medical Tourism ### Turkey's Deepest Discounts Sit on Its Safest Procedures August 22, 2026 Dental Tourism 22 AUG 2026 Dental Tourism ### Dental Implant Prices Abroad Hide Three Different Units August 22, 2026 --- # Spain and Greece Report IVF Success Differently URL: https://health-tourism-news.com/news/spain-and-greece-report-ivf-success-differently/ Fertility Tourism August 22, 2026 Fertility Tourism Spain and Greece Report IVF Success Differently Two of Europe's largest fertility destinations quote comparable prices and comparable-sounding success rates. Only one of them has a national registry a patient can check the claim against. Christian El-Khouri Editor-in-Chief Published August 22, 2026 · 6 min read A Spanish clinic and a Greek clinic can both advertise a 60 or 70 per cent success rate for donor-egg treatment. The prices they quote are within a few thousand dollars of each other, and both undercut a London list by half or more. What separates them is not the offer. It is whether there is anything to check the offer against. Spain runs a mandatory national activity registry. Greece does not publish detailed national outcome tables on the same model. That single difference changes what a quoted success rate means in each country, and it is the reason the Health Tourism News guides to IVF in Spain and IVF in Greece answer the success question in two different ways. ## What Spain publishes about itself The Spanish registry’s 2022 tables put own-egg live birth per fresh transfer at 34.0 per cent under 35, 24.7 per cent at 35 to 39 and 12.2 per cent at 40 and over. Counted per cycle started, which is the honest denominator for a patient deciding whether to fly, the same registry shows 9.3 per cent overall. Those figures do something a brochure cannot: they place Spain against Britain. The UK regulator reports 25 per cent births per embryo transferred; Spain’s registry shows 25.0 per cent per transfer. Two national registries, within a rounding error of each other. Spain does not win on own-egg success, whatever a marketing page implies, and a clinic quoting 60 or 70 per cent for own-egg treatment is describing selected good-prognosis patients or cumulative attempts across several transfers. Donor eggs are where the numbers genuinely change shape, and the registry shows that too. Live birth per fresh donor transfer holds at 47.0 per cent under 35, 46.5 per cent at 35 to 39 and 40.7 per cent at 40 and over, because embryo aneuploidy follows the donor’s age rather than the recipient’s. Cumulative clinical pregnancy per donation cycle reaches 64.2 per cent against 31.9 per cent with a patient’s own eggs. For a British patient in her mid-forties, that near-flat curve, not the price list, is the argument for treatment in Spain. ## What Greece asks you to take on trust Greece asks for more trust because it publishes less. In the absence of national outcome tables on the Spanish model, the honest figures for Greek donor treatment are the pan-European ones: donor-egg clinical pregnancy running around 45 to 50 per cent per transfer across recipient ages, with live birth somewhat lower. Greek donors are young and screened, and there is no reason to think Greek laboratories underperform. There is simply no national denominator to hold a Greek clinic’s own claim against. That is not an argument against Greece. It is an argument about what a number from a Greek clinic can and cannot prove, and it changes which questions are worth asking in the consulting room. ## The measure that flatters everyone Both countries share a reporting habit that does more damage than the registry gap. Clinics commonly advertise clinical-pregnancy rates, and clinical pregnancy is an earlier and higher measure than a baby. It counts a heartbeat on a scan. The two diverge by the miscarriage rate, and in donor treatment the Spanish registry puts pregnancy loss near 20 per cent at every recipient age, against own-egg miscarriage that climbs past 40 per cent after 40. The denominator moves the number as much as the clinic does. Per transfer is higher than per cycle started, because it drops every cycle that never reached a transfer. Cumulative across several attempts is higher again. A patient comparing 65 per cent at one clinic with 45 per cent at another may be comparing three different measures rather than two clinics, and neither figure is wrong on its own terms. Two questions settle it. Live birth, not clinical pregnancy. Per cycle started, not per transfer. ## The prices, which are checkable TreatmentGreece, publishedSpain, publishedUK reference Own-egg IVF cycle$3,400 - $5,100 ICSI usually included$5,600 - $6,650 ICSI included$5,100 - $10,200 ICSI often extra Patient medication+ $1,140 - $1,710+ $1,150 - $1,700+ comparable Egg-donation cycle$5,700 - $10,250$7,650 - $10,850$16,500 - $20,500 named London list Published clinic prices from the two Health Tourism News country guides, each with its own methodology note and dated exchange rate. Greece is the cheaper of the two on the headline cycle, and both are roughly half a London donor price. Neither country folds the patient’s gonadotrophin medication into the quoted figure, which is a market convention rather than a trick, and it is worth adding before the two are compared with anything at home. ## Two laws, one shared consequence Spain’s 2006 statute makes donation anonymous by law: the clinic matches by phenotype and immunological profile, and the child will never be able to trace the donor. Greece is predominantly anonymous in practice, with a 2022 reform making open, identifiable donation optional at the donor’s choice, a route reportedly little used. Britain went the other way in 2005, and a donor-conceived Briton can request identifying details at 18, with the first cohort eligible from October 2023. Each country has a feature the other lacks. Greece’s legal treatment age runs to 54, raised from 50 by the same 2022 reform, with the national authority assessing cases between 50 and 54. Spain sets no numeric ceiling in statute at all; the figure of 50 that circulates is professional guidance and clinic practice. Greece’s altruistic, court-authorised surrogacy route, long one of the few open to foreign patients, was effectively closed to non-residents by Article 46 of Law 5197/2025, which requires both the applicant and the surrogate to hold permanent residence in Greece before a court will approve an arrangement. The consequence they share arrives years later and appears in no quote. Embryos made with an anonymous donor generally cannot be imported to a British clinic, because the donor fails Britain’s identifiability requirement. The feature that brought the patient abroad is the feature that strands the surplus embryos there, with storage fees running on and every future transfer meaning another flight. Where all transfers will happen is a decision for before the first cycle, in writing, with both clinics. ## What this means for patients The price comparison is the easy half and it is the half most patients spend their time on. The harder half is that a success rate is only as good as the system that publishes it. In Spain a patient can hold a clinic’s claim against a national table. In Greece the honest anchor is the European band, and any figure above it should be read as a selected-patient number until the clinic explains its denominator. Ask for live birth per cycle started. Ask what the number excludes. Then compare the prices. Health Tourism News is a trade publication and sells no treatment. Prices are the figures clinics publish, held on file, with the limits of each panel stated in the guide it comes from. Sources (9) Registro Nacional de Actividad 2022 - Registro SEF, Informe Estadistico de Tecnicas de Reproduccion Asistida HFEA, Fertility treatment 2023: trends and figures, June 2025 ESHRE EIM, ART in Europe 2019, Human Reproduction Assisted reproduction in Greece: legal framework and the absence of a national registry, review, Sciences (MDPI), 2025 Greece, National Authority of Medically Assisted Reproduction (EAIYA), under Law 3305/2005 as amended Ley 14/2006 sobre tecnicas de reproduccion humana asistida, BOE consolidated text CNRHA, Registro Nacional de Centros de reproduccion humana asistida HFEA, Importing and exporting sperm, eggs and embryos HFEA, Fertility treatment abroad IVFSpainGreeceegg donationsuccess ratesfertility tourism ### The Wire Aug 30This Week in Medical Tourism: 20–26 August 2026 Aug 29This Week in Medical Tourism: 13–19 August 2026 Aug 22South Korea Undercuts America but Not Turkey All coverage ### Newsletter Get weekly health tourism intelligence in your inbox. Subscribe ### Knowledge Hub Medical Tourism Wellness Tourism Dental Tourism Fertility Tourism Cosmetic Tourism Longevity Tourism Explore the Hub Stay informed on the latest in global health tourism. Subscribe to our Newsletter ## Related Articles Weekly Digest 30 AUG 2026 Weekly Digest ### This Week in Medical Tourism: 20–26 August 2026 August 30, 2026 Weekly Digest 29 AUG 2026 Weekly Digest ### This Week in Medical Tourism: 13–19 August 2026 August 29, 2026 Cosmetic Tourism 22 AUG 2026 Cosmetic Tourism ### South Korea Undercuts America but Not Turkey August 22, 2026 --- # North America Outbound Medical Tourism: Why Patients Leave URL: https://health-tourism-news.com/news/strategic-growth-projected-for-north-america-s-outbound-medical-tourism-market/ Medical Tourism December 17, 2025 Medical Tourism North America Outbound Medical Tourism: Why Patients Leave Market forecasts put North America's outbound medical tourism market in the hundreds of billions. The forecast matters less than the reasons: Americans leave over price, Canadians leave over time. Christian El-Khouri Editor-in-Chief Published December 17, 2025 · Updated July 4, 2026 · 6 min read Coherent Market Insights values the North America outbound medical tourism services market at USD 153.10 billion in 2026 and projects USD 750.71 billion by 2033, a compound annual growth rate of 25.5 percent. Numbers like that say a great deal about where vendors think the money is and almost nothing about why patients get on the plane. The why is the better story, and it splits neatly along the 49th parallel. Americans leave because of the bill. Canadians leave because of the queue. ## A forecast with a credibility problem Start with what the report actually claims. Coherent Market Insights, the Pune-based research firm behind the figure, names cancer treatment as the largest revenue segment, which it attributes to the cost of oncology care in the United States, and lists India, Mexico, Thailand and Costa Rica as the main destinations for North American patients. Its favourite illustration of the push factor is a striking one: mean hospital charges for a heart transplant in the US run to USD 808,770. Now set that against the most careful patient-level count available. Patients Beyond Borders, which has tracked this industry for two decades, put the entire global medical travel market at USD 63 to 88 billion in 2023, built on roughly 21 to 22 million patients crossing a border for care and spending an average of USD 3,510 per visit including transport and accommodation. It estimates 1.8 million Americans travelled abroad for medical care in 2023. I cannot make those two pictures fit. The CMI valuation for North American outbound alone is nearly double the high end of the Patients Beyond Borders estimate for the whole planet. Run the arithmetic the other way: 1.8 million American travellers would each need to spend around USD 85,000 a trip to justify the 2026 figure, about 24 times the measured global average. Definitions explain part of the gap, since a services market can bundle facilitation fees, travel, insurance products and aftercare, but no definition stretches that far. My reading is that the 25.5 percent CAGR measures vendor optimism, not patient behaviour. The direction is real. The magnitude is marketing. ## Americans leave over price The push factor on the US side is documented well beyond the market research. KFF’s May 2025 Health Tracking Poll found 44 percent of American adults saying it is difficult to afford health care, and 36 percent reporting that they skipped or postponed care they needed in the past 12 months because of the cost. Among uninsured adults, three quarters did. KFF’s health care debt survey found about four in ten adults carrying debt from medical or dental bills. These are the customers the forecast is counting. The savings on offer are not subtle. Patients Beyond Borders puts the discount against US prices at 40 to 65 percent in Mexico, 45 to 65 percent in Costa Rica, 50 to 75 percent in Thailand and 65 to 90 percent in India, across a range of specialties. The CDC’s Yellow Book, the US government’s clinical reference for travel medicine, notes that millions of US residents travel internationally for medical care each year and that dental work is the most common purchase, in part because a substantial share of Americans have no dental insurance at all. Dental is the detail that convinces me this is structural. Nobody flies to Los Algodones for the experience of a root canal; they fly because the procedure is uncovered at home and a fraction of the price abroad. Travel concentrates exactly where coverage is thinnest. High-deductible plans have quietly extended that logic to general medicine: an insured patient staring at a USD 6,000 deductible is, for practical purposes, a cash buyer, and cash buyers compare prices across borders the way they compare flights. ## Canadians leave over time Canada supplies the cleaner experiment, because price cannot be the motive. Care at home is prepaid through taxes, so every Canadian who buys treatment abroad is paying twice. The Fraser Institute’s Waiting Your Turn survey for 2025 measured a median wait of 28.6 weeks from GP referral to treatment, the second longest it has ever recorded, down from 30.0 weeks in 2024 but roughly triple the 9.3 weeks of 1993. The wait splits into 15.3 weeks to see a specialist and another 13.3 weeks from specialist to treatment. Ontario patients waited least at 19.2 weeks; New Brunswick patients waited 60.9. An MRI alone took a median 18.1 weeks. The same institute estimates, in figures reported by The Hub in January 2026, that 105,529 Canadians received non-emergency medical treatment outside the country in 2025, a 66 percent increase over the past decade, with Ontario accounting for 51,538 of them. That is about 2.1 percent of patients nationally. Paying twice is the most honest measure I know of what a seven-month wait is worth to the person inside it. And the provincial split undercuts the lazy reading that only the worst queues drive people out. Ontario has the shortest waits in the country and still sends the most patients abroad, which mostly reflects its population, but also this: the best-performing province in 2025 still keeps patients waiting twice as long as the national norm of 1993. When the benchmark itself has slipped that far, even the winners lose patients. ## Aftercare is the missing line item The one restraint Coherent Market Insights flags deserves more attention than its growth curve. Patients returning from treatment abroad struggle to find physicians willing to manage complications from operations they did not perform, and that gap in follow-up care is the strongest argument the stay-home side has. Every savings table above assumes the procedure goes well. When it does not, the revision happens at home, at full domestic prices, and no line of the original invoice covered it. The costs of failed work abroad land first on the patient and then on the home system, which is a quiet subsidy running underneath every discount in this industry. ## What This Means Strip away the forecast and two engines remain, and they run on different fuel. The American engine is price: 36 percent of adults skipping care over cost is a standing reservoir of demand that discounts of 40 to 90 percent will keep draining southward and eastward. The Canadian engine is time: 105,529 people paid twice rather than wait 28.6 weeks, and that number has grown 66 percent in a decade. I would track those two indicators, KFF’s cost-skipping share and Fraser’s median wait, before I read another market report, because they lead the patient flow the way bookings lead arrivals. The forecast’s USD 750 billion is a number I do not believe; the direction underneath it is one I do. And the destinations that win the next decade will not be the ones with the cheapest operating theatres. They will be the ones that solve aftercare, because the follow-up gap is the last rational argument for staying home. Sources (6) Coherent Market Insights Patients Beyond Borders KFF Fraser Institute The Hub CDC Yellow Book North AmericaUnited StatesCanadaMexicoIndia ### The Wire Aug 30This Week in Medical Tourism: 20–26 August 2026 Aug 29This Week in Medical Tourism: 13–19 August 2026 Aug 22South Korea Undercuts America but Not Turkey All coverage ### Newsletter Get weekly health tourism intelligence in your inbox. Subscribe ### Knowledge Hub Medical Tourism Wellness Tourism Dental Tourism Fertility Tourism Cosmetic Tourism Longevity Tourism Explore the Hub Stay informed on the latest in global health tourism. Subscribe to our Newsletter ## Related Articles Medical Tourism 22 AUG 2026 Medical Tourism ### Mexico and Turkey Price Against Different Home Markets August 22, 2026 Medical Tourism 22 AUG 2026 Medical Tourism ### Turkey's Deepest Discounts Sit on Its Safest Procedures August 22, 2026 Medical Tourism ### Why Medical Tourism to Germany Declined August 11, 2026 --- # Telangana Plans Airport Health City for Medical Tourism URL: https://health-tourism-news.com/news/telanganas-strategic-leap-a-health-city-vision-to-transform-medical-tourism-and-domestic-healthcare/ Medical Tourism April 28, 2026 Medical Tourism Telangana Plans Airport Health City for Medical Tourism Telangana unveiled a health city near Hyderabad's airport for medical tourism, though the Chief Minister flagged weak air links and set no timeline. Christian El-Khouri Editor-in-Chief Published April 28, 2026 · Updated July 9, 2026 · 5 min read Telangana plans to build a dedicated health city near Rajiv Gandhi International Airport to expand its medical tourism, Chief Minister A Revanth Reddy announced at the inauguration of a 400-bed Apollo Hospitals facility in Hyderabad’s Financial District, Hyderabad Mail reported. Reddy said the state was working with the Centre on a “green channel for international patients”, a fast lane through the arrival and treatment process, but he named the obstacle in the same breath. Limited direct air connectivity remains the main hurdle for medical tourism, he said, and he set no timeline for fixing it. That pairing, a headline ambition beside an unresolved constraint, is the whole shape of the announcement. A green channel speeds patients who have already landed. It does nothing for the patient who cannot get a direct flight to Hyderabad in the first place, and Revanth Reddy offered no funded plan or date for new routes. ## A health city announced, not yet built The health city itself remains a vision rather than a site. Reddy unveiled it as a plan near the airport, Hyderabad Mail reported, without a published budget, a bed count or a construction timeline. In medical tourism the gap between an announcement and operating capacity is where most destination plans stall, and Telangana has announced the intent while leaving the capacity, the flights and the certification for later. The one concrete asset on the day was the 400-bed Apollo Hospitals facility whose opening provided the platform, and that is a private hospital rather than the state’s promised health city. ## Domestic healthcare gets the firm commitments Health Minister Damodar Rajanarsimha set out the domestic side, where the commitments were more specific, Hyderabad Mail reported. The state will expand its ambulance fleet from 30 to 100 vehicles and build 40 trauma care centres across Hyderabad, each meant to sit within a 35-kilometre radius of the next. Non-communicable disease clinics have been established in every district, offering medicines, diagnostics and specialist care, and they reach remote areas such as Mulugu and Adilabad. The government has launched a cancer registry to track disease trends and is setting up daycare centres across districts. These are health-system investments aimed at residents, not at foreign patients, and the distinction matters for how the medical tourism pitch should be read. A trauma network and a larger ambulance fleet strengthen the base a destination needs before it courts international custom, but Rajanarsimha presented neither as a medical tourism measure. The green channel was the only element tied directly to foreign patients, and it is a process rather than a building. ## The disease burden behind the pitch The case for the spending sits in the Apollo Hospitals Health of the Nation 2026 report, which Hyderabad Mail cited for a stark set of screening results in Telangana. More than 25 per cent of those screened in Hyderabad were diabetic, a figure that rose to nearly 29 per cent in Warangal. Over 81 per cent were overweight or obese, and more than 27 per cent had hypertension. Apollo founder Prathap C Reddy tied the numbers to technology, saying artificial intelligence could cut heart attack diagnosis time “from 60 minutes to 10”, while cautioning that clinical judgement remains essential. There is a tension worth naming here. A state carrying a chronic-disease burden on that scale is pitching to import foreign patients while its own screened population shows widespread diabetes, obesity and hypertension, with the diabetic share near 29 per cent in Warangal. The two goals are not incompatible, since the beds, scanners and specialists that serve medical tourists also serve residents. But the domestic numbers are the ones with hard commitments attached, and the export ambition is the one still waiting on air links and a built health city. ## What the announcement leaves open Telangana’s medical tourism case rests on infrastructure it has named but not yet delivered. India’s national ambitions give the state something to aim at. The country’s medical tourism market has been projected to nearly double to 16.2 billion US dollars by 2030 on easier medical visas and traditional-medicine demand, and Apollo Hospitals is among the chains named in forecasts that put the sector on a 13 billion US dollar path by 2026. A health city near Rajiv Gandhi International Airport fits that story. It is also, for now, a speech at a hospital opening. ## What to watch The tests are dated and checkable. Watch whether the health city moves from announcement to a site with a budget and a bed count, rather than staying a line in a speech. Watch for direct international air routes into Hyderabad, the constraint Chief Minister Revanth Reddy himself flagged. And watch whether the green channel for international patients is actually implemented with the Centre, because until it is, Telangana’s medical tourism ambition rests on domestic hospital investment that was built for residents. Sources (3) Hyderabad Mail TravTalk India Asian Hospitality IndiaTelanganaHyderabadMedical TourismApollo HospitalsNon-Communicable Diseases ### The Wire Aug 30This Week in Medical Tourism: 20–26 August 2026 Aug 29This Week in Medical Tourism: 13–19 August 2026 Aug 22South Korea Undercuts America but Not Turkey All coverage ### Newsletter Get weekly health tourism intelligence in your inbox. Subscribe ### Knowledge Hub Medical Tourism Wellness Tourism Dental Tourism Fertility Tourism Cosmetic Tourism Longevity Tourism Explore the Hub Stay informed on the latest in global health tourism. Subscribe to our Newsletter ## Related Articles Medical Tourism 22 AUG 2026 Medical Tourism ### Mexico and Turkey Price Against Different Home Markets August 22, 2026 Medical Tourism 22 AUG 2026 Medical Tourism ### Turkey's Deepest Discounts Sit on Its Safest Procedures August 22, 2026 Medical Tourism ### Why Medical Tourism to Germany Declined August 11, 2026 --- # The Decline of Medical Tourism in Germany URL: https://health-tourism-news.com/news/the-decline-of-medical-tourism-in-germany/ Medical Tourism The Decline of Medical Tourism in Germany And ITB Berlin 2025 Christian El-Khouri Editor-in-Chief Editor-in-Chief of Health Tourism News. Twelve-plus years across international patient services, healthcare consulting, and destination development in Europe, the Middle East, and beyond. Co-Founder and Vice President of the European Health and Medical Tourism Association (EHMTA). Read more Published March 1, 2025 · Updated July 2, 2026 · 4 min read After a deliberate hiatus from ITB Berlin, I will attend the event again this March. For those unfamiliar, ITB (International Tourism Börse/International Tourism Fair) is the world’s largest tourism industry gathering. Years ago, the organizers introduced a modest - truly modest - Health Tourism Pavilion. My first visit to the Health Tourism Pavilion left me disheartened. This is not a criticism of the organizers, whom I know to be dedicated and resourceful under challenging circumstances; rather, my disappointment arises from the systemic issues that repeatedly surface. Historically, Europe - and Germany in particular - was a leading destination in health and medical tourism. German healthcare was universally acknowledged for its excellence, and its reputation was almost self-evident. Germany’s natural prestige meant that, for a long time, little effort was needed to promote its healthcare services internationally. This might explain why only a few German healthcare providers attended that time. ## How Germany Lost Its Golden Era However, as the industry expanded and international competitors emerged, Germany missed the critical opportunity to market itself actively. The golden era faded, and the complacency born of past successes resulted in a significant decline: from a top-tier destination to a peripheral consideration. ## Structural and Legislative Headwinds Admittedly, this shift is not solely attributable to a lack of enthusiasm; structural changes within the healthcare system have also played a role. Legislative changes have diminished the attractiveness of medical tourism for all parties involved, and many German hospitals and clinics now struggle to compete with modern facilities available elsewhere. A lawsuit in Germany led to a court decision that caused major uncertainty in the medical tourism industry. Moreover, key stakeholders in Germany have often overlooked the importance of ambience and accommodations, factors that are vital to today’s discerning international patients. Additionally, the German healthcare system began to struggle domestically, waiting times increased, patients were unsatisfied and instead of seeing medical tourism as the lucrative extra-budgetary earning opportunity it was, people started to see it as a nuisance. ## Losing Ground to Global Competition Whereas medical tourism to once operated out of necessity, travelling to Germany for medical purposes is no longer a foregone conclusion, as reflected by the steady decline in international patients. The international competition is large, skilled and motivated. Often supported by their governments, other destinations have emerged and are reigning superior. While Germany used to offer an unbeatable combination of quality and price, this is no longer the case. Another reason German hospitals could no longer compete is the time it takes them to reply to international inquiries as well as the level of service provided to foreign patients. Go to the big medical tourism destinations on the globe and you will experience a level of service unseen. They do understand that travelling for medical reasons is beyond stressful and do their best to alleviate patients’ concerns by assisting them step by step. An art that has unfortunately not found itself into the German healthcare system. ## What This Means for ITB Berlin So, what does this mean for ITB? Numerous initiatives have sought to reposition Germany on the global map, yet I have observed a persistent reluctance - especially among hospitals - to actively engage in these efforts. The Health Tourism Pavilion at ITB stands as one of the few events in Germany dedicated to health and medical tourism, and it is disheartening to see many German providers refrain from participating or even offering a simple fam-trip. In contrast, numerous non-German and even non-EU institutions readily seize the opportunity to promote themselves in Berlin. This combination of complacency, ineptitude, and a failure to adapt has contributed significantly to the current state of affairs. It remains to be seen whether German hospitals are now willing to embrace change. I look forward to attending ITB this year to observe which institutions are ready to take a proactive step in the right direction. ### The Wire Aug 30This Week in Medical Tourism: 20–26 August 2026 Aug 29This Week in Medical Tourism: 13–19 August 2026 Aug 22South Korea Undercuts America but Not Turkey All coverage ### Newsletter Get weekly health tourism intelligence in your inbox. Subscribe ### Knowledge Hub Medical Tourism Wellness Tourism Dental Tourism Fertility Tourism Cosmetic Tourism Longevity Tourism Explore the Hub Stay informed on the latest in global health tourism. Subscribe to our Newsletter ## Related Articles Medical Tourism 22 AUG 2026 Medical Tourism ### Mexico and Turkey Price Against Different Home Markets August 22, 2026 Medical Tourism 22 AUG 2026 Medical Tourism ### Turkey's Deepest Discounts Sit on Its Safest Procedures August 22, 2026 Medical Tourism ### Why Medical Tourism to Germany Declined August 11, 2026 --- # Bupa Arabia's Digital Health Strategy URL: https://health-tourism-news.com/news/the-digital-architect/ Medical Tourism Bupa Arabia's Digital Health Strategy How Bupa Arabia's Ali Sheneamer is redefining Saudi healthcare, from insurer to digital health ecosystem. Christian El-Khouri Editor-in-Chief Editor-in-Chief of Health Tourism News. Twelve-plus years across international patient services, healthcare consulting, and destination development in Europe, the Middle East, and beyond. Co-Founder and Vice President of the European Health and Medical Tourism Association (EHMTA). Read more Published December 3, 2025 · Updated July 2, 2026 · 5 min read Speaking with Ali Sheneamer, Chief Business Development Officer for Bupa Arabia, at the Global Health Exhibition 2025 in Riyadh, one quickly realises that the conversation transcends the typical insurance discussion. While Bupa is globally recognised as a group with a vast international footprint (operating in over 190 countries and owning 20 hospitals and 400 clinics) I learned about a hyper-focused, vertically integrated strategy within Saudi Arabia that could serve as a powerful blueprint for the future of regional health and even beyond. The implications for the Kingdom’s healthcare landscape are profound, and while Sheneamer explicitly stated his focus is on their existing customers, the underlying mechanism being built has, be it only indirectly, an unavoidable resonance for health and medical tourism. ## The Payer Pivot: A Proactive Health Partner Sheneamer’s core message was a radical shift from the traditional insurance role. Bupa Arabia, through its healthcare provision arm, Bupa Care Connect, is moving aggressively to manage health, not just pay for sickness. The driving force is economic sustainability and clinical necessity. As Sheneamer revealed, chronic conditions - while only representing a small percentage of the population - “consume more than 52% of the healthcare cost.” This is where their strategy is concentrated. One should note that this is not only limited to the Kingdom of Saudi Arabia, but rather a phenomenon we see in most large markets. The model begins with a digital-first approach. He described the initial phase of Care Connect: Crucially, he noted their ultimate goal: “Ideally, you don’t want them to go to the physical clinics if you manage them remotely properly”. This statement confirms Saudi Arabia’s commitment to solving access and congestion through innovation, not merely by adding beds. In my experience, a large part of our healthcare professionals’ work is spent on fighting the consequences a lack of health management has caused in the first place. And shifting the priorities, voiding the necessity of a physical visit, certainly makes sense. ## The Open Network Orchestration Bupa Arabia is not attempting to become a fully closed system provider like Kaiser Permanente, as Sheneamer clarified. Instead, they are building an “open network that is being orchestrated through Bupa Care Connect”. This strategic choice focuses Bupa’s direct investment where it matters most: the patient journey and outpatient care, which Sheneamer noted accounts for a massive “97% of the incidents”. For the remaining 3% - the complex surgeries and admissions - Bupa uses its expertise to guide patients, saying: This orchestration model - direct digital management for the masses, and expertly curated referrals for the complex - is the intellectual property that is truly redefining the Saudi healthcare landscape. And it’s less the novelty of the concept that impresses me; in fact, it is the ambition of many healthcare markets. What left me deeply impressed is the decisiveness and goal-orientedness with which Sheneamer and his colleagues pursue this strategy. ## Drawing Conclusions for Health and Medical Tourism When discussing medical tourism, Sheneamer was unambiguous: “My focus is to manage the health of my customers… I’m not in the business of being a standalone health provider”. If my tenure in the medical tourism industry has taught me one thing, it is this: Becoming a destination for medical tourism without having your own house in order is an exercise in futility. And to me it sounds like the Saudi priorities are set correctly. While he disavows the standalone medical tourism provider role, his statements provide three undeniable conclusions for the regional industry: ### 1. The Domestic Base is the Prerequisite The Kingdom’s path to becoming a medical tourism destination must first rely on solving its domestic challenges. By tackling the 52% cost problem of chronic care and deploying the “clinic in your pocket” to manage 97% of patient incidents, Bupa Arabia is essentially creating the world-class digital health infrastructure that makes a future medical tourism offering viable. You cannot attract international patients without a digitally advanced, efficient, and quality-controlled local system. ### 2. Continuity of Care is the New Differentiator For a medical tourist, the most significant pain point is the fragmented care before arrival and after return. Bupa’s integrated model solves this. Their ability to manage a patient’s health remotely, dispense medication, and facilitate lab tests at home means they have the digital scaffolding necessary to manage an international patient before they board the plane and after they return home. This is the definition of “Health Tourism” - managing the journey, not just the procedure. ### 3. Global Trust, Local Delivery Sheneamer highlighted their ability to send Saudi patients abroad for treatment, cementing their status as both “local and international at the same time”. This dual identity - a listed Saudi company backed by a global giant operating in over 190 countries - is a stamp of assurance for international patients. When Bupa’s orchestrated network directs a patient to a local “centre of excellence”, international markets will trust that judgement. The energy at the Global Health Exhibition 2025, which Sheneamer noted was a crucial chance to “form partnerships with lots of partners within the health ecosystem”, confirms that Saudi Arabia views digital integration not as an option, but as the foundation of its Vision 2030 ambitions. Bupa Arabia is not merely observing this transformation; it is one of the strategic architects, building a new, digitally integrated reality that will inevitably attract global attention. ### The Wire Aug 30This Week in Medical Tourism: 20–26 August 2026 Aug 29This Week in Medical Tourism: 13–19 August 2026 Aug 22South Korea Undercuts America but Not Turkey All coverage ### Newsletter Get weekly health tourism intelligence in your inbox. Subscribe ### Knowledge Hub Medical Tourism Wellness Tourism Dental Tourism Fertility Tourism Cosmetic Tourism Longevity Tourism Explore the Hub Stay informed on the latest in global health tourism. Subscribe to our Newsletter ## Related Articles Medical Tourism 22 AUG 2026 Medical Tourism ### Mexico and Turkey Price Against Different Home Markets August 22, 2026 Medical Tourism 22 AUG 2026 Medical Tourism ### Turkey's Deepest Discounts Sit on Its Safest Procedures August 22, 2026 Medical Tourism ### Why Medical Tourism to Germany Declined August 11, 2026 --- # Vitiligo Treatment: A Growing Market And A Travel Niche URL: https://health-tourism-news.com/news/the-evolving-landscape-of-vitiligo-treatment-a-strategic-imperative-for-global-healthcare-destinations/ Medical Tourism March 20, 2026 Medical Tourism Vitiligo Treatment: A Growing Market And A Travel Niche The market researchers who size vitiligo care put it near USD 1.2 billion. Behind that number sit a first FDA-approved cream, decades-old phototherapy, and a patient-travel niche that runs through Havana. Christian El-Khouri Editor-in-Chief Published March 20, 2026 · Updated July 4, 2026 · 6 min read Vitiligo is not dangerous and it is not contagious, which is exactly why it went under-treated for so long. It takes pigment, not tissue. For most of the last century a diagnosis came with a shrug and a tube of steroid cream. That has changed in the past three years, and the change is worth reporting plainly, because it sits behind a search term - “vitiligo treatment market” - that people actually type. ## What the market numbers say, and who is counting The figure that circulates online comes from Renub Research, which values the global vitiligo market at about US$ 1.21 billion in 2025 and projects US$ 1.93 billion by 2034, a compound annual growth rate of 5.32 percent. Renub segments the market by treatment type, from topical drugs to light therapy to surgery, and names the companies with a stake in it: Incyte, Bristol-Myers Squibb, Pfizer, Astellas, Clinuvel and Dr Reddy’s Laboratories. I want to be careful with a number like that. A single research house’s projection is a sales document as much as a measurement, and the vitiligo “market” it sizes is mostly drug and device revenue in wealthy countries, not a headcount of patients treated. Roughly one to two percent of people worldwide have vitiligo; the paying market is a fraction of them. The useful signal in the figure is not the decimal. It is the direction. Money is moving into a condition that used to attract almost none, and the reason is a genuine shift in what doctors can offer. ## The treatment story is real, and recent The turning point has a date. On 18 July 2022 the US Food and Drug Administration approved topical ruxolitinib, sold as Opzelura, for nonsegmental vitiligo in patients 12 and older. It was the first drug the agency cleared to restore lost pigment rather than merely slow the spread. Ruxolitinib is a Janus kinase inhibitor; it interrupts the immune signalling that destroys melanocytes, the cells that make pigment. The European Medicines Agency followed in 2023. The results are meaningful without being miraculous, and the American Academy of Dermatology states them soberly. In the pivotal trials about 30 percent of patients regained 75 percent of facial pigment by week 24, and roughly 15 percent regained 90 percent. Treatment works slowly, colour returns “a little at a time,” and it does not cure anything. Stop applying the cream and about 40 percent of patients lose colour again within a year. That is the honest frame for anyone selling hope on this condition. Older tools still do most of the work. Narrowband ultraviolet B phototherapy remains a standard of care, endorsed in the Journal of the American Academy of Dermatology by the Vitiligo Working Group, which had to write dosing guidelines precisely because practice varied so widely across the world. Phototherapy means a light box two or three times a week for months, in a clinic or at home. Corticosteroids and calcineurin inhibitors fill in around it, and for stable disease there is surgery, grafting or melanocyte transplantation, which dermatologists avoid while the condition is still active. ## Why a skin condition becomes a travel niche Here is where the patient-travel angle earns its place, and it is not the glossy one the old market copy implied. People travel for vitiligo care for two unglamorous reasons: access and cost. The new cream illustrates the access gap. Opzelura carries a US list price around US$ 2,000 for a 60-gram tube, and a face-and-hands regimen burns through tubes. Insurance and copay cards blunt that inside the United States; outside a handful of rich markets the drug is either unavailable or unaffordable. Phototherapy’s real cost, meanwhile, is not the machine but the calendar - dozens of clinic visits that a working patient in a country with few phototherapy units simply cannot make. Into that gap steps Cuba, which has run a vitiligo destination programme for decades. Its Placental Histotherapy Centre in Havana treats foreign patients with Melagenina Plus, a human placental extract, and reports repigmentation in 86 percent of cases. I read that number the way I read Renub’s, with a hand on my wallet. OnCubaNews reports that Melagenina is only now going through a Phase 3 trial to meet international certification, and even its own clinicians say it “does not work miracles” and works best in patients under 15 with limited depigmentation. A treatment that has been marketed to medical travellers for forty years and is only now running a registration trial tells you how thin the evidence has been under the marketing. So the niche is real but small, and it splits in two. There is evidence-based care that travels because it is expensive at home, a patient flying somewhere with cheap, well-run phototherapy and a competent dermatologist. And there is hope-based care that travels because it promises what licensed medicine will not, which is where the buyer needs to read the trial data rather than the brochure. Anyone facilitating this trade is choosing which of those two businesses they are in. ## What This Means The vitiligo story is a good test of whether a treatment market is worth chasing. The demand is durable. People search for this because pigment loss is visible, permanent without care, and now, for the first time, partly reversible. The medicine finally has something to sell that works, which is what makes the market real rather than invented. But the honest version of the pitch is narrow: one licensed cream with a 30 percent facial response, a phototherapy regimen measured in months, and no cure at the end of any of it. A place that wants this patient should compete on the boring things, a dermatologist who will state the odds, a phototherapy schedule the patient can actually keep, and a price that beats staying home, and leave the 86 percent miracle to the clinics still selling it. The patients who travel well for vitiligo will be the ones who were told the truth before they booked. Sources (6) Renub Research American Academy of Dermatology US National Library of Medicine Journal of the American Academy of Dermatology OnCubaNews GoodRx VitiligoDermatologyCubaUnited StatesMedical Tourism ### The Wire Aug 30This Week in Medical Tourism: 20–26 August 2026 Aug 29This Week in Medical Tourism: 13–19 August 2026 Aug 22South Korea Undercuts America but Not Turkey All coverage ### Newsletter Get weekly health tourism intelligence in your inbox. Subscribe ### Knowledge Hub Medical Tourism Wellness Tourism Dental Tourism Fertility Tourism Cosmetic Tourism Longevity Tourism Explore the Hub Stay informed on the latest in global health tourism. Subscribe to our Newsletter ## Related Articles Medical Tourism 22 AUG 2026 Medical Tourism ### Mexico and Turkey Price Against Different Home Markets August 22, 2026 Medical Tourism 22 AUG 2026 Medical Tourism ### Turkey's Deepest Discounts Sit on Its Safest Procedures August 22, 2026 Medical Tourism ### Why Medical Tourism to Germany Declined August 11, 2026 --- # Integrative Medicine and the Provider-Patient Relationship URL: https://health-tourism-news.com/news/the-evolving-provider-patient-relationship-in-integrative-care/ Wellness Tourism Integrative Medicine and the Provider-Patient Relationship Integrative medicine replaces rushed, disease-centered visits with partnership-based care. What that shift means for patients and providers. Kevin Ciresi Contributor A career spanning the operating room to the boardroom. Former surgeon who founded and led multiple U.S. healthcare facilities, now focused on transparent frameworks for international care and blue-zone wellness destinations. Read more Published December 17, 2025 · Updated July 2, 2026 · 3 min read Reviewed by Christian El-Khouri, Editor-in-Chief One of the most profound shifts associated with integrative medicine is in the provider - patient relationship. Conventional biomedical care has often been criticized for being disease-centered and rushed, with brief visits and a prescriptive doctor-knows-best ethos. Integrative medicine, by contrast, emphasizes time, trust, and a holistic partnership between practitioner and patient. Providers seek to treat the “whole person” - addressing physical, mental, spiritual, and social dimensions - and to engage patients as active collaborators in their healing process. This approach inherently demands more listening, empathy, and personalization, which can transform clinical encounters. ## Patients Who Feel Heard and Empowered Patients often report feeling more heard and empowered under integrative care models. For instance, the U.S. Veterans Health Administration’s Whole Health program (an integrative, whole-person care model in VA hospitals) has demonstrated improved patient outcomes in managing chronic pain and PTSD, partly attributed to interventions like mindfulness meditation and acupuncture delivered alongside standard treatments. Providers note that discussing nutrition, stress management, and complementary therapies with patients, not just prescribing drugs, enriches the therapeutic relationship. By involving patients in lifestyle changes and self-care practices, integrative clinicians cultivate patient agency in health decisions, which strengthens trust and satisfaction on both sides. A recent commentary describes IM’s approach as one that “strengthens trust, cultivates compassion, and optimizes care” by making treatment a collaborative journey rather than a top-down directive, as noted in. ## Better Outcomes and Lower Costs Notably, evidence is emerging that this relationship-centered care yields system benefits. Patient satisfaction scores for integrative medicine clinics are often high, and some studies show measurable improvements in outcomes and utilization. In one integrative primary care model (an Illinois HMO where chiropractic physicians served as primary care providers, coordinating holistic care), IM patients had 43% fewer hospital admissions and 51.8% lower pharmaceutical costs compared to patients receiving conventional care over 4 years. Over the course of 7 years, the differences grew to a remarkable 60% fewer admissions and 85% lower drug costs, indicating that patients stayed healthier with less intensive medical intervention,\ as reported here. These outcomes were achieved by focusing on non-pharmacological therapies, lifestyle modifications, and early preventive measures - all of which were enabled by a more continuous and communicative doctor-patient relationship. Another program integrating meditation, yoga, and nutrition (the Maharishi Vedic approach) found that medical expenditures were ~60% lower for participants compared to matched controls over several years,. While multiple factors contribute to such successes, experts argue that engaging patients as whole persons - addressing stress, mindset, and behavior change in addition to prescriptions - creates conditions for better long-term health management. ## Easing Provider Burnout Furthermore, the integrative ethos extends to the well-being of providers. Burnout plagues many healthcare systems, but integrative practice models may mitigate it. VA clinics with Whole Health implementation reported that clinicians and staff involved were less likely to experience burnout or leave their jobs, citing greater intrinsic motivation and a stronger sense of purpose in their work.  Programs that train clinicians in acupuncture, mindfulness, or other complementary skills also find that those providers often regain a sense of meaning in patient care and feel re-energized professionally. In short, integrative medicine’s relational, humanistic approach not only improves patient engagement but can also restore the “healing vocation” spirit for providers - a crucial point for policymakers concerned with practitioner retention and healthcare quality. Sources (3) MDPI Child Neurology Society US Department of Veterans Affairs, Whole Health evaluation ### The Wire Aug 30This Week in Medical Tourism: 20–26 August 2026 Aug 29This Week in Medical Tourism: 13–19 August 2026 Aug 22South Korea Undercuts America but Not Turkey All coverage ### Newsletter Get weekly health tourism intelligence in your inbox. Subscribe ### Knowledge Hub Medical Tourism Wellness Tourism Dental Tourism Fertility Tourism Cosmetic Tourism Longevity Tourism Explore the Hub Stay informed on the latest in global health tourism. Subscribe to our Newsletter ## Related Articles Weekly Digest 08 JUL 2026 Weekly Digest ### Medical Tourism Records Concentrate In Penang And Seoul July 8, 2026 Weekly Digest 01 JUL 2026 Weekly Digest ### Nigeria, Iran And Seoul Redraw Medical Tourism July 1, 2026 Weekly Digest 24 JUN 2026 Weekly Digest ### Health Tourism As Badge, Escape Hatch And Disguise June 24, 2026 --- # Why Longevity Tourism Is the Future of Health Travel URL: https://health-tourism-news.com/news/the-long-game/ Longevity Tourism Why Longevity Tourism Is the Future of Health Travel Medical tourism solves a problem; longevity tourism prevents one. Why proactive health travel is the sector's long game. Ivan Rendulic Contributor Founder of ZagrebMed and President of the European Health and Medical Tourism Association (EHMTA). Over a decade facilitating international patients and shaping cross-border healthcare initiatives from Croatia. Read more Published June 23, 2025 · Updated July 2, 2026 · 3 min read Reviewed by Christian El-Khouri, Editor-in-Chief ## The Long Game: Why Longevity Tourism Is the True Future of Health Travel Medical tourism has always had its place in the global health ecosystem. People cross borders for surgeries, advanced diagnostics, dental work, fertility treatments - the list is long, and the rationale is often economic. But here’s the truth I believe in: while medical tourism solves a problem, longevity tourism is building a new lifestyle. This isn’t about fixing what’s broken - this is about staying whole, longer. Longevity tourism, once considered a luxury or a Silicon Valley fringe interest, is quickly emerging as the mainstream of future health travel. And it’s not just spa tourism with a science twist - it’s a multidisciplinary, proactive journey that fuses medical expertise, holistic well-being, and lifestyle transformation. So how did this all start? The earliest seeds of modern longevity travel trace back to pioneers like Dan Buettner, who introduced the concept of Blue Zones - regions where people live significantly longer due to a mix of diet, community, purpose, and movement. But while those zones inspired lifestyle change, the wellness travel industry took that further. Institutions in places like Switzerland, Austria, Thailand, and California began offering diagnostics, genomic profiling, and cellular regeneration alongside yoga, meditation, and curated diets. The result: a new category of travel that isn’t only about relaxation or recovery, but optimization. Longevity tourism is not spa tourism. Yes, it may include spa-like settings, but it’s about medical-grade health insights, biomarker tracking, tailored exercise, and nutrition protocols. In some cases, it involves hyperbaric oxygen chambers, cryotherapy, NAD+ infusions, and gut microbiome rebalancing. It’s not about pampering. It’s about performing - better, longer, and with more awareness. Where should one go? Winter is for destinations that offer internal restoration. Think Lanserhof in Austria, SHA Wellness in Spain, or Clinique La Prairie in Switzerland - places where you go inward, reset your physiology, and build mental resilience. Summer, on the other hand, lends itself to movement-based, outdoor-integrated longevity programs: Six Senses in Ibiza, Kamalaya in Thailand, or even a modernized take on hiking and detoxing retreats in northern Italy or Slovenia. And is this just for individuals? I don’t believe so. Longevity travel is maturing into a family experience. Parents are bringing teenagers to learn breathwork and sleep hygiene. Older adults are introducing their grandchildren to functional fitness and anti-inflammatory diets. It’s no longer hedonistic or solo - it’s generational health in action. Is longevity the same as wellness? No - and that distinction matters. Wellness is the broader umbrella, often lifestyle-driven and accessible. Longevity, on the other hand, is precision-based, combining lab results with curated interventions. Wellness is yoga and healthy meals. Longevity is VO2 max testing, inflammation markers, and mitochondrial repair. They coexist, but longevity pushes us further. It asks for discipline, science, and commitment. We’re entering a phase where health tourism is not event-based, but habit-based. Instead of waiting until something goes wrong, more people will build a rhythm of going abroad not for surgery, but for maintenance - preventive recalibration, early intervention, cognitive optimization. That, to me, is not a trend. That’s a future model. And it’s one I deeply believe in. ### The Wire Aug 30This Week in Medical Tourism: 20–26 August 2026 Aug 29This Week in Medical Tourism: 13–19 August 2026 Aug 22South Korea Undercuts America but Not Turkey All coverage ### Newsletter Get weekly health tourism intelligence in your inbox. Subscribe ### Knowledge Hub Medical Tourism Wellness Tourism Dental Tourism Fertility Tourism Cosmetic Tourism Longevity Tourism Explore the Hub Stay informed on the latest in global health tourism. Subscribe to our Newsletter ## Related Articles Weekly Digest 01 JUL 2026 Weekly Digest ### Nigeria, Iran And Seoul Redraw Medical Tourism July 1, 2026 Longevity Tourism 19 MAY 2026 Longevity Tourism ### Longevity Travel Market Valued at $18 Billion, $48.2 Billion by 2033 May 19, 2026 Longevity Tourism 18 MAY 2026 Longevity Tourism ### Grenada Expands Wellness Tourism With Two Resorts May 18, 2026 --- # The Risks and Benefits of AI in Healthcare: A Pandora's Box URL: https://health-tourism-news.com/news/the-pandoras-box-of-ai-in-healthcare/ Medical Tourism The Risks and Benefits of AI in Healthcare: A Pandora's Box Is artificial intelligence healthcare's Pandora's box? Where the fear is justified, where it is not, and what it means for global healthcare. Pierre Hollenbeck Contributor Founder of Medcom, a Paris-based marketing and international healthcare provider support company operating across 17 countries. Pioneered the French hair transplant market to Turkey in 2004 and has since expanded into dental and cosmetic surgery coordination. Read more Published July 9, 2025 · Updated July 2, 2026 · 10 min read Reviewed by Christian El-Khouri, Editor-in-Chief Is artificial intelligence the Pandora’s box of healthcare? Seeing both the fascination and fear that the technology triggers among providers, similarities with the famous Greek tale glow. Rarely has a technology mixed so much fascination - and so much anxiety. Our experience in the field of highly specialised medical customer service is a perfect user case that enlightens the paradox within. Medicine is in essence one of the very few fields considered a priority use for technological advances. Nevertheless, AI is not part of the group. The opposite is happening with AI: a massive popular use, and the technology is starting to embed itself in the everyday life of consumers while it stays outside of the clinic doors. So what exactly fuels this phenomenon in a field that has always had to be at the forefront of technical evolution? Our user case has some answers. ## Why Such a Strong Backlash? Let’s start with a simple analogy. When a company takes a new employee, a trial period is systematically given - both for the company as well as the employee - to assess the learning capacity and the compatibility of the pair. Mistakes are made, lessons are learned, and hopefully performance improves. Trial and error is part of the process. No one panics when a human trainee slips up; it is considered as the trial and errors period. Now, if you start introducing AI into the process, expectations are radically different. Expectations have skyrocketed and tolerance has reached the zero point. An AI mistake is viewed as a threat, a liability, and often a justification to pull the plug on the entire project. Why such a visceral reaction? Why does the mere possibility of an algorithmic error feel so much more dangerous than the human kind? AI is and should be considered as: an employee. A super powerful one, yes. A very fast one, yes. An ever-learning one, yes. A cheaper one, yes. But an omniscient one, no. That is why we hear the word: AI training. Training means the same thing as with another employee: errors, correction, and acknowledgment of mistakes and limitations. ## AI Fear in Medicine: Will Skynet Kill My Patient? Let’s look at the fears more closely. The recurring panic: “Will AI replace my job?” The reality is much subtler: “Your job won’t be replaced by AI, but it might be replaced by someone using AI.” The threat isn’t the machine itself, but the shift in skills and adaptability that it demands. That is applicable to all current positions in all fields. Physicians, in particular, have a different approach to AI. They are carrying the heavier burden of the life responsibility. But no one is believing - and even more so the physicians - that AI is holding the scalpel - yet. The physician’s worry about AI rests on the core starting point of any treatment: the diagnosis. Their fear is also driven by the same factors that drove their fear during the internet revolution. “Doctor, I checked on the internet, and I read that it could be cancer.” (This is an example, but I’m sure that this is quoting some patient, somewhere…) Physicians dread being forced to contradict a machine’s recommendation in front of a patient - a dynamic that feels both humiliating and risky. Strangely enough, these same doctors are comfortable prohibiting a new staff member from making diagnoses until they’re ready. But when it comes to AI, they fear losing control, as if, once set loose, the algorithm will become unstoppable. Will AI become some kind of Dr. Strangelove (yes, Kubrick also saw it in 2001: A Space Odyssey, but Dr. Strangelove felt more appropriate), making autonomous clinical decisions and holding the surgical scalpel? Hardly. But the very presence of such questions shows just how much our collective imagination is fueled by dystopian scenarios - not by real-world improvements that AI could offer. ## Medical Tourism: Diagnosis at a Distance and the Fear of Discrepancy Nowhere is this anxiety more pronounced than in medical tourism - a sector built on remote communication and virtual assessment. Every provider knows the reality: the diagnosis made at a distance is often adjusted in person (“This doesn’t look like the pictures!”). This is not a new risk; it’s an old reality of long-distance care. But somehow, when AI is involved, the margin for error becomes intolerable, as explained above. Let’s flip the script… Would you allow a brand-new employee, on their very first day, to confirm a patient’s surgery and book their flight? Of course not. Then why would you allow AI to do so? The real question isn’t about capability, but about control and boundaries. Trial and boundaries are an accepted factor when employing and working with humans. After all, this is what we have all been doing all our lives. Here comes this new employee… and people are whispering that it might be the best of us… more intelligent than us… Well, no matter the intelligence (artificial one of course), and just as new staff go through a trial period, AI training is a real thing. When the new way of working side by side with AI will have passed the fear of the unknown, we may be looking at a multi-sector, fast-paced, horizon-changing change of habit. Medical field included. Yuval Harari explains to us in Homo Deus that machines will be assisting mankind to a higher level, just as technology has pushed our lifespan as quickly as science has advanced. AI will assist the workplace in all sectors and on all levels: managerial, workforce, decision-making level. ## The Real Challenge: Redefining the Human Role Ultimately, the question is not whether AI will replace humans, but how it can augment them - and under what conditions. The real danger is not in opening Pandora’s box, but in refusing to open it at all, paralyzed by fear and fantasy. AI in healthcare is neither a monster nor a miracle. It is a tool, and it’s up to us to decide how - and when - to use it. ## What Does AI Actually Change? The Esthetic Planet Experiment It’s easy to discuss the risks and fears around AI in healthcare, but what about the reality on the ground - what actually changes when a marketplace like Esthetic Planet embraces artificial intelligence? Let’s put theory aside and look at a concrete case study. Esthetic Planet is a medical tourism platform operating in three primary languages: English, French, and Italian. Historically, the platform faced the same challenge as any international operation: limited human resources meant limited capacity. There simply weren’t enough multilingual agents available, around the clock, to field questions, nurture leads, and convert inquiries into actual bookings. Inevitably, this led to bottlenecks: delayed responses, missed opportunities, frustrated customers. How do you provide world-class service in multiple languages when your human team is finite - and global demand never sleeps? Enter Nalys, an AI-driven assistant, deployed on Esthetic Planet’s WhatsApp channel. Here’s where the paradigm shifted: instead of steering consumers through a traditional account-creation process - complete with forms, passwords, emails, and all the friction that entails - Esthetic Planet began redirecting traffic straight to WhatsApp. Why? Because it’s instant, familiar, and brutally efficient. For the consumer, there’s no need to “set up an account” or jump through administrative hoops; instead, you simply open a chat and ask whatever you want, in your own language, at your own pace. The impact? Nothing short of a revolution. For the first time in its history, Esthetic Planet began answering leads 24 hours a day, seven days a week. Language barriers fell away: with AI handling the first line of communication, queries in French, Italian, English, Czech, Arabic, Spanish, Russian - all received immediate, competent responses. Clients who once would have given up at the first sign of delay suddenly had a personal assistant in their pocket. ## The Out-of-the-Box Promise - What About the Failure? What about the trial period of AI? Did it magically work straight out of the box? Of course not! And nothing speaks better than experience. Let’s hear about the most noticeable failures: Failure 1: Missing information on lead generation. The AI would simply “forget” to ask for the client’s email or name. Failure 2: Sent the wrong webpage link to a customer (a contact page). Failure 3: Appointment booking. After a client insisted on a last-minute appointment, the AI confirmed a meeting with the staff. Failure 4: A client insisted on getting all documents (quotes, appointments) through WhatsApp (this is outside of company protocol and against privacy policy). The AI is instructed to be empathetic and to always encourage solutions with the customer. In these examples, the machine had failed and learned - and did not repeat the mistake again. Just like a new employee. Notice that all the failures are data-driven. Instructing the right data is the pillar of AI training, just like with a new employee. ## What Happens After the Trial Period? The numbers speak for themselves. Within two months, incoming leads jumped by 250%. Conversations that once languished in email inboxes or got lost in translation now happened in real time, with no lost momentum. Market share began to climb. The diversity of English- and Italian-speaking clients soared, quadrupling in volume. Italian leads, in fact, are now nearly as numerous as Esthetic Planet’s historically dominant French-speaking clientele - a demographic shift the company had never seen before. Even more telling: bookings began arriving from as far as Australia, a market previously out of reach. So what does this mean for the industry? It’s more than just statistics. It’s a direct challenge to the idea that AI is a cold, impersonal barrier. In practice, the right deployment of AI can make a service more human, more direct, more accessible - precisely because it removes the friction that so often blocks genuine exchange. Instead of “dehumanizing” customer service, AI gave Esthetic Planet the bandwidth and flexibility to be present, instantly, in any language the world demanded. ## The Box Is Open Of course, this is only the beginning. The real test, as always, will be whether the human team can build on this momentum - using AI as a tool, not a crutch. But one thing is clear: the Pandora’s box is open, and there’s no putting the genie back inside. AI is not here to replace what is uniquely human. It is here to amplify it, to accelerate the process from idea to expression. In healthcare, in customer service, in nearly every industry you can imagine, this will be the real revolution: AI will not erase the need for human expertise or judgment. It will make those human skills more valuable, more visible, and more effective than ever before. So as we peer into the future - two years, five years, a decade from now - one thing is certain: AI won’t take the place of the human voice. It will help that voice reach further, move faster, and shape the conversation in ways we’re only beginning to imagine. The box is open. The possibilities are ours to invent. ### The Wire Aug 30This Week in Medical Tourism: 20–26 August 2026 Aug 29This Week in Medical Tourism: 13–19 August 2026 Aug 22South Korea Undercuts America but Not Turkey All coverage ### Newsletter Get weekly health tourism intelligence in your inbox. Subscribe ### Knowledge Hub Medical Tourism Wellness Tourism Dental Tourism Fertility Tourism Cosmetic Tourism Longevity Tourism Explore the Hub Stay informed on the latest in global health tourism. Subscribe to our Newsletter ## Related Articles Medical Tourism 22 AUG 2026 Medical Tourism ### Mexico and Turkey Price Against Different Home Markets August 22, 2026 Medical Tourism 22 AUG 2026 Medical Tourism ### Turkey's Deepest Discounts Sit on Its Safest Procedures August 22, 2026 Medical Tourism ### Why Medical Tourism to Germany Declined August 11, 2026 --- # This Week in Medical Tourism: 13–19 August 2026 URL: https://health-tourism-news.com/news/this-week-in-medical-tourism-13-19-august-2026/ Weekly Digest August 29, 2026 Weekly DigestHealth Tourism This Week in Medical Tourism: 13–19 August 2026 China's National Health Commission put 1.28 million international patients through its key foreign-oriented hospitals, a rise of 73.6 per cent in three years. Latvia counted 35,851 and a fall of a quarter. The two numbers do not measure the same thing. Christian El-Khouri Editor-in-Chief Published August 29, 2026 · 7 min read This is the Health Tourism News roundup for 13 to 19 August 2026. ## China inbound patient count Key foreign-oriented hospitals in China received 1.28 million international patients, a rise of 73.6 per cent over three years, on figures in the National Health Commission’s 2025 report. The Boao Lecheng pilot zone on Hainan took more than 8,600 overseas medical tourists between January and July 2026, 5.4 times the same period a year earlier, from 14 countries and regions. Hainan admits citizens of 86 countries without a visa for up to 30 days, and the zone can import drugs and devices already approved in Europe or the United States before they complete mainland registration. Guangzhou introduced 12 supporting measures on 29 April covering visa support, remote pre-consultation and cross-border payment, and opened a service centre for overseas patients. Hong Kong’s Secretary for Health, Lo Chung-mau, led a delegation to the Hainan zone on 13 August to discuss Chinese medicine and public hospital development. ## Latvia, Egypt and the counting problem Latvia’s Centre for Disease Prevention and Control recorded 35,851 foreign patients receiving medical services in the country last year, down 25.9 per cent on the previous year. United States residents were the largest group at 3,843, ahead of Lithuania at 2,980 and the United Kingdom at 1,967. The centre published no explanation for the fall. Egypt’s General Authority for Healthcare reported revenue above 10 million US dollars, up 37 per cent year on year, from close to 42,000 international patients treated at its own hospitals. Chairman Ahmed El-Sobky named cosmetic procedures, in vitro fertilisation, obesity treatment and advanced dental care as the priority specialties. The two counts do not measure the same thing. Latvia works from a stated definition: a person who travels specifically for care and pays out of pocket or through insurance, rather than through the host country’s state budget. Egypt’s figure covers one state authority’s facilities rather than the country. Vietnam’s health ministry, meeting on 13 August to advance its own scheme, said its statistics cannot separate foreigners living in Vietnam who use hospitals routinely from visitors who travel for treatment, and proposed a steering committee and a national association to sit alongside the plan. ## Telangana suites and hospital margins Telangana’s decision to set aside elite suites for foreign patients at a public institute in Sanathnagar drew objections from senior doctors and public health specialists. They argued that foreign currency targets and international marketing panels change the purpose of a hospital built for local patients, and that waiting lists at the city’s government tertiary hospitals come first. The institute was established during the pandemic to provide high-end care for poorer and middle-income families at low cost. Its critics put the case as sequencing rather than principle, contesting the argument that revenue from international patients will fund upgrades later. Industry executives told Business Today that operating margins run at 24 to 25 per cent on Indian hospitals’ domestic business and about 30 per cent on international patients, with higher marketing and acquisition costs taking back part of the difference. ## Kerala medical value travel Kerala’s tourism minister, P.C. Vishnunath, set a 2030 target for the state to become a global medical travel hub, working with private hospitals and facilitators and focusing on Arab visitors travelling with their families. He named regulation, classification and standardisation as the conditions, and a training programme for service providers is under consideration with the state travel and tourism institute. A summit in Kochi on 31 August and 1 September has drawn more than 175 Arab travel agents and tour operators from 11 countries, with more than 100 Indian hospitals, hotels and Ayurveda centres exhibiting. Organisers are targeting 300,000 additional Arab visitors and more than 250 billion rupees, about 2.9 billion US dollars, over five years. India’s existing inbound sourcing was put more plainly in Kampala, where Sanjiv Patel of the Tomil Group told a trade expo running from 13 to 15 August that 86 per cent of Ugandan patients who travel abroad go to India. ## Johor Bahru and Singapore MediSave The only Johor Bahru hospital in Singapore’s overseas MediSave scheme has seen patients using the scheme double since the pandemic, and treats 150 to 200 international patients a day, mostly Singaporeans and Indonesians. Nine in ten of its MediSave patients are women, with obstetrics and gynaecology the most common treatments, Channel News Asia reported. A 2025 study by the ISEAS-Yusof Ishak Institute found Singaporeans could save between 24 and 74 per cent on procedures done in Malaysia, with in vitro fertilisation at the top of that range. Treatment in Johor Bahru can run up to 10 per cent higher in nominal terms, the hospital’s chief executive said, with the exchange rate accounting for the gap. Singaporeans and permanent residents have been able to use MediSave for elective hospitalisations and day surgery at accredited overseas facilities since March 2010, subject to clinical assessment and financial counselling. The Rapid Transit System link between the two cities opens in January 2027, with a five-minute crossing. ## Health councils and hotel groups Malaysia’s Healthcare Travel Council signed a memorandum of understanding with Marriott International on 12 August, under the country’s Year of Medical Tourism campaign. The council is mandated by Malaysia’s health ministry to develop and promote the national healthcare brand. Marriott announced a separate alliance with Therme Group the following day, covering customer experience, hotel design, wellness research and development opportunities, with the first phase offering Therme sites to its loyalty members. Therme has 10 projects under way across four regions, including a 720,000 square foot site in Singapore due in 2030. ## By the Numbers 1.28 million international patients treated at China’s key foreign-oriented hospitals, a rise of 73.6 per cent over three years, in the National Health Commission’s 2025 report. 35,851 foreign patients treated in Latvia last year, down 25.9 per cent on the year before, on Centre for Disease Prevention and Control figures. 8,600 overseas medical tourists received by the Boao Lecheng pilot zone on Hainan between January and July 2026, 5.4 times the same period in 2025, on provincial figures reported by CGTN. 24 to 74 per cent, the range of savings Singaporeans could make on procedures performed in Malaysia rather than Singapore, in a 2025 study by the ISEAS-Yusof Ishak Institute. 86 countries whose citizens may enter Hainan without a visa for up to 30 days, including for medical check-ups and treatment, under the province’s current entry rules. 86 per cent of Ugandan patients who travel abroad for treatment go to India, cited by an industry representative at a Kampala trade expo held from 13 to 15 August 2026. ## What to Watch Indo Arab Connect 2026 runs in Kochi from 31 August to 1 September, followed by a nine-day familiarisation tour for Gulf and West Asian delegates from 2 to 9 September. The Rapid Transit System link between Singapore and Johor Bahru begins operating in January 2027. Vietnam’s health ministry has proposed forming a steering committee and a national medical tourism association, to be included in the scheme it submits to government. Egypt’s General Authority for Healthcare has been instructed to open coordination with the Turkish medical centres it visited earlier this year. Sources (14) Businesstoday Ttnworldwide Theindependent Gulf News Dailynewsegypt Inbox Cgtn Newvision Bastillepost Vietnam Bastillepost Telanganatoday Athletechnews Bernama medical tourism dataChina inbound patientsLatviaKerala medical value travelMalaysia healthcare travelhospital hospitality partnerships ### The Wire Aug 30This Week in Medical Tourism: 20–26 August 2026 Aug 22South Korea Undercuts America but Not Turkey Aug 22Spain and Greece Report IVF Success Differently All coverage ### Newsletter Get weekly health tourism intelligence in your inbox. Subscribe ### Knowledge Hub Medical Tourism Wellness Tourism Dental Tourism Fertility Tourism Cosmetic Tourism Longevity Tourism Explore the Hub Stay informed on the latest in global health tourism. Subscribe to our Newsletter ## Related Articles Weekly Digest 30 AUG 2026 Weekly Digest ### This Week in Medical Tourism: 20–26 August 2026 August 30, 2026 Weekly Digest 14 AUG 2026 Weekly Digest ### This Week in Medical Tourism: 6–12 August 2026 August 14, 2026 Weekly Digest 07 AUG 2026 Weekly Digest ### This Week in Medical Tourism: 30 July – 5 August 2026 August 7, 2026 --- # This Week in Medical Tourism: 14–21 July 2026 URL: https://health-tourism-news.com/news/this-week-in-medical-tourism-1421-july-2026/ Health Tourism July 22, 2026 Health Tourism This Week in Medical Tourism: 14–21 July 2026 This is the Health Tourism News roundup for the week of 14 to 21 July 2026. A Frost and Sullivan analysis put Malaysia's private hospital capacity second in... Christian El-Khouri Editor-in-Chief Published July 22, 2026 · 9 min read This is the Health Tourism News roundup for the week of 14 to 21 July 2026. A Frost and Sullivan analysis put Malaysia’s private hospital capacity second in Asean. The Malaysia Healthcare Travel Council said nearly 12,000 Cambodians came for treatment in 2025. Thailand hosted a trade fair for the medical industry in Bangkok. Aga Khan University Hospital in Nairobi put Africa’s annual loss to medical tourism at $7 billion. In Kerala, police found a deal that paid a firm to send transplant patients to a hospital. Dubai and Uzbekistan both set out plans to make it easier for foreign patients to get in. ## Malaysia leads Asean on private hospital capacity Malaysia has about 290 private hospitals and nearly 19,000 private hospital beds, giving it the second-highest private bed ratio among major Asean markets at 0.58 beds per 1,000 people, behind Singapore on 0.75, CodeBlue reported. Rathanesh Ramasundram, who leads health care advisory for Asia Pacific at Frost and Sullivan, gave the figures at a Bursa Malaysia investment series in Kuala Lumpur on July 2. The Philippines has 0.52 private hospital beds per 1,000 people, followed by Thailand on 0.49, Vietnam on 0.39 and Indonesia on 0.28. Frost and Sullivan projects Malaysia will have about 27,000 private hospital beds by 2028. Health insurance claims paid in Malaysia rose six-fold over two decades, from RM960 million (US$235 million) in 2003 to RM6.75 billion (US$1.65 billion) in 2023. Medical tourism remains one of the sector’s main growth drivers. Malaysia recorded 1.8 million medical tourists and RM3.35 billion (US$820 million) in healthcare travel revenue in 2025, according to the Malaysia Healthcare Travel Council, with about 60 per cent of those patients arriving from Indonesia. The country holds eight of the world’s 30 accredited fertility centres, and its IVF success rate is 82.9 per cent against a global average near 50 per cent. A cycle costs US$4,000 to US$5,000 there, against US$12,000 to US$15,000 in the United States. Malaysia also has more than 30 heart centres, and ranks third in the Asia Pacific for cancer care readiness. Anwar Anis, honorary secretary of the Association of Private Hospitals of Malaysia, said the specialist numbers look adequate on paper but that 20 to 30 per cent of those aged 60 and above are now semi-retired. On nurses, he said: “if you don’t have the nurses, you cannot open those beds.” He also called for stronger primary care to cut needless hospital visits, citing a recent World Bank report ordered by the government. ## MHTC counts Cambodian patients and unveils two mascots Nearly 12,000 Cambodian patients sought treatment in Malaysia during 2025, generating RM30 million (US$7.4 million) in healthcare travel revenue, the Malaysia Healthcare Travel Council said in a statement carried by KLSE Screener. The council called Cambodia an emerging market next to its older ones. It said its 91 member hospitals draw foreign patients for cancer care, heart care, orthopaedics, fertility and health checks. The council held its first Malaysia Healthcare Expo in Phnom Penh this month, making Cambodia the first market outside Indonesia to host the show. Separately, the council unveiled two mascots, Dr Wira and Sister Manja, designed after the Malayan sun bear, Free Malaysia Today reported. The pair carry the Visit Malaysia 2026 campaign into the health sector. They sit alongside the singer Siti Nurhaliza, who is the council’s brand ambassador. The public met them at a wellness fair at Taylor’s University Lakeside Campus on July 16. ## Thailand hosts International Healthcare Week in Bangkok Thailand attracts more than a million foreign patients a year and hosted International Healthcare Week at the Queen Sirikit National Convention Center from July 8 to 10, The Manila Times reported. The event, organised by Informa Markets, brought together more than 1,200 companies from over 100 countries. Prime Minister Anutin Charnvirakul told the opening that the government means “to position Thailand as a world-class global medical hub” by lifting standards and pushing new services. Pattana Promphat, a Thai health ministry official, told Filipino reporters at the event that a package covers the medical visa, the scheduling, the hotel and the doctor. He said patients can also be booked back in for a check months later. The wider plan covers public and private hospitals, preventive care, rehabilitation and traditional Thai medicine, with support for medical devices, drugs and biotechnology. ## Aga Khan hospital puts Africa’s medical tourism losses at $7bn Africa loses an estimated $7 billion a year to medical tourism, and more than 300,000 Africans travel to India annually for treatment, Aga Khan University Hospital in Nairobi said at a media roundtable in Lagos on Wednesday, Vanguard reported. Chief operating officer Khurram Jamal blamed a shortage of specialists, uneven quality, broken referral systems and a belief that better care is only found abroad. Africa has about 1.5 health workers per 1,000 people, against the 4.45 urged by the World Health Organisation, he said, and many African doctors who train abroad never come home. “A building cannot heal a patient,” Jamal said, arguing that a specialist takes more than a decade to train. The hospital has more than 200 full-time specialists. It runs training posts in nine specialties and 16 fellowships, and was the first in East Africa to win international accreditation. Jamal said Africa carries about 25 per cent of the global disease burden but hosts around 4 per cent of clinical trials. The hospital plans a gene sequencing laboratory, and has a deal with Kenya Airways covering referrals, calls with doctors before travel, cheaper fares and follow-up once patients are home. Diplomats who visited Benjamin Mkapa Hospital in Dodoma on Friday called for wider international promotion of Tanzania’s specialist services, the Daily News reported. Tanzania’s ambassador to Burundi, Gelasius Byakanwa, met Burundian children treated there for congenital heart defects and said the hospital had exceeded his expectations. Burundi’s ambassador to Tanzania, Leontine Nzeyimana, said: “Africa needs to know that such services are available here, close to home.” ## Kerala organ trafficking probe uncovers referral agreement Police looking into an alleged organ trafficking network in Kerala have found a deal between a private hospital in Kochi and a medical tourism firm paid to refer transplant patients, Medical Dialogues reported. Under the deal, signed last year, the firm was to get up to Rs 1 lakh (US$1,000) a patient or 10 per cent of the hospital bill. That included Rs 1 lakh for each liver transplant sent over and Rs 50,000 (US$520) for each kidney case. Deccan Herald reported the same terms. Police said the network went after donors who were short of money and paid them between Rs 5 lakh and Rs 15 lakh (US$5,200 to US$15,600), while those receiving organs were charged as much as Rs 35 lakh (US$36,000). Officers also recovered forged papers, among them fake altruism certificates. The owner of Kallatharas Medical Tourism has been arrested, and the Enforcement Directorate is questioning doctors and hospital managers in a parallel money laundering case. ## Dubai, Uzbekistan and Bangladesh work on access Dubai’s residency directorate and the Dubai Health Authority have agreed to link visas, insurance and hospitals in one digital system, and licensed providers will be able to file medical visa papers for patients still abroad. The account came in an opinion piece in Gulf News by a doctor, who argued that days lost to paperwork can cost patients, and that destinations will compete on the whole journey rather than the treatment alone. Uzbekistan’s tourism committee chairman, Abdulaziz Akkulov, met business leaders to set priorities for medical tourism, UzDaily reported. Those at the meeting pointed to steady growth in patients from Tajikistan, Kazakhstan, Kyrgyzstan and Turkmenistan. Their list of priorities ran to simpler visas, telemedicine, tours for foreign operators, packages that mix treatment with travel, accredited local clinics and better support for family members who travel with a patient. In Dhaka, the medical travel agency Seok Healthcare said its patient numbers are growing 10 to 20 per cent a year, and that China has now passed Thailand among its clients, The Bangladesh Monitor reported. Founder and chief executive MM Masumuzzaman said a group from Bangladesh visited Chinese hospitals in March 2025. Several then took on bilingual staff, halal food, prayer rooms and Bangladeshi students as interpreters. “We recommended several practical measures to make Bangladeshi patients feel more comfortable,” he said. India remains the largest destination for Bangladeshi patients overall. ## Saudi Arabia and Vietnam target higher-value segments The Gulf Cooperation Council medical tourism market was worth $9.6 billion in 2025 and should reach $22.5 billion by 2034, according to an Arab News opinion piece by Majid Rafizadeh, a political scientist. Saudi Arabia’s own market is set to grow from $200 million in 2024 to about $680 million by 2030, helped by Vision 2030 money for hospitals and easier visas for medical travellers. The piece put the global market above $126 billion by 2035. Vietnam is drawing more foreign patients for facial rejuvenation, with demand shifting from single procedures towards combined treatment plans, DTiNews reported. Nguyen Quang Tuan, a plastic surgeon who works in Hanoi and Ho Chi Minh City, said patients now arrive better read up and ask hard questions about recovery time and how the work lasts. Cost may pull them in at first, he said, but safety and aftercare decide whether they tell others to come. ## What This Means Most of the week’s news was about capacity and access, not new buildings. Malaysia has the region’s second-largest private hospital base but too few nurses and specialists. Africa loses $7 billion a year. Dubai and Uzbekistan set out visa and coordination plans. Bangladesh’s Seok Healthcare said China had passed Thailand among its clients. The Kerala inquiry went on, with one arrest so far and the Enforcement Directorate still questioning hospital staff. Sources (13) Klsescreener Manilatimes Dailynews Dantri Medicaldialogues Arabnews Deccanherald Bangladeshmonitor Gulf News Vanguard Freemalaysiatoday Uzdaily Galencentre MalaysiaCambodiaIndonesiaThailandThailand’sAsiaTanzaniaAfrica ### The Wire Aug 30This Week in Medical Tourism: 20–26 August 2026 Aug 29This Week in Medical Tourism: 13–19 August 2026 Aug 22South Korea Undercuts America but Not Turkey All coverage ### Newsletter Get weekly health tourism intelligence in your inbox. Subscribe ### Knowledge Hub Medical Tourism Wellness Tourism Dental Tourism Fertility Tourism Cosmetic Tourism Longevity Tourism Explore the Hub Stay informed on the latest in global health tourism. Subscribe to our Newsletter ## Related Articles Weekly Digest 30 AUG 2026 Weekly Digest ### This Week in Medical Tourism: 20–26 August 2026 August 30, 2026 Weekly Digest 29 AUG 2026 Weekly Digest ### This Week in Medical Tourism: 13–19 August 2026 August 29, 2026 Weekly Digest 14 AUG 2026 Weekly Digest ### This Week in Medical Tourism: 6–12 August 2026 August 14, 2026 --- # This Week in Medical Tourism: 20–26 August 2026 URL: https://health-tourism-news.com/news/this-week-in-medical-tourism-20-26-august-2026/ Weekly Digest August 30, 2026 Weekly DigestHealth Tourism This Week in Medical Tourism: 20–26 August 2026 Indian government counts put foreign medical arrivals at 507,244 in 2025 against 644,387 in 2024. Bangladesh supplied 325,127 of the later figure and 482,336 of the earlier one. Four governments moved on the unregulated edge of the trade in the same week. Christian El-Khouri Editor-in-Chief Published August 30, 2026 · 7 min read This is the Health Tourism News roundup for 20 to 26 August 2026. ## India’s medical arrivals fell in 2025 India recorded 507,244 foreign nationals arriving for medical treatment in 2025, about 5.5 per cent of 9.15 million foreign tourist arrivals, on Press Information Bureau figures. Bangladesh supplied 325,127 of them, ahead of Iraq at 30,989, Uzbekistan at 13,699 and Somalia at 11,506. Bureau of Immigration figures presented by India’s Ministry of Tourism put foreign medical-purpose arrivals at 644,387 in 2024, of which Bangladesh supplied 482,336. The Bangladeshi figure was 499,951 in 2023 and 326,805 in 2022. On the sending side, the World Health Organization put Bangladesh’s universal health coverage service coverage index at 54 out of 100 in December 2025, with 41.7 per cent of the population, around 70 million people, facing financial hardship from out-of-pocket health spending. A WHO assessment counted 9.9 doctors, nurses and midwives per 10,000 population in 2020, against a global median of 48.6. ## Ethiopia costs the outflow More than 10,000 Ethiopians travel abroad for treatment each year at a cost of up to 700 million US dollars, on figures cited at the opening of a private medical complex in Addis Ababa. The 3 billion birr, 13-storey building holds 110 beds and eight operating theatres, and is the second site in Ethiopia and the third in East Africa with a PET-CT scanner. Deputy Prime Minister Temesgen Tiruneh opened the 13th East African Healthcare Federation conference in Addis Ababa on 21 August. He put specialised care and local manufacturing forward as a way to stop spending foreign currency on treatment abroad while earning it from regional patients. The Ethiopian Healthcare Federation has drawn up a 10-year plan whose stated first objective is treatment at home rather than continental leadership. Girma Ababi, its vice president, named facility standards, equipment, professional certification and training as the requirements, with public-private partnerships covering the financing gap. Ethiopia and neighbouring East African states are separately setting joint strategies to localise manufacturing of medical supplies. ## Nigeria buys robotic surgery A faith-based 300-bed hospital in Lagos put 4 million US dollars into robotic surgical services and training, working with a diaspora-founded United States firm. Chief executive Ademola Dada said procedures would be priced at about 5 per cent of comparable treatment in the United States or Europe, and that training would cover biomedical engineers, nurses and anaesthetists rather than surgeons alone. A public-private centre in Imo State performed its first robotic operation, for prostate cancer, on 21 August. Iziaq Salako, Minister of State for Health and Social Welfare, said the private sector already provides more than half of Nigeria’s health services, and tied robotic surgery to reversing the direction of medical travel. President Bola Tinubu approved a National Cancer Institute at a cost of 302.3 billion naira, to be completed within 36 months, with upgraded cancer centres in Katsina, Benin and Enugu already finished. ## Korea sells wholesale Seoul attracted 1.76 million foreign patients in 2025, 87.2 per cent of Korea’s national total that year, on Ministry of Health and Welfare data. The city holds the eighth edition of its medical tourism travel mart on 8 and 9 September, bringing about 70 overseas buyers to meet 300 domestic sellers. Last year’s edition drew 358 organisations from Korea and 17 other countries and generated 2,176 business consultations. Busan held its own buyer event on 26 and 27 August, organised by the Korea Health Industry Development Institute and co-hosted with Daegu, Gwangju and Jeju. Sixteen overseas buyers from 10 countries, including Thailand, China, the United States and Mongolia, met 41 Busan medical institutions and patient recruitment agencies. ## Four governments moved on the edge of the trade Australia’s Department of Foreign Affairs and Trade published new travel guidance warning that standard insurance usually excludes elective procedures abroad and their complications. Research it conducted with the Insurance Council of Australia found 46 per cent of Australian international travellers had undergone or would consider a procedure overseas, from a June 2025 survey of 1,001 people who had travelled in the previous 12 months. The United States State Department said nearly 900 visas had been revoked since it established a birth tourism task force earlier in August, up from more than 600 when the task force was announced. Spokesperson Tommy Pigott said the department is targeting networks that present themselves as healthcare services. Delhi police arrested 17 people and seized counterfeit and diverted anti-cancer medicines worth 90 million rupees, about 688,000 pounds, in raids across Delhi and Navi Mumbai. Investigators said vials were refilled with sterilised water and sold under fake batch numbers. The United States Embassy in Peru advised American citizens not to take ayahuasca or kambo at all, after three deaths at psychedelic retreats in Costa Rica, Mexico and Peru within fourteen months. A New York Times investigation published this week found retreats that did not screen for cardiac conditions and staff who encouraged patients to stop psychiatric medication. ## Dental is the volume and the least covered Only 33 per cent of Australian travellers knew a procedure abroad might require extra insurance, and among those chiefly motivated by cheaper treatment that fell to 10 per cent, in the same research. Price was the main draw for 69 per cent of those considering any procedure and 80 per cent of those considering dental work. Costa Rica certified five dental clinic groups for international patients this month, requiring documented experience with foreign patients, bilingual licensed specialists and treatment guarantees. Central Bank figures cited by the Costa Rican Health Chamber put medical tourism at about 13 per cent of international arrivals, roughly 70,000 patients a year generating around 465 million US dollars, with dental work accounting for 42 per cent of demand. A report published in June by the CareQuest Institute for Oral Health found that about 4 per cent of American adults, close to 9.6 million people, had travelled outside the United States for dental treatment, and that roughly 69 million American adults carry no dental insurance. A comparison across seven industrialised countries put the average cost of a root canal at 838 US dollars in the United States, against 542 in Canada and 436 in France. ## By the Numbers 507,244 foreign nationals arrived in India for medical treatment in 2025, against 644,387 in 2024, on Press Information Bureau and Bureau of Immigration figures. 95.6 per cent, the year-on-year rise in foreign patients treated at Guangdong’s 25 designated pilot hospitals since the province opened its international medical pilot in February 2026, on provincial health authority figures. 1.76 million foreign patients treated in Seoul in 2025, 87.2 per cent of Korea’s national total, on Ministry of Health and Welfare figures. 9.6 million American adults, about 4 per cent of the adult population, have travelled abroad for dental treatment, in a June 2026 report by the CareQuest Institute for Oral Health. 66 per cent of second-quarter 2026 revenue came from non-Thai patients at a Bangkok-listed hospital operator, in results published on 20 August 2026. 23 per cent, the rise in revenue from Chinese healthcare travellers to Malaysia in the first quarter of 2026, with traveller volume up 17 per cent, on Malaysia Healthcare Travel Council figures. ## What to Watch Seoul’s medical tourism travel mart runs on 8 and 9 September, with registration for domestic sellers closing on 3 September. Nigeria’s National Cancer Institute is contracted for completion within 36 months of the Federal Executive Council approval granted in August 2026. Azerbaijan’s Ministry of Health is required to prepare a health tourism strategy and action plan under the tourism state programme for 2026-2030, approved by presidential order on 20 August 2026. Iran’s tourism minister has asked for a measurable roadmap to lift Iran-Iraq tourist exchanges to five million in each direction, against about 3.6 million Iraqis and 3.5 million Iranians now crossing each way. Sources (21) Addisinsight Ethiopiatoday Streamlinefeed Thisdaylive Punchng Healthcareasiamagazine Businesstimes Bd Tehrantimes Businessday Tribuneonlineng Koreaherald Birrmetrics Independent Sedaily Karryon Americanbazaaronline Apa Tradingview Ticotimes Livemint Ecns medical tourism arrivalsIndiaBangladeshEthiopiadental tourismpatient safety enforcement ### The Wire Aug 29This Week in Medical Tourism: 13–19 August 2026 Aug 22South Korea Undercuts America but Not Turkey Aug 22Spain and Greece Report IVF Success Differently All coverage ### Newsletter Get weekly health tourism intelligence in your inbox. Subscribe ### Knowledge Hub Medical Tourism Wellness Tourism Dental Tourism Fertility Tourism Cosmetic Tourism Longevity Tourism Explore the Hub Stay informed on the latest in global health tourism. Subscribe to our Newsletter ## Related Articles Weekly Digest 29 AUG 2026 Weekly Digest ### This Week in Medical Tourism: 13–19 August 2026 August 29, 2026 Weekly Digest 14 AUG 2026 Weekly Digest ### This Week in Medical Tourism: 6–12 August 2026 August 14, 2026 Weekly Digest 07 AUG 2026 Weekly Digest ### This Week in Medical Tourism: 30 July – 5 August 2026 August 7, 2026 --- # This Week in Medical Tourism: 22–29 July 2026 URL: https://health-tourism-news.com/news/this-week-in-medical-tourism-22-29-july-2026/ Weekly Digest August 2, 2026 Weekly DigestHealth Tourism This Week in Medical Tourism: 22–29 July 2026 South Korea treated 2.01 million foreign patients in 2025, up 71.7 per cent on the year, and nearly a third of them came from China. Uzbekistan drew 93.9 per cent of its patients from three neighbours and 119 from the rest of the world combined. Eight days of government announcements were aimed at the country next door, not at long-haul demand. Christian El-Khouri Editor-in-Chief Published August 2, 2026 · 7 min read This is the Health Tourism News roundup for 22 to 29 July 2026, an eight-day period rather than the usual seven. ## South Korea foreign patient volume South Korea treated 2.01 million foreign patients in 2025, up 71.7 per cent on the previous year, on Ministry of Health and Welfare figures reported by the BBC and CNA. Chinese patients supplied 618,973 of that total, or 30.8 per cent, and Taiwanese arrivals rose 122.5 per cent to about 186,000, on ministry data cited by Maeil Business. The BBC put the draw as the single-visit comprehensive check-up, with results returned in seven to 14 days under state price regulation. Seoul city government figures put international arrivals to the capital up 21.3 per cent to 8.23 million in the first half of 2026, with foreign card spending up 56.8 per cent to KRW 5.62 trillion. Medical and wellness services took 24.4 per cent of that spending, rising 63.3 per cent to KRW 908.4 billion. A Seoul startup exhibiting at the Shenzhen medical tourism expo from 16 to 18 July was selling WeChat-based hospital matching, and reported more than 100 new business contacts over the three days. ## Thailand longevity strategy Thailand’s health minister set a three-year target for the country to lead Asia in wellness and longevity travel, VietnamPlus reported on 28 July. Pattana Promphat announced the plan ahead of a global wellness summit in Phuket from 10 to 13 November, which Thailand expects to generate at least THB 300 million. Thai wellness sector revenue reached USD 43 billion in 2024, ninth-largest in the Asia-Pacific region. Nation Thailand had reported on 25 July that Thailand has invested in genomic medicine and connected health data but lacks a national longevity strategy. Singapore restructured its system around preventive care in July 2023 and had registered about 960,000 people, roughly 40 per cent of its target population, by August 2024. Non-communicable diseases cost Thailand about THB 1.6 trillion a year, or 9.7 per cent of GDP, on 2019 data from a World Health Organization and Public Health Ministry study. Thailand earned THB 838.73 billion from international tourism in the year to date, which VnExpress put at USD 25.8 billion, on falling visitor numbers. China was the largest source market at 2.86 million, followed by Malaysia at 2.25 million and India at 1.31 million. ## Indonesia medical tourism pilot Indonesia has named 18 hospitals as medical tourism pilots, 15 in the Greater Jakarta area and three in Bali, with a promotional catalogue due in October 2026. The tourism ministry set the scheme out after a 22 July meeting in Jakarta with the health ministry, the Jakarta provincial health and tourism offices and two hospital associations, ANTARA reported. Hospitals that qualify receive promotion, training and fiscal incentives. Wellness activity accounted for 13.35 per cent of foreign arrivals to Indonesia on 2024 data, and the Global Wellness Institute put the country’s wellness economy at USD 55.77 billion, the largest in South East Asia. In the same week a private Bangkok hospital told thephilbiznews it had studied where Indonesians go for treatment abroad, found Singapore and Malaysia, and is targeting Indonesia first for partnerships with embassies and foreign chambers of commerce. “Cost is not the only factor,” one of its deputy managing directors said. ## Tanzania capacity investment Tanzania has spent TZS 283 billion over a decade on a government referral hospital in Dodoma and plans a medical tourism zone on university land. “It is no secret that India has made enormous progress,” the chief government spokesperson, Gerson Msigwa, said in a briefing reported by Daily News. Staff numbers have risen from 20 in 2015 to more than 1,000, and the hospital now offers 20 specialist and 18 super-specialist services. An international clinic opened at the hospital in July 2025 has treated 18,607 patients, of whom 390 came from abroad. Across the hospital, 2,897 patients have come from Burundi and 526 from the Comoros. A TZS 32 billion cancer centre and a TZS 44.9 billion kidney centre are under construction, the second co-financed with Japan’s development agency. ## Nigeria insurance coverage Insurance coverage rather than hospital capacity governs how many Africans travel abroad for treatment, the chief executive of a specialist hospital in Abuja told CNBC Africa at the Africa Social Impact Summit. “There’s too much outbound medical migration,” Brian Deaver said, describing approaches to health maintenance organisations and insurers in Nigeria and internationally so that covered patients can use his facility. Deaver said the Africa Life Sciences Foundation has raised USD 75 million, largely from Afreximbank, to subsidise care and fund research, and that only USD 75,000 of a separate USD 1 billion Afreximbank allocation for healthcare manufacturing in Nigeria has been drawn in two years. ## India medical travel intermediaries India recorded 507,244 foreign arrivals for medical treatment in 2025, about 5.5 per cent of all foreign tourist arrivals. Industry estimates cited by the Economic Survey 2025-26 put the market at USD 8.7 billion in 2025, rising to USD 16.2 billion by 2030, and medical visas now reach 172 countries, the Times of India reported. The 2026-27 budget proposes five regional medical hubs. Iraqi patients told Shafaq News they were billed for surgical technology they never saw used. One was quoted about USD 8,000 for spinal fusion, then paid a further USD 1,500 for robotic assistance. “I didn’t see any robotic device in the operating room,” he said. A Baghdad internal medicine specialist told the same outlet that the 95 to 99 per cent success rates advertised by some Indian hospitals function as marketing. India’s tourism ministry recorded 30,989 Iraqi arrivals for treatment in 2025, second only to Bangladesh. When a fire killed 22 people, most of them foreign nationals, near a Delhi guest house on 3 June, it was translators rather than hospitals or medical travel companies who found beds and rebuilt treatment schedules, ThePrint reported. India counts foreign patients and does not count the translators. ## Uzbekistan patient origins A total of 35,401 foreign nationals travelled to Uzbekistan for treatment in the first half of 2026. National Statistics Committee data reported by Kun.uz put Tajikistan first at 19,096, Kyrgyzstan second at 9,552 and Kazakhstan third at 4,582, with 1,280 from Afghanistan, 772 from Russia and 119 from every other country in the world combined. More than 86,000 people travelled to Uzbekistan for treatment across the whole of 2025. On 23 July Uzbekistan’s tourism committee and Iran’s ambassador discussed medical travel, direct air links and, in the committee’s account, an Iranian proposal to simplify visas for Iranian travellers, Trend reported. ## By the Numbers 2.01 million foreign patients treated in South Korea in 2025, on Ministry of Health and Welfare figures. 35,401 foreign nationals treated in Uzbekistan in the first half of 2026, on National Statistics Committee figures. USD 8.7 billion Indian medical tourism market in 2025, on industry estimates cited by the Economic Survey 2025-26. USD 21.49 billion global medical tourism market in 2025, on Astute Analytica figures. 563 million wellness tourism trips taken in Asia in 2024, against 348 million in Europe, reported by VietnamPlus. USD 47 trillion cumulative global economic loss from five groups of non-communicable diseases between 2010 and 2030, on World Economic Forum and Harvard School of Public Health estimates. ## What to Watch Indonesia’s promotional catalogue covering the 18 pilot hospitals is due in October 2026. The Global Wellness Summit runs in Phuket from 10 to 13 November 2026. Uzbekistan’s full-year total will show whether the second half of 2026 matched the 35,401 recorded in the first. Thailand’s health minister has set a three-year horizon, to 2029, for leading Asia in wellness and longevity travel. Sources (19) Streamlinefeed Vietnamplus Antaranews Nationthailand Cna Thephilbiznews Cnbcafrica Indiatimes Bbc Streamlinefeed Antaranews Dailynews Shafaq Trend Theprint Kun Mk Vnexpress Globenewswire South KoreaThailandIndonesiaTanzaniaIndiaUzbekistan ### The Wire Aug 30This Week in Medical Tourism: 20–26 August 2026 Aug 29This Week in Medical Tourism: 13–19 August 2026 Aug 22South Korea Undercuts America but Not Turkey All coverage ### Newsletter Get weekly health tourism intelligence in your inbox. Subscribe ### Knowledge Hub Medical Tourism Wellness Tourism Dental Tourism Fertility Tourism Cosmetic Tourism Longevity Tourism Explore the Hub Stay informed on the latest in global health tourism. Subscribe to our Newsletter ## Related Articles Weekly Digest 30 AUG 2026 Weekly Digest ### This Week in Medical Tourism: 20–26 August 2026 August 30, 2026 Weekly Digest 29 AUG 2026 Weekly Digest ### This Week in Medical Tourism: 13–19 August 2026 August 29, 2026 Weekly Digest 14 AUG 2026 Weekly Digest ### This Week in Medical Tourism: 6–12 August 2026 August 14, 2026 --- # This Week in Medical Tourism: 30 July – 5 August 2026 URL: https://health-tourism-news.com/news/this-week-in-medical-tourism-30-july-5-august-2026/ Weekly Digest August 7, 2026 Weekly DigestHealth Tourism This Week in Medical Tourism: 30 July – 5 August 2026 Dermatology has overtaken plastic surgery as the largest category of foreign medical spending in South Korea, at 67.5% against 21.3% in the first half of 2026, reversing the 2024 split. Medical services grew 98% year on year, faster than any other category BC Card reports. Australia, Nigeria and India each published figures on their own patient flows in the same week. Christian El-Khouri Editor-in-Chief Published August 7, 2026 · 7 min read This is the Health Tourism News roundup for 30 July to 5 August 2026. ## South Korea medical spending composition Dermatology accounted for 67.5% of foreign visitors’ medical card spending in South Korea in the first half of 2026 and plastic surgery for 21.3%, on BC Card figures released on 3 August. In the first half of 2024 the split ran the other way, plastic surgery at 46.2% against dermatology at 32.6%. The card company analysed transactions on 3.3 million foreign-issued cards. Medical services grew 98% on the first half of 2025, faster than any other category it reports, against 53.6% for foreign card spending overall. Seoul took 92.8% of foreign medical spending, and within the capital the Gangnam district’s share fell 10.4 percentage points to 39.8% while Seocho’s rose 6.7 points to 27.6%. The Korea National Tourism Organization put foreign spending on medical services at KRW 251.15 billion (about USD 176 million) in May 2026 alone, up 74.6% year on year. Against that, the Korean Dermatological Association counted about 3,000 dermatologists in 2025 and roughly 30,000 institutions offering cosmetic treatment, figures Nikkei Asia reported in coverage picked up by TravelMole on 1 August. ## Australian dental demand and South East Asian supply About 15,000 Australians travel abroad for healthcare each year, on Victorian government estimates, and dental work is the procedure travellers say they are most likely to consider, on a 2025 survey by the Insurance Council of Australia and the Department of Foreign Affairs and Trade. Australians spent AUD 12.5 billion (about USD 8.8 billion) on dental services in 2022-23, of which patients paid 61% directly and private health insurers covered 20%, on Australian Institute of Health and Welfare figures. In 2023-24, 28% of Australians aged 15 and over who needed dental care delayed or skipped it, and 18% gave cost as the reason. A single implant runs about AUD 1,200 to 2,000 (USD 840 to 1,410) in Vietnam and AUD 1,500 to 2,500 (USD 1,060 to 1,760) in Thailand, on indicative figures from a health economist at the University of Technology Sydney who has made no direct international fee comparison and cautions that most published prices come from medical travel businesses. Money put full-arch implant treatment at AUD 25,000 to 35,000 (USD 17,600 to 24,600) or more per arch in Australia against about AUD 6,000 to 12,000 (USD 4,200 to 8,400) in Vietnam. Ho Chi Minh City’s tourism department puts Vietnam’s dental visitor volume at about 100,000 a year on revenue of VND 3,500 billion, about USD 134 million, with roughly 80% of that traffic overseas Vietnamese returning home. Thanh Nien puts Thailand’s dental volume at 1.2 million visitors a year on USD 900 million to 1.1 billion, and Malaysia’s at 300,000 to 400,000 on USD 250 million to 300 million. ## India medical visa volumes India admitted 1,811,950 foreign nationals on medical tourism visas between 1 January 2023 and 31 December 2025, the Minister of State for Health and Family Welfare, Anupriya Patel, told the Lok Sabha in a written reply on 31 July. Ministry of Home Affairs data put 1,751,088 of those on medical visas, 56,908 on medical attendant visas, 3,375 on AYUSH visas and 579 on AYUSH attendant visas. The same reply recorded that e-medical visa validity has gone from 60 days to one year, that permitted entries have gone from three to multiple, and that the facility now reaches nationals of 176 countries. Uttar Pradesh has identified about 200 acres at Jewar for a medical hub costing an estimated Rs 5,000 crore (about USD 525 million), with a preliminary project report prepared by the World Bank, Medical Dialogues reported on 30 July. The Union Budget for 2026-27 proposed support for five regional hubs of this kind. ## African outbound spending About USD 7 billion leaves Africa each year with patients travelling abroad for treatment, and more than 300,000 Africans travel to India alone, on figures reported by BusinessDay on 31 July from a Lagos briefing given by the chief operating officer of a Nairobi teaching hospital. The World Health Organization sets 4.45 doctors, nurses and midwives per 1,000 people as the minimum for adequate care; Africa has about 1.5. Nigeria’s federal government put the country’s annual loss to medical tourism and preventable diseases together at NGN 4.8 trillion (about USD 3.5 billion). The Minister of State for Health and Social Welfare, Adekunle Salako, gave the figure at a diaspora awards dinner in Abuja reported by The Guardian on 30 July, alongside a diaspora health programme that he said had reached close to 10,000 people directly and trained more than 2,000 frontline health workers across the country’s six geopolitical zones in a single season. ## Turkey operator licensing Turkish medical travel intermediaries have operated under a new licensing regime since a regulation published in the Official Gazette on 26 April 2025 repealed the 2017 framework. Agencies now hold an international health tourism authorisation certificate issued by USHAS, the health ministry’s international services arm, rather than by provincial health directorates, and every treatment episode has to be registered on the state HealthTurkiye portal. Intermediaries already trading had until 26 October 2025 to comply, and USHAS reviews authorised operators annually against defined performance criteria. USHAS put Turkey’s international health patient volume at 1,506,442 in 2024 and related revenue at about USD 3 billion, roughly 5% of the country’s tourism receipts. ## Cosmetic surgery deaths in the Dominican Republic A 31-year-old United States police officer died in Santo Domingo after surgery to remove breast implants, the second recent death of an American law enforcement officer following cosmetic surgery in the Dominican Republic, Latin Times reported on 4 August. The country’s National Institute of Forensic Sciences has not returned an autopsy, and police have named no clinic and identified no provider under investigation. The US Centers for Disease Control and Prevention recorded 93 American deaths after cosmetic surgery in the Dominican Republic between 2009 and 2022, with fat embolism and pulmonary thromboembolism the leading causes, and liposuction present in every fatal case it reviewed. A separate CDC study published in June 2026 examined more than 2,100 reports of US residents travelling for cosmetic procedures at home and abroad between 2014 and 2024, and identified 21 reports covering about 145 patients with adverse outcomes, four of those reports involving a death. ## By the Numbers 1,176.9% rise in pharmacy spending by foreign visitors to South Korea in the first half of 2026 against the first half of 2025, on BC Card transaction data. 1.28 million international patient visits at China’s main foreign-facing hospitals in 2025, up 73.6% on three years earlier, on National Health Commission figures cited by Lianhe Zaobao. USD 1.26 billion medical tourism revenue in the Philippines in 2024, 23% of the country’s health and wellness tourism revenue, on Department of Tourism figures. 7.1 million international arrivals to Ho Chi Minh City between January and July 2026, on the municipal Department of Tourism’s count. 1,506,442 international health patients treated in Turkey in 2024, on USHAS figures. 3,375 AYUSH visas issued to foreign nationals in the three years to 31 December 2025, against 1,751,088 medical visas, on Ministry of Home Affairs data. ## What to Watch South Korea’s second-half card data will show whether dermatology holds the 67.5% share of foreign medical spending it took in the first half. The World Bank presentation on the Jewar medical hub to the Uttar Pradesh chief secretary, postponed from 28 July, has still to be rescheduled. The Dominican Republic’s National Institute of Forensic Sciences has yet to return the autopsy in the death reported on 4 August. Turkish intermediaries licensed under the April 2025 regulation face their first full annual USHAS performance cycle since the compliance deadline of 26 October 2025. Currencies converted at mid-market rates on 6 August 2026. Sources (16) Moneymag Latintimes Openpr Koreatimes Koreaherald Travelmole Businessday Sunstar Thehindubusinessline Aninews Medicaldialogues Guardian Vietnamplus Vietnam Usatoday Thinkchina South Korea medical tourismdental tourismIndia medical visasTurkey health tourism regulationcosmetic surgery safetyAfrica outbound care ### The Wire Aug 30This Week in Medical Tourism: 20–26 August 2026 Aug 29This Week in Medical Tourism: 13–19 August 2026 Aug 22South Korea Undercuts America but Not Turkey All coverage ### Newsletter Get weekly health tourism intelligence in your inbox. Subscribe ### Knowledge Hub Medical Tourism Wellness Tourism Dental Tourism Fertility Tourism Cosmetic Tourism Longevity Tourism Explore the Hub Stay informed on the latest in global health tourism. Subscribe to our Newsletter ## Related Articles Weekly Digest 30 AUG 2026 Weekly Digest ### This Week in Medical Tourism: 20–26 August 2026 August 30, 2026 Weekly Digest 29 AUG 2026 Weekly Digest ### This Week in Medical Tourism: 13–19 August 2026 August 29, 2026 Weekly Digest 14 AUG 2026 Weekly Digest ### This Week in Medical Tourism: 6–12 August 2026 August 14, 2026 --- # This Week in Medical Tourism: 6–12 August 2026 URL: https://health-tourism-news.com/news/this-week-in-medical-tourism-6-12-august-2026/ Weekly Digest August 14, 2026 Weekly DigestHealth Tourism This Week in Medical Tourism: 6–12 August 2026 Vietnam's health ministry has put both sides of its medical travel ledger in one document: an estimated USD 1 to 2 billion coming in each year against USD 2 to 3 billion going out. Nigeria, Bangladesh and India moved on the same arithmetic in the same week, and the market estimates their governments were working from do not agree. Christian El-Khouri Editor-in-Chief Published August 14, 2026 · 7 min read This is the Health Tourism News roundup for 6 to 12 August 2026. ## Vietnam medical tourism targets Vietnam’s Ministry of Health is targeting 750,000 international medical tourists and USD 1 billion in direct healthcare revenue by 2030, under a draft plan for 2026 to 2030 that went out for consultation this week. It puts current volume at about 300,000 international visitors using medical services each year, spending an estimated USD 1 to 2 billion including accommodation, travel and food. The plan also records the other direction. Vietnamese citizens spend an estimated USD 2 to 3 billion a year on treatment abroad, which the ministry states is more than the country earns from inbound medical visitors. Ho Chi Minh City accounts for about 40 per cent of international medical tourists, Hanoi second. The ministry lists what is missing: no dedicated legal framework, no standardised service packages, no national brand, and rules that stop public hospitals fully costing services for foreign patients. It wants at least 20 hospitals meeting international quality standards by 2030, five of them public, piloted in five to seven locations from 2026 to 2028 and extended nationwide from 2029. ## Nigeria outbound spending A Nigerian-domiciled company launched in Lagos on 7 August with plans to manufacture regenerative biologics locally, aimed at the USD 2.39 billion Nigerians spend each year on treatment abroad, Business Day reported. It pairs a United States manufacturing firm with a Nigerian hospital group. A Dangote Industries executive, delivering Aliko Dangote’s keynote at a Lagos regenerative medicine summit, said the pandemic had shown what dependence on imported medical products costs. “Dependence is a vulnerability,” she said. Enugu State’s international hospital, due to open within weeks, has been set a target of cutting Nigerians’ overseas treatment by up to 40 per cent within a year of opening, its chief executive told journalists touring the site on 12 August. It is to run cancer, cardiac, neurosciences, renal and nuclear medicine centres, with a cyclotron on site. A 250-bed hospital in Ogun State and a specialist centre in Abuja agreed a referral and training partnership on 2 August; the Abuja centre said it had treated patients from 23 countries in its first year. ## India inbound patient volumes Medical value travel to India from conflict-affected regions has fallen 40 to 60 per cent, with airfares up 15 to 25 per cent, the chair of the Federation of Indian Chambers of Commerce and Industry’s medical value travel committee told Arab News. Airspace restrictions following the US-Israeli war on Iran have run for five months. India ranks 10th of 46 destinations on the 2025 Medical Tourism Index. One large Indian hospital group treated 32,000 foreign patients last year, 5,000 of them from the Middle East, and its sales director said similar numbers were unlikely in 2026. Elective and wellness clinics have seen the steepest falls; cardiac, renal and oncology volumes held up better, those cases being harder to defer. Bangladesh’s High Commissioner to Pakistan told a meeting in Islamabad on 8 August that nearly 800,000 Bangladeshis travel abroad for treatment each year and spend more than USD 6 billion, and asked for visa facilitation and better air links. Those patients have historically gone to India, and The News tied the shift to strained Dhaka-New Delhi relations since the change of government in August 2024. Pakistan’s National Health Tourism Working Group chair said a quarter of that market would be 200,000 patients and USD 1.5 billion. ## Medical tourism market estimates Two governments were given materially different estimates of the same market in the same week. Vietnam’s health ministry told its own consultation that global medical tourism revenue in 2024 ran between about USD 40 billion and more than USD 100 billion, growing 8 to 16 per cent a year through 2035. Pakistan’s Special Investment Facilitation Council was told by industry experts that the 2024 figure was USD 144.5 billion, reaching USD 704.8 billion by 2033 at an annual rate above 19 per cent. India’s market was quoted twice in four days. A parliamentary standing committee report tabled in the Rajya Sabha on 7 August cited industry estimates of USD 8.7 billion in 2025, rising to USD 16.2 billion by 2030. On 10 August the FICCI committee chair put the sector at USD 13 billion. Neither government document names the research house behind its figure. The committee, which recommended that hospitals earning from international and wealthy patients cross-subsidise tertiary care for poor Indians, attributed its own figure to unspecified industry estimates. ## Egypt and Sarawak hospital investment A consortium led by Egypt’s Inventure Group with Italy’s Impresa Pizzarotti and China’s CSCEC plans to invest nearly USD 5.3 billion in two Egyptian medical cities, discussed with the prime minister in Cairo on 5 August. One, at USD 2.8 billion, goes in the new administrative capital near Cairo and the other, at USD 2.5 billion, at El-Alamein, both with hotels and recuperation centres. The government expects nearly 3 million medical tourists within three years of the sites opening, AGBI reported. Sarawak attracted more than 100,000 medical tourists in 2025, which the state Premier told reporters on 10 August was double the previous year. He put Sarawak’s own population at 2.5 million against 35 million in Borneo and 700 million across ASEAN, naming Indonesia and its 280 million people as the market. A Singapore-based operator broke ground the same day on a 300-bed private hospital in Kuching due for completion in 2029. ## Spa carbon measurement A typical spa visit produced about 5 kg of carbon dioxide equivalent at a large Bucharest wellness resort and about 3.5 kg at a smaller university-run sports-park spa, on measurements published on 22 July in the peer-reviewed journal Communications Sustainability. The calculator, SPA-DEC, was developed by Therme Group and the University of Surrey with co-funding from Innovate UK, and its authors call it the first standardised method for measuring a single spa visit’s footprint in real time. On-site renewable generation cut per-visit emissions by about 33 per cent at the larger site and about 14 per cent at the smaller one during 2024. The method divides total emissions across every visit and covers all three scopes of the Greenhouse Gas Protocol. ## By the Numbers Rs 50,508 (about USD 529) average cost of a hospitalisation in an Indian private hospital against Rs 6,631 (about USD 69) in a government hospital, January to December 2025, on the 80th round of the National Sample Survey. 43.4 per cent of India’s total health expenditure paid out of pocket in 2022-23, on figures cited by the Parliamentary Standing Committee on Health and Family Welfare. USD 1 billion in direct healthcare revenue from international patients, Vietnam’s target for 2030, on the Ministry of Health draft plan issued for consultation in August 2026. About 5 kg of carbon dioxide equivalent per spa visit at a large Bucharest wellness resort during 2024, on measurements published by Therme Group and the University of Surrey. USD 5.3 billion committed to two Egyptian medical cities at a meeting with Egypt’s prime minister on 5 August 2026, reported by AGBI. More than 100,000 medical tourists in Sarawak during 2025, on figures given by the state Premier. ## What to Watch Vietnam’s draft medical tourism plan was open for consultation as of 12 August, its first phase running from 2026 to 2028 across five to seven pilot locations. The Global Conference on Medical Tourism runs in Yerevan from 21 to 23 September 2026, organised by Armenia’s Tourism Committee with the United Nations World Tourism Organization. Pakistan and Bangladesh agreed on 8 August to expedite a health cooperation memorandum, unsigned on that date. The 300-bed private hospital that broke ground in Kuching on 10 August is due for completion in 2029. Currencies converted at mid-market rates on 14 August 2026. Sources (16) Guardian Tuoitre Businessday Dantri Armenpress Arabnews Arise Thestar Dayakdaily The Ethos Thenews Businessday Theprint Thenews Agbi Businessday medical tourism policyoutbound patient spendingVietnamNigeriaIndiawellness tourism ### The Wire Aug 30This Week in Medical Tourism: 20–26 August 2026 Aug 29This Week in Medical Tourism: 13–19 August 2026 Aug 22South Korea Undercuts America but Not Turkey All coverage ### Newsletter Get weekly health tourism intelligence in your inbox. Subscribe ### Knowledge Hub Medical Tourism Wellness Tourism Dental Tourism Fertility Tourism Cosmetic Tourism Longevity Tourism Explore the Hub Stay informed on the latest in global health tourism. Subscribe to our Newsletter ## Related Articles Weekly Digest 30 AUG 2026 Weekly Digest ### This Week in Medical Tourism: 20–26 August 2026 August 30, 2026 Weekly Digest 29 AUG 2026 Weekly Digest ### This Week in Medical Tourism: 13–19 August 2026 August 29, 2026 Weekly Digest 07 AUG 2026 Weekly Digest ### This Week in Medical Tourism: 30 July – 5 August 2026 August 7, 2026 --- # How to Become a Medical Tourism Destination URL: https://health-tourism-news.com/news/to-become-a-medical-tourism-destination/ Medical Tourism How to Become a Medical Tourism Destination Hotels, flights and branding do not make a medical tourism destination. A strong domestic health system does. Ivan Rendulic Contributor Founder of ZagrebMed and President of the European Health and Medical Tourism Association (EHMTA). Over a decade facilitating international patients and shaping cross-border healthcare initiatives from Croatia. Read more Published July 14, 2025 · Updated July 2, 2026 · 2 min read Reviewed by Christian El-Khouri, Editor-in-Chief There’s something that keeps getting missed in conversations about medical tourism. Everyone wants to talk about hotels, flights, branding, maybe even AI. But here’s the simple truth I’ve learned after years in this industry: you can’t export what you don’t have at home. If your own citizens are leaving the country for care, how do you expect to attract anyone from abroad? That’s why I always say: medical tourism can only happen in destinations with strong healthcare systems. And more importantly, to become a medical tourism destination, you need to first become a healthy destination. ## The Cost of a Broken Domestic System Nigeria offers a clear example of the challenge. Every year, over a billion dollars leave the country because patients don’t trust local care. Recently, Rep. Benjamin Kalu proposed the creation of a Specialized Medical Research and Training Centre, aimed at tackling diseases like cancer, kidney failure, and diabetes. The idea is ambitious, modeled after global best practices and built through public-private collaboration. But for now, it’s just that - an idea. Whether it will succeed depends entirely on long-term commitment, funding, and follow-through. Indonesia saw the same drain. Citizens flying to Malaysia, Singapore, even India, spending billions abroad. Now they’ve partnered with Mayo Clinic and are redesigning domestic hospitals to actually meet expectations. Not just to stop the leak, but to finally build something worth staying for. That’s how it starts. ## Building for Locals First Countries like Malaysia, South Korea, and Turkey didn’t become medical tourism leaders overnight. They built for locals first. They invested in real systems, international standards, proper accreditations, patient experience. They kept their own people in the system, and then opened the doors to the world. ## Medical Tourism as an Export Product That’s why medical tourism, done right, is the perfect export product. You earn foreign revenue. You increase your quality of care. You retain your talent. You create infrastructure that serves both the citizen and the visitor. Everyone wins. ## Why You Cannot Build on a Crumbling System But if you think you can build a medical tourism industry on top of a crumbling domestic system, you’re not building healthcare. You’re building fiction. I’ve seen both approaches. One is rooted in vision and discipline. The other in desperation and PR. Only one of them works. ### The Wire Aug 30This Week in Medical Tourism: 20–26 August 2026 Aug 29This Week in Medical Tourism: 13–19 August 2026 Aug 22South Korea Undercuts America but Not Turkey All coverage ### Newsletter Get weekly health tourism intelligence in your inbox. Subscribe ### Knowledge Hub Medical Tourism Wellness Tourism Dental Tourism Fertility Tourism Cosmetic Tourism Longevity Tourism Explore the Hub Stay informed on the latest in global health tourism. Subscribe to our Newsletter ## Related Articles Medical Tourism 22 AUG 2026 Medical Tourism ### Mexico and Turkey Price Against Different Home Markets August 22, 2026 Medical Tourism 22 AUG 2026 Medical Tourism ### Turkey's Deepest Discounts Sit on Its Safest Procedures August 22, 2026 Medical Tourism ### Why Medical Tourism to Germany Declined August 11, 2026 --- # Turkey's Deepest Discounts Sit on Its Safest Procedures URL: https://health-tourism-news.com/news/turkeys-deepest-discounts-sit-on-its-safest-procedures/ Medical Tourism August 22, 2026 Medical TourismDental TourismCosmetic Tourism Turkey's Deepest Discounts Sit on Its Safest Procedures Four Health Tourism News guides price four Turkish procedures against the same British patient. Rank them by saving and rank them by what goes wrong, and the two lists come out close to reversed. Christian El-Khouri Editor-in-Chief Published August 22, 2026 · 6 min read Turkey is the most heavily searched destination in medical travel, and it is usually discussed as one decision. It is not. Health Tourism News runs four Turkish guides, on dental implants, veneers, gastric sleeve and tummy tuck, and each of the four buys a different bargain against a different risk. Put the four side by side and the ranking by saving and the ranking by harm come out close to reversed. ## Ranked by the price gap ProcedureTurkey, publishedHome referenceMultiple Single implant, entry-tier brand, crown included$270 - $535UK median $3,355 £2,5006x - 12x Gastric sleeve, all-inclusive package$3,600 - $4,500 panel median $3,850UK named self-pay $13,000 - $18,0003x - 5x Veneer, E-max, per tooth$215 - $430 panel median $270UK median £614 about $825about 3x Single implant, premium brand$940 - $1,140UK median $3,355about 3x Full tummy tuck$3,900 - $4,950 panel median $4,500UK hospital groups $9,400 - $11,6002x - 3x Published Turkish panel prices from the four country guides, each with its own methodology note and dated exchange rate. An entry-tier implanted tooth is the deepest discount on the list, at a sixth to a twelfth of the British median. A tummy tuck is the shallowest, at a third to a half of what named UK hospital groups charge. Between them, the sleeve saves the most money in absolute terms: $9,000 to $14,000 on one operation. ## Ranked by what goes wrong Now reverse the question and ask what the record says about each. Abdominoplasty carries the highest serious-complication rate of the common aesthetic operations, 4 per cent in registry data against 1.4 per cent for other cosmetic surgery. A 2015 registry analysis of 25,478 abdominoplasties put major complications at 3.1 per cent for the operation alone, 4.6 per cent when liposuction and a breast procedure were added, and 10.4 per cent once liposuction and further body contouring joined, the shape most package upsells take. Roughly a fifth of those complications were clots, and the timing is the traveller’s problem: most clots arrive within two weeks, one study found 87 per cent of pulmonary embolisms after abdominoplasty struck after discharge around day ten, packages issue fit-to-fly letters at day six to eight, and surgeons’ guidance for long-haul flying after this class of surgery commonly says four to six weeks. The tummy tuck guide sets out that calendar in full. Veneers look benign and are not, because much of what is sold as veneers is crown work. A genuine veneer removes roughly 3 to 30 per cent of a tooth’s structure and survives at 95.5 per cent over ten years in a review of about 6,500 veneers. A crown requires cutting the whole tooth, measured at 63 to 72 per cent of coronal structure by weight in a gravimetric study, and prospective work found pulp necrosis in about 9 per cent of teeth after full-crown preparation. Across a 20-tooth case that is one or two root canals in the years after. For a 2022 BBC documentary, 70 of 120 Turkish clinics that replied to an enquiry from a person with healthy teeth proposed veneer or crown treatment; all 34 UK clinics that replied said none was needed. In the British Dental Association’s survey, 86 per cent of dentists had treated complications of dental work done abroad, with crowns the most likely to need remedial work. The veneers guide explains how to tell the two products apart before paying for either. The gastric sleeve is the operation with a death rate attached, and the registries put it low: 0.1 per cent 30-day mortality in a multicentre study of 3,983 patients, and 0.07 per cent across 41,241 bariatric operations in England’s hospital data. Staple-line leaks ran 0.17 per cent within 30 days in a study of 692,554 operations and about 1.5 per cent in a systematic review of 40,653 patients. The number that matters to a traveller is not the rate but the clock: leaks surface days or weeks after discharge, when a package patient has already flown. Aviation guidance sets about ten days after abdominal surgery, and Turkish packages run five to seven. The gastric sleeve guide sets the discharge checks against the schedule. Dental implants, the deepest discount of the four, have the mildest failure mode. Ten-year survival runs 93 to 96 per cent in the review literature wherever the work is done, the biology forces two trips months apart, and the thing that goes wrong at home is administrative rather than clinical: an unnamed fixture that no British dentist can service, or a warranty nobody will honour without a return flight. The implants guide covers the paperwork that makes a warranty travel. ## The two rankings do not line up The largest price gap on the list sits on the procedure whose worst case is a replacement tooth. The smallest sits on the procedure with the highest serious-complication rate and a clot window that opens after the flight home. A patient who picks Turkey and then picks a procedure is reasoning in the wrong order. The Foreign Office states that seven British nationals died in Turkey in 2025 following medical procedures. A surgical-association complications database logged about 200 returning cosmetic-tourism cases in its first two years, attributing some 76 to 80 per cent of them to surgery in Turkey. Those figures describe a large market, not a uniformly dangerous one, and the pattern inside them is consistent across all four guides: harm concentrates in the cheapest tier, in the multi-procedure bundle and in the compressed schedule, rather than in the country. Conservative plans, named surgeons and dentists, staged appointments and a flight booked for the far side of the risk window describe the good outcomes in every one of the four. The discount is not the risk signal. It never was. Health Tourism News is a trade publication and sells no treatment. Prices are the figures providers publish, held on file, with the limits of each panel stated in the guide it comes from. Sources (15) Winocour et al. Abdominoplasty: risk factors, complication rates, and safety of combined procedures. Plastic and Reconstructive Surgery, 2015 Comparative pulmonary embolism risk, cosmetic abdominoplasty versus functional panniculectomy, 2022 Edelhoff D, Sorensen JA. Tooth structure removal associated with various preparation designs for anterior teeth. Journal of Prosthetic Dentistry, 2002;87(5) Systematic review of porcelain laminate veneer survival, Journal of Clinical Medicine, 2021 Prospective study of pulp vitality after crown preparation, International Endodontic Journal, 2015 British Dental Association survey on dental tourism complications, July 2022 GENEVA collaborative study, 30-day outcomes of sleeve gastrectomy, 2021 In-hospital and post-discharge mortality after bariatric surgery in England (HES/NBSR analysis), BJS Open, 2017 Six-year MBSAQIP analysis of staple-line leak after sleeve gastrectomy, 2024 Gagner et al. Staple-line leak after sleeve gastrectomy, systematic review of 40,653 patients, Surgical Endoscopy, 2020 Howe, Keys, Richards. Long-term (10-year) dental implant survival, Journal of Dentistry, 2019 TreatCompare, UK dental implant cost sample of 1,125 practices, 2026 TreatCompare, UK veneer cost sample of 1,622 practices, May 2026 UK Foreign, Commonwealth and Development Office, Turkey travel advice: health UK Civil Aviation Authority, passenger guidance on flying after surgery Turkeydental implantsveneersgastric sleevetummy tuckpricespatient safety ### The Wire Aug 30This Week in Medical Tourism: 20–26 August 2026 Aug 29This Week in Medical Tourism: 13–19 August 2026 Aug 22South Korea Undercuts America but Not Turkey All coverage ### Newsletter Get weekly health tourism intelligence in your inbox. Subscribe ### Knowledge Hub Medical Tourism Wellness Tourism Dental Tourism Fertility Tourism Cosmetic Tourism Longevity Tourism Explore the Hub Stay informed on the latest in global health tourism. Subscribe to our Newsletter ## Related Articles Cosmetic Tourism 22 AUG 2026 Cosmetic Tourism ### South Korea Undercuts America but Not Turkey August 22, 2026 Medical Tourism 22 AUG 2026 Medical Tourism ### Mexico and Turkey Price Against Different Home Markets August 22, 2026 Dental Tourism 22 AUG 2026 Dental Tourism ### Dental Implant Prices Abroad Hide Three Different Units August 22, 2026 --- # U.S. vs. European Medical Tourism and Integrative Care URL: https://health-tourism-news.com/news/u-s-vs-european-medical-tourism-and-integrative-care/ Medical Tourism U.S. vs. European Medical Tourism and Integrative Care A Comparatative Analysis Kevin Ciresi Contributor A career spanning the operating room to the boardroom. Former surgeon who founded and led multiple U.S. healthcare facilities, now focused on transparent frameworks for international care and blue-zone wellness destinations. Read more Published September 22, 2025 · 22 min read Reviewed by Christian El-Khouri, Editor-in-Chief Medical tourism - patients traveling abroad for medical or wellness services - is a growing global phenomenon, and both the United States and Europe play significant yet distinct roles in this industry. Below is a comprehensive comparison of the U.S. and European medical tourism markets as of 2025, including inbound and outbound travel, popular destinations (with a spotlight on Sicily in Italy), patient preferences, cost differences, the role of integrative care, and emerging trends and policies. ### Overview and Market Trends (2025) Market Size Direction: The U.S. medical tourism market is valued at around $8-9 billion in 2023, with growth driven mainly by inbound patients seeking complex care (e.g., cancer and cardiac treatments). Europe’s medical tourism market is also significant, projected to reach approximately $18-19 billion in 2025 (mordorintelligence.com) and growing rapidly, with an expected threefold increase by 2030 (reportsnmarkets.com). Globally, roughly 14 million people travel internationally for healthcare each year. Inbound vs. Outbound Emphasis: The U.S. sees notable inbound medical travel - an estimated 1.9 million foreign patients annually - attracted by world-class hospitals and cutting-edge treatments. Simultaneously, many Americans travel abroad to other countries for affordable care or alternative therapies (over 1 million Americans visit Mexico alone each year for health services, according to travelperk.com). Europe exhibits a mixed pattern: Western Europe serves as a destination for high-quality yet cheaper care (drawing patients from the U.S., Middle East, and neighboring countries), while Europeans also travel outbound to lower-cost regions (Eastern Europe, Turkey, etc.), especially to avoid waits or high prices at home. Integrative Wellness Trend: Both regions are seeing a convergence of medical and wellness tourism. Resorts and clinics increasingly blend conventional medicine with holistic wellness services. This “integrative” approach has accelerated since the pandemic, meeting traveler demand for comprehensive health experiences. For example, luxury wellness retreats in Europe now offer medical check-ups alongside spa therapies, and top U.S. hospitals have integrative medicine centers - reflecting a global trend of merging clinical care with preventive wellness. (Historical context: Europe’s cross-border healthcare directive (2014) significantly eased travel for medical care within the EU, leading to new patient flows from high-cost or high-wait countries to more affordable EU destinations. In the U.S., rising domestic healthcare costs over the past decades and gaps in insurance coverage have fueled Americans’ interest in overseas treatment, a trend noted since the 2000s and still expanding.) ### Popular Medical Tourism Destinations Hubs Both the U.S. and Europe have specific regions and cities that have become hubs for medical travelers. Below, we highlight the key destinations in each market, including notable cities and an emphasis on Sicily in Europe. United States - Key Inbound Hubs Outbound Patterns Inbound Destinations (Foreigners Traveling to the U.S.): Despite the high cost of U.S. healthcare, the country attracts many international patients seeking top-tier quality or specialized procedures. Major medical hubs include: New York City and Baltimore: Home to renowned hospitals (e.g., NewYork-Presbyterian, Johns Hopkins) and specialized institutes. These attract patients for cutting-edge cardiac surgeries, cancer treatments, and advanced diagnostics. Top U.S. centers like Mayo Clinic (Minnesota), Cleveland Clinic (Ohio), and Cedars-Sinai (Los Angeles) collectively treat tens of thousands of foreign patients yearly. Florida (Miami/Tampa) and Texas (Houston): Florida is a gateway for Latin American and Caribbean patients, valued for its proximity and large Spanish-speaking medical workforce. Houston (Texas Medical Center) is known for cardiology and oncology, drawing patients from the Middle East and elsewhere. Florida, California, and New York are cited as states that attract a significant share of inbound medical tourists. Los Angeles and Chicago: Los Angeles is popular for specialized surgery and cosmetic procedures (Beverly Hills clinics, etc.), while Chicago and other big cities host internationally recognized hospitals for organ transplants and pediatrics. Foreign inbound patients choose the U.S. mainly for its quality and technology, including access to world-renowned surgeons, innovative treatments (e.g., experimental cancer therapies, robotic surgeries), and complex procedures not available at home. For instance, the U.S. offers many cutting-edge treatments (like certain gene therapies) and has a reputation for excellent outcomes in complicated cases. Inbound medical tourists often cite specialized expertise and trust in U.S. healthcare standards as reasons for visiting. (Notably, recent data show a significant portion of U.S. inbound patients come from China (about 15%) and other nations where affluent patients seek advanced care abroad. Outbound U.S. Destinations (Americans Traveling Abroad): On the other hand, high costs and coverage gaps in the U.S. prompt many Americans to seek treatment abroad. Popular destinations for outbound U.S. medical travelers include: Mexico: By far the top choice for Americans, due to its proximity and massive cost savings. Over 1 million Americans and Canadians obtain care in Mexico annually. Border cities (Tijuana, Juárez) and hubs like Cancún and Mexico City are famous for dental work, bariatric (weight-loss) surgery, and prescription medications, often at 50-80% lower cost than in the U.S. Mexican clinics catering to foreigners usually hold international accreditation (e.g., JCI) and offer package deals that include recovery in resort settings. Central and South America:Costa Rica, Colombia, the Dominican Republic, Cuba, Ecuador, Brazil, and Argentina are specifically noted as medical tourism destinations for U.S. residents. Costa Rica and Colombia are known for dental and cosmetic surgeries, Brazil and Argentina for advanced cosmetic/plastic surgery, and Cuba for certain niche treatments (e.g., eye surgery, specialized vaccines). These countries market high-quality care at a fraction of U.S. prices. Asia (Thailand, India, Malaysia) and Others: Although further away, Asia’s premier medical centers (e.g., Bumrungrad in Thailand, Apollo Hospitals in India) attract some Americans for major surgeries or wellness retreats at ultra-competitive prices. Southeast Asia offers 60-80% cost savings on many procedures, along with renowned hospitality. For example, India and Thailand each treat hundreds of thousands of foreign patients yearly and are known for expertise in **cardiac, orthopedic, and cosmetic surgeries (**media.market.us). Americans seeking alternative therapies (such as Ayurvedic medicine or stem cell treatments not approved in the U.S.) also travel to places like India, Thailand, or the Caribbean. In summary, the U.S. acts as a destination for complex, high-tech care (especially for inbound patients from less-developed healthcare systems), while simultaneously being a source of outbound patients who travel elsewhere for affordability or treatments not easily accessible at home. ## Europe - Top Destinations, Sicily’s Role, and Cross-Border Travel Leading European Medical Destinations: Europe is a geographically and culturally diverse continent, so medical tourism flows tend to occur both within the continent and from outside. Historically, Western European countries with strong healthcare systems have attracted patients from neighboring nations and beyond. Key destinations include: Germany: A longstanding leader in European medical travel, Germany’s advanced hospitals treat roughly 250,000 international patients each year, generating over €1.2 billion in revenue. Patients from Russia, the Middle East (UAE, Saudi Arabia, Kuwait), and across Europe come to Germany for its **high medical standards, renowned university clinics, and broad range of specialties (**hticonference.com). Germany is particularly noted for its expertise in cardiac surgery, oncology, orthopedics, and rehabilitative care, as well as some integrative cancer treatments (e.g., hyperthermia, naturopathic adjunct therapies) that attract patients seeking options unavailable at home. Crucially, medical care in Germany is significantly less expensive than in the U.S. for comparable quality - offering an “affordable cost-to-quality ratio” that appeals to self-paying foreign patients. Major cities like Berlin, Munich, and Frankfurt host internationally focused hospitals (e.g., Charité Berlin, University Clinic Munich) that provide multilingual staff and concierge services for foreigners. Spain: In recent years, Spain has emerged as a popular and affordable medical hub. The country prides itself on outstanding private hospitals at incredibly low costs.. Spain’s healthcare system ranks highly in Europe, and cities like Barcelona and Madrid have established a network of facilities targeting international patients. Spain offers elective surgeries, orthopedic and heart procedures, and fertility treatments at fees well below U.S. or UK prices, often with no waiting list. An added draw is the ability to recover in a vacation setting - “travelers, mainly from the US and UK, avail some treatment and enjoy a splendid vacation here,” as one report noted. Coastal regions and islands (e.g., Malaga in Andalusia, Alicante in Valencia, and the Balearic Islands) market medical + tourism packages (hence the industry cluster name SpainCares). Before the pandemic, Spain was expected to attract around 200,000 medical tourists annually by combining its healthcare strengths with its tourist appeal (hticonference.com). Italy (with Focus on Sicily): Italy is confirmed as one of Europe’s main medical tourism destinations as of 2025, thanks to high-quality healthcare services, a wide variety of treatments, and the country’s cultural and natural appeal. Northern Italy boasts well-established private clinics for cosmetic surgery, cardiac care, orthopedics, and oncology, often drawing patients from Europe and North America who trust Italian medical expertise and find the costs moderate relative to those in the U.S. Uniquely, Italy integrates its centuries-old spa and thermal wellness tradition into medical offerings: many Italian medical trips include rehabilitative stays at thermal spas, an added “prevention and wellness” tool that gives Italy a competitive edge. Sicily, in particular, is gaining attention as a regional hub for health and wellness within Italy. Sicily offers a unique blend of modern medical facilities and integrative wellness retreats set in a stunning Mediterranean environment. While not yet as medically famous as Milan or Rome, Sicily leverages its clean environment, mild climate, and rich culture to attract health travelers for recuperation and holistic programs. For example, the new Adler Spa Resort in Sicily introduced “ADLER MED” medical-wellness programs in 2023, offering guests medical consultations (with a physician specialized in phytotherapy/natural medicine) alongside detox, nutrition, and stress-management packages. Such programs epitomize integrative care in a resort context - allowing foreign visitors to improve their health while enjoying Sicily’s scenic tranquility. Sicily’s strategy is to become a “rehabilitation and wellness” hub for foreign patients (especially seniors or those recovering from surgery) who seek high-quality care with a vacation-like experience. The island’s relatively lower cost of living also means services (from private surgery to long-term stay) can be priced attractively. CareOnHoliday.com is one such emerging company to promote these ideas. (For example, luxury wellness resorts in Sicily charge around €450/night for comprehensive health packages, which is often half the nightly rate of comparable wellness retreats in the U.S.) Turkey (Transcontinental, but a major European-side player): Turkey (especially Istanbul and Ankara) has become a global medical tourism giant in the last decade. It is often grouped with Europe due to proximity and patient flows. Turkey offers **50-70% lower costs than the U.S., **highly trained doctors, and over 50 JCI-accredited hospitals. It receives an estimated 700,000+ foreign patients annually, with cosmetic surgery, hair transplants, dental care, and organ transplants among the top draws. A significant share of Turkey’s medical tourists are from Western Europe (the U.K., Germany, and the Netherlands) seeking affordable elective procedures, as well as from the Middle East. Istanbul alone accounts for ~40% of Turkey’s health tourists. Eastern Europe (Poland, Hungary, Czech Republic, etc.): Central/Eastern European countries (often the Visegrád Group: Hungary, Poland, Czechia, Slovakia) have flourished by offering high-quality care at rock-bottom prices to other Europeans. These countries are easily reachable for EU patients and have actively promoted health travel. For instance, Hungary is known as a “dental paradise”, with entire towns on the Austrian border filled with dental clinics catering to Western Europeans. Hungarian clinics offer treatments 40-70% cheaper than in the U.K. or U.S., and dental implants or full-mouth “new teeth” packages in Central Europe can cost around £1,000, vs. £2,500 in Britain. Similarly, Poland and Czechia excel in cosmetic surgery, fertility treatment, and eye surgeries for foreign clients. These nations benefit from shorter wait times (compared to U.K./Nordic public systems) and favorable regulations. For example, the Czech Republic allows anonymous egg/sperm donation for IVF, attracting thousands of fertility patients (especially from Germany, Italy, and the U.K.) who face restrictions or long waits at home. Across Eastern Europe, governments have invested in promoting medical tourism, with Poland’s state fund subsidizing clinics to upgrade for foreign patients. This has made the region a magnet for cost-conscious travelers from Western Europe and even the U.S. Intra-European Patient Mobility: It’s important to note that a significant portion of Europe’s “medical tourism” occurs within the EU itself. EU citizens have the right to obtain medical treatment in other member states (with some reimbursement conditions) due to the 2014 Cross-Border Healthcare Directive. This has led to, for example, Dutch and Belgian patients exchanging services (Belgium has become a preferred spot for Dutch patients needing orthopedic or cardiac surgeries due to shorter waits, hticonference.com), or Maltese patients going to U.K. hospitals under special agreements. The EU estimated that hundreds of thousands more citizens could seek care abroad each year thanks to reduced administrative barriers. Thus, Europe’s medical travel market is bolstered by regional flows driven by the pursuit of either higher quality or faster access within the public health framework. Spotlight: Sicily in the European Context*** Sicily, as a region of Italy, exemplifies how a locale can leverage its unique strengths for health tourism: Climate Natural Therapies: Sicily’s warm climate and natural resources (thermal springs, coastal environment) support programs for respiratory ailments, arthritis, and general convalescence. There is interest in reviving traditional Sicilian remedies (herbal medicine, etc.) in a modern integrative format. Integrated Wellness Resorts: As mentioned, new investments like Adler Spa Resort Sicilia provide medically supervised wellness holidays, combining Western medical diagnostics with holistic therapies (nutrition, yoga, herbal treatments). Such resorts attract visitors from Northern Europe and North America who seek preventive care or stress relief in an idyllic setting. Cultural and Language Appeal: Sicily’s rich history and hospitality make it appealing for long stays. Efforts are underway (e.g., the CareOnHoliday.com initiative) to position Sicily as a “health tourism hub” where international patients can undergo surgery or rehab at Sicilian hospitals and then recover by the sea under professional care. The region’s hospitals are forging partnerships with foreign doctors to refer patients to Sicily for certain procedures, followed by vacation-style recovery -. This model targets patients (especially Italian diaspora or English-speaking retirees) who value a comfortable, culturally enriching recuperation. In summary, Europe offers a wide range of destinations from high-end clinics in Germany or France, to sun-soaked wellness retreats in Italy (like Sicily) and Spain, to ultra-affordable dental and cosmetic surgery in Hungary or Turkey. Sicily’s case highlights how a region can focus on integrative wellness and scenic recovery to carve a niche in the competitive European medical tourism market. ### Consumer Preferences and Motivations Patients’ preferences - the treatments they seek and their motivations - differ somewhat between U.S.-related and Europe-related medical travel, although there is overlap. Below, I compare the services most sought after and why patients travel, for each region’s inbound and outbound flows. ## Types of Treatments in Demand Cosmetic and Dental Procedures: Globally, cosmetic surgery is estimated to account for ~25% of medical tourism, and dental treatments are estimated to account for around 15% of medical tourism. This trend holds true in both the U.S. and European contexts. These procedures are typically elective (not covered by insurance or public systems) and can be obtained much cheaper abroad. For example, Americans frequently travel to Mexico or Costa Rica for cosmetic surgeries and dental work - saving on everything from breast augmentations to full mouth restorations. Europeans also travel to Turkey, Hungary, or Spain for affordable veneers, implants, and hair transplants, among other procedures. Cosmetic and dental clinics are adept at marketing to foreign clients with all-inclusive packages (including accommodation and transfers), which appeals to consumers seeking a convenient, discreet experience. Orthopedic and Cardiac Surgeries: Expensive, major surgeries, such as joint replacements (hip/knee) and heart bypass or valve surgeries, are another high-demand category, especially for outbound medical tourism from the U.S. and Western Europe. Many American seniors or underinsured patients cannot afford a $50,000 knee replacement in the United States. Still, they can obtain it in India, Malaysia, or Eastern Europe for a fraction of the price. Likewise, patients in the U.K. or Canada facing long waits for orthopedic surgery might opt to pay out-of-pocket in Spain or Belgium to get it done sooner. Cardiac surgery is a top draw among inbound patients to both the U.S. and Europe: wealthy patients from the Middle East, Africa, or Asia often fly to U.S. cardiac centers (Cleveland Clinic, Texas Heart Institute) or to specialized European hospitals (Germany or Spain) to treat complex heart conditions. These patients are motivated by the reputation for excellence and the outcomes achieved in those centers. Oncology (Cancer Treatment): Cancer care is a growing driver of medical travel. Inbound travelers to the U.S. often seek advanced oncology (e.g., proton therapy, clinical trials, precision medicine) that may not be available at home. As of 2023, rising cancer cases were a significant factor in the growth of U.S. inbound medical tourism. Europe, too, sees cancer patients coming from abroad for specialized surgery or therapy (for instance, prostate cancer patients from the UK going to Germany for proton therapy not offered by the NHS). Additionally, some cancer patients pursue alternative or integrative oncology treatments overseas - a motivation discussed under integrative care below. Fertility and Reproductive Medicine: Fertility treatments (IVF, egg donation, surrogacy) are a notable segment of medical tourism, comprising about *12% of cases globally, *. Regulations and costs vary widely by country, so patients shop around internationally. Europe has an active fertility tourism scene; for example, couples from Italy or Germany travel to Spain or the Czech Republic for IVF with egg donation, as these countries have well-established donor programs and higher success rates, as well as legal anonymity for donors. Conversely, some Europeans go to the U.S. for surrogacy services, which are illegal or restricted in much of Europe - the U.S. is expensive but one of the few places with a structured surrogacy industry. Many American couples, facing IVF costs of $15-20k per cycle not covered by insurance, have started going to clinics in Greece, Czechia, or Mexico where equally advanced treatments cost a third of that. This indicates a cross-flow: Americans outbound for lower-cost IVF, Europeans outbound (or inbound within the EU) for either lower cost or more permissive laws. Wellness, Preventive, and Mental Health Programs: A distinct category is travel for wellness and preventive care - not to treat an illness, but to improve overall health. Europe has long attracted wellness tourists (think of British travelers spending a week at a German spa for “taking the waters”). Now, integrative wellness resorts (such as those in Sicily, Tuscany, and the Swiss Alps) often package medical check-ups with yoga, nutrition counseling, and naturopathic therapies. Such offerings appeal to health-conscious tourists from the U.S. and Northern Europe, especially in the wake of COVID-19, as people prioritize their wellbeing. The motivation here is often holistic rejuvenation and accessing therapies such as thermal baths, mud treatments, or traditional medicine (Ayurveda, acupuncture) in their authentic settings. In the U.S., domestic wellness tourism is strong (e.g., destinations like Sedona or California spas). Still, Americans also travel abroad for it: for instance, to India or Thailand for yoga and Ayurveda retreats, or to Bali and the Mediterranean for retreats focused on mental health and stress reduction. As of 2025, there has been a notable uptick in travel programs focused on mental health support, including meditation retreats and counseling in tranquil environments, globally (travelandtourworld.com). Countries like Italy and the U.S. have even integrated mental wellness initiatives into their tourism offerings (travelandtourworld.com). Key Motivations Driving Medical Tourists Across U.S. and European travelers, the core motivations can be summarized as the “Four Cs”: Cost, Care quality, Convenience (access/wait-time), and Choice of treatments - plus the desire to combine care with a vacation. Cost Savings: This is the dominant factor, especially for U.S. outbound and Western Europe outbound patients. Many medical tourists can save 50-80% on major procedures by going to countries with lower prices. For example, a heart bypass that costs $120k in the U.S. might be $20k in an accredited hospital abroad (saving $100k). Dental implants in the U.S., which cost approximately $4,000, may cost as little as $1,000 in Poland. Such differences can be life-changing for those paying out of pocket. In Western Europe, even with national healthcare available, patients sometimes choose to pay elsewhere if it’s cheaper than private care at home - for example, a Briton getting a complete dental makeover in Hungary for 60% less than in the UK (magazine.medicaltourism.com). Cost is cited by up to 70-80% of medical tourists as a key factor in choosing to go abroad. This includes Americans seeking affordable elective surgeries and uninsured or under-insured patients looking for options (about 25% of medical tourists go abroad because their needed procedure isn’t covered by insurance at home). Quality and Expertise: Interestingly, many travelers are also motivated by better quality of care or advanced expertise, even if it means leaving home. Approximately half of medical tourists select their destination based on access to high-quality healthcare services or technology not available locally. For instance, patients from Middle Eastern countries or China often believe the U.S. or Western Europe offer superior medical expertise and therefore travel for critical treatments. Even Americans and Western Europeans sometimes travel for quality reasons. For example, a patient might go to Germany for an innovative treatment that’s in clinical trials there, or a cancer patient may seek a renowned oncologist in the U.S. The reputation of specific hospitals or doctors can be a magnet. Additionally, some countries have centers of excellence for certain specialties - e.g., Germany for orthopedic rehab, Spain for certain transplant surgeries, or the U.S. for neurosurgery - drawing patients who prioritize the best outcomes. It’s noted that “trust” is paramount for most medical travelers (over 97% rate it as significant). Therefore, destinations that are perceived as safe and medically advanced (such as the U.S. and Germany) have an edge in attracting those who can afford them. Wait Times Convenience: In countries with single-payer systems or limited specialist availability, long wait lists drive patients abroad. This is a significant factor for European outbound travel. For example, a Canadian or Briton might face a 6-12 month wait for a hip replacement - but can have it done next month in a private clinic abroad. Surveys indicate that about 20% of medical tourists travel to gain faster access to treatment. EU patients often cite the use of their cross-border rights as a reason for escaping wait times for surgeries or diagnostics. Convenience also includes geographical proximity: many Americans cross the border to Mexico because it’s easy, and many Western Europeans travel to nearby Eastern European countries for a weekend getaway. Availability of Procedures (Legal/Regulatory): Patients sometimes seek treatments not available or not allowed at home. This includes alternative therapies, experimental treatments, or procedures banned by regulations. For instance: Combining Treatment with Travel: A significant portion of medical tourists (estimated ~40% globally) explicitly plan to enjoy a vacation alongside their medical care.. This is a strong motivator, especially in Europe, where the concept of “medical tourism” often involves rehab at a resort or a spa town. Patients often choose attractive locales (beaches of Spain, mountains of Switzerland, cultural cities like Istanbul or Rome) so that recovery feels like a holiday. For example, dental patients from the U.K. getting implants in Budapest will also take time to sightsee in that historic city. Americans traveling to Thailand for surgery may recuperate on Phuket’s beaches. The motivation here is partly psychological (to reduce the stress of medical treatment by being in a pleasant environment) and partly practical (some treatments require rest, so why not rest in a nice location). Sicily, with its scenic beauty, is capitalizing on this motive - marketing the island as a place to heal amid nature and history. Other Factors:Referrals/Word-of-Mouth play a role too - about 1 in 4 patients say recommendations influenced their decision to go abroad. Additionally, language and cultural affinity can be essential factors: patients may prefer countries where they speak the same language or share cultural ties (e.g., Arab patients often choose France or Germany, where translators and cultural accommodations are common; Spanish-speaking Americans feel more comfortable in Latin America). Lastly, some seek privacy - getting a procedure done far from home to avoid others knowing (for instance, cosmetic surgery “vacations” are popular for this reason). In essence, American medical tourists are primarily driven by cost savings and access to treatments not covered or available at home, whereas European medical tourists (both intra-European and those coming from outside) often balance cost, quality, and wait-time considerations, leveraging the proximity of many countries. Both groups, however, appreciate quality healthcare and the opportunity to recuperate in a pleasant setting as secondary benefits that are equally critical. ### Cost Comparison Across Treatment Categories One of the most apparent contrasts between the U.S. and many medical tourism destinations (including European ones) is cost. The U.S. generally has the highest medical prices in the world,, whereas Europe - even its high-end private care - tends to be cheaper than U.S. equivalents. Meanwhile, some European countries and other global destinations offer dramatically lower prices. Below is a comparison table highlighting typical cost differences for various treatments (approximate 2025 figures): Sources (11) Horwath HTL Market.us TravelPerk Medical Tourism Magazine HTI Conference Mordor Intelligence Luxe Wellness Club Magna Sicilia LinkedIn Fertility Clinics Abroad Mitosis ### The Wire Aug 30This Week in Medical Tourism: 20–26 August 2026 Aug 29This Week in Medical Tourism: 13–19 August 2026 Aug 22South Korea Undercuts America but Not Turkey All coverage ### Newsletter Get weekly health tourism intelligence in your inbox. Subscribe ### Knowledge Hub Medical Tourism Wellness Tourism Dental Tourism Fertility Tourism Cosmetic Tourism Longevity Tourism Explore the Hub Stay informed on the latest in global health tourism. Subscribe to our Newsletter ## Related Articles Medical Tourism 22 AUG 2026 Medical Tourism ### Mexico and Turkey Price Against Different Home Markets August 22, 2026 Medical Tourism 22 AUG 2026 Medical Tourism ### Turkey's Deepest Discounts Sit on Its Safest Procedures August 22, 2026 Medical Tourism ### Why Medical Tourism to Germany Declined August 11, 2026 --- # Vietnam Courts US Patients For Medical Tourism URL: https://health-tourism-news.com/news/viet-nams-strategic-imperative-cultivating-the-us-market-for-high-value-medical-tourism/ Medical Tourism April 11, 2026 Medical Tourism Vietnam Courts US Patients For Medical Tourism Vietnam's tourism authority is pitching Americans on treatment plus a long stay. The visas and the flights are ready. The harder question is whether the hospitals are. Christian El-Khouri Editor-in-Chief Published April 11, 2026 · Updated July 4, 2026 · 6 min read Vietnam wants American patients, and the pitch has moved from posters to paperwork. Nhan Dan reports the Viet Nam National Authority of Tourism courting the US as a priority market for long-stay, high-spending visitors, with medical travel named among the most promising areas for cooperation between the two countries. The raw material is there: nearly 850,000 Americans visited Vietnam in 2025, part of a record year for the country’s tourism. But the coverage never quite asks the question that decides everything. Around 40,000 Vietnamese still fly abroad for treatment every year, spending about $2 billion between them. Why would Americans fly in while Vietnamese with money fly out? ## A tourism agency makes the healthcare pitch At the Hanoi discussions covered by Nhan Dan, Nguyen Thi Hoa Mai, Deputy Director General of the Viet Nam National Authority of Tourism, described the US as a major source market and a long-standing partner, and said Vietnam wants more visitors in the long-stay, high-spending segment that medical travellers occupy almost by definition. James Peranteau of the US Embassy returned the compliment, picking out medical and healthcare travel as one of the most promising areas for cooperation and crediting Vietnam with reasonable costs, improving service quality and a qualified medical workforce. “These are important advantages that can help Viet Nam enhance its appeal to international visitors, including those from the US,” he said of the country’s assets. Both sides leaned on the same structural advantage: the large Vietnamese community in the United States, whose trips home already combine family visits with long stays, and whose members can vet a Ho Chi Minh City hospital the way a local would. The diaspora point is the substance here, and it deserves more weight than the scenery Peranteau praised alongside it. A Vietnamese American booking a health check or dental work during a family visit is not a medical tourist who needs persuading; the airfare is already justified and the trust already exists. What I notice is who is doing the talking. This is the tourism authority selling healthcare, with no health ministry official quoted alongside. Vietnam’s health and wellness market is being marketed a step ahead of being built, and that gap runs through every number that follows. ## The visas and the flights are already in place The access layer is genuinely done. Under Resolution 127/NQ-CP, in force since 15 August 2023, Vietnam issues e-visas to citizens of every country and territory, valid for up to 90 days with single or multiple entries and accepted at 13 international airports, according to the Vietnamese Embassy in Washington. Vietnam Airlines, the only Vietnamese carrier with a direct US route, flies nonstop from San Francisco to Ho Chi Minh City in about 15 hours, four days a week. The headline numbers reward the effort. The Viet Nam National Authority of Tourism and the National Statistics Office counted nearly 21.2 million international arrivals in 2025, up 20.4 percent on 2024 and 17.8 percent above pre-pandemic 2019, with the US the fourth-largest source market. A 90-day multiple-entry e-visa is a better medical product than most governments realise. Staged dental work does not fit inside a two-week holiday visa; a document that lets a patient enter, go home, and come back for the follow-up within three months does. Vietnam built that for tourists and got a patient visa for free. The flight map is thinner, a single West Coast gateway, but a 15-hour nonstop from San Francisco puts Ho Chi Minh City within one flight of California and its Vietnamese American communities. ## The hospitals have more to prove The clinical layer is where the pitch thins out. The proof point everyone reaches for is FV Hospital in Ho Chi Minh City, JCI-accredited since 2016 and re-accredited in January 2021 with a 99 percent compliance score, 230 beds across more than 30 specialties, with foreigners making up about a quarter of its patients, mostly from Korea, Japan, France, the US, Canada and Cambodia. Note the hospital’s own framing, though. FV says it develops to international standards “so that Vietnamese citizens do not need to go abroad for treatment.” The wider system numbers come from the US International Trade Administration’s country guide, updated in March 2026: Vietnam’s health spending passed $22 billion in 2024, hospitals in Hanoi and Ho Chi Minh City absorb up to 60 percent of the country’s patients and operate beyond capacity, and the private sector’s 384 hospitals amount to 24 percent of facilities but just 5.8 percent of beds. Read together, those figures explain the $2 billion outflow better than any survey could. The internationally accredited layer is real but narrow - FV is a 230-bed hospital in a country of a hundred million people - and the public system beside it is overloaded before a single inbound patient arrives. FV’s mission statement is aimed inward, at keeping Vietnamese patients home, and that is the honest sequencing. A hospital sector still working to convince its own middle class is not yet built to absorb American patients at scale, and every foreign arrival in the meantime competes for the same narrow band of accredited beds. ## What This Means Vietnam has done the fast, cheap parts of a medical tourism build first: visas, a nonstop flight, promotion, and a record 21.2 million arrivals to show for it. The slow, expensive part - accredited beds, spare capacity, a private sector larger than 5.8 percent of the total - lags years behind, and the 40,000 patients flying out each year are the honest measure of where domestic confidence sits. For now the credible offer is narrow and real: Vietnamese Americans folding dental work, health checks and elective procedures into family visits at a small set of internationally accredited private hospitals in Ho Chi Minh City and Hanoi. That market needs no persuasion, only availability. The broader American patient, the one weighing Vietnam against Bangkok or Kuala Lumpur, will wait for proof rather than promotion. The signal I would watch is not arrivals but the outflow. When the $2 billion Vietnamese spend abroad on treatment starts shrinking, the hospitals will have won the argument at home, and that is the moment the inbound pitch to Americans stops being aspirational. Sources (6) Nhan Dan VietnamPlus Vietnam Embassy in the US FV Hospital International Trade Administration Vietnam Airlines VietnamUSSoutheast AsiaWellness Tourism ### The Wire Aug 30This Week in Medical Tourism: 20–26 August 2026 Aug 29This Week in Medical Tourism: 13–19 August 2026 Aug 22South Korea Undercuts America but Not Turkey All coverage ### Newsletter Get weekly health tourism intelligence in your inbox. Subscribe ### Knowledge Hub Medical Tourism Wellness Tourism Dental Tourism Fertility Tourism Cosmetic Tourism Longevity Tourism Explore the Hub Stay informed on the latest in global health tourism. Subscribe to our Newsletter ## Related Articles Medical Tourism 22 AUG 2026 Medical Tourism ### Mexico and Turkey Price Against Different Home Markets August 22, 2026 Medical Tourism 22 AUG 2026 Medical Tourism ### Turkey's Deepest Discounts Sit on Its Safest Procedures August 22, 2026 Medical Tourism ### Why Medical Tourism to Germany Declined August 11, 2026 --- # Welcome to Health Tourism News URL: https://health-tourism-news.com/news/welcome-to-health-tourism-news/ Medical Tourism Welcome to Health Tourism News The Rationale Behind Starting Medical Tourism News Christian El-Khouri Editor-in-Chief Editor-in-Chief of Health Tourism News. Twelve-plus years across international patient services, healthcare consulting, and destination development in Europe, the Middle East, and beyond. Co-Founder and Vice President of the European Health and Medical Tourism Association (EHMTA). Read more Published January 10, 2024 · Updated July 2, 2026 · 4 min read Medical Tourism News was conceived to address the increasing demand for a specialized, reliable, and comprehensive source of information in the rapidly growing field of health and medical tourism. This niche has gained substantial global attention in recent years, with millions of patients traveling across borders to seek affordable and high-quality healthcare. The industry encompasses various sectors, including medical treatments, dental care, wellness retreats, and cosmetic procedures, all of which have seen rapid growth driven by technological advancements, changing patient preferences, and the rising cost of healthcare in many countries. Given this landscape, the need for a dedicated, focused news platform that provides timely, relevant, and well-researched information became apparent. Medical Tourism News was established to fill this gap and serve as the go-to source for all things related to health and medical tourism. Several key factors underpin the reasoning behind its launch: ## A Focussed News Source for Health and Medical Tourism Medical tourism is a multifaceted industry, and keeping up with the latest trends, innovations, regulatory changes, and destination highlights can be challenging. While general news outlets may touch on medical tourism occasionally, they rarely provide the in-depth coverage that industry stakeholders and travelers need to make informed decisions. Medical Tourism News addresses this by focusing exclusively on the industry, offering content tailored specifically for healthcare providers, facilitators, policy-makers, insurers, and patients alike. By covering the latest developments, including treatment innovations, emerging destinations, and regulatory updates, the platform serves as a valuable resource for anyone interested in the field. ## Bridging the Information Gap While medical tourism is becoming increasingly popular, the industry remains fragmented. Information about medical procedures, destination safety, healthcare standards, and patient experiences can vary widely across sources. This can create confusion for prospective medical tourists who need accurate, comprehensive, and unbiased information to make informed decisions. Medical Tourism News aims to bridge this information gap by curating and delivering content that covers all aspects of the industry. The platform’s goal is to become a one-stop resource that answers critical questions about the safety, quality, and cost-effectiveness of seeking medical care abroad. ## Highlighting Emerging Destinations and Innovations As the medical tourism industry evolves, new destinations and treatment options continually emerge. These changes are often driven by advancements in medical technology, shifts in healthcare policies, and economic factors influencing the affordability of treatments. Medical Tourism News serves as a platform to spotlight these emerging destinations and innovative treatments, giving stakeholders insights into where the industry is headed. By covering breakthroughs such as regenerative medicine, telehealth, and robotic surgery, the platform helps readers stay ahead of the curve in a competitive marketplace. ## Supporting Industry Growth and Best Practices Medical Tourism News also aims to support the growth of the industry by encouraging best practices and ethical standards. The platform provides insights into patient safety, accreditation, and international healthcare quality standards, which are critical for ensuring positive patient outcomes. By highlighting successful case studies, regulatory developments, and expert opinions, the news outlet fosters an environment of knowledge sharing and continuous improvement across the industry. ## Navigating Regulatory and Insurance Considerations Navigating different countries’ healthcare regulations, insurance requirements, and legal frameworks is one of the most challenging aspects of medical tourism. By covering updates in these areas, Medical Tourism News helps stakeholders understand the implications of regulatory changes and insurance options, thereby reducing the risks associated with cross-border healthcare. Medical Tourism News exists to inform, educate, and inspire those involved in or considering medical tourism. Its focused approach ensures that all aspects of the industry are covered in detail, making it an indispensable resource for understanding the dynamic and ever-expanding field of health and medical tourism. Finally it is also a place for editorials and opinion pieces as we believe that only through honest and sometimes even confrontational debate we can reach better outomes. ### The Wire Aug 30This Week in Medical Tourism: 20–26 August 2026 Aug 29This Week in Medical Tourism: 13–19 August 2026 Aug 22South Korea Undercuts America but Not Turkey All coverage ### Newsletter Get weekly health tourism intelligence in your inbox. Subscribe ### Knowledge Hub Medical Tourism Wellness Tourism Dental Tourism Fertility Tourism Cosmetic Tourism Longevity Tourism Explore the Hub Stay informed on the latest in global health tourism. Subscribe to our Newsletter ## Related Articles Medical Tourism 22 AUG 2026 Medical Tourism ### Mexico and Turkey Price Against Different Home Markets August 22, 2026 Medical Tourism 22 AUG 2026 Medical Tourism ### Turkey's Deepest Discounts Sit on Its Safest Procedures August 22, 2026 Medical Tourism ### Why Medical Tourism to Germany Declined August 11, 2026 --- # What Is Health Tourism? URL: https://health-tourism-news.com/news/what-is-health-tourism/ Wellness Tourism What Is Health Tourism? Mapping the Spectrum from Medical to Wellness Travel Christian El-Khouri Editor-in-Chief Editor-in-Chief of Health Tourism News. Twelve-plus years across international patient services, healthcare consulting, and destination development in Europe, the Middle East, and beyond. Co-Founder and Vice President of the European Health and Medical Tourism Association (EHMTA). Read more Published August 4, 2025 · Updated July 2, 2026 · 6 min read I have been actively involved in Health Tourism for as long as I can remember. The older I got, the more involved I became with the industry. Health Tourism is easy enough to understand, at least prima facie. It has something to do with health and tourism, and most people accurately understand it not to be about the health of tourism, as we would correctly refer to it as “Tourism Health” rather than “Health Tourism”. But when looking closer, many still struggle with the definitions of Health Tourism and Medical Tourism, which undoubtedly also causes confusion on where Wellness Tourism fits into the mix. Since I have an academic background in business law, I love definitions. They make life much easier. Definitions, with measured use of interpretation and combined with syllogisms and deductive reasoning, allow us to draw conclusions, structuring and thus simplifying the world around us. They also lay the groundstone of any productive debate: Agreeing what and using which terms you are arguing about. ## Why Clear Definitions Matter In the context of global healthcare travel, the need for clear definitions becomes even more pronounced. Patients, providers, facilitators, and policymakers each bring different expectations and frameworks to the table. A traveller seeking cardiovascular surgery abroad is operating in a different dimension than someone booking a detox program at a Balinese retreat, yet both are technically engaging in cross-border health tourism. This definitional ambiguity is not just an academic challenge. It has real-world implications for how health insurance companies, travel agents, ministries of health, and international accreditation bodies approach regulation, marketing, and risk assessment. But what makes a definition a definition? Usually it is set, either by law or an organisation that, be it through authority or public recognition, is seen as authoritative. The world of Health- and Medical Tourism doesn’t lack definitions or attempts at definitions, but lacks authoritative sources that stakeholders are willing to trust and recognise. However, this piece is neither the right place nor am I inclined to decry this circumstance. I might, however, some time in the future, attempt myself at an explanation for it. What this article shall do, though, is provide my initial considerations and my own attempt at structuring the Health Tourism continuum. ## Health Tourism as a Spectrum That is indeed how I see Health Tourism. Rather than being black and white, it is a spectrum on which both Medical Tourism and Wellness Tourism are represented. The increase in international patient travel and the emergence of hybrid services - where elements of medical care and wellness are offered under one roof - further reinforce this spectrum model. This also reflects broader trends in consumer health behaviour: more individuals now combine their search for medical solutions with interest in holistic healing, preventive interventions, or simply stress reduction. Many medical tourists book massages, mindfulness training, or yoga alongside their surgeries. To visualise this spectrum, I have developed the following graphic: The graphic illustrates Health Tourism as a continuum along two axes. The top axis represents the degree of HCP involvement, ranging from high (medical interventions) to low or non-existent (self-guided wellness activities). The bottom axis maps the purpose of travel: from remedying a negative health state to improving a neutral or good one. In between lie hybrid forms - such as longevity medicine or thalassotherapy - that blur the line between medical and wellness objectives. ## Telling Medical and Wellness Tourism Apart Health Tourism includes both experiences in which healthcare professionals (HCPs) have high and low involvement, as well as experiences in which the remediation of a negative state of health and the improvement of a neutral or good state of health are the target. Another good indicator for medical tourism, as opposed to wellness tourism, is the setting in which the procedure is provided. If it’s a hospital or a clinic, it tends to be medical tourism. If the setting is more akin to a resort or hotel, we are likely looking at wellness tourism. An additional differentiator is intent. People seeking healthcare abroad may do so for financial reasons, shorter waiting times, or access to procedures that are unavailable at home. By contrast, wellness travellers tend to be driven by lifestyle aspirations, personal growth, or the desire to escape daily stressors. Both are reacting to structural deficits in their domestic health systems, but in different ways. This distinction is especially relevant in regions where health resorts, rehabilitation centres, and private clinics coexist. Think of Central Europe, where cross-border healthcare services often blend spa traditions with regulated clinical oversight. The rise of such integrated care models invites even more blurred lines between what is “medical” and what is “wellness”. Emerging destinations like Hungary, Turkey, South Korea, and Thailand have become notable hubs for this very reason. They not only offer affordable surgeries but also wrap them in leisure packages designed to enhance recovery and satisfaction. This bundling of care and comfort is a central driver of growth in global medical tourism. These spheres of differentiation are by no means final, but they allow us to organise procedures according to their traits or characteristics. ## Medical and Wellness Tourism Side by Side Without aiming to generalise or oversimplify, here are some good points to start in differentiating between medical tourism and wellness tourism. Medical Tourism: High HCP involvement Remedying a negative state of health Tends to involve invasive procedures Addresses acute or chronic conditions Diagnostics and treatment plans The procedure might come with complications and side effects May involve long pre- and post-operative planning Typically occurs in hospitals or accredited clinics Popular procedures: cardiac surgeries, orthopedic interventions, cancer treatments Often regulated or subject to international patient safety standards (JCI, ISO) Can include reproductive medicine, dental implants, organ transplants, and bariatric surgery Wellness Tourism: Low HCP involvement Improving a neutral state of health Non-invasive treatments and procedures Preventative care; addresses overall health Lifestyle changes, mindfulness, balance Less risky procedures and applications Often includes traditional or holistic methods (Ayurveda, TCM, thalassotherapy) Takes place in wellness retreats, thermal spas, resorts Popular offerings: stress reduction, detox, anti-aging programs May include plant-based nutrition programs, sound therapy, forest bathing, or even spiritual coaching Increasingly integrated with digital wellness tracking and biohacking tools ## Where Cosmetic Tourism Fits In At the risk of sounding like a broken record, there is no clear border between medical tourism and cosmetic tourism. However, these indicators can come in handy when looking at the individual case, trying to form an opinion on the matter. Cosmetic tourism, in particular, represents a fast-growing and highly visible segment. Procedures such as rhinoplasty, breast augmentation, and hair transplants often combine elements of both categories: they are medically performed, but their motivation is aesthetic. The rise of ‘Instagram clinics’ and influencer marketing has only accelerated the globalisation of cosmetic healthcare services. Similarly, elective medical procedures such as bariatric surgery or fertility treatments may blur conventional categorisations, particularly when bundled with recuperation stays in wellness-focused environments. This complexity is part of what makes the study of healthcare travel and health-seeking behaviour so rich. ### The Wire Aug 30This Week in Medical Tourism: 20–26 August 2026 Aug 29This Week in Medical Tourism: 13–19 August 2026 Aug 22South Korea Undercuts America but Not Turkey All coverage ### Newsletter Get weekly health tourism intelligence in your inbox. Subscribe ### Knowledge Hub Medical Tourism Wellness Tourism Dental Tourism Fertility Tourism Cosmetic Tourism Longevity Tourism Explore the Hub Stay informed on the latest in global health tourism. Subscribe to our Newsletter ## Related Articles Weekly Digest 08 JUL 2026 Weekly Digest ### Medical Tourism Records Concentrate In Penang And Seoul July 8, 2026 Weekly Digest 01 JUL 2026 Weekly Digest ### Nigeria, Iran And Seoul Redraw Medical Tourism July 1, 2026 Weekly Digest 24 JUN 2026 Weekly Digest ### Health Tourism As Badge, Escape Hatch And Disguise June 24, 2026 --- # Medical Tourism Facilitators: Evolve or Face Extinction URL: https://health-tourism-news.com/news/why-medical-tourism-facilitators-must-evolve-or-risk-extinction-in-a-digital-cost-driven-industry/ Medical Tourism Medical Tourism Facilitators: Evolve or Face Extinction Why medical tourism facilitators must evolve - or risk extinction in a digital, cost-driven industry Pierre Hollenbeck Contributor Founder of Medcom, a Paris-based marketing and international healthcare provider support company operating across 17 countries. Pioneered the French hair transplant market to Turkey in 2004 and has since expanded into dental and cosmetic surgery coordination. Read more Published September 15, 2025 · Updated July 2, 2026 · 7 min read Reviewed by Christian El-Khouri, Editor-in-Chief Like a lot of out of border trades, Medical tourism has long relied on middlemen. Their purpose was to oil the angles with a deeper knowledge of all particularities of parties involved. In Medical tourism, this middleman is rightfully called “the facilitator”, often presented as “agencies”, developing their own brand and their own marketing. A lot like the wholesaler in china making the bag in the shenzhen factory, and the french luxury brand sticking a logo on it at the end. The agencies are “selling and branding” the treatment abroad in their local market , while the service is being outsourced to the medical provider abroad. Although this element of the chain has been an indispensable brick in the industry’s launch, it might be time to wonder if the industry’s rocket ship should now consider dropping the launch boosters… Has the facilitators become a burden to industry acceleration or is it still pushing forward ? We believe that the role of facilitators is deeply changing and that the roles and responsibilities are being redistributed today. It’s a new deal, and the actor’s cards have been changed. ## The Agent Reflex Let’s quickly summarize the past purposes of agents in our industry. The primary role of agents in medical tourism has been simple: to bridge the geographical and cultural gap between patient and provider. A local “facilitator”, bridging the gap with an unknown clinic in an unfamiliar country makes sense and strengthens the chain of service. An agent is supposed to be the local support. The agent is familiar to the patient: language wise , geographically and culturally. Before and after the treatment abroad, the agent is here and has a reassuring role. And that matters: medical treatment abroad is, by nature, intimidating. By anchoring the service chain in the patient’s home country, the facilitator makes the entire experience feel less daunting. This is the historical first and most important ADDED VALUE of the facilitator. ## Comparison With the Parent Industry: Tourism Just like the tourism industry, the most successful facilitators had offices to physically see potential clients, and made the human bridge between the fancy website pictures and the client’s expectations. That was no more than 10 years ago only. Travel agencies still exist. But who really uses them anymore? Most consumers now book flights and hotels directly online. Why? Because these platforms have empowered the client’s decisions making and accompanied a general shift in consumer behavior. Consumers have changed the decision factors and stripped the old fashioned travel agent from its added value. Consumer choose for themselves! Hence, is using a medical facilitator today just like buying a plane ticket through an agent back in the 1990s? Some will argue: “medical treatment is not the same”, “patient needs the human touch” , or “I care for my clients”. Really? Are we in the business of boutique hand-holding, or in an industry dealing with international medical law, financial exchanges, and insurance claims? The temptation to romanticize the agent is strong, just as we all fantasize about vintage cars. Everyone would love to channel Robert Redford’s coolness in a 1968 Porsche (Spy Game). But reality looks different: most of us are driving a connected SUV, CarPlay plugged in, Waze tracking our route, and Spotify running in the background. ## The Three Pillars of Medical Tourism: Money, Time, Availability This market is first and foremost driven by cost-efficiency. Money: finding the lowest price for acceptable quality. Time: avoiding endless waiting lists in domestic health systems. Availability: accessing techniques, or expertise not available at home. In such a cost-driven market, how many middlemen can be tolerated before the service becomes too expensive, or inefficient? Especially when provider countries are facing runaway inflation. Take Turkey: in August 2025, the official annual inflation rate hit 32.95%. In a market where patients are counting every euro, every extra layer of commission quickly turns from “added value” to “added burden.” ## The Facilitator’s Business Model Let’s look at economics plainly. Facilitators live off a commission deducted from the medical act. Rarely more than 15-20% gross margin. Almost never billed directly to the patient (who would never willingly pay a “brokerage fee”). The result? A fragile, dependent, and often grey model. Clinics do not always declare the full commission. Cash flows off the record. The market remains partially invisible, preventing serious industry-level growth or investment. ## The Consequences On a micro scale: some of these actors could buy himself a Lamborghini in fresh cash ( in some countries) and no one will be the wiser. On a macro scale: an entire industry cannot structure itself or attract serious investors, for lack of transparency and measurable projections. Of course, the facilitator isn’t personally responsible for this dysfunction. But the business model itself, and the habits it has created, are. ## Undefined Roles and Responsibilities The facilitator is indispensable for reassuring the patient, yet trapped in a double paradox: Underpaid for over-service. In most industries, margins are designed to cover risk. Think of the bag made in China: by the time a luxury brand stamps its logo, the margin has multiplied two, three, sometimes tenfold. Basically enough to absorb returns, handle complaints, and fund growth! Facilitators, by contrast, work on razor-thin margins that leave no room to scale or absorb shocks. Responsibility without definition. Who manages a post-op complication? the facilitator or the clinic? In medicine, responsibility is normally crystal clear: the doctor is licensed, insured, and accountable. The facilitator? No license, no insurance, maximum exposure. I recall a conference two years ago where a facilitator advised his peers to “put a little aside” from each commission in case of complications. The sheer irresponsibility of that statement is staggering. First, if a patient dies or suffers permanent injury, a small contingency fund won’t even scratch the surface. Second, it effectively admits liability for a treatment the facilitator is not qualified to provide. In other words, a perfect case study in what not to do. If i was asked for a advice to give, i would probably say “do the exact opposite of what that statement is suggesting”. In the end, the facilitator becomes the perfect scapegoat: blamed by the patient, tolerated by the clinic. then one day….. everything blows. ## What About Tomorrow? *In short : * Digitalization: integrated platforms are replacing agents, centralizing quotes, documents, and follow-up. Regulation: sooner or later, the industry will have to comply with fiscal and legal rules, shrinking the space for “grey” intermediaries. Value-added service: only those facilitators who can provide a clear, premium service with genuine patient follow-up and contractual responsibility will survive. *In details : *The future of facilitating won’t be decided by regulation or technology alone. These are just the conditions of the game. The real driver will be value-added service. Facilitators who bring nothing more than a name and added cost will disappear. But those who reinvent their role, by creating genuine patient support, integrating technology, and taking on clear responsibility, will not only survive, they will strengthen the industry as a whole. Digitalization will accelerate this shift, pushing out the passive middlemen. Regulation will enforce it, closing the space for “grey” practices. But in the end, it’s the creative players, the ones who add something tangible to the chain, who will carry the industry forward. ## A Final Word If you are a clinic: consider building partnerships only with local actors who bring real added value for patients. Make your product stronger, but also make sure responsibilities are clearly defined and secured within a proper legal framework. If you are a facilitator: ask yourself whether you have truly explored the full scope of your capacity to enhance services. Economic dynamics are forcing change. If reading this article made you reflect on the new features and services you already offer compared to the “classic” facilitator model, then you are likely on the right path, because you are already thinking in terms of industry development, not survival. In short: “the inconvenient necessity” of yesterday has two choices, fade into irrelevance, or evolve into tomorrow’s key actor by inventing new added value to the service. Sources (1) Trading Economics, Turkish Statistical Institute data ### The Wire Aug 30This Week in Medical Tourism: 20–26 August 2026 Aug 29This Week in Medical Tourism: 13–19 August 2026 Aug 22South Korea Undercuts America but Not Turkey All coverage ### Newsletter Get weekly health tourism intelligence in your inbox. Subscribe ### Knowledge Hub Medical Tourism Wellness Tourism Dental Tourism Fertility Tourism Cosmetic Tourism Longevity Tourism Explore the Hub Stay informed on the latest in global health tourism. Subscribe to our Newsletter ## Related Articles Medical Tourism 22 AUG 2026 Medical Tourism ### Mexico and Turkey Price Against Different Home Markets August 22, 2026 Medical Tourism 22 AUG 2026 Medical Tourism ### Turkey's Deepest Discounts Sit on Its Safest Procedures August 22, 2026 Medical Tourism ### Why Medical Tourism to Germany Declined August 11, 2026 --- # Why Medical Tourism to Germany Declined URL: https://health-tourism-news.com/news/why-medical-tourism-germany-declined/ HTN ANALYSIS GERMANY Foreign patients treated in Germany 2015 to 2017 260,000 250,000 240,000 255,000 2015 2016 2017 Recorded totals: Hochschule Bonn-Rhein-Sieg. Scale starts at 240,000. Medical Tourism Why Medical Tourism to Germany Declined The Legal and Systemic Causes Christian El-Khouri Editor-in-Chief Editor-in-Chief of Health Tourism News. Twelve-plus years across international patient services, healthcare consulting, and destination development in Europe, the Middle East, and beyond. Co-Founder and Vice President of the European Health and Medical Tourism Association (EHMTA). Read more Published August 11, 2026 · 23 min read For most of the 2000s and early 2010s, Germany was one of the premier destinations for medical tourism, drawing self-paying and state-sponsored patients from Russia, the former Soviet republics and the Gulf. That business has been shrinking since the middle of the last decade, and the common explanation, that cheaper rivals such as Turkey took the patients, covers only part of it. The larger part is internal. A series of billing scandals broke the trust of the state payers who funded the trade, two changes in German law closed the commercial channel it ran through, the hospital sector fell into a staffing and financing crisis that made foreign patients a burden rather than extra income, and a change in how senior doctors are paid removed the personal incentive that once drove clinicians to pursue the work. This article sets out those factors in turn. This report concentrates on the internal, legal and systemic causes. For the wider view of the fall, including the market data and the demand-side story, see our companion overview of the decline of medical tourism in Germany. Text description of the diagramFive forces, three mechanisms, one outcome. Demand side. 01 Source-market shocks. Russia: EU sanctions, weak rouble, 2022 war. Gulf: budget cuts, VAT, embassy reform. Systemic, Germany. 02 Billing scandals. Libyan war-wounded losses and the Kuwaiti embassy-patient affair erode payer trust. 03 Legal change closes the channel. §299a/b StGB (2016) can criminalise paid referrals. §138 BGB (LG Kiel 2011, LG Stuttgart 2024) makes brokerage contracts void. Supply side. 04 Hospital staffing and funding crisis. Nurse and bed shortages and deficits turn foreign patients into a burden, not income. 05 Doctors' pay incentive removed. Liquidationsrecht gives way to Beteiligungsvergütung: the hospital keeps the fee. Mechanisms. Forces 01 and 02 drive demand falls among premium non-EU patients. Force 03 closes the acquisition channel. Forces 04 and 05 collapse provider willingness. Competition, from Turkey and from Gulf states building their own capacity, is an accelerant rather than a root cause. Outcome. The premium inbound business collapses. Low-value EU cross-border day-traffic masks the fall in the profitable core. How the factors combined: demand-side shocks, German-specific systemic breaks, and supply-side withdrawal converging on the decline of the premium inbound business. ## The scale of Germany’s medical tourism decline Germany’s inbound patient numbers peaked in the middle of the last decade and have trended down since. The most-cited data comes from the Hochschule Bonn-Rhein-Sieg, whose researchers have tracked the German market for years. Their figures put the country at around 255,000 foreign patients in 2015, then about 253,000 in 2016 and roughly 247,500 in 2017, with revenue holding near 1.2 billion euros. On the surface that looks like a modest, gradual decline. Beneath it the picture is sharper. The headline count masked what was happening underneath. By 2018, close to two-thirds of all foreign patients came from within the EU, most of them from Poland, and much of that is low-value cross-border and day-case traffic. The consulting firm MESC frames the same split from the operator’s side, noting that of up to 250,000 foreign patients a year, only around 40 to 45 per cent are true medical tourists, most from neighbouring Europe, followed by the Gulf and the former Soviet states. The premium segment, the non-EU inpatient business that hospitals built dedicated international departments to capture, is the part that collapsed. The aggregate number fell gently; the profitable core fell hard. That is why the sector is much diminished even where the raw statistics look only modestly lower. ## The source markets collapsed The two markets that made German medical tourism lucrative, Russia and the Gulf, both contracted for reasons largely outside German control. Russia was the single biggest source country. From 2014, the falling rouble, the low oil price and EU sanctions made treatment in Germany far more expensive, and the Hochschule Bonn-Rhein-Sieg reported that Russians increasingly travelled only for urgent cases. The 2022 invasion of Ukraine, with the banking cut-off, airspace closures and political rupture that followed, ended most of what remained. The Gulf decline was steeper in places and more instructive, because it was not only about money. Budget deficits, the introduction of VAT in Saudi Arabia and the United Arab Emirates, and general spending cuts reduced the funds Gulf governments set aside for foreign treatment. But the German trade press has consistently pointed to a change in behaviour as much as budget: the once-generous payers began scrutinising German invoices closely and sending fewer patients where they suspected overcharging. Kuwait, once a flagship market, fell by 62 per cent in a single year, with Saudi Arabia and Oman also down sharply. That shift toward suspicion did not come from nowhere. ## Billing scandals broke payer trust The trust the trade depended on was broken by a series of billing scandals in the mid-2010s, and German commentators have named these directly as a cause of the Gulf pull-back. The most documented is the case of a Stuttgart teaching hospital, whose international unit treated around 370 Libyan war-wounded and ran up a roughly nine-million-euro deficit, amid cash carried in suitcases and disordered bookkeeping. Analysts at the Hochschule Bonn-Rhein-Sieg listed that affair, alongside inflated billing of Libyan patients more generally and the disappearance of large sums in the treatment of Kuwaiti embassy patients, in a picture that Kuwaiti media called one of the largest frauds they had seen, with a state commission examining hospital and agency contracts. The trade analysis was blunt about the effect. Reporting in the German sector press tied the collapse in Arab-region patient numbers from late 2016 to three things together: reduced Gulf funding, structural changes in the embassies and consulates, and the scandal around the Stuttgart hospital’s international department. When a business rests on a handful of foreign ministries and those ministries conclude they are being overbilled, they redirect the flow rather than renegotiate. ## The law closed the intermediary channel Two developments in German law removed the commercial machinery that the inbound trade ran on, and this is the internal factor most often overlooked outside Germany. The business depended on agents and facilitators who were paid a commission to steer patients to particular clinics. Since June 2016, that model has been legally hazardous, because Sections 299a and 299b of the Criminal Code extended anti-corruption law across the healthcare sector, so that demanding or granting a benefit for referring patients can, in the right circumstances, be treated as a criminal offence. The provisions are not a blanket ban on working with intermediaries, but they raised the level of scrutiny sharply, and with it the legal requirements for structuring these partnerships. MESC, which advises on exactly this problem, has set out how these provisions apply to patient brokerage in its explainer on the Sections 299a and 299b question in medical tourism. The civil law then closed the same door from the other side, and it did so long before the recent cases. The foundational ruling came from the Regional Court of Kiel in 2011, which held that a commission contract for referring patients to a hospital is immoral and void under Section 138 of the Civil Code. That case sits squarely on theme: a doctor with contacts in the Gulf had agreed with a university hospital’s international department to channel private patients from Oman and the United Arab Emirates in return for a commission of 15 to 22.5 per cent of the hospital’s income, and the court dismissed his fee claim and extended the doctors’ referral ban to the hospital itself. The Regional Court of Stuttgart confirmed and widened that line in November 2024, ruling that such commissions are void even in federal states whose hospital laws contain no explicit prohibition, that the so-called hospital privilege does not save them, and that a brokerage arrangement bundled with interpreting or visa help is void in its entirety, denying a claim of 119,000 euros. MESC, which advises on exactly this problem, has argued that the compliant contractual constellations which remain tend to be uneconomic enough that clinic and agency simply drop the cooperation. For any provider still weighing the business, the message is that the standard way of acquiring international patients is now legally unsafe. ## Payment risk became a deterrent Even where a foreign patient did come, collecting the fee became a structural risk that pushed finance directors away from the trade. Once a self-paying patient has flown home, recovery is difficult and slow, and if the intermediary refuses to pay, the hospital is left litigating in a foreign jurisdiction. German case law shows how this plays out: in one 2023 matter, a hospital’s claim of around 130,000 euros against an agency failed because it could not prove the agency had agreed to cover the costs. Cases like these taught hospitals to treat unsecured foreign-patient revenue as a bad-debt risk rather than easy income, and many concluded the margin did not justify the exposure. ## The domestic hospital crisis For years, international patients were presented internally as extra revenue on top of the case-based hospital budget, and that logic holds only when a hospital has spare beds and spare staff. Germany now has neither. The nursing shortage became acute enough to drive strikes for binding staffing ratios at major Berlin hospitals, and once beds and nurses are the constraint, a foreign self-payer stops being extra income and becomes a bed a domestic patient needs, with the added optics of queue-jumping. During the pandemic this became explicit and public. At Hamburg’s university hospital, the drop in foreign patients was reported as a board decision not to fill beds with them rather than a lack of demand, while at a large Munich university hospital the international business largely came to a standstill. The exits followed. Düsseldorf University Hospital stopped targeting international patients, saying the revenue was no longer important, and Berlin’s Vivantes closed its central international-medicine unit, explaining that Gulf states were setting different priorities and signing contracts with other countries, so remaining non-EU patients would be handled directly by specialist departments. When institutions this large decide the business is not worth the beds, the market has already turned. ## The shift in doctors’ pay incentives The final factor concerns how senior hospital doctors are paid, and it removed their personal reason to pursue foreign patients. Under the traditional model, a chief physician holding a personal billing right, the Liquidationsrecht, could invoice elective physician services directly to private patients under the German medical fee schedule and keep the income, paying the hospital only a usage fee. Foreign self-payers and embassy patients fall squarely into this, billed as private patients, so the senior doctor who attracted a Gulf or Russian patient was in large part billing for their own account. The German medical press has described private liquidation as making up a large share of chief-physician pay, and the trade literature of the era was explicit that treating foreign private patients could be very lucrative for the chief physician, especially where the hospital itself was under financial pressure. That personal upside has thinned out. New chief-physician contracts increasingly grant no personal billing right at all, only a share of the proceeds, a Beteiligungsvergütung, while the hospital holds the billing right and books the revenue itself. This is not one reform statute but a structural, contractual migration, pushed by the German Hospital Federation and enabled by the fact that a chief physician has no enforceable right to be granted the billing privilege in the first place. The consequence for international patients is direct. The clinician most able to attract them, the specialist the patient travelled for, no longer captures the upside; the hospital does. And the hospital, as above, increasingly did not want the business. The two incentives that once pointed the same way, the doctor’s private motive and the institution’s revenue motive, weakened at roughly the same time. ## Competition as accelerant External competition then completed what the internal failures had started, though it is better understood as the accelerant than the root cause. For Arabic-speaking markets in particular, Turkey grew attractive because its surgeons were often German- or US-trained and share the patients’ faith, while the Gulf states built their own tertiary capacity and, as Vivantes noted, signed bilateral treatment agreements elsewhere. The competition bit hard because Germany had already hollowed out its own trust, its legal channel, its payment security and its institutional appetite. With those foundations intact a market can absorb new competitors. Germany’s could not, because they had already given way. ## What it means for the sector The German case shows how a high-value inbound market can be fragile beneath strong headline numbers. It depended on opaque, intermediary-driven flows from a small set of volatile state payers, and it had little professionalised base to fall back on when conditions turned. Only around 10 to 12 per cent of German hospitals ever ran the business seriously, and the Hochschule Bonn-Rhein-Sieg’s standing point was that international work is not a self-runner, demanding trained staff, real relationships in the source countries and constant oversight. When the scandals broke payer trust, the anti-corruption law and the civil-law rulings closed the commission channel, the domestic system ran short of beds and staff, and the pay shift removed the clinician’s private incentive, the lucrative core of the trade had nothing structural to stand on. The cross-border EU day-traffic that remains is real, but it was never the business anyone meant when they spoke of medical tourism to Germany. For destinations and providers elsewhere, the lesson is that trust, a legally sound acquisition model, secured payment and genuine institutional commitment are not optional extras. They are foundations, and the German experience shows what happens when they give way together. ## Frequently asked questions ### Why did medical tourism to Germany decline? It declined for several reasons at once, most of them internal. The high-value source markets in Russia and the Gulf contracted, a run of billing scandals broke the trust of the state payers who funded the trade, a 2016 anti-corruption law and a 2024 Stuttgart court ruling closed the commission-based channel that agents relied on, the hospital sector ran short of beds and staff, and a shift in how senior doctors are paid removed their personal incentive to pursue foreign patients. Cheaper competition abroad accelerated the fall rather than causing it. ### When did medical tourism to Germany peak? It peaked around 2015, at roughly 255,000 foreign patients and about 1.2 billion euros in revenue, according to data from the Hochschule Bonn-Rhein-Sieg. The headline count then fell only gently, but the profitable non-EU segment collapsed underneath it. ### Is Germany still a medical tourism destination? Yes, but the lucrative part of the business has shrunk. By 2018 close to two-thirds of foreign patients came from within the EU, most of them from Poland, and much of that is low-value cross-border and day-case traffic rather than the premium inpatient work the sector was built on. ### Which German laws affected medical tourism? Two are central. Sections 299a and 299b of the Criminal Code, in force since June 2016, mean that granting or demanding a benefit for referring patients can amount to a criminal offence in certain circumstances, and they raised both the scrutiny applied to these arrangements and the legal requirements for structuring them. On the civil side, the Regional Court of Kiel held in 2011 that commission-based patient brokerage to a hospital is void under Section 138 of the Civil Code, and the Regional Court of Stuttgart confirmed and widened this in November 2024, ruling that it applies even where a state’s hospital law contains no explicit ban. Sources (18) Deutsches Ärzteblatt Deutsches Ärzteblatt Middle East Service Center Hochschule Bonn-Rhein-Sieg Stuttgarter Zeitung Medical Tribune MT Dialog Gesetze im Internet Middle East Service Center Gesetze im Internet Ärzte Zeitung Otto Schmidt Verlag Med-Juris SchengenVisaInfo Deutsches Ärzteblatt IWW Institut Deutsches Ärzteblatt IGP Magazin Germanymedical tourismregulationmarket analysis ### The Wire Aug 30This Week in Medical Tourism: 20–26 August 2026 Aug 29This Week in Medical Tourism: 13–19 August 2026 Aug 22South Korea Undercuts America but Not Turkey All coverage ### Newsletter Get weekly health tourism intelligence in your inbox. Subscribe ### Knowledge Hub Medical Tourism Wellness Tourism Dental Tourism Fertility Tourism Cosmetic Tourism Longevity Tourism Explore the Hub Stay informed on the latest in global health tourism. Subscribe to our Newsletter ## Related Articles Medical Tourism 22 AUG 2026 Medical Tourism ### Mexico and Turkey Price Against Different Home Markets August 22, 2026 Medical Tourism 22 AUG 2026 Medical Tourism ### Turkey's Deepest Discounts Sit on Its Safest Procedures August 22, 2026 Weekly Digest 08 JUL 2026 Weekly Digest ### Medical Tourism Records Concentrate In Penang And Seoul July 8, 2026 --- # Why Medical Tourism Should Not Exist URL: https://health-tourism-news.com/news/why-medical-tourism-should-not-exist/ Medical Tourism Why Medical Tourism Should Not Exist Editorial by Christian El-Khouri Christian El-Khouri Editor-in-Chief Editor-in-Chief of Health Tourism News. Twelve-plus years across international patient services, healthcare consulting, and destination development in Europe, the Middle East, and beyond. Co-Founder and Vice President of the European Health and Medical Tourism Association (EHMTA). Read more Published February 19, 2025 · Updated July 2, 2026 · 5 min read Sometimes, probably more often than I like to admit, I have the urge to utter something so stupidly candid that some people have called it career suicide and discourteous towards my industry peers. This, I fear, maybe one of those moments - perhaps even more so than the time I told a Health Economics Master’s Student that I would prefer a world in which medical tourism facilitators did not exist. A bold statement, indeed. Especially considering that, at the time, I had just overseen what was arguably one of our most successful business years - one in which a substantial portion of revenue stemmed precisely from that: medical tourism facilitation. And yet, I would not be who I am - nor even half as content - if I spent my days worrying over how others perceive my thoughts. No, I stand by that statement. In fact, I would go further. Not only do I believe medical tourism facilitators should not exist, but medical tourism itself would be obsolete in an ideal world. My reasoning is far more measured than most might expect. ## Medical Tourism Is a Symptom Medical tourism is a symptom. It’s the piercing neon sign of global health inequality brightening the highway shoulder. And yes, some might consider it a sign of health inequity, but I do not like to use or even acknowledge the term. Inequity is a concept so achingly distant from reality that it is too far removed from anything I can grasp, even when talking about the loftiest of ideals I might hold. Maybe I am not optimistic enough. I probably ain’t. I leave that for others to decide. If the world were as it should be, if healthcare were truly just, then there would be no need for desperate journeys across borders in search of something as fundamental as competent medical care. Or affordable medical care. Or timely medical care. Or any medical care at all. ## Why Travel Becomes a Necessity However, that is not the world we live in - nor is it likely to be anytime soon. At its core, medical tourism is bound to the necessity of travel. In my view, seeking medical care while abroad does not qualify as medical tourism. Of course, in the absence of a universally accepted definition, I rely on my own: incidental medical treatment while travelling is not the same as medical tourism. But that is not the point I wish to spend my evening or your time on. The point is that medical tourism is not just an industry - it is, again, a symptom. It exists because, for some, travelling is not a choice but a necessity - their only path to receiving the care they need. The reasons for this inequality are diverse. Political incompetence, resource distribution, conflict or simply by design. There is many others. I know people who travelled to receive medical services due to the immense distrust they had in their healthcare system. You might not consider this a necessity, but if you feel safer and more comfortable travelling abroad for a service you can have in a timely manner and within your budget in your domestic setting, it probably is a necessity even if it’s one only for you. ## Holding the Industry to a Higher Standard Why, beyond my own conviction, do I feel compelled to say this? Because I believe we must all recognize the uncomfortable truth: we work in an industry that, in an ideal world, would have no reason to exist. It could not sustain itself, nor should it. If healthcare were equal and accessible to all, medical tourism would simply have no justification. And yet, as ever so often, here we are. Which is precisely why those of us who operate in this industry - those of us who are entrusted with the hopes and vulnerabilities of others - must hold ourselves to the highest standard. If this industry exists because the world is imperfect, then let our work be the proof that even within that imperfection, integrity and responsibility can prevail. ## A Closing Note on Difference and Charm In closing, I want to return some of the levity from which I might have derived you in this short read. And it has absolutely nothing to do with medical tourism. I received a large shipment of dates from Saudi Arabia. Believe me when I say there are few things in life as delicious. I have eaten many a date in my life but it is still beyond me how something can be tender to the bite, slightly chewy, a tiny bit austere but still juicy. Once I figure that out I’ll probably write a post on Substack about that. In others words, yes, our world is unequal. Divided by borders, shaped by circumstance, often marked by disparity. And while that inequality often breeds hardship, it also carves out something rare. It harbors contrast, character, charm. The elements adding colour to our often so black and white world. Some of life’s most treasured moments exist because of these differences, not despite them. The places, the flavors, the stories that could not have been in a world mushed into sameness. Inequality may be unjust, but it is also, in its own way, inevitable. And within that inevitability, something undeniably human endures. Lifes most cherishable charms would not be, if all places were the same. ### The Wire Aug 30This Week in Medical Tourism: 20–26 August 2026 Aug 29This Week in Medical Tourism: 13–19 August 2026 Aug 22South Korea Undercuts America but Not Turkey All coverage ### Newsletter Get weekly health tourism intelligence in your inbox. Subscribe ### Knowledge Hub Medical Tourism Wellness Tourism Dental Tourism Fertility Tourism Cosmetic Tourism Longevity Tourism Explore the Hub Stay informed on the latest in global health tourism. Subscribe to our Newsletter ## Related Articles Medical Tourism 22 AUG 2026 Medical Tourism ### Mexico and Turkey Price Against Different Home Markets August 22, 2026 Medical Tourism 22 AUG 2026 Medical Tourism ### Turkey's Deepest Discounts Sit on Its Safest Procedures August 22, 2026 Medical Tourism ### Why Medical Tourism to Germany Declined August 11, 2026 --- # World’s Healthcare Leaders Set to Return to Riyadh for Global Health Exhibition 2025 in October URL: https://health-tourism-news.com/news/worlds-healthcare-leaders-set-to-return-to-riyadh-for-global-health-exhibition-2025-in-october/ Wellness Tourism World’s Healthcare Leaders Set to Return to Riyadh for Global Health Exhibition 2025 in October Press Release Christian El-Khouri Editor-in-Chief Editor-in-Chief of Health Tourism News. Twelve-plus years across international patient services, healthcare consulting, and destination development in Europe, the Middle East, and beyond. Co-Founder and Vice President of the European Health and Medical Tourism Association (EHMTA). Read more Published October 6, 2025 · 6 min read ## World’s Healthcare Leaders Set to Return to Riyadh for Global Health Exhibition 2025 in October *Global Health Exhibition 2024 had an unprecedented 105,000 attendance, with a 72% increase in international visitors in from the previous year. * Doubling in size, Global Health Exhibition is set to host 20 international pavilions - driving further overseas growth for 2025. *Global Health Exhibition announces new co-located event -VIBE- to champion holistic health and wellness. * Riyadh, Saudi Arabia - 06th October 2025: Under the patronage of the Ministry of Health and supported by Vision 2030, KSA Health Sector Transformation Program and organised by Tahaluf - the Global Health Exhibition (GHE) returns to the Riyadh Exhibition and Convention Centre from 27-30 October 2025. ## Global Health Exhibition’s surging international footprint Global healthcare giants exhibiting include Zimmer Biomed, GE HealthCare, Novo Nordisk, Paxera Health, Davita and Samsung will convene in Riyadh, drawn by the Saudi Arabia’s transformation momentum and investment potential. The event will feature more than 500 speakers and over 2,000 exhibiting brands representing a diverse cross-section of countries, disciplines, and healthcare systems, enabling powerful global knowledge exchange. **His Excellency Mr. Fahad bin Abdulrahman Aljalajel, Minister of Health of the Kingdom of Saudi Arabia, said: **“As Saudi Arabia continues its journey of healthcare transformation under Vision 2030, we are proud of the significant strides made in building a more efficient, patient-centred, and sustainable health system. Strengthening collaboration with the private sector is central to this journey, enabling us to expand access, elevate quality, and accelerate innovation across the Kingdom. *“The Global Health Exhibition offers a unique platform to connect with visionary investors, pioneering startups, and technology leaders shaping the future of healthcare. We invite stakeholders from around the world to join us in Saudi Arabia to address global health challenges and forge transformative partnerships that will redefine healthcare delivery through enhanced public-private collaboration.” * Following strong international interest, GHE 2025 is set to host 20 international pavilions, increasing from 12 in 2024, with confirmed participation from the USA, Turkey, China, Italy, Germany, the UK, Finland, Canada, Taiwan, Pakistan, and South Korea. Surging demand has led organisers to expand the event’s floorspace by 40%, adding three new exhibition halls. With a clear focus on cross-border partnerships and multi-market investments, GHE 2025 is fast becoming a global hub for future-focused healthcare collaboration. “This year’s edition is shaped by an unprecedented level of international engagement,” said Rachel Sturgess, Senior Vice President at Tahaluf. “Global leaders across the healthcare system are choosing to convene at Global Health Exhibition to engage in strategic dialogue, form key partnerships and drive forward investment. This momentum is a clear reflection of Saudi Arabia’s growing influence as a hub for healthcare innovation and investment.” Exhibitors such as Olympus have praised the event’s unparalleled ROI and international reach. “Olympus is pleased to participate in the Global Health Exhibition, which brings together key voices from across the healthcare sector. The event provides an important opportunity to share our latest innovations, exchange ideas, and engage with stakeholders who are shaping the future of healthcare in Saudi Arabia. We are committed to supporting the Kingdom’s ongoing efforts to enhance healthcare delivery and outcomes,” added Ronald Boueri, Vice President Managing Director, Medical Systems Division, Olympus META. ## Driving the future of health The Leaders Summit at GHE 2025 will bring together a collection of the world’s most powerful healthcare leaders, uniting ministers, senior government officials, Fortune 500 CEOs, and impact-driven investors. This year’s edition marks a decisive shift, from policy dialogue to action, spotlighting real-world innovations from AI-powered diagnostics at scale to national prevention strategies delivering measurable impact. The summit will explore policy implementation, healthcare financing, longevity strategies, and the real-world impact of digital transformation. Attendees will hear from healthcare leaders each renowned for driving large-scale transformation in global health systems, including Dr. David Rhew, Global Chief Medical Officer VP of Healthcare, Microsoft (USA) - Dr. Rhew leads Microsoft’s global health strategy across 190+ countries and holds six U.S. patents in clinical AI and EHR. Twice named among Modern Healthcare’s 100 Most Influential People in Healthcare, he has been behind some of the world’s most impactful public-private health innovation partnerships. Baroness Nicola Blackwood, Chair, Genomics England; Former Minister of Health, UK - Baroness Blackwood has held key ministerial portfolios under two UK Prime Ministers. A global authority on life sciences, NHS data strategy, and digital transformation, she has played a pivotal role in shaping policies around genomic medicine and global health security. Dr. Katharina Grimm, Head of Medical, FIFA (Switzerland) - As FIFA’s top medical expert, Dr. Grimm is advancing athlete health at a global scale, including innovations in injury prevention, longevity, and high-performance care. Her insights bridge elite sports medicine and public health, with implications that extend far beyond the playing field. ## New for 2025 Introducing VIBE, a dedicated wellness event co-located with GHE 2025 and backed by the Ministry of Health’s LiveWell initiative. Launched in response to growing demand for holistic health and longevity solutions, VIBE focuses on empowering individuals to live longer, healthier lives through personalised and preventive care. With Saudi Arabia’s wellness economy now valued at approximately** $19 billion USD**, VIBE offers a timely platform for cross-sector collaboration, business development, and public engagement. With bold national investment in digital health, regulatory reform, and public-private collaboration, Saudi Arabia is driving one of the world’s most ambitious healthcare transformation agendas. The Global Health Exhibition is where this momentum comes to life, bringing together global innovators, investors, and health leaders to accelerate solutions that meet real-world challenges. For more information on Global Health Exhibition 2025, please visit: ENDSAbout Global Health ExhibitionEstablished in 2018, Global Health Exhibition (GHE) is Saudi Arabia’s premier platform for showcasing next-generation healthcare innovation. GHE is organised by Tahaluf, a strategic alliance between Informa PLC, the Saudi Arabian Federation for Cyber Security and Programming (SAFCSP), and the Events Investment Fund (EIF). The event brings together global leaders, investors, and innovators to shape the future of healthcare. Set against the backdrop of Vision 2030, it positions Riyadh as a driving force in global health transformation. **Press Media Inquiries: ** Jessica Homan, Tahaluf jessica.homan@ Sources (2) Global Health Exhibition Informa ### The Wire Aug 30This Week in Medical Tourism: 20–26 August 2026 Aug 29This Week in Medical Tourism: 13–19 August 2026 Aug 22South Korea Undercuts America but Not Turkey All coverage ### Newsletter Get weekly health tourism intelligence in your inbox. Subscribe ### Knowledge Hub Medical Tourism Wellness Tourism Dental Tourism Fertility Tourism Cosmetic Tourism Longevity Tourism Explore the Hub Stay informed on the latest in global health tourism. Subscribe to our Newsletter ## Related Articles Weekly Digest 08 JUL 2026 Weekly Digest ### Medical Tourism Records Concentrate In Penang And Seoul July 8, 2026 Weekly Digest 01 JUL 2026 Weekly Digest ### Nigeria, Iran And Seoul Redraw Medical Tourism July 1, 2026 Weekly Digest 24 JUN 2026 Weekly Digest ### Health Tourism As Badge, Escape Hatch And Disguise June 24, 2026 --- # ZagrebMed Turns Two URL: https://health-tourism-news.com/news/zagrebmed-turns-two-a-patient-centered-revolution-in-croatian-medical-tourism/ Medical Tourism ZagrebMed Turns Two A Patient-Centered Revolution in Croatian Medical Tourism Ivan Rendulic Contributor Founder of ZagrebMed and President of the European Health and Medical Tourism Association (EHMTA). Over a decade facilitating international patients and shaping cross-border healthcare initiatives from Croatia. Read more Published June 16, 2025 · 3 min read Reviewed by Christian El-Khouri, Editor-in-Chief ## ZagrebMed Turns Two: A Patient-Centered Revolution in Croatian Medical Tourism When we first launched ZagrebMed two years ago, the idea was simple - but ambitious: to build a modern digital platform that unlocks the full potential of medical tourism in Zagreb and Croatia. Not as another listing site or aggregator, but as a curated, high-touch, patient-first ecosystem. What started as a bold initiative has become a trusted gateway to Croatian healthcare for thousands around the world. Backed by the Croatian Ministry of Health, the City of Zagreb, the Croatian Chamber of Economy, and the Zagreb Tourist Board - and powered by strategic alliances with Croatia Airlines and Obzor Holidays - ZagrebMed wasn’t just built to showcase clinics. It was built to deliver peace of mind. In the first year, we reached approximately 5,000 users per month. By year two, that number more than doubled - crossing 12,000 monthly users, surpassing 100,000 total users, and enabling over half a million euros’ worth of medical services. But beyond numbers, this growth tells a story of trust. Patients are no longer “just looking” - they are choosing, booking, flying, healing. Medical tourism itself is not new to Croatia. In fact, we are among the pioneers in Europe - our spa and wellness traditions trace back to the 18th century. But for too long, the success of health travel here was driven by individual clinics and mostly centered around dental services. It was fragmented. It lacked a cohesive vision. ZagrebMed is changing that. What makes the platform work is not technology - it’s how we use it. ZagrebMed is easy to navigate, transparent, and free of charge for patients. But the real secret sauce? Every patient gets a dedicated hospitality manager. Someone who listens, adapts, and takes care of the details - before, during, and after their medical journey. We are not a booking engine. We are an experience curator. What I’ve learned from working with patients from all over the world is that trust is everything. It’s never just about price. People seek clarity, honesty, and someone who genuinely cares about their journey. They want communication that is proactive, support that feels personal, and an experience that exceeds expectations. Regardless of where they come from, patients need to feel seen, heard, and respected. That’s not a strategy - it’s a standard. And it’s the only way to truly build a lasting connection in health tourism. And the industry has noticed. Last year, we signed our first insurance partnership with Merkur Insurance in Slovenia. Soon after, partnerships followed with Erste Bank in Croatia, Erste Bank in Austria, and Unicredit Bank in Austria. Corporate clients are seeing ZagrebMed not just as a patient platform - but as a healthcare ally. A tool that complements wellness programs, boosts employee satisfaction, and reduces sick days. ZagrebMed was created to raise the standard. And now, two years in, we’re not just raising it - we’re resetting it. This is only the beginning. ### The Wire Aug 30This Week in Medical Tourism: 20–26 August 2026 Aug 29This Week in Medical Tourism: 13–19 August 2026 Aug 22South Korea Undercuts America but Not Turkey All coverage ### Newsletter Get weekly health tourism intelligence in your inbox. Subscribe ### Knowledge Hub Medical Tourism Wellness Tourism Dental Tourism Fertility Tourism Cosmetic Tourism Longevity Tourism Explore the Hub Stay informed on the latest in global health tourism. Subscribe to our Newsletter ## Related Articles Medical Tourism 22 AUG 2026 Medical Tourism ### Mexico and Turkey Price Against Different Home Markets August 22, 2026 Medical Tourism 22 AUG 2026 Medical Tourism ### Turkey's Deepest Discounts Sit on Its Safest Procedures August 22, 2026 Medical Tourism ### Why Medical Tourism to Germany Declined August 11, 2026 --- # Zagreb: Central Europe's Quiet Capital of Medical Excellence URL: https://health-tourism-news.com/destinations/croatia/zagreb/ City Medical Tourism Guide Croatia Zagreb: Central Europe's Quiet Capital of Medical Excellence Croatia's Medical Hub Orthopaedics Stem Cell Therapy Ophthalmology Dental Reconstruction Cosmetic Surgery Oncology Diagnostics Zagreb concentrates Croatia's most internationally recognised specialty hospitals and private clinics in a compact, walkable capital city - with direct flights from London, Frankfurt, Vienna, Amsterdam, and beyond. 13 featured clinics meet international standards, many attracting medical tourists for decades. 13 Featured clinics and healthcare providersprepared for international patients 500+ Daily patient capacityacross the ZagrebMed network 600+ Individual medical servicesavailable through ZagrebMed 365 Days of patient access,guidance and care planning Editorial partner Destination Authority Zagreb's Medical Tourism Platform ZagrebMed: Zagreb's Medical Tourism Platform Through ZagrebMed, international patients can access a structured network of premium clinics, hospitals, doctors, diagnostics, rehabilitation providers and travel partners in one compact European capital. Visit ZagrebMed → HTN works with institutional partners who share our commitment to editorial quality and verified patient information. ZagrebMed is Zagreb's medical tourism platform for international patients. Backed by Zagreb's institutional partners Ministry of Health City of Zagreb Zagreb Tourism Board Croatian Chamber of Economy " Zagreb's strength is not only the quality of individual clinics. Its strength is that patients can access diagnostics, treatment, rehabilitation, travel support and a strong city experience through a connected ecosystem. ZagrebMed was built to make that ecosystem visible, understandable and easier to use for international patients. Ivan Rendulic Founder of ZagrebMed ## Zagreb as a Medical Tourism Destination Zagreb combines several advantages that matter to international patients: a compact city layout, strong medical expertise, advanced diagnostics, rehabilitation options, specialist care and a growing network of private healthcare providers prepared for cross-border patients. ### What makes Zagreb work for international patients Compact city layout that keeps appointments, hotels and recovery within short distances Strong medical expertise across orthopaedics, ophthalmology, dentistry, fertility, dermatology and aesthetics Advanced diagnostics including imaging, laboratory and genetic testing Rehabilitation options built into clinical pathways and available after surgery Specialist care across sub-specialty fields and dedicated specialty hospitals A growing network of private healthcare providers prepared for cross-border patients ### A connected patient pathway through ZagrebMed Unlike larger and more fragmented destinations, Zagreb allows patients to move between consultations, diagnostics, treatment and recovery with less logistical pressure. Through ZagrebMed, this offer is organized into a clearer patient pathway, making it easier to identify the right provider, request information and plan care before arrival. ### Who Zagreb is for For patients from Europe, the wider region and long-haul markets, Zagreb offers a practical balance between medical quality, accessibility, urban comfort and recovery-friendly surroundings. ## Featured ZagrebMed Partners A curated selection of clinics, hospitals and diagnostic providers within the ZagrebMed network, covering orthopedics, fertility, women's health, dialysis, dermatology, pediatrics, rehabilitation and laboratory diagnostics. Healthcare System Zagreb Agram Zagreb One of Croatia's largest private healthcare systems, with a broad offer that includes prevention, diagnostics, surgery, internal medicine, radiology, laboratory diagnostics, gynecology, urology, neurology, orthopedics, physical medicine and other specialist services. Agram provides more than 1,000,000 medical services annually across its system. Multi-Specialty Diagnostics Surgery Radiology Internal Medicine Orthopedic Hospital Zagreb Akromion Zagreb Croatia's largest private orthopedic hospital, focused on orthopedics, traumatology, joint replacement, arthroscopic surgery, sports medicine and post-operative rehabilitation. Akromion has delivered more than 330,000 medical services and more than 23,000 surgical procedures, with in-house rehabilitation available after orthopedic surgery. Orthopedics Joint Replacement Arthroscopic Surgery Sports Medicine Rehabilitation Diagnostic Center & Laboratory Zagreb Analiza Zagreb & nationwide A modern diagnostic health center and laboratory chain specializing in laboratory diagnostics, preventive testing, genetic tests, allergy tests, food intolerance testing and specialized laboratory panels. Analiza has been operating since 2001 and has a network of locations across Croatia, including Zagreb, Split, Rijeka, Zadar, Sibenik, Varazdin and Dugopolje. Laboratory Diagnostics Genetic Tests Allergy Tests Preventive Testing National Network Dialysis & Internal Medicine Zagreb Avitum Zagreb A specialized provider for kidney dialysis and internal medicine, especially relevant for patients who need continuity of dialysis treatment while traveling. Avitum's dialysis centers use modern B. Braun dialysis equipment, HDF dialysis procedures and quality systems aligned with recognized international standards. Kidney Dialysis HDF Dialysis B. Braun Equipment Holiday Dialysis Internal Medicine Aesthetic & Dental Zagreb Bagatin Zagreb A leading Croatian and regional multidisciplinary clinic for aesthetic surgery, dermatology, dental medicine and aesthetic medicine. Bagatin has grown from a private practice founded in 1995 into one of the region's most recognized private clinics, with multiple locations and expertise across several medical specialties. Aesthetic Surgery Dermatology Dental Medicine Aesthetic Medicine Established 1995 Fertility & Reproductive Medicine Zagreb IVF Zagreb Zagreb A leading fertility and reproductive medicine clinic led by Prof. Dr. Velimir Simunic, one of the most important names in Croatian reproductive medicine. Dr. Simunic led the expert team that made Croatia the 7th country in the world to achieve conception and birth of its first IVF child. He has helped more than 4,500 children be born through these methods. IVF Reproductive Medicine Prof. Dr. Simunic 4,500+ Births Physical Medicine & Rehabilitation Zagreb Kaliper Zagreb A clinic for physical medicine, rehabilitation, orthopedics, sports medicine and recreation. Kaliper is especially relevant for individualized rehabilitation, sports medicine and recovery programs. Its founder, Dr. Natasa Desnica, is connected with elite sports medicine as chief physician of the Croatian ski team. Physical Medicine Rehabilitation Sports Medicine Individualized Programs Special Hospital Near Zagreb Naftalan Near Zagreb A unique special hospital for medical rehabilitation, dermatology and physical medicine near Zagreb. Naftalan is especially relevant for psoriasis, neurodermatitis, psoriatic arthritis, inflammatory rheumatic diseases, joint and spine diseases, and post-operative recovery. Its medical approach is based on the rare natural health factor naftalan, used for medicinal purposes in only a very small number of destinations worldwide. Psoriasis Rheumatic Diseases Spine & Joints Post-Operative Recovery Naftalan Therapy Orthopedics & Sports Rehabilitation Zagreb Patela Zagreb A Zagreb clinic focused on orthopedics, sports injuries, physiotherapy and rehabilitation. Patela is especially relevant for professional athletes, recreationally active adults, post-operative patients and people recovering from injury, overload or long-term orthopedic pain. Its clinical model connects diagnosis, treatment planning and structured rehabilitation. Orthopedics Sports Injuries Physiotherapy Post-Operative Care Gynecology, Obstetrics & Maternity Zagreb Podobnik Zagreb A specialized hospital for gynecology, obstetrics, maternity care and women's health. Podobnik offers an integrated approach to women's health, including pregnancy care, maternity care, gynecology, gynecological surgery and intimate health. Its maternity care model includes a gynecologist, anesthesiologist, neonatologist, nurses and midwives during the patient's stay. Gynecology Obstetrics Maternity Care Women's Health Gynecological Surgery Regenerative & Aesthetic Dermatology Zagreb Poliderma Zagreb A leading Zagreb clinic for regenerative medicine, aesthetic dermatology, laser medicine, minimally invasive procedures and anti-aging medicine. Poliderma places special emphasis on the combination of advanced technology, regenerative medicine, genetic testing, stem cells, exosomes, enzyme therapy and fat transfer. Regenerative Medicine Aesthetic Dermatology Laser Medicine Stem Cells Anti-Aging Pediatric Healthcare Zagreb Sabol Zagreb A renowned pediatric institution in Zagreb and the first private pediatric healthcare institution in Croatia, founded in 1993. Sabol provides specialist and subspecialist pediatric care for children up to 18 years of age, including general pediatrics, diagnostics, neuropediatrics, pediatric pulmonology, cardiology, allergology, immunology, ophthalmology, orthopedics, psychology, speech therapy and neonatal care. Pediatrics Subspecialist Care Neonatal Care Cardiology Established 1993 Multidisciplinary Polyclinic Zagreb & Opatija Sinteza Zagreb & Opatija A multidisciplinary polyclinic with 30 specialists across 14 medical fields, operating in Zagreb and Opatija. Sinteza combines specialist consultations, diagnostics, surgery, physical medicine, rehabilitation, dermatology, cosmetology and aesthetic medicine, with MRI and X-ray services available without waiting and results available the same day. 14 Medical Fields MRI & X-Ray Surgery Rehabilitation Same-Day Results ## Zagreb by Specialty Orthopedics & Sports Medicine Joint replacement, arthroscopic surgery, traumatology, sports injury treatment and post-operative rehabilitation, with regenerative medicine options including stem cell-based approaches available within Zagreb's network. Aesthetic Surgery & Dermatology Aesthetic surgery, dermatology, laser medicine and minimally invasive procedures, alongside regenerative and aesthetic medicine combining advanced technology and individualized treatment plans. Dental Medicine Dental medicine and oral health within Zagreb's multidisciplinary clinics, including consultations, diagnostics and treatment planning supported by English-language patient coordination. Fertility & Women's Health Reproductive medicine, IVF, gynecology, obstetrics and maternity care, with integrated pathways covering pregnancy care, gynecological surgery and women's health diagnostics. Diagnostics & Laboratory Imaging, laboratory diagnostics, preventive testing, genetic and allergy testing through Zagreb's diagnostic centers, often with same-day results and standardized international protocols. Rehabilitation & Recovery Physical medicine, post-operative rehabilitation, sports recovery and structured recovery programs, including dedicated rehabilitation hospitals near Zagreb for orthopedic and dermatological conditions. ## The Zagreb Patient Journey ### Getting to Zagreb Zagreb Franjo Tuman Airport (ZAG) is the main international gateway to Croatia's capital, served by direct flights from major European hubs including the United Kingdom, Germany, Austria, the Netherlands, Switzerland, France, Belgium and Scandinavia, with onward connections to the Middle East, the Gulf and long-haul markets. Flight times from London are around 2 hours 20 minutes and from Frankfurt under 90 minutes. The airport sits about 30 minutes by road from the city centre, with taxis, ride-hailing services and shuttle buses available. ### Staying in Zagreb Zagreb is a compact European capital, which makes it well suited to medical visits. International-standard hotels in the city centre and around the main business districts are within a short ride - often under 20 minutes - of the city's clinics and hospitals. Patients typically choose accommodation that balances proximity to their treating clinic, access to pharmacies and food, and walkability to the historic city centre and its parks for recovery. Zagreb's old town (Gornji Grad), the Lower Town's grid of green squares, and central pedestrian streets such as Tkalieva are easy to reach on foot for ambulatory patients and travel companions. English is widely spoken in hospitality and healthcare, and the city operates on the Euro. ### After Treatment: Recovery Around Zagreb Zagreb sits within easy reach of recovery-friendly destinations. The Zagorje region, around an hour's drive north, is known for its natural thermal springs and dedicated medical rehabilitation, often used for post-operative physiotherapy and hydrotherapy. Plitvice Lakes National Park and the green hills around the city offer gentler, low-impact options for patients who want fresh air and walks during recovery. For patients mobile enough to travel further, Croatia's Adriatic coast and islands are accessible by a 4 to 5 hour drive or a short domestic flight, offering a Mediterranean climate suited to longer convalescence. ## Zagreb: Common Questions Is Zagreb well-connected for international patients? Yes. Zagreb Airport (ZAG) offers direct connections from across Europe, including the United Kingdom, Germany, Austria, the Netherlands, Switzerland, France, Belgium and Scandinavia, with onward connections to the Middle East and Gulf hubs. Multiple airlines serve the city, which makes it straightforward to schedule a flight around a treatment date and to plan return trips for follow-up consultations. What makes Zagreb different from other Central European medical hubs? Zagreb combines depth across several medical specialties - including orthopedics, fertility, women's health, dialysis, dermatology, pediatrics, rehabilitation and laboratory diagnostics - with a compact, walkable city that lets patients move between consultations, diagnostics, treatment and recovery without long transfers. Croatia's EU membership, the Euro currency, the Mediterranean climate and proximity to the Adriatic coast for convalescence, plus the ZagrebMed coordination platform, reduce logistical complexity for international patients. Do I need a facilitator to plan treatment in Zagreb? For most international patients, ZagrebMed is the simplest starting point. As Zagreb's medical tourism platform, ZagrebMed offers a free coordination service that connects international patients with the right clinic in the network, helps gather and share medical information, and supports planning across diagnostics, treatment, recovery and travel logistics. Because ZagrebMed is backed by Zagreb's institutional partners and works across the wider network of clinics, it gives patients a single, neutral point of contact, rather than negotiating directly with one provider at a time. Independent facilitators are usually only needed for highly complex multi-stage cases or patients travelling from long-haul markets. How should I prepare before contacting a clinic in Zagreb? Patients can prepare in a few practical steps. Write down the medical issue, key symptoms and how long they have lasted. Gather a short summary of relevant medical history, any chronic conditions and current medications. Collect any recent investigations - blood tests, imaging reports, scans on disc or in digital form, and previous specialist letters. Note your preferred travel window, who will travel with you, and any constraints (mobility, language, dietary, religious). Sharing this through ZagrebMed or directly with a clinic at first contact lets the medical team make a faster and more accurate assessment. Can I have a video consultation with a Zagreb specialist before travelling? Yes. Many clinics in the ZagrebMed network offer pre-travel video consultations in English, and often in German and other languages, so patients can meet the specialist, review their case, ask questions about the proposed treatment, and confirm the plan and indicative costs before booking flights. ZagrebMed can help arrange this end to end, including securely sharing prior medical records with the treating doctor in advance. What can I do to plan a smooth visit and recovery in Zagreb? Plan accommodation close to your treating clinic so transfers after appointments and procedures are short. Allow buffer days before and after treatment for travel fatigue, pre-operative checks and post-operative monitoring rather than booking back-to-back flights. Confirm whether companions are welcome and where they can stay. Ask the clinic in writing about your post-procedure plan: medication, mobility, follow-up schedule, fitness to fly, and how to reach the clinic if questions arise after you return home. ZagrebMed and the clinic's international patient team can help map all of this in advance.